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Abstract 
 The applications of nickel-catalyzed cross-coupling strategy to the synthesis of 
organofluorine compounds are explored in this thesis.  
Chapter 2 describes the development of the first enantioselective cross-coupling 
method using secondary geminal dihalides as electrophiles. This method provides a 
unique approach for the generation of enantioenriched tertiary alkyl fluorides. These 
cross-coupling products can be further transformed into a variety of potentially valuable 
chiral building blocks. 
 Chapter 3 describes the development of a practical and versatile Negishi 
alkylation method employing α-halo-α-perfluoroalkyl secondary electrophiles. Target 
molecules bearing perfluoroalkyl-substituted (including trifluoromethyl-substituted) 
tertiary carbons can be easily generated from fluorinated electrophiles. Competition 
experiments and mechanistic studies have been performed to reveal the unique properties 
of these electrophiles and also prove the existence of alkyl radicals. 
 Chapter 4 describes the development of an asymmetric Negishi arylation protocol 
with α-halo-α-trifluoromethyl secondary electrophiles. This study provides a unique 
approach to construct trifluoromethyl-substituted tertiary stereocenters. The optimized 
condition can also be directly applied to substrates bearing an array of fluoroalkyl groups. 
 Chapter 5 details the progress towards the development of an asymmetric 
alkynylation method employing α-halo-α-trifluoromethyl secondary electrophiles. 
Preliminary studies also demonstrate that the protocol we developed has the potential to 
be used for other non-fluorinated secondary electrophiles. 
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CHAPTER 1 
An Overview 
 
 
1.1 Nickel-Catalyzed Cross-Coupling Methods Developed in the Fu Group: Recent 
Developments 
 Transition-metal catalyzed cross-coupling reactions have become a powerful tool 
to construct carbon–carbon bonds and carbon–heteroatom bonds.1 Although early studies 
in this area mainly focused on using palladium complexes as catalysts, recently more and 
more evidence has proven that nickel catalysts might be a better choice for certain 
challenging cases.2 
 The Fu group started working in the field of cross-coupling more than 15 years 
ago. Initially, we employed palladium complexes as catalysts and developed a series of 
non-asymmetric cross-coupling reactions.3 Later on, we also observed that nickel 
catalysts are more powerful than their palladium counterparts for more challenging 
processes, especially when alkyl electrophiles are present. Starting from 2003,4 we 
initiated a series of projects employing nickel catalysts in cross-coupling methods with 
secondary alkyl electrophiles as substrates. In 2005, for the first time we demonstrated 
that nickel catalyst could promote an enantioselective and stereoconvergent cross-
coupling between a racemic secondary alkyl electrophile and a primary alkyl 
nucleophile.5 Since then, our group has devoted tremendous effort towards the 
developments of novel nickel-catalyzed cross-coupling processes using alkyl 
electrophiles.6 We were especially interested in providing new protocols of 
	 2 
enantioselective cross-coupling reactions starting from racemic starting materials. Some 
of our recent progress (including non-asymmetric methods) will be summarized below. 
 In terms of exploring new classes of electrophiles, Dr. Alexander J. Oleke and Dr. 
Jianwei Sun were able to demonstrate that enantioselective Negishi arylations can be 
performed using secondary alkyl electrophiles bearing an oxygen leaving group instead of 
a halogen atom (eq 1.1).7  
TMS
n-Bu
O O
O
OMe
OMeMeO
racemic
Ph ZnI
10% NiCl2(PCy3)2
13% A
NO
N N
OH
H H
H
DME/THF
10 ºC
1.5 equiv
TMS
n-Bu
Ph
81% yield
90% ee
(1.1)
A  
 Dr. Alexander S. Dudnik and graduate student Susan L. Zultanski showcased that 
unactivated tertiary alkyl halides can be used in non-asymmetric nickel-catalyzed 
carbon–boron8 and carbon–carbon9 bond-forming processes (eqs 1.2 and 1.3). 
Br
MeMe
Ph pinB Bpin
1.5 equiv
10% NiBr2•diglyme
13% B
1.4 equiv KOEt
i-Pr2O/DMA, r.t.
NO
N N
O
i-Pr i-PrB
Bpin
MeMe
Ph
70% yield
(1.2)
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Br
MeMe
(9-BBN)Ph
2.5 equiv
10% NiBr2•diglyme
11% C
2.4 equiv LiOt-Bu
2.4 equiv i-BuOH
benzene, 40 ºC
86% yield
(1.3)
Ph Ph
MeMe
Ph
N N
t-Bu t-Bu
C  
 In terms of demonstrating new reactivity of nucleophiles, Dr. Jorge T. Binder and 
Dr. Christopher J. Cordier demonstrated for the first time that enantioselective secondary 
alkyl–secondary alkyl cross-couplings are feasible (eq 1.4).10 Although only one 
stereocenter is formed in such a process, this study provides very promising lead for 
further investigations on asymmetric cross-couplings using secondary alkyl nucleophiles. 
Br
Me
racemic
ZnI
1.8 equiv
10% NiBr2•glyme
13% (S)–D
1.2 equiv CsI
DCM/dioxane
–30 ºC
N
N
O
(S)–D t-Bu
Me
91% yield
95% ee
(1.4)
 
 Dr. Christopher J. Cordier and Dr. Rylan J. Lundgren were able to provide a new 
enantioconvergent cross-coupling employing a racemic alkylmetal reagent and 
unactivated secondary electrophiles (eq 1.5).11  
	 4 
N
Boc
1. 1.6 equiv s-BuLi, 1.5 equiv TMEDA;
0.75 equiv ZnI2
1.5 equiv
2. 1.0 equiv Cy–I
15% NiCl2•glyme, 17% (R,R)–E, THF, r.t.
NHMe HN Me
(R,R)–E
N
Boc
Cy
80% yield
93% ee
(1.5)
 
 Dr. Huan Cong showcased that stereoselective cross-coupling reactions can also 
be initiated from achiral nucleophiles via a cyclization/cross-coupling sequence (eq 
1.6).12  
O
9-BBN
BrPh
2.1 equiv
achiral
O
Ph
77% yield
95% ee
10% NiBr2•diglyme
12% (S,S)–F
1.7 equiv KOt-Bu
2.1 equiv i-BuOH
i-Pr2O/THF, r.t.
(1.6)
Ph Ph
NHMe HN Me
(S,S)–F  
 Furthermore, Dr. Nathan D. Schley completed the first detailed mechanistic study 
on an enantioselective Negishi arylation method.13 The results and observations 
accumulated in this project might shed some light on the mechanisms of other 
asymmetric nickel-catalyzed cross-coupling reactions. 
 Although these studies all serve as proof-of-principle examples that might help us 
to exploit new territories, by the time I joined the Fu laboratory in early 2011, most of the 
accomplished and ongoing projects in the group have been focused on the development 
of novel enantioselective cross-coupling reactions employing racemic secondary alkyl 
electrophiles with all types of nucleophilic organometallic reagents (eq 1.7). 
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racemic
R R1
X
R2 M
chiral nickel catalyst
M: Zn, B, Mg, Si, Zr
R2: alkyl, aryl, alkenyl
R R1
R2
enantioenriched
(1.7)
 
 This is a really powerful and versatile method to construct tertiary stereocenters 
through enantioselective carbon-carbon bond-forming processes. A variety of 
enantioenriched products bearing synthetically valuable functional groups can be 
generated using this strategy (Figure 1.1). Many recently accomplished projects in the 
group have been devoted to expanding the electrophile scope of this type of chemistry.14 
 
O
Me
PhS
Me
TMS
OMe
OMe
OMe EtO2C
Me
O
O
Me
Me
N
O
Bn
Ph
Et
Me
O
O
n-BuAr
 
Figure 1.1. Selected Chiral Cross-Coupling Products 
 
 The overall theme of my graduate studies is to apply this established strategy to a 
previously underdeveloped field, namely organofluorine chemistry. We were trying to 
employ fluorine- and fluoroalkyl-substituted electrophiles in the cross-coupling methods 
and generate fluorine-containing compounds as targets. We believed that the success of 
such a strategy would benefit both nickel-catalyzed cross-coupling chemistry and also 
organofluorine community. 
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1.2 Carbon–Carbon Bond-Forming Strategy for the Synthesis of Organofluorine 
Compounds 
 During the last decade, substantial progress has been made in the field of 
organofluorine chemistry.15 Although numerous methods have been reported for the 
synthesis of target molecules containing sp2 C–F16 and sp2 C–CF317 moieties, the 
construction of sp3 C–F and sp3 C–CF3 subunits are still challenging. 
 We were especially interested in two types of targets (Figure 1.2), namely chiral 
tertiary alkyl fluorides and chiral molecules containing CF3-substituted tertiary 
stereocenters. At the time I joined the Fu group in 2011, there were very few general 
methods for the asymmetric syntheses of these chiral building blocks. The existing 
catalytic enantioselective methods also suffer from limited scope. Thus, it left a lot of 
space for the development of general and novel asymmetric approaches for the 
construction of these structures. 
 
∗
F
∗
CF3
tertiary alkyl fluorides CF3-substituted 
tertiary stereocenters  
Figure 1.2. Challenging and Interesting Fluorine Compounds 
 
 Typically, there are two strategies to create these stereocenters. The first one, 
which is also the most popular one, is through enantioselective fluorinations or 
trifluoromethylations (Figure 1.3a).18 Although some success has been achieved by 
adopting this method, it is not without limitations. For us, the biggest obstacle to apply 
this strategy is that transition-metal-catalyzed sp3 C–F bonds and sp3 C–CF3 bonds 
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formations can be very challenging in a cross-coupling process partially due to the 
difficulties in the reductive-elimination step.19 Therefore, we decided to pursue the other 
approach, namely through carbon–carbon bond-forming processes with fluorinated 
starting materials (Figure 1.3b). Despite the indirect nature of this strategy, it can 
sometimes provide certain benefits and solve problems that cannot be tackled by the 
other strategy.20   
 
∗
F
∗
CF3
a. fluorination/trifluoromethylation
strategies
b. carbon–carbon bond-forming
strategies
∗
F
∗
CF3
 
Figure 1.3. Two Strategies to Construct Fluorine and CF3-Substituted Stereocenters 
 
 In order to achieve these transformations using our nickel-catalyzed cross-
coupling reactions, we need to develop new types of fluorinated electrophiles. Through 
my graduate studies, we have introduced two classes of electrophiles in our cross-
coupling systems (Figure 1.4) 
 
Ar
O
alkyl
X F F3C alkyl
X
 
Figure 1.4. New Families of Electrophiles 
 
 By applying nickel-catalyzed cross-coupling chemistry to these fluorinated 
electrophiles, we were able to establish four novel cross-coupling methods, including 
	 8 
three asymmetric protocols. They provide unique approaches to access potentially 
valuable fluorine-containing building blocks (Figure 1.5) that cannot be synthesized by 
other existing methods. 
  
Ar
O
alkyl
Ar1 F F3C alkyl
alkyl
F3C alkyl
Ar
F3C alkyl
R
 
Figure 1.5. Fluorine-Containing Cross-Coupling Products 
 
 On the other hand, these new methods also help to enrich the cross-coupling 
chemistry. Specifically, through the development of an asymmetric alkynylation protocol 
for CF3-substituted electrophiles (see Chapter 5 for details), we revealed a universal 
method to enantioselectively incorporate an alkynyl nucleophile with a variety of classes 
of secondary alkyl electrophiles. A longstanding problem in our system, namely, how to 
enantioselective cross-couple sp-hybridized nucleophiles, has been partially solved. 
 
1.3 Overview of Individual Chapters 
 We started our journey by examining the possibility to construct fluorine-
containing tertiary stereocenters. In Chapter 2, a catalytic asymmetric Negishi arylation 
method with germinal dihalides as electrophiles is described (eq 1.8). This method serves 
as the first example of enantioselective cross-coupling employing alkyl germinal 
dihalides as substrate. It also demonstrates the idea that our carbon–carbon bond-forming 
approach can actually be used to generate enantioenriched tertiary alkyl fluorides. 
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Ar
O
alkyl
Ar1 F
Ar
O
alkyl
X F
Ar1 ZnCl
chiral nickel catalyst
racemic enantioenriched
(1.8)
 
 During the course of this study, we were questioning the possibility of applying 
the same concept to the construction of trifluoromethyl-substituted tertiary carbons. In 
Chapter 3, as a proof-of-concept, we showcased a Negishi alkylation protocol to cross-
couple α-halo-α-trifluoromethyl secondary electrophiles (eq 1.9). This method can also 
be applied without modifications to other perfluoroalkyl-substituted substrates.  
F3C alkyl
X
alkyl ZnBr
nickel catalyst
F3C alkyl
alkyl
(1.9)
 
 However, despite the practical and versatile nature of this protocol, we were not 
able to develop an enantioselective version at this stage. Fortunately, at the same time, we 
obtained very promising leading results by switching the nucleophiles from an alkylzinc 
reagent to an arylzinc reagent. Based on these preliminary results, we developed an 
asymmetric Negishi arylation reaction to generate CF3-substituted tertiary stereocenters 
in excellent enantioselectivity and good yield (eq 1.10). Details of this study are provided 
in Chapter 4. 
F3C alkyl
X
F3C alkyl
Ar
(1.10)Ar ZnCl
racemic enantioenriched
chiral nickel catalyst
 
 Finally, in Chapter 5, the details of the development of an asymmetric 
alkynylation method using these trifluoromethyl-substituted electrophiles are provided 
(eq 1.11). We were able to solve the longstanding alkynylation problem with our 
fluorine-containing electrophiles and a Suzuki cross-coupling protocol. More importantly, 
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we were very pleased to realize that this enantioselective alkynylation protocol can be 
directly applied to an array of racemic secondary alkyl electrophiles (eq 1.12). Some of 
these preliminary results are also included in Chapter 5.   
F3C alkyl
X
F3C alkyl
(1.11)
racemic
enantioenriched
R B(OMe)3Li
R
chiral nickel catalyst
 
R1 R2
X
R1 R2
(1.12)
racemic
enantioenriched
R B(OMe)3Li
R
chiral nickel catalyst
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CHAPTER 2 
Asymmetric Negishi Cross-Couplings of Racemic α-Halo-α-Fluoroketones+ 
 
 
2.1 Introduction 
 Small molecules containing fluorine atoms have shown potential applications in a 
variety of disciplines.1 Thus, significant effort has been made in the development of 
methods for the preparation of organofluorine compounds.2 In the case of alkyl fluorides, 
a number of methods have been reported in the asymmetric synthesis of stereocenters 
bearing a fluorine atom,3 particularly α to a carbonyl group. Although the construction of 
secondary stereocenters has been addressed by many studies,4 only a few methods have 
studied the generation of tertiary stereocenters. To date, only cyclic or doubly activated 
acyclic α-fluorocarbonyl compounds5 can be synthesized via existing asymmetric 
catalytic methods.6 As far as we are aware, no general catalytic asymmetric methods have 
been developed for the synthesis of simple tertiary α-fluorinated acyclic ketones.7–9 
 During the past decade, the Fu group has developed a variety of nickel-catalyzed 
enantioselective cross-coupling methods, employing racemic alkyl electrophiles as 
substrates.10 So far, all of the successful electrophiles have been secondary alkyl 
electrophiles (Scheme 2.1a). In order to further explore the power of this carbon–carbon 
bond-forming strategy, we have now begun to investigate enantioselective cross-
couplings of other families of electrophiles, starting with secondary germinal dihalides 																																																								
+ Portions of this chapter have appeared in the previous publication and the supporting 
information found therein: Liang, Y.; Fu, G. C. J. Am. Chem. Soc. 2014, 136, 5520–5524. 
Copyright 2014 American Chemical Society.  
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(Scheme 2.1b). The goal of such a transformation is to achieve selective cleavage of the 
C–X bond with the C–F bond intact and at the same time to form the new C–C bond 
efficiently and highly enantioselectively. This new strategy would provide an 
unprecedented enantioselective cross-coupling method employing alkyl germinal 
dihalides11 and also a unique approach for the catalytic asymmetric synthesis of tertiary 
alkyl fluorides. 
 
Scheme 2.1. Geminal Dihalides as Electrophiles in Asymmetric Cross-Coupling 
Reactions 
R alkyl
H X
racemic
chiral Ni catalyst R alkyl
H R1
enantioenriched
R1 M
R = saturated or unsaturated carbon substituent
X = Cl, Br, I
a. Previous studies:
R alkyl
F X
racemic
chiral Ni catalyst R alkyl
F R1
enantioenriched
R1 M
b. This study:
 
 
2.2 Optimization 
 Considering the high interest in the asymmetric synthesis of α-fluorocarbonyl 
compounds, we decided to start our study by choosing α-bromo-α-fluoro aromatic 
ketones as the model substrates (eq 2.1). This decision is based on two reasons. First, 
these electrophiles can be easily prepared from readily available aromatic ketones in two 
steps using commercially available and cheap fluorinating reagents.12 Second, our group 
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has already reported two enantioselective cross-coupling methods using structurally 
related α-bromo aromatic ketones as susbtrates.13 These success can serve as a starting 
point for the optimization of our desired transformation.  
R
F Br
O
Ar
α-bromo-α-fluoro
aromatic ketone
R1 M
chiral Ni catalyst R
F R1
O
Ar (2.1)
 
 Unfortunately, our attempts to employ the racemic α-bromo-α-fluoroketone 
under previously developed asymmetric Negishi13a and Kumada13b conditions failed to 
give any cross-coupling product (<2% yield). After extensive screening, we identified a 
suitable condition to provide the cross-coupling product in moderate yield and 
enantioselectivity (eq 2.2). 
n-Pentyl
F Br
racemic
O
Ph
15% NiCl2  •glyme
20% (4R,5S)–L1
2 equiv n-Bu4NBF4
THF/diglyme
–40 ºC
n-Pentyl
F Ph
O
PhPh ZnI
1.5 equiv
N N
O O
Ph Ph
Ph Ph
(4R,5S)–L1
69% yield
89% ee
(2.2)
 
 Although the condition shown in eq 2.2 led to promising results, further 
optimization based on this system failed to improve the enantioselectivity. Moreover, a 
brief survey of the substrate scope also gave very disappointing results. One feature of 
the reaction shown in eq 2.2 is that the nucleophilic arylzinc reagent is prepared in situ 
from the corresponding aryl Grignard reagent and ZnI2 (eq 2.3). 
Ph ZnIPh MgBr ZnI2
THF, r.t.
(2.3)  
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 Lei and co-workers have reported that aryl zinc reagents prepared from aryl 
Grignard reagents and aryllithium reagents can display significantly different properties 
in palladium-catalyzed Negishi arylation reactions.14 Thus, we decided to test the 
reactivity of arylzinc reagents which are prepared from aryllithium reagents (eq 2.4). We 
were delighted to see that this new type of arylzinc reagent provided much better results 
(eq 2.5) under related conditions. Prior to this study, we have never applied this method 
to the generation of arylzinc reagents in Negishi cross-coupling methods. Thus, these 
results also provided an alternative way to in situ generate arylzinc reagents from readily 
available materials. 
Ph ZnClPh Li (2.4)
ZnCl2
THF, r.t.
Ph Br
n-BuLi
THF, –78 ºC  
n-Pentyl
F Br
racemic
O
Ph
15% NiCl2  •glyme
20% (4R,5S)–L1
2 equiv n-Bu4NBF4
THF/diglyme
–20 ºC
n-Pentyl
F Ph
O
PhPh ZnCl
1.5 equiv
N N
O O
Ph Ph
Ph Ph
(4R,5S)–L1
79% yield
94% ee
(2.5)
 
 Further optimization helped to establish a suitable condition that can deliver the 
cross-coupling product in moderate yield and excellent enantioselectivity (Table 2.1, 
entry 1). The impact of various reaction parameters on the efficiency of this new method 
has been provided in Table 2.1. 
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Table 2.1. Effect of Reaction Parametersa 
entry variation from the "standard" conditions ee (%) yield (%)b
1
2
3
4
5
6
7
8
9
10
none
no NiCl2  •  glyme
no (4R,5S)–L1
10% NiCl2  •  glyme, 11% (4R,5S)–L1
1.2 equiv PhZnCl
r.t.
THF only
diglyme only
0.1 equiv H2O
in air in a closed vial
68
<2
<2
49
51
17
38
19
65
27
aAll data are the average of two experiments. bThe yields were 
determined through analysis by 19F NMR spectroscopy, with the aid
of an internal standard.
97
–
–
97
97
83
90
91
97
94
Et
F Br
racemic
O
Ph
15% NiCl2  •glyme
16% (4R,5S)–L1
THF/diglyme
–25 ºC
"standard" conditions
Et
F Ph
O
PhPh ZnCl
2.0 equiv
 
 
 In the absence of the nickel source or of the ligand L1, essentially no product 
formation is observed (entries 2 and 3). The employment of less catalyst (entry 4) or less 
arylzinc reagent (entry 5) leads to a modest decrease in yield. Performing the cross-
coupling reaction at room temperature or with a single solvent leads to significantly 
worse results (entries 6 to 8). The reaction is not very sensitive to moisture (entry 9). 
Conducting the reaction under air results in decreased efficiency (entry 10). From a 
practical point of view, both the nickel source and ligand L1 are commercially available 
and air-stable. 
 The choice of the nucleophilic cross-coupling partner is quite crucial to this 
transformation. A number of previously reported aryl nucleophiles have been tested 
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under the optimized conditions. As shown in Scheme 2.2, the arylzinc reagents prepared 
from aryllithium reagents give the best results.  
   
Scheme 2.2. Effect of Nucleophiles 
Et
F Br
racemic
O
Ph
15% NiCl2  •glyme
16% (4R,5S)–L1
THF/diglyme
–25 ºC
Et
F Ph
O
Phnucleophile
2.0 equiv
Ph ZnCl
from Ph–Li + ZnCl2
68% yield
97% ee
Ph ZnI
from Ph–MgBr + ZnI2
43% yield
47% ee
Ph MgCl Ph2Zn
<2% yield 56% yield
98% ee  
 
 The ligand L1 plays a vital role in this reaction. Several structurally related or 
previously employed chiral ligands have been tested under the optimized conditions. As 
shown in Scheme 2.3, none of these ligands can give even comparable results. 
 
 
 
 
 
 
 
 
 
	 19 
Scheme 2.3. Effect of Ligands 
O
N N
O
Ph Ph
PhPh
Me Me
NO
N N
O
MeO OMe
Ph Ph
NH
PhPh
HNMe Me
O
N N
O
Ph Ph
Me Me
N N
O O
Ph Ph
Ph Ph
(4R,5S)–L1
68% yield, 97% ee
O
N N
O
Ph Ph
11% yield, –76% ee 8% yield, –70% ee
<2% yield 40% yield, 50% ee <2% yield
Et
F Br
racemic
O
Ph
15% NiCl2  •glyme
16%  ligand
THF/diglyme
–25 ºC
Et
F Ph
O
PhPh ZnCl
2.0 equiv
A negative ee value signifies that the major product of the reaction is the opposite (R)
enantiomer.  
 
 One possible explanation for the importance of ligand L1 is that the proton in the 
methylene position is acidic enough to be deprotonated by basic nucleophiles during the 
course of the reaction. This might lead to active nickel complexes that can display 
different properties. We performed a control experiment to test this hypothesis. Ligand 
L1 is deprotonated with n-BuLi and an anionic ligand is generated prior to the cross-
coupling reaction (eq 2.6). However, under our optimized conditions, reactions conducted 
using the anionic ligand cannot provide comparable results (eq 2.7). Thus, the effect of 
this ligand L1 might be more complicated than we assumed and further studies are 
needed to provide more insights. 
	 20 
O
N N
O
Ph Ph
PhPh 1 equiv n-BuLi
–78 °C, then 0 °C
diglyme
O
N N
O
Ph Ph
PhPh
Li
anionic ligand
(2.6)
 
Et
F Br
racemic
O
Ph
15% NiCl2  •glyme
16%  anionic ligand
THF/diglyme
–25 ºC
Et
F Ph
O
PhPh ZnCl
2.0 equiv
32% yield
88% ee
(2.7)
 
 
2.3 Scope 
 With the optimized conditions in hand, we started to explore the scope of this new 
method. The scope with respect to the alkyl side-chains (R) is fairly broad (Table 2.2). 
An electrophile bearing a bulky isopropyl substituent can even cross-couple with the 
nucleophile to give the product in moderate yield and enantioselectivity (entry 5). 
Functional groups including a terminal olefin (entry 3) and a primary alkyl chloride 
(entry 6) can both be compatible with our conditions. 
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Table 2.2. Scope with Respect to the Electrophile: Alkyl Side-Chaina 
R
F Br
racemic
O
Ph
15% NiCl2  •glyme
16% (4R,5S)–L1
THF/diglyme
–25 ºC
R
F Ph
O
PhPh ZnCl
2.0 equiv
entry ee (%) yield (%)b
1 97 62
aAll data are the average of two experiments. b  Yield of purified product.
Et
Cl
R
4
5
6
3
98 73
97 43
91 59
98 62
82 55
2 CH2Ph
i-Pr
 
 
 Highly enantioselective cross-coupling can be uniformly achieved whether the 
aryl group (Ar) is para-, meta-, or ortho-substituted, and whether it is electron-rich or 
electron-deficient (Table 2.3). Additionally, ortho-substituted electrophiles (entries 8 and 
9) can deliver the product in good ee, which is quite different from the trends we 
observed previously in other asymmetric arylation projects.13 
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Table 2.3. Scope with Respect to the Electrophile: Aryl Groupa 
entry ee (%) yield (%)b
aAll data are the average of two experiments. b  Yield of purified product.
Ar R
X
Me
X
Me
X
X = OMe
t  -Bu
Ph
F
X =
X =
OMe
F
OMe
Me
1
2
3
4
5
6
8
9
7
10
96
98
96
97
97
97
92
94
62
76
54
63
54
59
62
70
97
65
51
CH2Ph
Et
Et
CH2Ph
Et
CH2Ph
Et
Et
Cl
Cl
97
R
F Br
racemic
O
Ar
15% NiCl2  •glyme
16% (4R,5S)–L1
THF/diglyme
–25 ºC
R
F Ph
O
ArPh ZnCl
2.0 equiv
 
 
Next, we turned our attention towards the scope of nucleophiles (Table 2.4). A 
variety of para- and meta-substituted arylzinc reagents can be employed under our 
optimized conditions. Functional groups including a silyl ether, an aryl chloride, and an 
aryl bromide can all be tolerated.  
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Table 2.4. Scope with Respect to the Nucleophilea 
entry ee (%) yield (%)b
aAll data are the average of two experiments. b  Yield of purified product.  
c
 Reaction temperature: –20 °C.
ArR
i  -Pr
i  -Pr
F
Br
97 71
97 73
TBSO
99 78
98 58
94 65
Cl
93 70
91 58
90 65
F3C
2
6
5
9
3c
4c
7c
8c
97 671
TBSO
CH2Ph
Et
CH2Ph
Et
CH2Ph
CH2Ph
CH2Ph
CH2Ph
Cl
R
F Br
racemic
O
Ph
15% NiCl2  •glyme
16% (4R,5S)–L1
THF/diglyme
–25 ºC
R
F Ar
O
PhAr ZnCl
2.0 equiv
 
 
 Additionally, we are also pleased to observe that this method is not limited to 
cross-couple α-bromo-α-fluoroketones. A racemic α-chloro-α-fluoroketone can undergo 
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cross-coupling reaction under related conditions to generate the product in moderate yield 
and excellent enantioselectivity (eq 2.8). 
F Cl
racemic
O
Ph
15% NiCl2  •glyme
16% (4R,5S)–L1
THF/diglyme
–20 ºC F Ph
O
PhPh ZnCl
2.0 equiv
68% yield
98% ee
(2.8)Ph Ph
 
 To test the scalability of this method, a gram-scale experiment was performed (eq 
2.9). Using 7.0 mmol electrophile, the reaction proceeded smoothly to generate 1.41 
gram product in excellent enantioselectivity. 
F Br
racemic
7.0 mmol
O
Ph
15% NiCl2  •glyme
16% (4R,5S)–L1
THF/diglyme
–25 ºC F Ph
O
PhPh ZnCl
2.0 equiv
1.41 g
66% yield
97% ee
(2.9)Ph Ph
 
 However, this cross-coupling method is not without limitations. Several 
unsuccessful electrophiles and nucleophiles under our optimized conditions (entry 1 in 
Table 2.1) are shown in Figure 2.1.  
 
O
F
Br
Ph H
F Br
O
Et
F Br
O
Me
Me
Me
S
ZnCl
S
ZnCl
S ZnCl N
Me
ZnCl
Me
ZnCl
 
Figure 2.1. Unsuccessful Cross-Coupling Partners 
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 Some other notable features of this cross-coupling method are summarized below: 
 A. One major side reaction is the hydrodebromination of the electrophiles and the 
products are generated as racemates. 
 B. No kinetic resolution of the electrophile was observed (<5% ee) during the 
course of the reaction. 
 C. The cross-coupling product was stable (no C–F bond cleavage or erosion in ee) 
under our optimized conditions and its ee value was a constant. 
 
2.4 Derivatization of Cross-Coupling Products 
 To highlight the utility of these enantioenriched cross-coupling products, we 
performed a series of transformations to convert them into a variety of valuable chiral 
organofluorine compounds. 
 When the enantioenriched α-fluoroketone is treated with an allyl Grignard 
reagent and an aryllithium reagent, nucleophilic additions to the carbonyl group proceed 
with excellent diastereoselectivity to generate densely functionalized products (eqs 2.10 
and 2.11).15 Additionally, reducing the ketone moiety with NaBH4 also leads to the 
alcohol product as a single diastereomer (eq 2.12).16 
F Ph
O
Ph
97% ee
MgCl
F Ph
Ph Ph
OH
99% yield
>20:1 dr, 97% ee
(2.10)
THF, –78 °C to r.t.Ph
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Cl Li
F Ph
Ph Ph
OH
Cl
96% yield
>20:1 dr, 98% ee
(2.11)
THF, –78 °CF Ph
O
Ph
97% ee
Ph
 
F Ph
Ph Ph
99% yield
>20:1 dr, 97% ee
(2.12)
THF, EtOHF Ph
O
Ph
97% ee
Ph
NaBH4
OH
 
 Moreover, regioselective Baeyer–Villiger oxidation of the cross-coupling 
products can be achieved (eqs 2.13 and 2.14, HFIP = 1,1,1,3,3,3-hexafluoro-2-
propanol).17 The relative migratory aptitudes of the ketone substituents can determine the 
regioselectivity of the reaction.18 To the best of our knowledge, these reactions serve as 
the first asymmetric synthesis of acylated fluorohydrins19 and an indirect method for the 
catalytic enantioselective synthesis of tertiary α-fluoroesters.20 
F Ph
O
Ph Ph
97% ee
m-CPBA
pH 7 buffer
HFIP/CH2Cl2
O
F Ph
Ph
>20:1 regioselectivity
81% yield
98% ee
O
Ph
(2.13)
 
F Ph
O
Ph
97% ee
MeO F Ph
O
O Ph
MeO
>20:1 regioselectivity
84% yield
97% ee
(2.14)
m-CPBA
pH 7 buffer
HFIP/CH2Cl2
 
 
2.5 Conclusions 
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 In conclusion, the first catalytic enantioselective cross-coupling method that 
employs germinal dihalides as substrates has been developed. This method provides a 
unique approach for the generation of chiral tertiary α-fluoroketones, which can be 
challenging to synthesize via other existing methods. These enantioenriched products can 
be further transformed into a variety of valuable chiral fluorine-containing building 
blocks. 
 After our study was published in 2014, Gandelman and co-workers adopted the 
same strategy and developed two nickel-catalyzed cross-coupling methods employing 
different classes of α-halo-α-fluoro alkyl electrophiles.21 
 
2.6 Experimental Section 
2.6.1 General Information 
Anhydrous THF and CH2Cl2 were purified and dried using a solvent-purification 
system that contained activated alumina. The following reagents were purchased and 
used as received: NiCl2•glyme (Aldrich), ZnCl2 (Aldrich; reagent grade, ≥98%), diglyme 
(Aldrich; anhydrous), n-BuLi (Aldrich; ~2.5 M in hexanes; titrated using diphenylacetic 
acid according to Kofron’s method22), diisopropylamine (Aldrich; ≥99.5%), N-
fluorobenzenesulfonimide (Oakwood), trimethylsilyl trifluoromethanesulfonate 
(Oakwood), triethylamine (Aldrich; ≥99.5%), butyrophenone (Aldrich), 3-
phenylpropiophenone (Alfa Aesar), 4-chlorobutyrophenone (Alfa Aesar), 3-methyl-1-
phenyl-1-butanone (Aldrich), 4'-tert-butyl-4-chlorobutyrophenone (Alfa Aesar), 4-
chloro-4'-fluorobutyrophenone (Alfa Aesar), allylmagnesium chloride (Aldrich; 2.0 M in 
THF), 3-chloroperbenzoic acid (Aldrich; ≤77%), and 1,1,1,3,3,3-hexafluoro-2-propanol 
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(Oakwood). N-Bromosuccinimide (Aldrich) and N-chlorosuccinimide (Aldrich) were 
recrystallized prior to use. Ligand (4R,5S)-L1 was purchased from Aldrich. Ligand 
(4S,5R)-L1 was synthesized according to a literature procedure23 (it is commercially 
available from Sh-Icon Inc.) All aryl bromides were purchased (Aldrich, Alfa Aesar, TCI, 
and Oakwood) and used as received. 
All reactions were carried out in oven-dried glassware under an inert atmosphere. 
HPLC analyses were carried out on an Agilent 1100 Series system, using Daicel 
CHIRALCEL® columns or Daicel CHIRALPAK® columns (internal diameter 4.6 mm, 
column length 250 mm, particle size 5 µm). 
 
2.6.2 Preparation of Electrophiles 
The yields have not been optimized. 
Ar
O
R
1. LDA
2. NFSI Ar
O
R
F
1. TMSOTf, NEt3
2. NBS Ar
O
R
F Br  
General Procedure A: This was based on published procedures.24 
Fluorination. n-BuLi in hexane (2.30 M; 12.0 mL, 27.5 mmol; 1.10 equiv) was 
added over 5 min to a solution of diisopropylamine (4.24 mL, 30.3 mmol; 1.21 equiv) in 
THF (20 mL) at −78 °C. The mixture was allowed to stir for 10 min at −78 °C, and then 
it was warmed to r.t. and stirred for another 10 min. The clear solution was cooled to −78 
°C, and a solution of the ketone (25.0 mmol) in THF (15 mL) was added over 5 min to 
the freshly prepared solution of LDA. The mixture was stirred at −78 °C for 1.5 h, and 
then a solution of N-fluorobenzenesulfonimide (NFSI; 9.46 g, 30.0 mmol; 1.20 equiv) in 
THF (30 mL) was added over 5 min to the solution of the enolate at −78 °C.  The mixture 
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was allowed to stir at −78 °C for 5 min, and then it was allowed to warm to r.t. (white or 
light-yellow suspension) and stirred for 6–12 h. Next, aqueous solutions of NH4Cl 
(saturated; 20 mL) and of HCl (1 N; 50 mL) were added in turn. The mixture was 
extracted with CH2Cl2 (3 × 70 mL), and the organic layers were combined, dried over 
Na2SO4, and concentrated. The desired product was purified by flash chromatography on 
silica gel (10:1 hexane/diethyl ether, unless otherwise noted). 
Bromination. Et3N (3.07 mL, 22.0 mmol; 1.10 equiv) and trimethylsilyl 
trifluoromethanesulfonate (TMSOTf; 3.62 mL, 20.0 mmol; 1.00 equiv) were added to a 
solution of the α-fluoroketone (20.0 mmol) in CH2Cl2 (20 mL) at 0 °C. The reaction 
mixture was allowed to warm to r.t., and then it was stirred for 2.5 h. Next, N-
bromosuccinimide (NBS; 4.63 g, 26.0 mmol; 1.30 equiv) was added in one portion to the 
reaction mixture, followed by CH2Cl2 (20 mL). The orange or red solution was allowed 
to stir at r.t. for 16 h, during which it became dark red. Then, the reaction was quenched 
with water (30 mL), and the mixture was extracted with CH2Cl2 (3 × 50 mL). The organic 
layers were combined, dried over Na2SO4, and concentrated. The desired product was 
purified by flash chromatography on silica gel (100:1 hexane/dichloromethane, unless 
otherwise noted). 
 
Ar
O
R
1. LDA
2. NFSI Ar
O
R
F
1. TMSOTf, NEt3
2. NCS Ar
O
R
F Cl  
General Procedure B: The first step is the same as for General Procedure A. 
Chlorination. Et3N (3.07 mL, 22.0 mmol; 1.10 equiv) and trimethylsilyl 
trifluoromethanesulfonate (TMSOTf; 3.62 mL, 20.0 mmol; 1.00 equiv) were added to a 
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solution of the α-fluoroketone (20.0 mmol) in CH2Cl2 (20 mL) at 0 °C. The reaction 
mixture was allowed to warm to r.t., and then it was stirred for 2.5 h. Next, N-
chlorosuccinimide (NCS; 3.47 g, 26.0 mmol; 1.30 equiv) was added in one batch to the 
reaction mixture, followed by the addition of CH2Cl2 (20 mL). The orange or red solution 
was allowed to stir at r.t. for 16 h, during which it became dark red. Then, the reaction 
was quenched with water (30 mL), and the mixture was extracted with CH2Cl2 (3 × 50 
mL). The organic layers were combined, dried over Na2SO4, and concentrated. The 
desired product was purified by flash chromatography on silica gel (100:1 
hexane/dichloromethane, unless otherwise noted). 
 
Et
F Br
O
Ph
 
2-Bromo-2-fluoro-1-phenylbutan-1-one [76650-11-8]. The title compound was 
synthesized according to General Procedure A from butyrophenone. The overall yield (2 
steps) was 64%. The title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 8.19 – 8.16 (m, 2H), 7.63 – 7.59 (m, 1H), 7.50 – 
7.47 (m, 2H), 2.66 – 2.50 (m, 2H), 1.17 (t, 3H, J = 7.3 Hz); 
13C NMR (126 MHz, CDCl3) δ 190.1 (d, J = 28.5 Hz), 133.8, 132.1 (d, J = 3.6 
Hz), 130.6 (d, J = 5.8 Hz), 128.4, 106.0 (d, J = 272.2 Hz), 34.2 (d, J = 21.1 Hz), 8.6 (d, J 
= 3.8 Hz); 
19F NMR (282 MHz, CDCl3) δ −118.1 (t, 1F, J = 21.8 Hz); 
FT-IR (film) 2982, 2944, 1690, 1598, 1448, 1262, 1152, 887, 828 cm-1; 
GC-MS (EI) m/z (M+−Br) calcd for C10H10FO: 165, found: 165. 
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F Br
O
Ph Ph
 
2-Bromo-2-fluoro-1,3-diphenylpropan-1-one. The title compound was 
synthesized according to General Procedure A from 3-phenylpropiophenone. The overall 
yield (2 steps) was 43%. The title compound was isolated as a white solid. 
1H NMR (500 MHz, CDCl3) δ 8.09 – 8.06 (m, 2H), 7.60 – 7.57 (m, 1H), 7.46 – 
7.43 (m, 2H), 7.36 – 7.30 (m, 5H), 3.99 (dd, 1H, J = 14.7, 25.6 Hz), 3.86 (dd, 1H, J = 
14.7, 20.8 Hz); 
13C NMR (126 MHz, CDCl3) δ 190.4 (d, J = 28.3 Hz), 133.8, 133.3, 132.2 (d, J = 
3.7 Hz), 131.1, 130.4 (d, J = 5.7 Hz), 128.4, 128.3, 127.6, 103.7 (d, J = 274.1 Hz), 46.4 
(d, J = 19.8 Hz); 
19F NMR (282 MHz, CDCl3) δ −116.5 (dd, 1F, J = 20.7, 25.7 Hz); 
FT-IR (film) 3063, 3032, 1690, 1597, 1448, 1262, 1135, 1087, 955, 885, 846, 743 
cm-1; 
GC-MS (EI) m/z (M+−Br) calcd for C15H12FO: 227, found: 227. 
 
F Br
O
Ph
 
2-Bromo-2-fluoro-1-phenylpent-4-en-1-one. The title compound was 
synthesized according to General Procedure A from 1-phenylpent-4-en-1-one. The 
overall yield (2 steps) was 38%. The title compound was isolated as a colorless oil (it 
should be stored in a refrigerator (~5 °C)). 
	 32 
1H NMR (500 MHz, CDCl3) δ 8.18 – 8.16 (m, 2H), 7.63 – 7.60 (m, 1H), 7.50 – 
7.47 (m, 2H), 5.94 – 5.86 (m, 1H), 5.33 – 5.29 (m, 2H), 3.36 – 3.29 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 189.8 (d, J = 27.9 Hz), 133.9, 132.0 (d, J = 3.9 
Hz), 130.6 (d, J = 5.8 Hz), 129.8 (d, J = 2.8 Hz), 128.4, 121.4, 103.5 (d, J = 273.0 Hz), 
45.0 (d, J = 20.9 Hz); 
19F NMR (282 MHz, CDCl3) δ −116.7 (tt, 1F, J = 1.9, 22.1 Hz); 
FT-IR (film) 3077, 1694, 1598, 1448, 1263, 1137, 932, 870, 711 cm-1; 
GC-MS (EI) m/z (M+) calcd for C11H1079BrFO: 256, found: 256, 258 (M++2). 
 
F Br
O
Ph
 
2-Bromo-3-cyclopentyl-2-fluoro-1-phenylpropan-1-one. The title compound 
was synthesized according to General Procedure A from 3-cyclopentyl-1-phenylpropan-
1-one. The overall yield (2 steps) was 50%. The title compound was isolated as a yellow 
oil. 
1H NMR (500 MHz, CDCl3) δ 8.17 – 8.14 (m, 2H), 7.63 – 7.59 (m, 1H), 7.50 – 
7.46 (m, 2H), 2.70 (d, 1H, J = 6.6 Hz), 2.66 (dd, 1H, J = 1.1, 6.5 Hz), 2.15 – 2.06 (m, 
1H), 1.91 – 1.82 (m, 2H), 1.67 – 1.60 (m, 2H), 1.56 – 1.48 (m, 2H), 1.30 – 1.12 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 190.7 (d, J = 28.2 Hz), 133.7, 132.3 (d, J = 3.3 
Hz), 130.6 (d, J = 5.6 Hz), 128.4, 105.5 (d, J = 273.7 Hz), 46.2 (d, J = 19.7 Hz), 37.0, 
33.3 (dd, J = 1.5, 21.5 Hz), 24.7 (d, J = 23.1 Hz); 
19F NMR (282 MHz, CDCl3) δ −114.6 (t, 1F, J = 23.6 Hz); 
FT-IR (film) 2953, 2869, 1693, 1598, 1448, 1258, 1144, 915, 704 cm-1; 
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GC-MS (EI) m/z (M+−Br) calcd for C14H16FO: 219, found: 219. 
 
F Br
O
Ph Me
Me
 
2-Bromo-2-fluoro-3-methyl-1-phenylbutan-1-one. The title compound was 
synthesized according to General Procedure A from 3-methyl-1-phenyl-1-butanone. The 
overall yield (2 steps) was 49%. The title compound was isolated as a light-yellow oil. 
1H NMR (500 MHz, CDCl3) δ 8.13 – 8.11 (m, 2H), 7.62 – 7.59 (m, 1H), 7.50 – 
7.46 (m, 2H), 2.91 – 2.81 (m, 1H), 1.35 (d, 3H, J = 6.8 Hz), 1.07 (dd, 3H, J = 0.8, 6.7 
Hz); 
13C NMR (126 MHz, CDCl3) δ 191.2 (d, J = 27.6 Hz), 133.6, 132.9 (d, J = 3.4 
Hz), 130.3 (d, J = 6.2 Hz), 128.4, 109.9 (d, J = 275.6 Hz), 37.5 (d, J = 20.6 Hz), 17.6 (d, 
J = 2.9 Hz), 17.0 (d, J = 3.3 Hz); 
19F NMR (282 MHz, CDCl3) δ −127.1 (d, 1F, J = 26.8 Hz); 
FT-IR (film) 2980, 2940, 1692, 1598, 1448, 1263, 1026, 913, 843, 817 cm-1; 
GC-MS (EI) m/z (M+−Br) calcd for C11H12FO: 179, found: 179. 
 
F Br
O
Ph Cl
 
2-Bromo-4-chloro-2-fluoro-1-phenylbutan-1-one. The title compound was 
synthesized according to General Procedure A from 4-chlorobutyrophenone. The overall 
yield (2 steps) was 26%. The title compound was isolated as a light-yellow oil. 
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1H NMR (500 MHz, CDCl3) δ 8.18 – 8.16 (m, 2H), 7.65 – 7.62 (m, 1H), 7.52 – 
7.48 (m, 2H), 3.83 (ddd, 1H, J = 5.5, 9.6, 10.9 Hz), 3.74 (ddd, 1H, J = 6.2, 9.7, 10.9 Hz), 
3.13 – 2.98 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 189.1 (d, J = 27.4 Hz), 134.2, 131.3 (d, J = 3.9 
Hz), 130.7 (d, J = 5.5 Hz), 128.5, 102.4 (d, J = 272.7 Hz), 43.3 (d, J = 20.2 Hz), 38.4 (d, 
J = 4.1 Hz); 
19F NMR (282 MHz, CDCl3) δ −117.1 (t, 1F, J = 19.9 Hz); 
FT-IR (film) 3063, 2970, 1691, 1597, 1448, 1269, 1249, 1175, 1139, 1086, 898, 
822 cm-1; 
GC-MS (EI) m/z (M+−Cl) calcd for C10H979BrFO: 243, found: 243, 245 
(M+−Cl+2). 
 
F Br
O
MeO
Ph
 
2-Bromo-2-fluoro-1-(4-methoxyphenyl)-3-phenylpropan-1-one. The title 
compound was synthesized according to General Procedure A from 1-(4-
methoxyphenyl)-3-phenylpropan-1-one. The overall yield (2 steps) was 45%. The title 
compound was isolated as a light-yellow oil. 
1H NMR (500 MHz, CDCl3) δ 8.13 – 8.09 (m, 2H), 7.35 – 7.28 (m, 5H), 6.93 – 
6.90 (m, 2H), 3.96 (dd, 1H, J = 14.7, 24.9 Hz), 3.88 – 3.79 (m, 4H); 
13C NMR (126 MHz, CDCl3) δ 188.5 (d, J = 27.1 Hz), 164.0, 133.5, 133.0 (d, J = 
6.4 Hz), 131.1, 128.2, 127.5, 124.7 (d, J = 4.0 Hz), 113.7 (d, J = 1.2 Hz), 104.2 (d, J = 
274.4 Hz), 55.5, 46.4 (d, J = 19.8 Hz); 
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19F NMR (282 MHz, CDCl3) δ −115.3 (dd, 1F, J = 21.7, 24.7 Hz); 
FT-IR (film) 3032, 2935, 2840, 1680, 1601, 1511, 1263, 1177, 1134, 1029, 853, 
725 cm-1; 
GC-MS (EI) m/z (M+−Br) calcd for C16H14FO2: 257, found: 257. 
 
F Br
O
t-Bu
Cl
 
2-Bromo-1-(4-(tert-butyl)phenyl)-4-chloro-2-fluorobutan-1-one. The title 
compound was synthesized according to General Procedure A from 4'-tert-butyl-4-
chlorobutyrophenone. The overall yield (2 steps) was 34%. The title compound was 
isolated as a light-yellow oil. 
1H NMR (500 MHz, CDCl3) δ 8.14 – 8.11 (m, 2H), 7.53 – 7.50 (m, 2H), 3.82 
(ddd, 1H, J = 5.6, 9.7, 10.8 Hz), 3.73 (ddd, 1H, J = 6.1, 9.8, 10.8 Hz), 3.12 – 2.97 (m, 
2H), 1.36 (s, 9H); 
13C NMR (126 MHz, CDCl3) δ 188.6 (d, J = 27.3 Hz), 158.3, 130.7 (d, J = 5.7 
Hz), 128.5 (d, J = 3.7 Hz), 125.6 (d, J = 0.7 Hz), 102.6 (d, J = 273.0 Hz), 43.4 (d, J = 
20.2 Hz), 38.5 (d, J = 4.0 Hz), 35.3, 31.0; 
19F NMR (282 MHz, CDCl3) δ −116.6 (t, 1F, J = 19.9 Hz); 
FT-IR (film) 2965, 2905, 2869, 1687, 1604, 1272, 1136, 1112, 899, 853 cm-1; 
GC-MS (EI) m/z (M+−Cl) calcd for C14H1779BrFO: 299, found: 299, 301 
(M+−Cl+2). 
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Et
F Br
O
Ph  
1-([1,1'-Biphenyl]-4-yl)-2-bromo-2-fluorobutan-1-one. The title compound was 
synthesized according to General Procedure A from 1-([1,1'-biphenyl]-4-yl)butan-1-one. 
The overall yield (2 steps) was 59%. The title compound was isolated as a light-yellow 
solid. 
1H NMR (500 MHz, CDCl3) δ 8.29 – 8.27 (m, 2H), 7.73 – 7.70 (m, 2H), 7.67 – 
7.64 (m, 2H), 7.51 – 7.48 (m, 2H), 7.45 – 7.41 (m, 1H), 2.70 – 2.53 (m, 2H), 1.20 (t, 3H, 
J = 7.3 Hz); 
13C NMR (126 MHz, CDCl3) δ 189.6 (d, J = 27.9 Hz), 146.5, 139.6, 131.2 (d, J = 
5.9 Hz), 130.7 (d, J = 3.8 Hz), 129.0, 128.4, 127.3, 127.0, 106.2 (d, J = 272.2 Hz), 34.2 
(d, J = 21.1 Hz), 8.6 (d, J = 3.7 Hz); 
19F NMR (282 MHz, CDCl3) δ −117.9 (t, 1F, J = 21.8 Hz); 
FT-IR (film) 2981, 1687, 1604, 1264, 1152, 885, 856, 745, 723 cm-1; 
GC-MS (EI) m/z (M+−HBr) calcd for C16H13FO: 240, found: 240. 
 
F Br
O
F
Cl
 
2-Bromo-4-chloro-2-fluoro-1-(4-fluorophenyl)butan-1-one. The title 
compound was synthesized according to General Procedure A from 4-chloro-4'-
fluorobutyrophenone. The overall yield (2 steps) was 42%. The title compound was 
isolated as a light-yellow oil. 
	 37 
1H NMR (500 MHz, CDCl3) δ 8.23 – 8.20 (m, 2H), 7.19 – 7.14 (m, 2H), 3.82 
(ddd, 1H, J = 5.5, 9.5, 10.9 Hz), 3.73 (ddd, 1H, J = 6.2, 9.6, 10.9 Hz), 3.11 – 2.96 (m, 
2H); 
13C NMR (126 MHz, CDCl3) δ 187.5 (d, J = 27.5 Hz), 166.2 (d, J = 258.0 Hz), 
133.6 (dd, J = 5.9, 9.5 Hz), 127.5, 115.9 (d, J = 22.2 Hz), 102.4 (d, J = 272.5 Hz), 43.2 
(d, J = 20.1 Hz), 38.4 (d, J = 4.1 Hz); 
19F NMR (282 MHz, CDCl3) δ −102.2 (m, 1F), −117.0 (t, 1F, J = 20.0 Hz); 
FT-IR (film) 2971, 1695, 1599, 1506, 1412, 1277, 1241, 1162, 1139, 899, 854, 
710 cm-1; 
GC-MS (EI) m/z (M+−Cl) calcd for C10H879BrF2O: 261, found: 261, 263 
(M+−Cl+2). 
 
Et
F Br
O
MeO
 
2-Bromo-2-fluoro-1-(3-methoxyphenyl)butan-1-one. The title compound was 
synthesized according to General Procedure A from 1-(3-methoxyphenyl)butan-1-one. 
The overall yield (2 steps) was 52%. The title compound was isolated as a light-yellow 
oil. 
1H NMR (500 MHz, CDCl3) δ 7.80 (dddd, 1H, J = 0.9, 1.6, 2.2, 7.7 Hz), 7.66 (dt, 
1H, J = 1.5, 2.8 Hz), 7.39 (t, 1H, J = 8.0 Hz), 7.15 (ddd, 1H, J = 0.9, 2.7, 8.3 Hz), 3.86 (s, 
3H), 2.65 – 2.49 (m, 2H), 1.16 (t, 3H, J = 7.3 Hz); 
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13C NMR (126 MHz, CDCl3) δ 189.9 (d, J = 28.0 Hz), 159.4, 133.3 (d, J = 3.4 
Hz), 129.4 (d, J = 1.2 Hz), 123.2 (d, J = 7.4 Hz), 120.3, 114.9 (d, J = 4.6 Hz), 106.0 (d, J 
= 272.5 Hz), 55.4, 34.3 (d, J = 21.2 Hz), 8.6 (d, J = 3.7 Hz); 
19F NMR (282 MHz, CDCl3) δ −117.9 (t, 1F, J = 21.7 Hz); 
FT-IR (film) 2979, 2943, 1694, 1598, 1580, 1489, 1463, 1428, 1271, 1226, 1152, 
1039, 719 cm-1; 
GC-MS (EI) m/z (M+) calcd for C11H1279BrFO2: 274, found: 274, 276 (M++2). 
 
F Br
O
PhF
 
2-Bromo-2-fluoro-1-(3-fluorophenyl)-3-phenylpropan-1-one. The title 
compound was synthesized according to General Procedure A from 1-(3-fluorophenyl)-3-
phenylpropan-1-one. The overall yield (2 steps) was 31%. The title compound was 
isolated as a light-yellow oil. 
1H NMR (500 MHz, CDCl3) δ 7.86 (dtd, 1H, J = 1.0, 1.7, 7.9 Hz), 7.73 (ddt, 1H, 
J = 1.6, 2.9, 9.6 Hz), 7.42 (td, 1H, J = 5.6, 8.1 Hz), 7.33 – 7.28 (m, 6H), 3.96 (dd, 1H, J = 
14.7, 25.9 Hz), 3.84 (dd, 1H, J = 14.7, 20.6 Hz); 
13C NMR (126 MHz, CDCl3) δ 189.2 (dd, J = 2.3, 28.4 Hz), 162.3 (d, J = 247.9 
Hz), 134.0 (dd, J = 3.7, 4.8 Hz), 133.1, 131.1 (d, J = 1.0 Hz), 130.1 (dd, J = 0.8, 7.7 Hz), 
128.4, 127.7, 126.2 (dd, J = 3.1, 6.4 Hz), 120.9 (d, J = 21.4 Hz), 117.3 (dd, J = 5.7, 23.4 
Hz), 103.5 (d, J = 273.5 Hz), 46.4 (d, J = 19.7 Hz); 
19F NMR (282 MHz, CDCl3) δ −111.5 (m, 1F), −117.1 (dd, 1F, J = 20.6, 25.6 
Hz); 
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FT-IR (film) 3067, 3034, 1694, 1587, 1440, 1270, 1124, 894, 721 cm-1; 
GC-MS (EI) m/z (M+−Br) calcd for C15H11F2O: 245, found: 245. 
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2-Bromo-1-(3,5-dimethylphenyl)-2-fluorobutan-1-one. The title compound was 
synthesized according to General Procedure A from 1-(3,5-dimethylphenyl)butan-1-one. 
The overall yield (2 steps) was 61%. The title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 7.78 – 7.77 (m, 2H), 7.25 – 7.24 (m, 1H), 2.63 – 
2.50 (m, 2H), 2.39 (s, 6H), 1.15 (t, 3H, J = 7.3 Hz); 
13C NMR (126 MHz, CDCl3) δ 190.6 (d, J = 27.9 Hz), 138.0, 135.5, 132.3 (d, J = 
3.6 Hz), 128.2 (d, J = 5.7 Hz), 106.1 (d, J = 272.7 Hz), 34.3 (d, J = 21.2 Hz), 21.3, 8.6 (d, 
J = 3.7 Hz); 
19F NMR (282 MHz, CDCl3) δ −117.7 (t, 1F, J = 21.8 Hz); 
FT-IR (film) 2980, 2944, 2919, 1690, 1604, 1459, 1301, 1215, 1152, 1060, 922, 
869 cm-1; 
GC-MS (EI) m/z (M+) calcd for C12H1479BrFO: 272, found: 272, 274 (M++2). 
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2-Bromo-2-fluoro-1-(2-methoxyphenyl)butan-1-one. The title compound was 
synthesized according to General Procedure A from 1-(2-methoxyphenyl)butan-1-one. 
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The overall yield (2 steps) was 60%. The title compound was isolated as a light-yellow 
oil. 
1H NMR (500 MHz, CDCl3) δ 7.54 (dt, 1H, J = 1.4, 7.6 Hz), 7.46 (ddd, 1H, J = 
1.7, 7.5, 8.3 Hz), 7.01 (td, 1H, J = 0.9, 7.5 Hz), 6.97 (dd, 1H, J = 0.9, 8.4 Hz), 3.84 (s, 
3H), 2.59 – 2.47 (m, 2H), 1.16 (t, 3H, J = 7.3 Hz); 
13C NMR (126 MHz, CDCl3) δ 196.2 (d, J = 31.8 Hz), 157.5 (d, J = 0.8 Hz), 
132.7, 129.6 (d, J = 2.8 Hz), 125.2 (d, J = 2.4 Hz), 120.3, 111.4, 106.0 (d, J = 272.0 Hz), 
55.7, 34.0 (d, J = 21.0 Hz), 8.6 (d, J = 3.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −119.8 (t, 1F, J = 20.9 Hz); 
FT-IR (film) 2982, 2943, 2839, 1719, 1599, 1488, 1462, 1435, 1291, 1256, 1162, 
1021, 893, 753   cm-1; 
GC-MS (EI) m/z (M+−Br) calcd for C11H12FO2: 195, found: 195. 
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2-Bromo-2-fluoro-3-phenyl-1-(o-tolyl)propan-1-one. The title compound was 
synthesized according to General Procedure A from 3-phenyl-1-(o-tolyl)propan-1-one. 
The overall yield (2 steps) was 22%. The title compound was isolated as a light-yellow 
oil. 
1H NMR (500 MHz, CDCl3) δ 7.44 (ddd, 1H, J = 1.3, 3.9, 8.0 Hz), 7.35 – 7.29 
(m, 6H), 7.20 (dt, 1H, J = 0.7, 7.8 Hz), 7.14 (tdd, 1H, J = 0.6, 1.3, 7.4 Hz), 4.04 (dd, 1H, 
J = 14.4, 30.7 Hz), 3.85 (dd, 1H, J = 14.4, 15.7 Hz), 2.18 (s, 3H); 
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13C NMR (126 MHz, CDCl3) δ 195.4 (d, J = 29.9 Hz), 138.4, 133.5 (d, J = 2.8 
Hz), 133.2, 131.4, 131.3, 131.1 (d, J = 1.3 Hz), 128.8 (d, J = 8.1 Hz), 128.5, 127.8, 124.9, 
103.2 (d, J = 274.9 Hz), 47.0 (d, J = 19.5 Hz), 19.9; 
19F NMR (282 MHz, CDCl3) δ −115.6 (ddd, 1F, J = 4.0, 15.8, 30.7 Hz); 
FT-IR (film) 3064, 3033, 2930, 1700, 1496, 1455, 1264, 1226, 1122, 940, 886, 
724 cm-1; 
GC-MS (EI) m/z (M+−Br) calcd for C16H14FO: 241, found: 241. 
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2-Bromo-2-fluoro-1-(naphthalen-2-yl)butan-1-one. The title compound was 
synthesized according to General Procedure A from 1-(naphthalen-2-yl)butan-1-one. The 
overall yield (2 steps) was 41%. The title compound was isolated as a light-yellow oil. 
1H NMR (500 MHz, CDCl3) δ 8.81 – 8.80 (m, 1H), 8.17 (dt, 1H, J = 1.7, 8.7 Hz), 
7.99 (dd, 1H, J = 0.7, 8.2 Hz), 7.92 – 7.87 (m, 2H), 7.65 – 7.61 (m, 1H), 7.58 – 7.55 (m, 
1H), 2.73 – 2.56 (m, 2H), 1.22 (t, 3H, J = 7.3 Hz); 
13C NMR (126 MHz, CDCl3) δ 190.0 (d, J = 27.9 Hz), 135.7, 132.9 (d, J = 7.8 
Hz), 132.2 (d, J = 0.7 Hz), 130.0, 129.3 (d, J = 3.6 Hz), 129.1, 128.2 (d, J = 0.8 Hz), 
127.7, 126.8, 125.6 (d, J = 4.0 Hz), 106.3 (d, J = 272.2 Hz), 34.3 (d, J = 21.2 Hz), 8.6 (d, 
J = 3.7 Hz); 
19F NMR (282 MHz, CDCl3) δ −117.4 (t, 1F, J = 21.6 Hz); 
FT-IR (film) 3060, 2981, 2942, 1686, 1627, 1462, 1280, 1230, 1151, 1123, 1108, 
979, 910, 868, 741 cm-1; 
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GC-MS (EI) m/z (M+) calcd for C14H1279BrFO: 294, found: 294, 296 (M++2). 
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2-Chloro-2-fluoro-1,3-diphenylpropan-1-one [1062229-21-3]. The title 
compound was synthesized according to General Procedure B from 3-
phenylpropiophenone. The overall yield (2 steps) was 40%. The title compound was 
isolated as a light-yellow solid. 
1H NMR (500 MHz, CDCl3) δ 8.09 – 8.07 (m, 2H), 7.61 – 7.58 (m, 1H), 7.47 – 
7.44 (m, 2H), 7.36 – 7.29 (m, 5H), 3.86 (dd, 1H, J = 14.5, 22.5 Hz), 3.70 (dd, 1H, J = 
14.6, 22.2 Hz); 
13C NMR (126 MHz, CDCl3) δ 190.0 (d, J = 29.8 Hz), 133.9, 132.6, 132.1 (d, J = 
3.8 Hz), 131.2, 130.4 (d, J = 5.5 Hz), 128.4 (d, J = 0.6 Hz), 128.3, 127.6, 109.0 (d, J = 
262.1 Hz), 45.1 (d, J = 20.8 Hz); 
19F NMR (282 MHz, CDCl3) δ −114.9 (t, 1F, J = 22.4 Hz); 
FT-IR (film) 3065, 3033, 1694, 1598, 1497, 1455, 1448, 1264, 1135, 893, 853, 
749 cm-1; 
GC-MS (EI) m/z (M+−Cl) calcd for C15H12FO: 227, found: 227. 
 
2.6.3 Asymmetric Negishi Cross-Couplings 
General procedure for the preparation of solutions of the arylzinc reagent 
(0.30 M): In the air, ZnCl2 (Aldrich; reagent grade, ≥98%; dried with a heat gun under 
high vacuum for 20 min before the reaction; 2.04 g, 15.0 mmol; 1.50 equiv) was added 
	 43 
quickly to an oven-dried 20 mL vial equipped with a stir bar. The vial was closed with a 
PTFE septum cap and then evacuated and back-filled with nitrogen (three cycles). THF 
(8.5 mL) was added to this vial, and the resulting mixture was stirred vigorously until the 
ZnCl2 had completely dissolved. THF was then added to provide a 1.50 M solution of 
ZnCl2. Next, an oven-dried 40 mL vial equipped with a stir bar was charged with the aryl 
bromide (9.00 mmol) and then closed with a PTFE septum cap. The vial was evacuated 
and back-filled with nitrogen (three cycles), and then THF (6.5 mL) was added to this 
vial. 
A solution of n-BuLi (2.61 M; 3.45 mL, 9.00 mmol; 1.00 equiv) was added over 
~5 min to the vial that contained the solution of the aryl bromide, which had been cooled 
to −78 °C. The mixture was allowed to stir at −78 °C for another 5 min, and then the 
solution of ZnCl2 (1.50 M; 9.00 mL, 13.5 mmol; 1.50 equiv) was added to the vial. The 
mixture was allowed to warm to r.t., and then it was stirred for 40 min at r.t. 
The arylzinc solution was titrated using I2 according to Knochel’s method25 
(concentration ~0.4 M). This solution was then diluted with THF to generate a 0.30 M 
solution in an oven-dried 40 mL vial. 
  
General procedure for asymmetric Negishi cross-couplings: In the air, 
NiCl2•glyme (33.0 mg, 0.150 mmol) and (4R,5S)-L1 (73.4 mg, 0.160 mmol) were added 
to an oven-dried 40 mL vial equipped with a stir bar. The vial was closed with a PTFE 
septum cap and then evacuated and back-filled with nitrogen (three cycles). Diglyme (2.5 
mL) was added to the vial, and the mixture was vigorously stirred at r.t. for 45 min. In the 
air, an oven-dried 4 mL vial was charged with the α-bromo-α-fluoroketone (1.00 mmol), 
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and then the vial was sparged with nitrogen for 10 min. Diglyme (0.9 mL) was added, 
and the resulting solution was transferred via syringe to the 40 mL reaction vial. The 4 
mL vial was rinsed with diglyme (0.8 mL × 2), and the washings were transferred to the 
reaction vial. The reaction vial was wrapped with electrical tape and then cooled to −25 
°C for 15 min; at the same time, an oven-dried 40 mL vial that contained the arylzinc 
solution (0.30 M) was also cooled to −25 °C for 15 min (a nitrogen-filled balloon was 
attached to each vial). To the vigorously stirred solution of catalyst and electrophile was 
added the solution of the arylzinc reagent (0.30 M; 6.67 mL, 2.00 mmol; 2.00 equiv) over 
3 min, during which the reaction mixture turned to orange. The balloon was removed, 
and the septum cap was sealed with grease.  The mixture was stirred vigorously at −25 °C 
for 36 h. Then, the reaction was quenched by the addition of EtOH (2 mL), and the 
mixture was allowed to warm to r.t. and then diluted with Et2O (100 mL) and washed 
with deionized water (25 mL × 4). The organic layer was dried over Na2SO4 and then 
concentrated, and the residue was purified by flash chromatography. 
A second run was performed with the (4S,5R)-L1. 
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(S)-2-Fluoro-1,2-diphenylbutan-1-one (Table 2.2, Entry 1) [1355165-74-0]. 2-
Bromo-2-fluoro-1-phenylbutan-1-one (245 mg, 1.00 mmol) and the arylzinc chloride 
reagent prepared from bromobenzene were used. Solvent system for chromatography: (1) 
normal-phase silica, 5%→7.5%→10%→12.5% dichloromethane in hexane; (2) reverse-
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phase silica (C-18), 40%→50% MeCN in water. The title compound was isolated as a 
colorless oil. 
Run 1, 151 mg (62% yield, 97% ee); Run 2, 150 mg (62% yield, 97% ee). 
The ee was determined on an AD-H column (0.25% i-PrOH/hexane, flow rate 0.8 
mL/min); retention times for compound obtained using (4R,5S)-L1: 8.4 min (minor), 14.1 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.90 – 7.87 (m, 2H), 7.52 – 7.47 (m, 3H), 7.41 – 
7.30 (m, 5H), 2.51 – 2.39 (m, 1H), 2.26 – 2.14 (m, 1H), 0.93 (t, 3H, J = 7.4 Hz); 
13C NMR (126 MHz, CDCl3) δ 198.5 (d, J = 28.2 Hz), 138.8 (d, J = 22.1 Hz), 
135.1 (d, J = 3.5 Hz), 132.9, 129.9 (d, J = 6.4 Hz), 128.7 (d, J = 1.8 Hz), 128.1, 124.1 (d, 
J = 9.3 Hz), 103.7 (d, J = 189.5 Hz), 32.8 (d, J = 23.7 Hz), 7.5 (d, J = 4.2 Hz); 
19F NMR (282 MHz, CDCl3) δ −165.2 (t, 1F, J = 24.6 Hz); 
FT-IR (film) 3061, 2978, 2940, 1683, 1447, 1259, 974, 858, 842, 754, 709 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C16H15FNaO: 265, found: 265; 
[α]25D = −176° (c = 1.00, CHCl3); 97% ee, from (4R,5S)-L1. 
The spectral data are in agreement with literature data.9d 
 
F Ph
O
Ph Ph
 
(S)-2-Fluoro-1,2,3-triphenylpropan-1-one (Table 2.2, Entry 2). 2-Bromo-2-
fluoro-1,3-diphenylpropan-1-one (307 mg, 1.00 mmol) and the arylzinc chloride reagent 
prepared from bromobenzene were used. Solvent system for chromatography: 20:1→10:1 
hexane/dichloromethane. The title compound was isolated as a white solid. 
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Run 1, 224 mg (74% yield, 98% ee); Run 2, 218 mg (72% yield, 97% ee). 
This compound was also prepared on a 7.00 mmol scale (eq 2.9), using 2-bromo-
2-fluoro-1,3-diphenylpropan-1-one (2.15 g, 7.00 mmol) and the arylzinc chloride reagent 
prepared from bromobenzene (0.30 M, 46.7 mL, 14.0 mmol; 2.00 equiv). Following the 
general procedure, the title compound was isolated in 66% yield (1.41 g) and 97% ee. 
The ee was determined on an AD-H column (2% i-PrOH/hexane, flow rate 0.6 
mL/min); retention times for compound obtained using (4R,5S)-L1: 12.4 min (minor), 
14.3 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.79 – 7.76 (m, 2H), 7.46 – 7.42 (m, 3H), 7.37 – 
7.29 (m, 5H), 7.20 – 7.17 (m, 3H), 7.09 – 7.07 (m, 2H), 3.74 (dd, 1H, J = 14.4, 24.7 Hz), 
3.47 (dd, 1H, J = 14.4, 26.1 Hz); 
13C NMR (126 MHz, CDCl3) δ 198.1 (d, J = 28.1 Hz), 138.3 (d, J = 22.1 Hz), 
135.0 (d, J = 3.5 Hz), 134.6, 132.9, 130.9, 129.9 (d, J = 6.2 Hz), 128.6 (d, J = 2.1 Hz), 
128.3 (d, J = 0.7 Hz), 128.1, 127.8, 126.7, 124.2 (d, J = 9.0 Hz), 102.7 (d, J = 191.7 Hz), 
45.5 (d, J = 22.5 Hz); 
19F NMR (282 MHz, CDCl3) δ −160.9 (t, 1F, J = 25.4 Hz); 
FT-IR (film) 3062, 3031, 1686, 1598, 1496, 1447, 1261, 1075, 1029, 942, 763 
cm-1; 
MS (ESI) m/z (M+Na+) calcd for C21H17FNaO: 327, found: 327; 
[α]25D = −215° (c = 1.03, CHCl3); 98% ee, from (4R,5S)-L1. 
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(S)-2-Fluoro-1,2-diphenylpent-4-en-1-one (Table 2.2, Entry 3). 2-Bromo-2-
fluoro-1-phenylpent-4-en-1-one (257 mg, 1.00 mmol) and the arylzinc chloride reagent 
prepared from bromobenzene were used. Solvent system for chromatography: 25:1→10:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 104 mg (41% yield, 97% ee); Run 2, 115 mg (45% yield, 96% ee). 
The ee was determined on an AD-H column (0.25% i-PrOH/hexane, flow rate 0.6 
mL/min); retention times for compound obtained using (4R,5S)-L1: 12.5 min (minor), 
19.5 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.89 – 7.87 (m, 2H), 7.51 – 7.46 (m, 3H), 7.41 – 
7.31 (m, 5H), 5.73 (ddt, 1H, J = 7.0, 10.2, 17.2 Hz), 5.15 – 5.08 (m, 2H), 3.18 (dddt, 1H, 
J = 1.2, 7.0, 14.8, 25.7 Hz), 2.94 (dddt, 1H, J = 1.3, 7.0, 14.8, 24.3 Hz); 
13C NMR (126 MHz, CDCl3) δ 197.8 (d, J = 27.9 Hz), 138.4 (d, J = 22.2 Hz), 
134.8 (d, J = 3.6 Hz), 133.0, 131.1 (d, J = 3.4 Hz), 130.0 (d, J = 6.3 Hz), 128.7 (d, J = 1.9 
Hz), 128.3, 128.1, 124.1 (d, J = 9.2 Hz), 119.7, 102.5 (d, J = 190.4 Hz), 44.0 (d, J = 22.8 
Hz); 
19F NMR (282 MHz, CDCl3) δ −161.8 (t, 1F, J = 24.9 Hz); 
FT-IR (film) 3074, 3028, 1687, 1598, 1448, 1259, 1239, 923, 759, 723 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C17H15FNaO: 277, found: 277; 
[α]25D = −208° (c = 1.00, CHCl3); 97% ee, from (4R,5S)-L1. 
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(S)-3-Cyclopentyl-2-fluoro-1,2-diphenylpropan-1-one (Table 2.2, Entry 4). 2-
Bromo-3-cyclopentyl-2-fluoro-1-phenylpropan-1-one (299 mg, 1.00 mmol) and the 
arylzinc chloride reagent prepared from bromobenzene were used. Solvent system for 
chromatography: (1) normal-phase silica, 5%→10% dichloromethane in hexane; (2) 
reverse-phase silica (C-18), 70% MeCN in water. The title compound was isolated as a 
colorless oil. 
Run 1, 174 mg (59% yield, 91% ee); Run 2, 175 mg (59% yield, 90% ee). 
The ee was determined on an AD-H column (0.25% i-PrOH/hexane, flow rate 0.8 
mL/min); retention times for compound obtained using (4R,5S)-L1: 11.5 min (minor), 
14.8 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.89 – 7.87 (m, 2H), 7.54 – 7.42 (m, 2H), 7.50 – 
7.46 (m, 1H), 7.41 – 7.30 (m, 5H), 2.48 (ddd, 1H, J = 6.2, 14.8, 25.8 Hz), 2.31 (ddd, 1H, 
J = 5.6, 14.8, 26.7 Hz), 1.84 – 1.77 (m, 2H), 1.64 – 1.51 (m, 3H), 1.47 – 1.36 (m, 2H), 
1.19 – 1.03 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 198.9 (d, J = 28.4 Hz), 139.3 (d, J = 22.6 Hz), 
135.1 (d, J = 3.4 Hz), 132.8, 129.9 (d, J = 6.3 Hz), 128.7 (d, J = 1.9 Hz), 128.1, 128.0, 
124.1 (d, J = 9.2 Hz), 104.0 (d, J = 190.3 Hz), 45.2 (d, J = 22.1 Hz), 35.7, 33.7 (dd, J = 
1.4, 9.7 Hz), 24.8 (d, J = 17.0 Hz). 
19F NMR (282 MHz, CDCl3) δ −162.3 (t, 1F, J = 26.2 Hz); 
FT-IR (film) 3061, 2952, 2868, 1687, 1683, 1598, 1447, 1259, 757, 712 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C20H21FNaO: 319, found: 319; 
[α]25D = −154° (c = 1.02, CHCl3); 91% ee, from (4R,5S)-L1. 
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(S)-2-Fluoro-3-methyl-1,2-diphenylbutan-1-one (Table 2.2, Entry 5). 2-
Bromo-2-fluoro-3-methyl-1-phenylbutan-1-one (259 mg, 1.00 mmol) and the arylzinc 
chloride reagent prepared from bromobenzene were used. Solvent system for 
chromatography: 25:1 hexane/dichloromethane. The title compound was isolated as a 
colorless oil. 
Run 1, 142 mg (55% yield, 83% ee); Run 2, 140 mg (55% yield, 81% ee). 
The ee was determined on an AD-H column (0.25% i-PrOH/hexane, flow rate 0.6 
mL/min); retention times for compound obtained using (4R,5S)-L1: 10.6 min (minor), 
17.0 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.89 – 7.86 (m, 2H), 7.57 – 7.54 (m, 2H), 7.50 – 
7.46 (m, 1H), 7.41 – 7.35 (m, 4H), 7.32 – 7.29 (m, 1H), 2.87 (ddq, 1H, J = 6.8, 13.7, 32.1 
Hz), 1.09 (d, 3H, J = 6.7 Hz), 0.74 (d, 3H, J = 7.0 Hz); 
13C NMR (126 MHz, CDCl3) δ 200.1 (d, J = 29.3 Hz), 138.2 (d, J = 22.5 Hz), 
136.0 (d, J = 3.4 Hz), 132.7, 129.6 (d, J = 6.3 Hz), 128.6 (d, J = 2.2 Hz), 128.1 (d, J = 0.8 
Hz), 128.0, 124.4 (d, J = 10.1 Hz), 106.0 (d, J = 194.8 Hz), 36.6 (d, J = 22.6 Hz), 17.2 (d, 
J = 4.6 Hz), 15.8 (d, J = 3.1 Hz); 
19F NMR (282 MHz, CDCl3) δ −180.3 (d, 1F, J = 32.1 Hz); 
FT-IR (film) 2973, 1685, 1598, 1447, 1259, 1012, 836, 749 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C17H17FNaO: 279, found: 279; 
[α]25D = −94.0° (c = 1.00, CHCl3); 83% ee, from (4R,5S)-L1. 
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(S)-4-Chloro-2-fluoro-1,2-diphenylbutan-1-one (Table 2.2, Entry 6). 2-
Bromo-4-chloro-2-fluoro-1-phenylbutan-1-one (280 mg, 1.00 mmol) and the arylzinc 
chloride reagent prepared from bromobenzene were used. Solvent system for 
chromatography: 25:1 hexane/dichloromethane. The title compound was isolated as a 
colorless oil. 
Run 1, 171 mg (62% yield, 98% ee); Run 2, 168 mg (61% yield, 98% ee). 
The ee was determined on an AD-H column (0.25% i-PrOH/hexane, flow rate 0.6 
mL/min); retention times for compound obtained using (4R,5S)-L1: 15.9 min (minor), 
24.0 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.89 – 7.87 (m, 2H), 7.51 – 7.48 (m, 3H), 7.43 – 
7.40 (m, 2H), 7.38 – 7.33 (m, 3H), 3.60 (td, 1H, J = 5.6, 10.8 Hz), 3.45 (td, 1H, J = 4.9, 
10.7 Hz), 2.91 (dddd, 1H, J = 5.6, 10.8, 14.5, 23.5 Hz), 2.70 (dddd, 1H, J = 4.9, 10.9, 
14.5, 22.9 Hz); 
13C NMR (126 MHz, CDCl3) δ 196.6 (d, J = 27.4 Hz), 137.6 (d, J = 21.8 Hz), 
134.1 (d, J = 3.5 Hz), 133.0, 130.1 (d, J = 5.7 Hz), 129.1 (d, J = 2.1 Hz), 128.7, 128.3 (d, 
J = 0.6 Hz), 123.8 (d, J = 9.1 Hz), 102.1 (d, J = 190.5 Hz), 42.6 (d, J = 22.6 Hz), 38.6 (d, 
J = 5.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −163.2 (t, 1F, J = 23.2 Hz); 
FT-IR (film) 3061, 2971, 1686, 1597, 1448, 1265, 1065, 758, 709 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C16H14ClFNaO: 299, found: 299; 
[α]25D = −201° (c = 0.99, CHCl3); 98% ee, from (4R,5S)-L1. 
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(S)-2-Fluoro-1-(4-methoxyphenyl)-2,3-diphenylpropan-1-one (Table 2.3, 
Entry 1). 2-Bromo-2-fluoro-1-(4-methoxyphenyl)-3-phenylpropan-1-one (337 mg, 1.00 
mmol) and the arylzinc chloride reagent prepared from bromobenzene were used. Solvent 
system for chromatography: 8:1→3:1 hexane/dichloromethane. The title compound was 
isolated as a white solid. 
Run 1, 205 mg (61% yield, 97% ee); Run 2, 212 mg (63% yield, 95% ee). 
The ee was determined on an AD-H column (2% i-PrOH/hexane, flow rate 0.8 
mL/min); retention times for compound obtained using (4R,5S)-L1: 23.7 min (minor), 
25.1 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.87 – 7.83 (m, 2H), 7.40 – 7.38 (m, 2H), 7.34 – 
7.27 (m, 3H), 7.18 – 7.15 (m, 3H), 7.07 – 7.04 (m, 2H), 6.80 – 6.77 (m, 2H), 3.79 (s, 3H), 
3.71 (dd, 1H, J = 14.4, 23.8 Hz), 3.45 (dd, 1H, J = 14.4, 27.0 Hz); 
13C NMR (126 MHz, CDCl3) δ 195.9 (d, J = 26.8 Hz), 163.3, 138.7 (d, J = 22.2 
Hz), 134.8, 132.6 (d, J = 6.7 Hz), 130.9, 128.5 (d, J = 2.0 Hz), 128.1, 127.8, 127.5 (d, J = 
3.6 Hz), 126.6, 124.2 (d, J = 8.9 Hz), 113.4 (d, J = 1.2 Hz), 102.8 (d, J = 191.7 Hz), 55.3, 
45.4 (d, J = 22.6 Hz); 
19F NMR (282 MHz, CDCl3) δ −160.1 (t, 1F, J = 25.2 Hz); 
FT-IR (film) 3031, 1676, 1600, 1259, 1175, 1030, 839, 751 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C22H19FNaO2: 357, found: 357; 
[α]25D = −157° (c = 0.98, CHCl3); 97% ee, from (4R,5S)-L1. 
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  (S)-1-(4-(tert-Butyl)phenyl)-4-chloro-2-fluoro-2-phenylbutan-1-one (Table 
2.3, Entry 2). 2-Bromo-1-(4-(tert-butyl)phenyl)-4-chloro-2-fluorobutan-1-one (336 mg, 
1.00 mmol) and the arylzinc chloride reagent prepared from bromobenzene were used. 
Solvent system for chromatography: 25:1 hexane/dichloromethane. The title compound 
was isolated as a colorless oil. 
Run 1, 245 mg (74% yield, 98% ee); Run 2, 257 mg (77% yield, 98% ee). 
The ee was determined on an AD-H column (0.25% i-PrOH/hexane, flow rate 0.6 
mL/min); retention times for compound obtained using (4R,5S)-L1: 17.1 min (minor), 
23.2 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.85 – 7.83 (m, 2H), 7.50 – 7.47 (m, 2H), 7.42 – 
7.32 (m, 5H), 3.59 (td, 1H, J = 5.5, 10.8 Hz), 3.45 (td, 1H, J = 4.9, 10.8 Hz), 2.90 (dddd, 
1H, J = 5.5, 10.9, 14.5, 23.8 Hz), 2.68 (dddd, 1H, J = 4.9, 11.0, 14.4, 22.6 Hz), 1.28 (s, 
9H); 
13C NMR (126 MHz, CDCl3) δ 196.0 (d, J = 26.8 Hz), 157.2, 137.8 (d, J = 22.0 
Hz), 131.4 (d, J = 3.5 Hz), 130.2 (d, J = 6.0 Hz), 129.0 (d, J = 1.8 Hz), 128.6, 125.3, 
123.8 (d, J = 9.1 Hz), 102.2 (d, J = 190.5 Hz), 42.6 (d, J = 22.6 Hz), 38.7 (d, J = 5.0 Hz), 
35.1, 30.9; 
19F NMR (282 MHz, CDCl3) δ −162.9 (t, 1F, J = 23.3 Hz); 
FT-IR (film) 2965, 1681, 1605, 1449, 1269, 1106, 707 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C20H22ClFNaO: 355, found: 355; 
[α]25D = +124° (c = 1.02, CHCl3); 98% ee, from (4S,5R)-L1. 
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(S)-1-([1,1'-Biphenyl]-4-yl)-2-fluoro-2-phenylbutan-1-one (Table 2.3, Entry 
3). 1-([1,1'-Biphenyl]-4-yl)-2-bromo-2-fluorobutan-1-one (321 mg, 1.00 mmol) and the 
arylzinc chloride reagent prepared from bromobenzene were used. Solvent system for 
chromatography: 20:1→10:1 hexane/dichloromethane. The title compound was isolated 
as a colorless oil. 
Run 1, 161 mg (51% yield, 96% ee); Run 2, 181 mg (57% yield, 95% ee). 
The ee was determined on an AD-H column (2% i-PrOH/hexane, flow rate 0.8 
mL/min); retention times for compound obtained using (4R,5S)-L1: 13.9 min (minor), 
17.6 min (major). 
1H NMR (500 MHz, CDCl3) δ 8.01 – 7.99 (m, 2H), 7.60 – 7.53 (m, 6H), 7.46 – 
7.32 (m, 6H), 2.48 (ddq, 1H, J = 7.3, 14.6, 24.9 Hz), 2.23 (ddq, 1H, J = 7.4, 14.8, 24.4 
Hz), 0.95 (t, 3H, J = 7.3 Hz); 
13C NMR (126 MHz, CDCl3) δ 197.8 (d, J = 27.9 Hz), 145.6, 139.9, 138.8 (d, J = 
22.2 Hz), 133.7 (d, J = 3.8 Hz), 130.6 (d, J = 6.7 Hz), 128.9, 128.7 (d, J = 1.8 Hz), 128.2, 
128.1, 127.2, 126.8 (d, J = 0.9 Hz), 124.1 (d, J = 8.8 Hz), 103.8 (d, J = 189.5 Hz), 32.8 
(d, J = 23.8 Hz), 7.5 (d, J = 4.6 Hz). 
19F NMR (282 MHz, CDCl3) δ −165.0 (t, 1F, J = 24.7 Hz); 
FT-IR (film) 3059, 3030, 2978, 2939, 2882, 1681, 1604, 1448, 1259, 1008, 857, 
760, 748, 738 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C22H19FNaO: 341, found: 341; 
[α]25D = −46.2° (c = 1.02, CHCl3); 96% ee, from (4R,5S)-L1. 
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  (S)-4-Chloro-2-fluoro-1-(4-fluorophenyl)-2-phenylbutan-1-one (Table 2.3, 
Entry 4). 2-Bromo-4-chloro-2-fluoro-1-(4-fluorophenyl)butan-1-one (298 mg, 1.00 
mmol) and the arylzinc chloride reagent prepared from bromobenzene were used. Solvent 
system for chromatography: 25:1 hexane/dichloromethane. The title compound was 
isolated as a colorless oil. 
Run 1, 181 mg (61% yield, 97% ee); Run 2, 192 mg (65% yield, 97% ee). 
The ee was determined on an AD-H column (0.25% i-PrOH/hexane, flow rate 0.6 
mL/min); retention times for compound obtained using (4R,5S)-L1: 17.5 min (minor), 
20.9 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.94 (ddd, 2H, J = 1.7, 5.4, 9.0 Hz), 7.47 – 7.34 
(m, 5H), 7.04 – 7.01 (m, 2H), 3.59 (td, 1H, J = 5.6, 10.7 Hz), 3.44 (td, 1H, J = 4.9, 10.7 
Hz), 2.90 (dddd, 1H, J = 5.6, 10.7, 14.5, 23.4 Hz), 2.70 (dddd, 1H, J = 4.9, 10.8, 14.5, 
23.2 Hz); 
13C NMR (126 MHz, CDCl3) δ 194.8 (d, J = 27.1 Hz), 165.7 (d, J = 256.6 Hz), 
137.4 (d, J = 22.0 Hz), 133.0 (dd, J = 6.6, 9.5 Hz), 130.3 (t, J = 3.4 Hz), 129.1 (d, J = 2.0 
Hz), 128.8 (d, J = 0.9 Hz), 123.7 (d, J = 9.1 Hz), 115.5 (d, J = 21.5 Hz), 102.2 (d, J = 
190.3 Hz), 42.4 (d, J = 22.6), 38.5 (d, J = 5.1 Hz); 
19F NMR (282 MHz, CDCl3) δ −103.9 (m, 1F), −163.0 (t, 1F, J = 23.3 Hz); 
FT-IR (film) 1685, 1599, 1506, 1449, 1263, 1239, 1160, 845, 743 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C16H13ClF2NaO: 317, found: 317; 
[α]25D = +174° (c = 1.06, CHCl3); 97% ee, from (4S,5R)-L1. 
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(S)-2-Fluoro-1-(3-methoxyphenyl)-2-phenylbutan-1-one (Table 2.3, Entry 5). 
2-Bromo-2-fluoro-1-(3-methoxyphenyl)butan-1-one (275 mg, 1.00 mmol) and the 
arylzinc chloride reagent prepared from bromobenzene were used. Solvent system for 
chromatography: 10:1→5:1 hexane/dichloromethane. The title compound was isolated as 
a white solid. 
Run 1, 154 mg (57% yield, 97% ee); Run 2, 140 mg (51% yield, 97% ee). 
The ee was determined on an AD-H column (2% i-PrOH/hexane, flow rate 0.6 
mL/min); retention times for compound obtained using (4R,5S)-L1: 9.9 min (minor), 11.6 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.51 – 7.48 (m, 3H), 7.42 – 7.37 (m, 3H), 7.33 – 
7.30 (m, 1H), 7.27 – 7.24 (m, 1H), 7.03 (ddd, 1H, J = 1.0, 2.7, 8.2 Hz), 3.78 (s, 3H), 2.45 
(ddq, 1H, J = 7.3, 14.6, 24.6 Hz), 2.20 (ddq, 1H, J = 7.4, 14.7, 24.5 Hz), 0.93 (t, 3H, J = 
7.3 Hz); 
13C NMR (126 MHz, CDCl3) δ 198.1 (d, J = 28.6 Hz), 159.2, 138.8 (d, J = 22.1 
Hz), 136.2 (d, J = 3.5 Hz), 129.1 (d, J = 1.5 Hz), 128.7 (d, J = 1.8 Hz), 128.1, 124.0 (d, J 
= 9.0 Hz), 122.6 (d, J = 7.6 Hz), 119.4, 114.2 (d, J = 5.0 Hz), 103.6 (d, J = 190.0 Hz), 
55.3, 32.7 (d, J = 23.7 Hz), 7.4 (d, J = 4.5 Hz); 
19F NMR (282 MHz, CDCl3) δ −165.2 (t, 1F, J = 24.6 Hz); 
FT-IR (film) 2975, 2942, 1686, 1579, 1446, 1431, 1270, 1218, 763, 734 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C17H17FNaO2: 295, found: 295; 
[α]25D = −158° (c = 1.03, CHCl3); 97% ee, from (4R,5S)-L1. 
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  (S)-2-Fluoro-1-(3-fluorophenyl)-2,3-diphenylpropan-1-one (Table 2.3, Entry 
6). 2-Bromo-2-fluoro-1-(3-fluorophenyl)-3-phenylpropan-1-one (325 mg, 1.00 mmol) 
and the arylzinc chloride reagent prepared from bromobenzene were used. Solvent 
system for chromatography: 7.5%→10%→12.5% dichloromethane in hexane. The title 
compound was isolated as a white solid. 
Run 1, 197 mg (61% yield, 97% ee); Run 2, 185 mg (57% yield, 97% ee). 
The ee was determined on an AD-H column (0.25% i-PrOH/hexane, flow rate 0.8 
mL/min); retention times for compound obtained using (4R,5S)-L1: 12.4 min (minor), 
14.0 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.56 (dtd, 1H, J = 1.0, 1.7, 7.8 Hz), 7.46 (ddt, 1H, 
J = 1.5, 2.8, 9.7 Hz), 7.43 – 7.41 (m, 2H), 7.38 – 7.26 (m, 4H), 7.21 – 7.18 (m, 3H), 7.15 
(tdd, 1H, J = 1.0, 2.7, 8.3 Hz), 7.10 – 7.07 (m, 2H), 3.73 (dd, 1H, J = 14.4, 25.3 Hz), 3.45 
(dd, 1H, J = 14.4, 25.7 Hz); 
13C NMR (126 MHz, CDCl3) δ 196.8 (dd, J = 2.3, 28.4 Hz), 162.1 (d, J = 247.2 
Hz), 137.9 (d, J = 22.1 Hz), 136.7 (dd, J = 3.5, 6.6 Hz), 134.4, 130.9 (d, J = 0.7 Hz), 
129.7 (d, J = 7.9 Hz), 128.7 (d, J = 1.9 Hz), 128.5, 127.9, 126.8, 125.7 (dd, J = 3.2, 6.7 
Hz), 124.2 (d, J = 8.9 Hz), 119.9 (d, J = 21.4 Hz), 116.7 (dd, J = 6.3, 23.1 Hz), 102.8 (d, 
J = 191.8 Hz), 45.5 (d, J = 22.2 Hz). 
19F NMR (282 MHz, CDCl3) δ −112.2 (m, 1F), −161.3 (t, 1F, J = 25.5 Hz); 
FT-IR (film) 1687, 1643, 1586, 1438, 1269, 770, 733 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C21H16F2NaO: 345, found: 345; 
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[α]25D = +192° (c = 0.98, CHCl3); 97% ee, from (4S,5R)-L1. 
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(S)-1-(3,5-Dimethylphenyl)-2-fluoro-2-phenylbutan-1-one (Table 2.3, Entry 
7). 2-Bromo-1-(3,5-dimethylphenyl)-2-fluorobutan-1-one (273 mg, 1.00 mmol) and the 
arylzinc chloride reagent prepared from bromobenzene were used. Solvent system for 
chromatography: 20:1 hexane/dichloromethane. The title compound was isolated as a 
colorless oil. 
Run 1, 166 mg (61% yield, 97% ee); Run 2, 187 mg (69% yield, 96% ee). 
The ee was determined on an AD-H column (0.05% i-PrOH/hexane, flow rate 0.3 
mL/min); retention times for compound obtained using (4R,5S)-L1: 21.2 min (minor), 
22.3 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.53 – 7.49 (m, 4H), 7.41 – 7.38 (m, 2H), 7.34 – 
7.30 (m, 1H), 7.13 – 7.12 (m, 1H), 2.44 (ddq, 1H, J = 7.3, 14.7, 25.4 Hz), 2.29 (s, 6H), 
2.19 (ddq, 1H, J = 7.4, 14.7, 23.8 Hz), 0.93 (t, 3H, J = 7.4 Hz); 
13C NMR (126 MHz, CDCl3) δ 199.0 (d, J = 28.2 Hz), 138.9 (d, J = 22.1 Hz), 
137.7, 135.2 (d, J = 3.4 Hz), 134.6, 128.6 (d, J = 1.8 Hz), 128.0 (d, J = 1.0 Hz), 127.6 (d, 
J = 6.3 Hz), 124.1 (d, J = 9.2 Hz), 103.7 (d, J = 189.9 Hz), 32.9 (d, J = 23.7 Hz), 21.2, 
7.5 (d, J = 4.4 Hz); 
19F NMR (282 MHz, CDCl3) δ −165.0 (t, 1F, J = 24.6 Hz); 
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FT-IR (film) 2977, 2923, 1682, 1604, 1448, 1303, 1207, 1060, 975, 762, 733 cm-
1; 
MS (ESI) m/z (M+Na+) calcd for C18H19FNaO: 293, found: 293; 
[α]25D = −132° (c = 1.02, CHCl3); 97% ee, from (4R,5S)-L1. 
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(S)-2-Fluoro-1-(2-methoxyphenyl)-2-phenylbutan-1-one (Table 2.3, Entry 8). 
2-Bromo-2-fluoro-1-(2-methoxyphenyl)butan-1-one (275 mg, 1.00 mmol) and the 
arylzinc chloride reagent prepared from bromobenzene were used. Solvent system for 
chromatography: 10:1→5:1 hexane/dichloromethane. The title compound was isolated as 
a light-yellow oil. 
Run 1, 174 mg (64% yield, 92% ee); Run 2, 160 mg (59% yield, 92% ee). 
The ee was determined on an AD-H column (2% i-PrOH/hexane, flow rate 0.6 
mL/min); retention times for compound obtained using (4R,5S)-L1: 11.4 min (minor), 
26.7 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.53 – 7.50 (m, 2H), 7.41 – 7.36 (m, 3H), 7.34 – 
7.31 (m, 1H), 7.06 (ddd, 1H, J = 0.8, 1.7, 7.7 Hz), 6.91 – 6.88 (m, 2H), 3.67 (s, 3H), 2.46 
(ddq, 1H, J = 7.3, 14.6, 24.3 Hz), 2.20 (ddq, 1H, J = 7.4, 14.7, 24.0 Hz), 0.94 (t, 3H, J = 
7.4 Hz); 
13C NMR (126 MHz, CDCl3) δ 204.4 (d, J = 33.4 Hz), 157.2 (d, J = 1.5 Hz), 
138.6 (d, J = 22.8 Hz), 131.9, 128.4 (d, J = 3.1 Hz), 128.2 (d, J = 2.0 Hz), 128.0 (d, J = 
	 59 
2.2 Hz), 127.7, 124.5 (d, J = 9.6 Hz), 120.0, 111.2, 103.0 (d, J = 190.4 Hz), 55.3, 33.0 (d, 
J = 23.1 Hz), 7.5 (d, J = 4.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −169.3 (t, 1F, J = 24.1 Hz); 
FT-IR (film) 2976, 2940, 1708, 1598, 1488, 1462, 1290, 1256, 1024, 754 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C17H17FNaO2: 295, found: 295; 
[α]25D = −96.5° (c = 1.03, CHCl3); 92% ee, from (4R,5S)-L1. 
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(S)-2-Fluoro-2,3-diphenyl-1-(o-tolyl)propan-1-one (Table 2.3, Entry 9). 2-
Bromo-2-fluoro-3-phenyl-1-(o-tolyl)propan-1-one (321 mg, 1.00 mmol) and the arylzinc 
chloride reagent prepared from bromobenzene were used. Solvent system for 
chromatography: 7.5%→10%→12.5% dichloromethane in hexane. The title compound 
was isolated as a colorless oil. 
Run 1, 219 mg (69% yield, 94% ee); Run 2, 224 mg (70% yield, 94% ee). 
The ee was determined on an AD-H column (2% i-PrOH/hexane, flow rate 0.8 
mL/min); retention times for compound obtained using (4R,5S)-L1: 6.9 min (minor), 9.0 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.60 – 7.57 (m, 2H), 7.45 – 7.41 (m, 2H), 7.40 – 
7.36 (m, 1H), 7.27 – 7.23 (m, 6H), 7.13 (dt, 1H, J = 0.7, 7.7 Hz), 7.03 – 6.99 (m, 1H), 
6.88 (ddd, 1H, J = 1.3, 3.2, 7.8 Hz), 3.82 (dd, 1H, J = 14.3, 31.1 Hz), 3.44 (dd, 1H, J = 
14.3, 19.8 Hz), 2.00 (s, 3H); 
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13C NMR (126 MHz, CDCl3) δ 203.5 (d, J = 31.8 Hz), 138.3 (d, J = 22.6 Hz), 
137.2, 136.4 (d, J = 2.5 Hz), 134.7, 131.1 (d, J = 1.1 Hz), 131.0, 130.5, 128.6 (d, J = 1.7 
Hz), 128.4, 128.0, 127.8 (d, J = 7.1 Hz), 126.9, 124.5, 124.4 (d, J = 9.5 Hz), 102.6 (d, J = 
192.8 Hz), 45.8 (d, J = 21.7 Hz), 19.5. 
19F NMR (282 MHz, CDCl3) δ −161.4 (ddd, 1F, J = 3.1, 19.8, 31.1 Hz); 
FT-IR (film) 3063, 3031, 2927, 1694, 1496, 1455, 1448, 1253, 934, 761, 746, 732 
cm-1; 
MS (ESI) m/z (M+Na+) calcd for C22H19FNaO: 341, found: 341; 
[α]25D = −138° (c = 1.03, CHCl3); 94% ee, from (4R,5S)-L1. 
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(S)-2-Fluoro-1-(naphthalen-2-yl)-2-phenylbutan-1-one (Table 2.3, Entry 10). 
2-Bromo-2-fluoro-1-(naphthalen-2-yl)butan-1-one (295 mg, 1.00 mmol) and the arylzinc 
chloride reagent prepared from bromobenzene were used. Solvent system for 
chromatography: 25:1→20:1 hexane/dichloromethane. The title compound was isolated 
as a colorless oil. 
Run 1, 145 mg (50% yield, 97% ee); Run 2, 151 mg (52% yield, 96% ee). 
The ee was determined on an AD-H column (0.5% i-PrOH/hexane, flow rate 0.6 
mL/min); retention times for compound obtained using (4R,5S)-L1: 16.0 min (minor), 
23.7 min (major). 
1H NMR (500 MHz, CDCl3) δ 8.51 (s, 1H), 7.95 (dt, 1H, J = 1.7, 8.7 Hz), 7.88 
(dd, 1H, J = 1.2, 8.2 Hz), 7.82 – 7.79 (m, 2H), 7.59 – 7.54 (m, 3H), 7.51 – 7.48 (m, 1H), 
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7.43 – 7.40 (m, 2H), 7.35 – 7.31 (m, 1H), 2.53 (ddq, 1H, J = 7.3, 14.6, 24.8 Hz), 2.27 
(ddq, 1H, J = 7.4, 14.7, 24.5 Hz), 0.98 (t, 3H, J = 7.3 Hz); 
13C NMR (126 MHz, CDCl3) δ 198.2 (d, J = 27.7 Hz), 138.9 (d, J = 22.2 Hz), 
135.3, 132.24 (d, J = 3.5 Hz), 132.18 (d, J = 1.2 Hz), 132.13 (d, J = 8.6 Hz), 129.8, 128.7 
(d, J = 1.8 Hz), 128.5, 128.1, 127.8, 127.6, 126.5, 125.4 (d, J = 4.5 Hz), 124.1 (d, J = 8.9 
Hz), 103.9 (d, J = 189.6 Hz), 32.8 (d, J = 23.6 Hz), 7.5 (d, J = 4.5 Hz). 
19F NMR (282 MHz, CDCl3) δ −164.6 (t, 1F, J = 24.6 Hz); 
FT-IR (film) 3060, 2978, 2940, 1681, 1627, 1448, 1278, 775, 762, 749 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C20H17FNaO: 315, found: 315; 
[α]25D = −10.2° (c = 1.05, CHCl3); 97% ee, from (4R,5S)-L1. 
 
F
O
Ph Ph
OTBS  
(S)-2-(4-((tert-Butyldimethylsilyl)oxy)phenyl)-2-fluoro-1,3-diphenylpropan-1-
one (Table 2.4, Entry 1). 2-Bromo-2-fluoro-1,3-diphenylpropan-1-one (307 mg, 1.00 
mmol) and the arylzinc chloride reagent prepared from (4-bromophenoxy)(tert-
butyl)dimethylsilane were used. Solvent system for chromatography: 20:1→10:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 300 mg (69% yield, 97% ee); Run 2, 277 mg (64% yield, 97% ee). 
The ee was determined of 2-fluoro-2-(4-hydroxyphenyl)-1,3-diphenylpropan-1-
one (obtained by deprotection of the TBS group with TBAF) on an AD-H column (10% 
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i-PrOH/hexane, flow rate 1.0 mL/min); retention times for compound obtained using 
(4R,5S)-L1: 16.0 min (minor), 18.4 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.78 – 7.76 (m, 2H), 7.46 – 7.43 (m, 1H), 7.33 – 
7.29 (m, 2H), 7.28 – 7.25 (m, 2H), 7.19 – 7.17 (m, 3H), 7.07 – 7.05 (m, 2H), 6.83 – 6.80 
(m, 2H), 3.68 (dd, 1H, J = 14.3, 24.0 Hz), 3.45 (dd, 1H, J = 14.4, 26.7 Hz), 0.98 (s, 9H), 
0.19 (s, 6H); 
13C NMR (126 MHz, CDCl3) δ 198.3 (d, J = 28.1 Hz), 155.7, 135.0 (d, J = 3.2 
Hz), 134.7, 132.8, 130.94 (d, J = 22.4 Hz), 130.94, 129.9 (d, J = 5.9 Hz), 128.0, 127.8, 
126.6, 125.6 (d, J = 8.5 Hz), 120.2 (d, J = 1.5 Hz), 102.6 (d, J = 190.7 Hz), 45.4 (d, J = 
22.7 Hz), 25.6, 18.2, −4.4 (d, J = 2.6 Hz). 
19F NMR (282 MHz, CDCl3) δ −159.6 (t, 1F, J = 25.4 Hz); 
FT-IR (film) 2955, 2929, 2857, 1686, 1606, 1508, 1260, 913, 839, 782, 698 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C27H31FNaO2Si: 457, found: 457; 
[α]25D = −156° (c = 1.05, CHCl3); 97% ee, from (4R,5S)-L1. 
 
Et
F
O
Ph
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(S)-2-Fluoro-2-(4-isopropylphenyl)-1-phenylbutan-1-one (Table 2.4, Entry 2). 
2-Bromo-2-fluoro-1-phenylbutan-1-one (245 mg, 1.00 mmol) and the arylzinc chloride 
reagent prepared from 1-bromo-4-isopropylbenzene were used. Solvent system for 
chromatography: 20:1 hexane/dichloromethane. The title compound was isolated as a 
light-yellow oil. 
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Run 1, 205 mg (72% yield, 97% ee); Run 2, 198 mg (70% yield, 97% ee). 
The ee was determined on an AD-H column (0.25% i-PrOH/hexane, flow rate 0.7 
mL/min); retention times for compound obtained using (4R,5S)-L1: 8.4 min (minor), 12.5 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.92 – 7.90 (m, 2H), 7.50 – 7.46 (m, 1H), 7.44 – 
7.41 (m, 2H), 7.38 – 7.35 (m, 2H), 7.26 – 7.24 (m, 2H), 2.93 – 2.88 (m, 1H), 2.45 (ddq, 
1H, J = 7.3, 14.6, 25.6 Hz), 2.19 (ddq, 1H, J = 7.4, 14.7, 23.6 Hz), 1.24 (dd, 6H, J = 1.4, 
6.9 Hz), 0.94 (t, 3H, J = 7.3 Hz); 
13C NMR (126 MHz, CDCl3) δ 198.7 (d, J = 28.4 Hz), 148.7, 136.1 (d, J = 22.1 
Hz), 135.2 (d, J = 3.4 Hz), 132.8, 130.0 (d, J = 6.3 Hz), 128.1, 126.7 (d, J = 1.8 Hz), 
124.1 (d, J = 9.0 Hz), 103.8 (d, J = 189.0 Hz), 33.7, 32.8 (d, J = 23.6 Hz), 23.9 (d, J = 2.7 
Hz), 7.5 (d, J = 4.6 Hz). 
19F NMR (282 MHz, CDCl3) δ −164.6 (t, 1F, J = 24.6 Hz); 
FT-IR (film) 2961, 2871, 1671, 1448, 1260, 1219, 826 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C19H21FNaO: 307, found: 307; 
[α]25D = +38.4° (c = 0.97, CHCl3); 97% ee, from (4S,5R)-L1. 
 
F
O
Ph Ph
F  
(S)-2-Fluoro-2-(4-fluorophenyl)-1,3-diphenylpropan-1-one (Table 2.4, Entry 
3). 2-Bromo-2-fluoro-1,3-diphenylpropan-1-one (307 mg, 1.00 mmol) and the arylzinc 
chloride reagent prepared from 1-bromo-4-fluorobenzene were used. The reaction was 
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run at −20 °C for 36 h. Solvent system for chromatography: 20:1→10:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 210 mg (65% yield, 94% ee); Run 2, 211 mg (65% yield, 93% ee). 
The ee was determined on an AD-H column (1% i-PrOH/hexane, flow rate 0.8 
mL/min); retention times for compound obtained using (4R,5S)-L1: 12.1 min (minor), 
14.4 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.77 – 7.74 (m, 2H), 7.48 – 7.45 (m, 1H), 7.41 – 
7.37 (m, 2H), 7.34 – 7.31 (m, 2H), 7.21 – 7.18 (m, 3H), 7.07 – 7.02 (m, 4H), 3.71 (dd, 
1H, J = 14.4, 23.8 Hz), 3.45 (dd, 1H, J = 14.4, 27.2 Hz); 
13C NMR (126 MHz, CDCl3) δ 198.1 (d, J = 27.8 Hz), 162.6 (d, J = 246.7 Hz), 
134.8 (d, J = 3.3 Hz), 134.3, 134.1 (dd, J = 3.1, 22.7 Hz), 133.0, 130.9, 129.9 (d, J = 6.2 
Hz), 128.1, 127.9, 126.8, 126.2 (t, J = 8.7 Hz), 115.6 (dd, J = 1.7, 21.8 Hz), 102.5 (d, J = 
192.3 Hz), 45.5 (d, J = 22.6 Hz). 
19F NMR (282 MHz, CDCl3) δ −113.7 (m, 1F), −159.8 (t, 1F, J = 25.4 Hz); 
FT-IR (film) 3064, 3031, 2927, 1686, 1508, 1260, 1236, 1162, 837 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C21H16F2NaO: 345, found: 345; 
[α]25D = +191° (c = 1.06, CHCl3); 93% ee, from (4S,5R)-L1. 
 
F
O
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(S)-2-(4-Chlorophenyl)-2-fluoro-1,3-diphenylpropan-1-one (Table 2.4, Entry 
4). 2-Bromo-2-fluoro-1,3-diphenylpropan-1-one (307 mg, 1.00 mmol) and the arylzinc 
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chloride reagent prepared from 1-bromo-4-chlorobenzene were used. The reaction was 
run at −20 °C for 36 h. Solvent system for chromatography: 20:1→10:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 232 mg (68% yield, 93% ee); Run 2, 243 mg (72% yield, 93% ee). 
The ee was determined on an AD-H column (1% i-PrOH/hexane, flow rate 0.8 
mL/min); retention times for compound obtained using (4R,5S)-L1: 13.3 min (minor), 
18.2 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.75 – 7.73 (m, 2H), 7.48 – 7.45 (m, 1H), 7.36 – 
7.30 (m, 6H), 7.20 – 7.18 (m, 3H), 7.07 – 7.05 (m, 2H), 3.70 (dd, 1H, J = 14.4, 23.7 Hz), 
3.44 (dd, 1H, J = 14.4, 27.2 Hz); 
13C NMR (126 MHz, CDCl3) δ 197.9 (d, J = 27.7 Hz), 136.8 (d, J = 22.8 Hz), 
134.7 (d, J = 3.5 Hz), 134.4, 134.2, 133.1, 130.9 (d, J = 1.0 Hz), 129.8 (d, J = 6.1 Hz), 
128.8 (d, J = 1.8 Hz), 128.2, 127.9, 126.9, 125.8 (d, J = 9.0 Hz), 102.4 (d, J = 192.6 Hz), 
45.4 (d, J = 22.4 Hz). 
19F NMR (282 MHz, CDCl3) δ −160.6 (t, 1F, J = 25.6 Hz); 
FT-IR (film) 3063, 3031, 1684, 1490, 1260, 1094, 1083, 733, 698 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C21H16ClFNaO: 361, found: 361; 
[α]25D = −195° (c = 1.00, CHCl3); 93% ee, from (4R,5S)-L1. 
 
F
O
Ph Ph
OTBS
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(S)-2-(3-((tert-Butyldimethylsilyl)oxy)phenyl)-2-fluoro-1,3-diphenylpropan-1-
one (Table 2.4, Entry 5). 2-Bromo-2-fluoro-1,3-diphenylpropan-1-one (307 mg, 1.00 
mmol) and the arylzinc chloride reagent prepared from (3-bromophenoxy)(tert-
butyl)dimethylsilane were used. Solvent system for chromatography: 15:1→10:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 338 mg (78% yield, 99% ee); Run 2, 334 mg (77% yield, 99% ee). 
The ee was determined of 2-fluoro-2-(3-hydroxyphenyl)-1,3-diphenylpropan-1-
one (obtained by deprotection of the TBS group with TBAF) on an AD-H column (10% 
i-PrOH/hexane, flow rate 1.0 mL/min); retention times for compound obtained using 
(4R,5S)-L1: 13.5 min (minor), 18.9 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.80 – 7.78 (m, 2H), 7.47 – 7.43 (m, 1H), 7.33 – 
7.29 (m, 2H), 7.21 – 7.16 (m, 4H), 7.08 – 7.06 (m, 2H), 7.00 – 6.97 (m, 1H), 6.89 – 6.88 
(m, 1H), 6.76 (ddd, 1H, J = 1.0, 2.4, 8.1 Hz), 3.68 (dd, 1H, J = 14.4, 22.9 Hz), 3.47 (dd, 
1H, J = 14.4, 28.2 Hz), 0.95 (s, 9H), 0.12 (d, 6H, J = 1.0 Hz); 
13C NMR (126 MHz, CDCl3) δ 197.7 (d, J = 28.0 Hz), 155.9 (d, J = 2.3 Hz), 
139.7 (d, J = 22.2 Hz), 134.8 (d, J = 3.4 Hz), 134.6, 132.9, 130.9, 129.9 (d, J = 5.8 Hz), 
129.7 (d, J = 1.7 Hz), 128.1, 127.8, 126.7, 120.0, 117.2 (d, J = 8.4 Hz), 116.1 (d, J = 9.6 
Hz), 102.4 (d, J = 191.7 Hz), 45.2 (d, J = 22.4 Hz), 25.7, 18.2, −4.5 (d, J = 4.5 Hz). 
19F NMR (282 MHz, CDCl3) δ −160.5 (dd, 1F, J = 22.9, 28.1 Hz); 
FT-IR (film) 2956, 2929, 2858, 1685, 1599, 1484, 1280, 1258, 946, 830, 783, 696 
cm-1; 
MS (ESI) m/z (M+Na+) calcd for C27H31FNaO2Si: 457, found: 457; 
[α]25D = +180° (c = 1.05, CHCl3); 99% ee, from (4S,5R)-L1. 
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(S)-2-Fluoro-2-(3-isopropylphenyl)-1-phenylbutan-1-one (Table 2.4, Entry 6). 
2-Bromo-2-fluoro-1-phenylbutan-1-one (245 mg, 1.00 mmol) and the arylzinc chloride 
reagent prepared from 1-bromo-3-isopropylbenzene were used. Solvent system for 
chromatography: 20:1 hexane/dichloromethane. The title compound was isolated as a 
light-yellow oil. 
Run 1, 202 mg (71% yield, 98% ee); Run 2, 213 mg (75% yield, 96% ee). 
The ee was determined on an AD-H column (100% hexane, flow rate 0.4 
mL/min); retention times for compound obtained using (4R,5S)-L1: 16.0 min (minor), 
17.5 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.91 – 7.88 (m, 2H), 7.50 – 7.46 (m, 1H), 7.38 – 
7.30 (m, 5H), 7.20 – 7.18 (m, 1H), 2.95 – 2.89 (m, 1H), 2.46 (ddq, 1H, J = 7.3, 14.6, 25.6 
Hz), 2.20 (ddq, 1H, J = 7.4, 14.7, 23.6 Hz), 1.25 (dd, 6H, J = 0.7, 6.9 Hz), 0.94 (t, 3H, J = 
7.3 Hz); 
13C NMR (126 MHz, CDCl3) δ 198.6 (d, J = 28.8 Hz), 149.4 (d, J = 1.8 Hz), 
138.7 (d, J = 22.3 Hz), 135.3 (d, J = 3.0 Hz), 132.8, 129.9 (d, J = 5.8 Hz), 128.6 (d, J = 
1.6 Hz), 128.1, 126.1, 122.3 (d, J = 8.9 Hz), 121.6 (d, J = 9.3 Hz), 103.9 (d, J = 188.9 
Hz), 34.2, 32.9 (d, J = 23.7 Hz), 23.9 (d, J = 11.0), 7.5 (d, J = 4.6 Hz). 
19F NMR (282 MHz, CDCl3) δ −164.6 (m, 1F); 
FT-IR (film) 2962, 2882, 1682, 1598, 1447, 1258, 795, 703 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C19H21FNaO: 307, found: 307; 
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[α]25D = −121° (c = 1.00, CHCl3); 98% ee, from (4R,5S)-L1. 
 
F
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(S)-2-(3-Bromophenyl)-2-fluoro-1,3-diphenylpropan-1-one (Table 2.4, Entry 
7). 2-Bromo-2-fluoro-1,3-diphenylpropan-1-one (307 mg, 1.00 mmol) and the arylzinc 
chloride reagent prepared from 1,3-dibromobenzene were used. The reaction was run at 
−20 °C for 36 h. Solvent system for chromatography: 15:1 hexane/dichloromethane. The 
title compound was isolated as a colorless oil. 
Run 1, 224 mg (58% yield, 92% ee); Run 2, 221 mg (58% yield, 90% ee). 
The ee was determined on an AS-H column (0.05% i-PrOH/hexane, flow rate 0.6 
mL/min); retention times for compound obtained using (4R,5S)-L1: 18.0 min (major), 
22.2 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.75 – 7.73 (m, 2H), 7.59 (t, 1H, J = 1.9 Hz), 7.49 
– 7.43 (m, 2H), 7.37 – 7.31 (m, 3H), 7.24 – 7.18 (m, 4H), 7.09 – 7.07 (m, 2H), 3.71 (dd, 
1H, J = 14.4, 25.3 Hz), 3.42 (dd, 1H, J = 14.4, 25.6 Hz); 
13C NMR (126 MHz, CDCl3) δ 197.7 (d, J = 27.9 Hz), 140.6 (d, J = 22.5 Hz), 
134.7 (d, J = 3.6 Hz), 134.1, 133.1, 131.5, 130.9 (d, J = 1.2 Hz), 130.2 (d, J = 1.9 Hz), 
129.8 (d, J = 6.2 Hz), 128.2, 128.0, 127.4 (d, J = 9.7 Hz), 126.9, 123.0 (d, J = 8.9 Hz), 
122.9 (d, J = 2.3 Hz), 102.2 (d, J = 193.8 Hz), 45.6 (d, J = 22.3 Hz). 
19F NMR (282 MHz, CDCl3) δ −160.5 (t, 1F, J = 25.4 Hz); 
FT-IR (film) 3063, 3031, 1685, 1596, 1567, 1260, 1076, 781, 715, 692 cm-1; 
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MS (ESI) m/z (M+Na+) calcd for C21H1679BrFNaO: 405, found: 405, 407 
(M+Na++2); 
[α]25D = −180° (c = 1.00, CHCl3); 92% ee, from (4R,5S)-L1. 
 
F
O
Ph Ph
CF3
 
(S)-2-Fluoro-1,3-diphenyl-2-(3-(trifluoromethyl)phenyl)propan-1-one (Table 
2.4, Entry 8). 2-Bromo-2-fluoro-1,3-diphenylpropan-1-one (307 mg, 1.00 mmol) and the 
arylzinc chloride reagent prepared from 1-bromo-3-(trifluoromethyl)benzene were used. 
The reaction was run at −20 °C for 36 h. Solvent system for chromatography: 20:1→15:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 237 mg (64% yield, 90% ee); Run 2, 247 mg (66% yield, 90% ee). 
The ee was determined on an OJ-H column (0.5% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (4R,5S)-L1: 21.6 min (minor), 
25.9 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.76 – 7.74 (m, 2H), 7.71 – 7.70 (m, 1H), 7.65 – 
7.63 (m, 1H), 7.60 – 7.57 (m, 1H), 7.50 – 7.46 (m, 2H), 7.35 – 7.32 (m, 2H), 7.21 – 7.18 
(m, 3H), 7.08 – 7.06 (m, 2H), 3.76 (dd, 1H, J = 14.4, 24.9 Hz), 3.46 (dd, 1H, J = 14.4, 
26.2 Hz); 
13C NMR (126 MHz, CDCl3) δ 197.8 (d, J = 27.9 Hz), 139.4 (d, J = 22.7 Hz), 
134.7 (d, J = 3.6 Hz), 133.9, 133.2, 130.8 (d, J = 1.1 Hz), 129.8 (d, J = 6.4 Hz), 129.1 (d, 
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J = 2.0 Hz), 128.2, 128.0, 127.7 (m), 127.0, 125.2 (m), 124.9, 122.7, 121.3 (m), 102.4 (d, 
J = 193.9), 45.7 (d, J = 22.3 Hz). 
19F NMR (282 MHz, CDCl3) δ −62.7 (s, 3F), −160.7 (t, 1F, J = 25.6 Hz); 
FT-IR (film) 3065, 3032, 1685, 1448, 1332, 1169, 1129, 1078, 699 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C22H16F4NaO: 395, found: 395; 
[α]25D = −151° (c = 1.00, CHCl3); 90% ee, from (4R,5S)-L1. 
 
F
O
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(S)-4-Chloro-2-fluoro-2-(naphthalen-2-yl)-1-phenylbutan-1-one (Table 2.4, 
Entry 9). 2-Bromo-4-chloro-2-fluoro-1-phenylbutan-1-one (280 mg, 1.00 mmol) and the 
arylzinc chloride reagent prepared from 2-bromonaphthalene were used. Solvent system 
for chromatography: 20:1→15:1 hexane/dichloromethane. The title compound was 
isolated as a colorless oil. 
Run 1, 190 mg (58% yield, 98% ee); Run 2, 190 mg (58% yield, 97% ee). 
The ee was determined on an AD-H column (1% i-PrOH/hexane, flow rate 0.8 
mL/min); retention times for compound obtained using (4R,5S)-L1: 15.5 min (minor), 
22.0 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.97 (d, 1H, J = 1.9 Hz), 7.93 – 7.83 (m, 5H), 7.58 
(dd, 1H, J = 1.9, 8.6 Hz), 7.55 – 7.50 (m, 2H), 7.48 (ddt, 1H, J = 1.3, 7.2, 8.7 Hz), 7.36 – 
7.33 (m, 2H), 3.64 (td, 1H, J = 5.5, 10.8 Hz), 3.48 (td, 1H, J = 4.9, 10.7 Hz), 3.00 (dddd, 
1H, J = 5.5, 10.7, 14.5, 23.1 Hz), 2.81 (dddd, 1H, J = 4.9, 10.9, 14.5, 23.3 Hz); 
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13C NMR (126 MHz, CDCl3) δ 196.6 (d, J = 27.0 Hz), 134.9 (d, J = 22.0 Hz), 
134.1 (d, J = 3.5 Hz), 133.03 (d, J = 0.8 Hz), 132.99 (d, J = 1.8 Hz), 133.0, 130.2 (d, J = 
6.3 Hz), 129.2 (d, J = 2.0 Hz), 128.29, 128.26, 128.25, 127.7, 126.8 (d, J = 3.9 Hz), 123.1 
(d, J = 9.6 Hz), 121.2 (d, J = 8.6 Hz), 102.3 (d, J = 190.6 Hz), 42.5 (d, J = 22.5 Hz), 38.7 
(d, J = 4.9 Hz). 
19F NMR (282 MHz, CDCl3) δ −162.6 (t, 1F, J = 23.2 Hz); 
FT-IR (film) 3059, 2968, 1684, 1597, 1448, 1264, 1244, 819, 748, 708 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C20H16ClFNaO: 349, found: 349; 
[α]25D = +202° (c = 0.60, CHCl3); 97% ee, from (4S,5R)-L1. 
 
F Ph
O
Ph Ph
 
(S)-2-Fluoro-1,2,3-triphenylpropan-1-one (eq 2.8). 2-Chloro-2-fluoro-1,3-
diphenylpropan-1-one (263 mg, 1.00 mmol) and the arylzinc chloride reagent prepared 
from bromobenzene were used. The reaction was run at −20 °C for 36 h. Solvent system 
for chromatography: 20:1→10:1 hexane/dichloromethane. The title compound was 
isolated as a white solid. 
Run 1, 205 mg (67% yield, 98% ee); Run 2, 206 mg (68% yield, 98% ee). 
The ee was determined on an AD-H column (2% i-PrOH/hexane, flow rate 0.6 
mL/min); retention times for compound obtained using (4R,5S)-L1: 12.4 min (minor), 
14.3 min (major). 
For the characterization data, see Table 2.2, Entry 2 (above). 
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2.6.4 Derivatization of the Cross-Coupling Products 
F Ph
Ph Ph
OH
 
  (2S,3S)-2-Fluoro-1,2,3-triphenylhex-5-en-3-ol (eq 2.10). A solution of 
allylmagnesium chloride (2.0 M in THF; 0.21 mL, 0.42 mmol; 1.2 equiv) was added over 
1 min to a solution of (S)-2-fluoro-1,2,3-triphenylpropan-1-one (107 mg, 0.350 mmol; 
98% ee; Table 2.2, entry 2; from a Negishi cross-coupling reaction using (4R,5S)-L1) in 
THF (1.0 mL) at −78 °C. The mixture was allowed to stir at −78 °C for 10 min, and then 
it was stirred at r.t. for 60 min. Next, the reaction mixture was cooled to 0 °C, and 
aqueous NH4Cl (saturated; 2 mL) was added to quench the reaction. The mixture was 
washed with brine and extracted with Et2O (3 × 20 mL). The organic layers were 
combined, dried over Na2SO4, and concentrated. The product was purified by flash 
chromatography on silica gel. Solvent system for chromatography: 50%→75% 
dichloromethane in hexane. The title compound was isolated as a white solid. 
Run 1, 121 mg (100% yield, >20:1 dr, 97% ee); Run 2, 119 mg (98% yield, >20:1 
dr, 97% ee). 
The ee was determined on an AS-H column (1% i-PrOH/hexane, flow rate 1.0 
mL/min); retention time: 7.5 min (major), 9.9 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.26 – 7.21 (m, 5H), 7.14 – 7.08 (m, 3H), 7.06 – 
7.03 (m, 3H), 6.98 – 6.93 (m, 4H), 5.54 – 5.45 (m, 1H), 5.19 (d, 1H, J = 17.1 Hz), 5.09 
(d, 1H, J = 10.2, Hz), 3.87 (dd, 1H, J = 10.3, 14.6 Hz), 3.20 (dd, 1H, J = 14.6, 41.7 Hz), 
2.94-2.83 (m, 2H), 2.64 (s, 1H); 
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13C NMR (126 MHz, CDCl3) δ 140.0 (d, J = 2.4 Hz), 137.9 (d, J = 22.1 Hz), 
136.0, 133.4, 130.7 (d, J = 1.8 Hz), 128.0 (d, J = 1.6 Hz), 127.5, 127.3, 127.23, 127.19, 
127.0, 126.8, 126.0, 120.0, 102.6 (d, J = 185.9 Hz), 79.5 (d, J = 24.7 Hz), 40.3 (d, J = 3.9 
Hz), 39.5 (d, J = 20.9 Hz); 
19F NMR (282 MHz, CDCl3) δ −165.2 (dd, 1F, J = 10.3, 41.7 Hz); 
FT-IR (film) 3552, 3060, 3029, 1497, 1446, 1032, 1000, 977, 722, 700 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C24H23FNaO: 369, found: 369; 
[α]25D = −73.3° (c = 0.97, CHCl3). 
 
F Ph
Ph Ph
OH
Cl
 
  (1R,2S)-1-(4-Chlorophenyl)-2-fluoro-1,2,3-triphenylpropan-1-ol (eq 2.11). A 
solution of n-BuLi in hexane (2.61 M; 0.17 mL, 0.46 mmol; 1.3 equiv) was added over 1 
min to a solution of 1-chloro-4-bromobenzene (95.8 mg, 0.500 mmol; 1.43 equiv) in THF 
(0.7 mL) at −78 °C. The mixture was stirred at −78 °C for 10 min, and then a solution of 
(S)-2-fluoro-1,2,3-triphenylpropan-1-one (107 mg, 0.350 mmol; 98% ee; Table 2.2, entry 
2; from a Negishi cross-coupling reaction using (4R,5S)-L1) in THF (1.0 mL) was added 
to the aryllithium solution at −78 °C. The mixture was allowed to stir at −78 °C for 60 
min, and then the reaction was quenched with aqueous NH4Cl (saturated; 2 mL). The 
mixture was washed with brine and extracted with Et2O (3 × 20 mL). The organic layers 
were combined, dried over Na2SO4, and concentrated. The product was purified by flash 
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chromatography on silica gel. Solvent system for chromatography: 15%→50% 
dichloromethane in hexane. The title compound was isolated as a white solid. 
Run 1, 137 mg (94% yield, >20:1 dr, 98% ee); Run 2, 143 mg (98% yield, >20:1 
dr, 98% ee). 
The ee was determined on an AS-H column (2% i-PrOH/hexane, flow rate 1.0 
mL/min); retention times: 12.1 min (major), 15.6 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.83 – 7.81 (m, 2H), 7.39 – 7.36 (m, 2H), 7.33 – 
7.31 (m, 2H), 7.22 – 7.20 (m, 2H), 7.15 – 7.11 (m, 6H), 7.06 – 7.04 (m, 3H), 6.91 – 6.89 
(m, 2H), 3.62 – 3.45 (m, 2H), 2.83 (s, 1H); 
13C NMR (126 MHz, CDCl3) δ 142.9 (d, J = 1.3 Hz), 142.0 (d, J = 2.2 Hz), 138.4 
(d, J = 22.3 Hz), 135.6 (d, J = 1.5 Hz), 133.2, 130.6 (d, J = 1.3 Hz), 129.3 (d, J = 5.2 Hz), 
128.1, 127.57, 127.56, 127.4 (d, J = 1.2 Hz), 127.3 (d, J = 2.1 Hz), 127.2 (d, J = 2.2 Hz), 
127.1 (m), 126.1, 102.6 (d, J = 190.6 Hz), 81.0 (d, J = 25.6 Hz), 41.4 (d, J = 20.3 Hz); 
19F NMR (282 MHz, CDCl3) δ −161.3 (dd, 1F, J = 11.4, 37.6 Hz); 
FT-IR (film) 3568, 3069, 3031, 1491, 1446, 1013, 746, 699 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C27H22ClFNaO: 439, found: 439; 
[α]25D = +65.6° (c = 0.99, CHCl3). 
 
O
F Ph
Ph
O
Ph
 
(S)-1-Fluoro-1,2-diphenylethyl benzoate (eq 2.13). This procedure is based on a 
published procedure.17 To a solution of (S)-2-fluoro-1,2,3-triphenylpropan-1-one (122 
mg, 0.400 mmol; 98% ee; Table 2.2, entry 2; from a Negishi cross-coupling reaction 
using (4R,5S)-L1) and 3-chloroperbenzoic acid (m-CPBA, ≤77% purity; 448 mg, 2.00 
	 75 
mmol; 5.00 equiv) in CH2Cl2 (1.0 mL) was added 1,1,1,3,3,3-hexafluoro-2-propanol 
(HFIP; 1.0 mL) and phosphate buffer solution (pH 7; 0.4 mL). The mixture was stirred 
vigorously at r.t. for 36 h. The reaction was then quenched with aqueous Na2S2O3 
(saturated; 7 mL). The mixture was washed with aqueous NaHCO3 (saturated; 15 mL) 
and extracted with CH2Cl2 (3 × 30 mL). The organic layers were combined, dried over 
Na2SO4, and concentrated. The product was purified by flash chromatography on silica 
gel. Solvent system for chromatography: (1) flash chromatography on silica, 15%→30% 
dichloromethane in hexane; (2) preparative TLC on silica, 15% ethyl acetate in hexane. 
The title compound was isolated as a white solid. 
Run 1, 104 mg (81% yield, 98% ee); Run 2, 104 mg (81% yield, 98% ee). 
The ee was determined on an AD-H column (5% i-PrOH/hexane, flow rate 1.0 
mL/min); retention times: 8.3 min (major), 10.6 min (minor). 
1H NMR (500 MHz, CDCl3) δ 8.04 – 8.02 (m, 2H), 7.61 – 7.58 (m, 1H), 7.48 – 
7.44 (m, 2H), 7.35 – 7.33 (m, 5H), 7.28 – 7.25 (m, 3H), 7.15 – 7.13 (m, 2H), 3.63 – 3.51 
(m, 2H); 
 13C NMR (126 MHz, CDCl3) δ 163.1, 138.7 (d, J = 26.2 Hz), 133.5, 133.3 (d, J = 
3.5 Hz), 130.9, 129.9, 129.8, 128.7 (d, J = 1.2 Hz), 128.5, 128.2, 128.0, 127.1, 124.7 (d, J 
= 6.9 Hz), 113.8 (d, J = 236.4 Hz), 47.4 (d, J = 26.4 Hz); 
 19F NMR (282 MHz, CDCl3) δ −113.5 (t, 1F, J = 17.5 Hz); 
FT-IR (film) 3063, 3032, 2929, 1740, 1451, 1265, 1135, 1084, 1066, 1024, 1008, 
999, 707, 701, 603 cm-1; 
MS (ESI) m/z (M+Na+) calcd for C21H17FNaO2: 343, found: 343; 
[α]25D = −74.2° (c = 0.97, CHCl3). 
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F Ph
O
O Ph
MeO
 
4-Methoxyphenyl (S)-2-fluoro-2,3-diphenylpropanoate (eq 7).  This procedure 
is based on a published procedure.17 To a solution of (S)-2-fluoro-1-(4-methoxyphenyl)-
2,3-diphenylpropan-1-one (117 mg, 0.350 mmol; 97% ee; Table 2.3, entry 1; from a 
Negishi cross-coupling reaction using (4R,5S)-L1) and 3-chloroperbenzoic acid (m-
CPBA, 77% purity; 392 mg, 1.75 mmol; 5.00 equiv) in CH2Cl2 (1.0 mL) was added 
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP; 1.0 mL) and phosphate buffer solution (pH 7; 
0.4 mL).  The mixture was stirred vigorously at r.t. for 36 h. The reaction was quenched 
with aqueous Na2S2O3 (saturated; 7 mL). The mixture was washed with aqueous NaHCO3 
(saturated; 15 mL) and extracted with CH2Cl2 (3 × 30 mL). The organic layers were 
combined, dried over Na2SO4, and concentrated. The product was purified by flash 
chromatography on silica gel. Solvent system for chromatography: (1) flash 
chromatography on silica, 20%→50% dichloromethane in hexane; (2) preparative TLC 
on silica, 20% ethyl acetate in hexane. The title compound was isolated as a white solid. 
Run 1, 104 mg (85% yield, 97% ee); Run 2, 100 mg (82% yield, 97% ee). 
The ee was determined on an AD-H column (5% i-PrOH/hexane, flow rate 1.0 
mL/min); retention times: 15.6 min (minor), 20.7 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.70 – 7.68 (m, 2H), 7.47 – 7.39 (m, 3H), 7.36 – 
7.29 (m, 5H), 6.83 – 6.80 (m, 2H), 6.74 – 6.70 (m, 2H), 3.78 (dd, 1H, J = 14.5, 32.9 Hz), 
3.76 (s, 3H), 3.51 (dd, 1H, J = 14.5, 18.4 Hz); 
13C NMR (126 MHz, CDCl3) δ 168.8 (d, J = 27.1 Hz), 157.5, 143.5, 137.7 (d, J = 
22.6 Hz), 134.1, 130.7 (d, J = 1.5 Hz), 128.8 (d, J = 1.3 Hz), 128.6 (d, J = 1.5 Hz), 128.3, 
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127.3, 124.8 (d, J = 9.3 Hz), 121.9, 114.4, 96.8 (d, J = 194.2 Hz), 55.5, 44.9 (d, J = 21.4 
Hz); 
19F NMR (282 MHz, CDCl3) δ −161.8 (dd, 1F, J = 18.5, 32.8 Hz); 
FT-IR (film) 3062, 3032, 2931, 2836, 1774, 1753, 1503, 1248, 1189, 1031, 696 
cm-1; 
MS (ESI) m/z (M+H+) calcd for C22H20FO3: 351, found: 351; 
[α]25D = +9.7° (c = 1.02, CHCl3). 
 
2.6.5 Assignment of the Absolute Stereochemistry of the Cross-Coupling Products 
Ph
O
F Ph
Ph
 
Absolute stereochemistry of product from Entry 2.2 of Table 2 (run with 
(4R,5S)-L1).  (S)-2-Fluoro-1,2,3-triphenylpropan-1-one.  
 
A crystal of C21H17F1O1 was selected and mounted in a nylon loop in immersion 
oil. All measurements were made on a Rigkau Saturn944+ with filtered Cu-Kα radiation 
at a temperature of 93 K. Using Olex2 [1], the structure was solved with the ShelXS [2] 
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structure solution program using Direct Methods and refined with the ShelXL [3] 
refinement package using Least Squares minimization. The absolute stereochemistry was 
determined on the basis of the absolute structure parameter. 
 1. O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. 
Puschmann, OLEX2: a complete structure solution, refinement, and analysis program. J. 
Appl. Cryst. 2009, 42, 339–341. 
 2. SHELXS, G.M. Sheldrick, Acta Cryst. 2008, A64, 112–122. 
 3. SHELXL, G.M. Sheldrick, Acta Cryst. 2008, A64, 112–122. 
 
Table 2.5. Crystal Data and Structure Refinement for Crystal_001. 
Identification code  crystal_001 
Empirical formula  C21 H17 F1 O1 
Formula weight  304.36 
Temperature  93 K 
Wavelength  1.54187 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions a = 5.89490(10) Å α= 90°. 
 b = 15.2807(3) Å β= 90 °. 
 c = 17.2167(12) Å γ = 90 °. 
Volume 1550.85(12) Å3 
Z 4 
Density (calculated) 1.303 Mg/m3 
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Absorption coefficient 0.697 mm-1 
F(000) 640 
Crystal size 0.2 x 0.05 x 0.05 mm3 
Theta range for data collection 3.868 to 68.146°. 
Index ranges -7<=h<=7, -18<=k<=18, -20<=l<=20 
Reflections collected 53111 
Independent reflections 2831 [R(int) = 0.0685] 
Completeness to theta = 67.687° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.902 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2831 / 0 / 208 
Goodness-of-fit on F2 1.063 
Final R indices [I>2sigma(I)] R1 = 0.0252, wR2 = 0.0621 
R indices (all data) R1 = 0.0258, wR2 = 0.0626 
Absolute structure parameter 0.06(4) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.102 and -0.154 e/Å-3 
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Table 2.6. Atomic Coordinates  (x 104) and Equivalent Isotropic Displacement 
Parameters (Å2 x 103) for Crystal_001. U(eq) is defined as one third of  the trace of the 
orthogonalized U
ij
 tensor. 
________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________ 
F(1) 1126(2) 6163(1) 7538(1) 21(1) 
O(1) -3721(2) 5645(1) 6546(1) 27(1) 
C(1) -392(3) 6179(1) 5945(1) 19(1) 
C(2) -1906(3) 6014(1) 6624(1) 20(1) 
C(3) -1220(3) 6315(1) 7451(1) 18(1) 
C(4) -2440(3) 5754(1) 8058(1) 21(1) 
C(5) 1456(3) 6748(1) 5966(1) 21(1) 
C(6) 2811(3) 6861(1) 5316(1) 23(1) 
C(7) 2325(3) 6410(1) 4638(1) 24(1) 
C(8) 465(3) 5855(1) 4608(1) 26(1) 
C(9) -891(3) 5737(1) 5257(1) 23(1) 
C(10) -1677(3) 7287(1) 7554(1) 18(1) 
C(11) -3756(3) 7631(1) 7329(1) 23(1) 
C(12) -4232(3) 8511(1) 7445(1) 25(1) 
C(13) -2646(3) 9056(1) 7786(1) 25(1) 
C(14) -574(3) 8713(1) 8014(1) 25(1) 
C(15) -82(3) 7833(1) 7900(1) 22(1) 
C(16) -1913(3) 5999(1) 8888(1) 20(1) 
C(17) -3448(3) 6488(1) 9323(1) 22(1) 
C(18) -2990(3) 6698(1) 10091(1) 25(1) 
C(19) -997(3) 6417(1) 10435(1) 25(1) 
C(20) 550(3) 5933(1) 10009(1) 25(1) 
C(21) 97(3) 5726(1) 9239(1) 23(1) 
________________________________________________________________________
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Table 2.7.  Bond Lengths [Å] and Angles [°] for Crystal_001. 
_____________________________________________________  
F(1)-C(3)  1.4103(17) 
O(1)-C(2)  1.216(2) 
C(1)-C(2)  1.492(2) 
C(1)-C(5)  1.394(2) 
C(1)-C(9)  1.396(2) 
C(2)-C(3)  1.551(2) 
C(3)-C(4)  1.529(2) 
C(3)-C(10)  1.520(2) 
C(4)-C(16)  1.510(2) 
C(5)-C(6)  1.385(2) 
C(6)-C(7)  1.386(3) 
C(7)-C(8)  1.388(3) 
C(8)-C(9)  1.385(2) 
C(10)-C(11)  1.388(2) 
C(10)-C(15)  1.392(2) 
C(11)-C(12)  1.388(2) 
C(12)-C(13)  1.383(3) 
C(13)-C(14)  1.385(3) 
C(14)-C(15)  1.390(2) 
C(16)-C(17)  1.392(2) 
C(16)-C(21)  1.394(2) 
C(17)-C(18)  1.388(2) 
C(18)-C(19)  1.384(3) 
C(19)-C(20)  1.384(3) 
C(20)-C(21)  1.390(2) 
 
C(5)-C(1)-C(2) 123.58(14) 
C(5)-C(1)-C(9) 119.24(15) 
C(9)-C(1)-C(2) 117.18(15) 
O(1)-C(2)-C(1) 121.19(15) 
O(1)-C(2)-C(3) 117.93(14) 
C(1)-C(2)-C(3) 120.87(14) 
F(1)-C(3)-C(2) 107.73(12) 
F(1)-C(3)-C(4) 107.24(12) 
F(1)-C(3)-C(10) 108.79(12) 
C(4)-C(3)-C(2) 109.77(13) 
C(10)-C(3)-C(2) 110.49(13) 
C(10)-C(3)-C(4) 112.64(13) 
C(16)-C(4)-C(3) 114.25(14) 
C(6)-C(5)-C(1) 120.48(15) 
C(5)-C(6)-C(7) 119.99(16) 
C(6)-C(7)-C(8) 119.84(17) 
C(9)-C(8)-C(7) 120.45(17) 
C(8)-C(9)-C(1) 119.98(16) 
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C(11)-C(10)-C(3) 119.62(14) 
C(11)-C(10)-C(15) 119.22(15) 
C(15)-C(10)-C(3) 121.09(15) 
C(10)-C(11)-C(12) 120.36(16) 
C(13)-C(12)-C(11) 120.50(16) 
C(12)-C(13)-C(14) 119.28(16) 
C(13)-C(14)-C(15) 120.61(17) 
C(14)-C(15)-C(10) 120.03(16) 
C(17)-C(16)-C(4) 120.56(16) 
C(17)-C(16)-C(21) 118.68(16) 
C(21)-C(16)-C(4) 120.74(15) 
C(18)-C(17)-C(16) 120.72(17) 
C(19)-C(18)-C(17) 120.01(17) 
C(18)-C(19)-C(20) 119.98(16) 
C(19)-C(20)-C(21) 119.99(17) 
C(20)-C(21)-C(16) 120.61(17) 
_____________________________________________________________  
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Table 2.8. Anisotropic Displacement Parameters (Å
2 
x 10
3
) for Crystal_001. The 
anisotropic displacement factor exponent takes the form:  -2π
2
[ h
2
 a*
2
U
11
 + ...  + 2 h k a* 
b* U
12
 ] 
________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________ 
F(1) 18(1)  21(1) 22(1)  0(1) -2(1)  3(1) 
O(1) 24(1)  34(1) 24(1)  -4(1) 1(1)  -10(1) 
C(1) 21(1)  17(1) 18(1)  2(1) -1(1)  2(1) 
C(2) 21(1)  17(1) 22(1)  0(1) 0(1)  1(1) 
C(3) 15(1)  20(1) 19(1)  0(1) -1(1)  0(1) 
C(4) 24(1)  19(1) 21(1)  0(1) 1(1)  -2(1) 
C(5) 22(1)  22(1) 19(1)  0(1) -3(1)  -2(1) 
C(6) 19(1)  25(1) 26(1)  5(1) -1(1)  -2(1) 
C(7) 26(1)  25(1) 22(1)  3(1) 5(1)  3(1) 
C(8) 35(1)  22(1) 21(1)  -4(1) 3(1)  0(1) 
C(9) 26(1)  20(1) 23(1)  -1(1) 1(1)  -3(1) 
C(10) 20(1)  17(1) 15(1)  1(1) 2(1)  -1(1) 
C(11) 21(1)  24(1) 23(1)  2(1) -1(1)  -1(1) 
C(12) 24(1)  26(1) 27(1)  5(1) 4(1)  6(1) 
C(13) 32(1)  17(1) 26(1)  4(1) 8(1)  2(1) 
C(14) 30(1)  20(1) 26(1)  -3(1) 2(1)  -4(1) 
C(15) 21(1)  21(1) 23(1)  1(1) -2(1)  -1(1) 
C(16) 24(1)  14(1) 21(1)  3(1) 2(1)  -2(1) 
C(17) 24(1)  21(1) 23(1)  3(1) 0(1)  1(1) 
C(18) 32(1)  21(1) 23(1)  0(1) 3(1)  3(1) 
C(19) 33(1)  23(1) 20(1)  1(1) -1(1)  -5(1) 
C(20) 24(1)  27(1) 24(1)  6(1) -4(1)  -3(1) 
C(21) 23(1)  22(1) 25(1)  3(1) 3(1)  0(1) 
________________________________________________________________________
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Table 2.9. Hydrogen Coordinates ( x 10
4
) and Isotropic Displacement Parameters (Å
2 
x 
10
3
) for Crystal_001. 
________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________  
H(4A) -4063 5805 7976 25 
H(4B) -2027 5147 7977 25 
H(5) 1780 7055 6419 26 
H(6) 4046 7239 5335 28 
H(7) 3244 6480 4203 29 
H(8) 125 5561 4150 32 
H(9) -2134 5362 5233 27 
H(11) -4835 7269 7100 27 
H(12) -5628 8736 7291 30 
H(13) -2967 9645 7862 30 
H(14) 498 9076 8246 30 
H(15) 1313 7609 8056 26 
H(17) -4796 6675 9096 27 
H(18) -4024 7028 10376 30 
H(19) -696 6554 10951 30 
H(20) 1893 5746 10239 30 
H(21) 1144 5402 8955 28 
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Ph F
MeO
Ph
 
 
Absolute stereochemistry of product from Entry 1 of Table 2.3 (run with 
(4S,5R)-L1).  (R)-2-Fluoro-1-(4-methoxyphenyl)-2,3-diphenylpropan-1-one.  
 
A crystal of C22H19F1O2 was selected and mounted in a nylon loop in immersion 
oil. All measurements were made on a Rigkau Saturn944+ with filtered Cu-Kα radiation 
at a temperature of 93 K. Using Olex2 [1], the structure was solved with the ShelXS [2] 
structure solution program using Direct Methods and refined with the ShelXL [3] 
refinement package using Least Squares minimization. The absolute stereochemistry was 
determined on the basis of the absolute structure parameter. 
 1. O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. 
Puschmann, OLEX2: a complete structure solution, refinement, and analysis program. J. 
Appl. Cryst. 2009, 42, 339–341. 
 2. SHELXS, G.M. Sheldrick, Acta Cryst. 2008, A64, 112–122. 
 3. SHELXL, G.M. Sheldrick, Acta Cryst. 2008, A64, 112–122. 
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Table 2.10.  Crystal Data and Structure Refinement for Crystal_002. 
Identification code  crystal_002 
Empirical formula  C22 H19 F1 O2  
Formula weight  334.37 
Temperature  93 K 
Wavelength  1.54187 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions a = 5.86120(10) Å α= 90°. 
 b = 15.7648(3) Å β= 90 °. 
 c = 18.3237(13) Å γ = 90 °. 
Volume 1693.12(13) Å3 
Z 4 
Density (calculated) 1.312 Mg/m3 
Absorption coefficient 0.731 mm-1 
F(000) 704 
Crystal size 0.15 x 0.05 x 0.05 mm3 
Theta range for data collection 3.699 to 68.208°. 
Index ranges -7<=h<=7, -18<=k<=18, -21<=l<=22 
Reflections collected 58234 
Independent reflections 3085 [R(int) = 0.0587] 
Completeness to theta = 67.687° 99.9 %  
Absorption correction Semi-empirical from equivalents 
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Max. and min. transmission 1.000 and 0.912 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3085 / 0 / 227 
Goodness-of-fit on F2 1.058 
Final R indices [I>2sigma(I)] R1 = 0.0237, wR2 = 0.0599 
R indices (all data) R1 = 0.0238, wR2 = 0.0600 
Absolute structure parameter -0.01(3) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.109 and -0.166 e.Å-3 
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Table 2.11. Atomic Coordinates  ( x 10
4
) and Equivalent Isotropic Displacement 
Parameters (Å
2 
x 10
3
) for Crystal_002. U(eq) is defined as one third of  the trace of the 
orthogonalized U
ij
 tensor. 
________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________ 
F(1) -1506(2) -9122(1) -7196(1) 21(1) 
O(1) 3412(2) -9778(1) -8002(1) 28(1) 
O(2) -2372(2) -8682(1) -10727(1) 27(1) 
C(1) 1652(3) -9363(1) -7999(1) 20(1) 
C(2) 862(2) -8975(1) -7264(1) 19(1) 
C(3) 2025(3) -9430(1) -6627(1) 22(1) 
C(4) 404(3) -9191(1) -8689(1) 19(1) 
C(5) -1648(3) -8745(1) -8735(1) 22(1) 
C(6) -2659(3) -8565(1) -9401(1) 23(1) 
C(7) -1597(3) -8832(1) -10040(1) 22(1) 
C(8) 435(3) -9294(1) -10001(1) 24(1) 
C(9) 1410(3) -9473(1) -9339(1) 23(1) 
C(10) 1425(3) -9081(1) -5884(1) 20(1) 
C(11) 2943(3) -8551(1) -5519(1) 22(1) 
C(12) 2455(3) -8252(1) -4822(1) 25(1) 
C(13) 434(3) -8480(1) -4484(1) 24(1) 
C(14) -1107(3) -9001(1) -4844(1) 25(1) 
C(15) -619(3) -9299(1) -5541(1) 23(1) 
C(16) 1281(3) -8024(1) -7265(1) 17(1) 
C(17) 3364(3) -7707(1) -7509(1) 22(1) 
C(18) 3794(3) -6842(1) -7503(1) 25(1) 
C(19) 2163(3) -6281(1) -7243(1) 24(1) 
C(20) 96(3) -6593(1) -6993(1) 25(1) 
C(21) -349(3) -7461(1) -7003(1) 21(1) 
C(22) -4298(3) -8134(1) -10802(1) 29(1) 
________________________________________________________________________
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Table 2.12. Bond Lengths [Å] and Angles [°] for Crystal_002. 
_____________________________________________________  
F(1)-C(2)  1.4127(17) 
O(1)-C(1)  1.222(2) 
O(2)-C(7)  1.3585(18) 
O(2)-C(22)  1.429(2) 
C(1)-C(2)  1.549(2) 
C(1)-C(4)  1.487(2) 
C(2)-C(3)  1.531(2) 
C(2)-C(16)  1.520(2) 
C(3)-C(10)  1.511(2) 
C(4)-C(5)  1.395(2) 
C(4)-C(9)  1.402(2) 
C(5)-C(6)  1.386(2) 
C(6)-C(7)  1.392(2) 
C(7)-C(8)  1.398(2) 
C(8)-C(9)  1.371(2) 
C(10)-C(11)  1.391(2) 
C(10)-C(15)  1.396(2) 
C(11)-C(12)  1.391(2) 
C(12)-C(13)  1.385(2) 
C(13)-C(14)  1.387(2) 
C(14)-C(15)  1.391(2) 
C(16)-C(17)  1.393(2) 
C(16)-C(21)  1.390(2) 
C(17)-C(18)  1.387(2) 
C(18)-C(19)  1.387(2) 
C(19)-C(20)  1.385(2) 
C(20)-C(21)  1.393(2) 
 
C(7)-O(2)-C(22) 117.34(12) 
O(1)-C(1)-C(2) 117.93(13) 
O(1)-C(1)-C(4) 120.60(14) 
C(4)-C(1)-C(2) 121.35(13) 
F(1)-C(2)-C(1) 107.80(11) 
F(1)-C(2)-C(3) 107.06(12) 
F(1)-C(2)-C(16) 108.70(11) 
C(3)-C(2)-C(1) 110.19(12) 
C(16)-C(2)-C(1) 109.88(12) 
C(16)-C(2)-C(3) 113.03(12) 
C(10)-C(3)-C(2) 114.42(12) 
C(5)-C(4)-C(1) 124.58(13) 
C(5)-C(4)-C(9) 118.12(14) 
C(9)-C(4)-C(1) 117.26(14) 
C(6)-C(5)-C(4) 121.65(14) 
C(5)-C(6)-C(7) 119.18(14) 
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O(2)-C(7)-C(6) 125.24(15) 
O(2)-C(7)-C(8) 115.02(14) 
C(6)-C(7)-C(8) 119.74(14) 
C(9)-C(8)-C(7) 120.50(15) 
C(8)-C(9)-C(4) 120.78(15) 
C(11)-C(10)-C(3) 120.15(14) 
C(11)-C(10)-C(15) 118.75(14) 
C(15)-C(10)-C(3) 121.07(14) 
C(12)-C(11)-C(10) 120.84(15) 
C(13)-C(12)-C(11) 119.92(15) 
C(12)-C(13)-C(14) 119.86(15) 
C(13)-C(14)-C(15) 120.19(15) 
C(14)-C(15)-C(10) 120.42(15) 
C(17)-C(16)-C(2) 119.69(13) 
C(21)-C(16)-C(2) 121.25(13) 
C(21)-C(16)-C(17) 119.02(14) 
C(18)-C(17)-C(16) 120.59(15) 
C(19)-C(18)-C(17) 120.29(15) 
C(20)-C(19)-C(18) 119.39(14) 
C(19)-C(20)-C(21) 120.51(15) 
C(16)-C(21)-C(20) 120.19(15) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms  
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Table 2.13. Anisotropic Displacement Parameters  (Å
2 x 10
3
) for Crystal_002. The 
anisotropic displacement factor exponent takes the form: -2π
2
[ h
2
 a*
2
U
11
 + ...  + 2 h k a* 
b* U
12
 ]  
________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________ 
F(1) 18(1)  23(1) 22(1)  -1(1) 2(1)  -3(1) 
O(1) 24(1)  30(1) 29(1)  -6(1) -2(1)  8(1) 
O(2) 38(1)  25(1) 18(1)  0(1) -2(1)  7(1) 
C(1) 20(1)  16(1) 24(1)  -2(1) 1(1)  -1(1) 
C(2) 16(1)  20(1) 21(1)  0(1) 0(1)  0(1) 
C(3) 24(1)  18(1) 23(1)  2(1) -1(1)  4(1) 
C(4) 22(1)  16(1) 21(1)  -2(1) 2(1)  -2(1) 
C(5) 22(1)  26(1) 20(1)  -3(1) 4(1)  1(1) 
C(6) 21(1)  25(1) 23(1)  -1(1) 2(1)  1(1) 
C(7) 29(1)  17(1) 19(1)  1(1) 0(1)  -3(1) 
C(8) 32(1)  21(1) 21(1)  -3(1) 6(1)  2(1) 
C(9) 25(1)  18(1) 26(1)  -2(1) 3(1)  3(1) 
C(10) 22(1)  16(1) 21(1)  4(1) -2(1)  3(1) 
C(11) 22(1)  22(1) 22(1)  4(1) 0(1)  0(1) 
C(12) 30(1)  21(1) 23(1)  1(1) -4(1)  -2(1) 
C(13) 31(1)  22(1) 20(1)  1(1) 1(1)  5(1) 
C(14) 23(1)  27(1) 25(1)  6(1) 2(1)  2(1) 
C(15) 24(1)  20(1) 25(1)  3(1) -3(1)  -2(1) 
C(16) 19(1)  18(1) 15(1)  0(1) -3(1)  1(1) 
C(17) 19(1)  24(1) 24(1)  0(1) 1(1)  2(1) 
C(18) 22(1)  26(1) 27(1)  3(1) -1(1)  -5(1) 
C(19) 32(1)  18(1) 23(1)  2(1) -5(1)  -2(1) 
C(20) 28(1)  20(1) 26(1)  -2(1) 0(1)  6(1) 
C(21) 21(1)  22(1) 21(1)  1(1) 3(1)  2(1) 
C(22) 29(1)  34(1) 24(1)  3(1) -2(1)  4(1) 
________________________________________________________________________
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Table 2.14. Hydrogen Coordinates ( x 10
4
) and Isotropic Displacement Parameters (Å
2
x 
10
3
) for Crystal_002. 
________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________ 
H(3A) 1611 -10026 -6642 26 
H(3B) 3665 -9394 -6692 26 
H(5) -2355 -8564 -8308 27 
H(6) -4030 -8269 -9421 28 
H(8) 1130 -9482 -10428 29 
H(9) 2754 -9786 -9321 28 
H(11) 4302 -8395 -5744 27 
H(12) 3486 -7899 -4584 30 
H(13) 111 -8285 -4016 29 
H(14) -2470 -9150 -4618 30 
H(15) -1662 -9646 -5780 27 
H(17) 4476 -8079 -7678 27 
H(18) 5182 -6637 -7674 30 
H(19) 2454 -5702 -7236 29 
H(20) -1004 -6220 -6818 30 
H(21) -1741 -7664 -6833 26 
H(22A) -3947 -7590 -10595 44 
H(22B) -5582 -8375 -10553 44 
H(22C) -4657 -8067 -11310 44 
________________________________________________________________________ 
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2.6.6 Assignment of the Stereochemistry of the Derivatization Products 
F Ph
Ph Ph
OH
 
Relative stereochemistry of product from eq 2.10 (run with the product of a 
cross-coupling conducted with (4R,5S)-L1).  (2S,3S)-2-Fluoro-1,2,3-triphenylhex-5-
en-3-ol. 
 
A crystal of C24H23F1O1 was selected and mounted in a nylon loop in immersion 
oil. All measurements were made on a Bruker Smart with filtered Mo-Kα radiation at a 
temperature of 100 K. Using Olex2 [1], the structure was solved with the ShelXS [2] 
structure solution program using Direct Methods and refined with the ShelXL [3] 
refinement package using Least Squares minimization. The absolute stereochemistry 
could not be determined on the basis of the absolute structure parameter, but was instead 
assigned by reference to the tertiary stereocenter in the starting material ((S)-2-fluoro-
1,2,3-triphenylpropan-1-one). 
 1. O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. 
Puschmann, OLEX2: a complete structure solution, refinement, and analysis program. J. 
	 94 
Appl. Cryst. 2009, 42, 339–341. 
 2. SHELXS, G.M. Sheldrick, Acta Cryst. 2008, A64, 112–122. 
 3. SHELXL, G.M. Sheldrick, Acta Cryst. 2008, A64, 112–122. 
 
Table 2.15. Crystal Data and Structure Refinement for Crystal_004. 
Identification code  crystal_004 
Empirical formula  C24 H23 F O 
Formula weight  346.42 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2 
Unit cell dimensions a = 16.777(6) Å α= 90°. 
 b = 15.082(5) Å β= 110.639(6) °. 
 c = 15.600(6) Å γ = 90 °. 
Volume 3694(2) Å3 
Z 8 
Density (calculated) 1.246 Mg/m3 
Absorption coefficient 0.081 mm-1 
F(000) 1472 
Crystal size 0.27 x 0.21 x 0.17 mm3 
Theta range for data collection 1.395 to 26.357°. 
Index ranges -20<=h<=20, -18<=k<=18, -19<=l<=19 
	 95 
Reflections collected 25299 
Independent reflections 7544 [R(int) = 0.1056] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7544 / 1 / 471 
Goodness-of-fit on F2 1.057 
Final R indices [I>2sigma(I)] R1 = 0.0797, wR2 = 0.1624 
R indices (all data) R1 = 0.1120, wR2 = 0.1746 
Absolute structure parameter -0.5(5) 
Largest diff. peak and hole 0.334 and -0.379 e/Å-3 
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Table 2.16. Atomic Coordinates ( x 10
4
) and Equivalent Isotropic Displacement 
Parameters (Å
2 
x 10
3
) for Crystal_004. U(eq) is defined as one third of the trace of the 
orthogonalized U
ij
 tensor. 
________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________ 
F(1) 1016(2) 1283(2) 191(2) 23(1) 
O(1) 459(3) -295(3) -636(3) 22(1) 
C(1) 1455(4) 912(4) -357(4) 16(1) 
C(2) 1352(4) -117(4) -277(4) 16(1) 
C(3) 1762(4) -618(4) -873(4) 14(1) 
C(4) 2605(5) -914(4) -521(4) 20(2) 
C(5) 2962(5) -1357(4) -1074(4) 20(1) 
C(6) 2495(5) -1518(4) -1975(4) 24(2) 
C(7) 1667(5) -1233(4) -2346(4) 21(2) 
C(8) 1294(5) -801(4) -1793(4) 16(1) 
C(9) 1698(5) -412(4) 728(4) 20(2) 
C(10) 1571(4) -1379(4) 866(4) 21(2) 
C(11) 1105(4) -1680(4) 1319(4) 18(1) 
C(12) 979(5) 1245(4) -1329(4) 26(2) 
C(13) 926(4) 2236(4) -1457(4) 22(2) 
C(14) 355(5) 2730(5) -1188(5) 34(2) 
C(15) 250(5) 3644(5) -1350(5) 32(2) 
C(16) 713(5) 4059(5) -1813(5) 32(2) 
C(17) 1290(5) 3585(5) -2094(4) 29(2) 
C(18) 1380(5) 2673(4) -1921(4) 28(2) 
C(19) 2370(4) 1211(4) 60(4) 16(1) 
C(20) 2704(5) 1510(4) 962(4) 22(2) 
C(21) 3555(5) 1745(5) 1350(4) 30(2) 
C(22) 4088(5) 1683(4) 848(5) 28(2) 
C(23) 3764(4) 1384(4) -43(4) 22(2) 
C(24) 2919(5) 1156(4) -439(4) 24(2) 
F(1B) -1077(2) -1387(2) -5179(2) 21(1) 
O(1B) -359(3) -2912(3) -4322(3) 22(1) 
C(1B) -1411(4) -1774(4) -4552(4) 15(1) 
C(2B) -1270(4) -2804(4) -4616(4) 17(1) 
C(3B) -1590(4) -3340(4) -3988(4) 15(1) 
C(4B) -2425(4) -3634(4) -4252(4) 19(1) 
C(5B) -2708(5) -4135(4) -3680(4) 23(2) 
C(6B) -2166(5) -4346(4) -2807(5) 28(2) 
C(7B) -1331(5) -4069(4) -2522(4) 22(2) 
C(8B) -1034(4) -3573(4) -3096(4) 18(1) 
C(9B) -1665(4) -3114(4) -5627(4) 17(1) 
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C(10B) -1501(4) -4077(4) -5750(4) 21(2) 
C(11B) -1125(6) -4372(5) -6301(6) 47(3) 
C(12B) -884(5) -1389(4) -3617(4) 24(2) 
C(13B) -857(5) -392(4) -3562(4) 22(2) 
C(14B) -328(5) 97(5) -3902(4) 25(2) 
C(15B) -299(5) 1010(5) -3825(5) 31(2) 
C(16B) -765(5) 1464(4) -3402(4) 27(2) 
C(17B) -1292(5) 992(4) -3069(4) 24(2) 
C(18B) -1342(5) 67(4) -3149(4) 24(2) 
C(19B) -2339(4) -1537(4) -4850(4) 12(1) 
C(20B) -2771(4) -1204(4) -5730(4) 15(1) 
C(21B) -3633(4) -1034(4) -6025(4) 20(2) 
C(22B) -4087(5) -1199(4) -5467(5) 29(2) 
C(23B) -3672(5) -1520(4) -4597(5) 27(2) 
C(24B) -2806(5) -1678(4) -4290(4) 19(2) 
________________________________________________________________________
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Table 2.17.  Bond Lengths [Å] and Angles [°] for Crystal_004. 
_____________________________________________________  
F(1)-C(1)  1.426(7) 
O(1)-C(2)  1.428(8) 
C(1)-C(2)  1.572(8) 
C(1)-C(12)  1.527(8) 
C(1)-C(19)  1.509(9) 
C(2)-C(3)  1.534(8) 
C(2)-C(9)  1.534(8) 
C(3)-C(4)  1.398(9) 
C(3)-C(8)  1.400(8) 
C(4)-C(5)  1.383(9) 
C(5)-C(6)  1.368(9) 
C(6)-C(7)  1.372(10) 
C(7)-C(8)  1.393(9) 
C(9)-C(10)  1.500(8) 
C(10)-C(11)  1.307(9) 
C(12)-C(13)  1.507(9) 
C(13)-C(14)  1.390(11) 
C(13)-C(18)  1.389(10) 
C(14)-C(15)  1.402(10) 
C(15)-C(16)  1.384(11) 
C(16)-C(17)  1.393(10) 
C(17)-C(18)  1.399(9) 
C(19)-C(20)  1.393(8) 
C(19)-C(24)  1.403(9) 
C(20)-C(21)  1.386(10) 
C(21)-C(22)  1.384(11) 
C(22)-C(23)  1.378(9) 
C(23)-C(24)  1.374(10) 
F(1B)-C(1B)  1.414(6) 
O(1B)-C(2B)  1.440(8) 
C(1B)-C(2B)  1.579(9) 
C(1B)-C(12B)  1.529(8) 
C(1B)-C(19B)  1.502(9) 
C(2B)-C(3B)  1.508(8) 
C(2B)-C(9B)  1.553(8) 
C(3B)-C(4B)  1.386(9) 
C(3B)-C(8B)  1.419(8) 
C(4B)-C(5B)  1.374(8) 
C(5B)-C(6B)  1.383(10) 
C(6B)-C(7B)  1.377(10) 
C(7B)-C(8B)  1.388(8) 
C(9B)-C(10B)  1.503(8) 
C(10B)-C(11B)  1.311(10) 
C(12B)-C(13B)  1.507(9) 
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C(13B)-C(14B)  1.396(9) 
C(13B)-C(18B)  1.387(10) 
C(14B)-C(15B)  1.380(10) 
C(15B)-C(16B)  1.371(10) 
C(16B)-C(17B)  1.373(10) 
C(17B)-C(18B)  1.400(9) 
C(19B)-C(20B)  1.400(8) 
C(19B)-C(24B)  1.380(8) 
C(20B)-C(21B)  1.378(9) 
C(21B)-C(22B)  1.367(10) 
C(22B)-C(23B)  1.377(10) 
C(23B)-C(24B)  1.381(10) 
 
F(1)-C(1)-C(2) 104.2(5) 
F(1)-C(1)-C(12) 105.4(5) 
F(1)-C(1)-C(19) 106.7(4) 
C(12)-C(1)-C(2) 111.7(5) 
C(19)-C(1)-C(2) 112.6(5) 
C(19)-C(1)-C(12) 115.2(5) 
O(1)-C(2)-C(1) 106.5(5) 
O(1)-C(2)-C(3) 107.5(5) 
O(1)-C(2)-C(9) 108.3(5) 
C(3)-C(2)-C(1) 110.6(5) 
C(9)-C(2)-C(1) 110.8(4) 
C(9)-C(2)-C(3) 112.8(5) 
C(4)-C(3)-C(2) 121.8(5) 
C(4)-C(3)-C(8) 117.6(6) 
C(8)-C(3)-C(2) 120.6(6) 
C(5)-C(4)-C(3) 120.7(6) 
C(6)-C(5)-C(4) 120.6(7) 
C(5)-C(6)-C(7) 120.4(6) 
C(6)-C(7)-C(8) 119.6(6) 
C(7)-C(8)-C(3) 121.0(6) 
C(10)-C(9)-C(2) 114.0(5) 
C(11)-C(10)-C(9) 123.9(6) 
C(13)-C(12)-C(1) 116.3(5) 
C(14)-C(13)-C(12) 120.4(7) 
C(18)-C(13)-C(12) 121.5(6) 
C(18)-C(13)-C(14) 117.8(6) 
C(13)-C(14)-C(15) 121.9(7) 
C(16)-C(15)-C(14) 118.8(7) 
C(15)-C(16)-C(17) 120.8(7) 
C(16)-C(17)-C(18) 118.9(7) 
C(13)-C(18)-C(17) 121.7(7) 
C(20)-C(19)-C(1) 121.2(6) 
C(20)-C(19)-C(24) 118.1(6) 
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C(24)-C(19)-C(1) 120.7(5) 
C(21)-C(20)-C(19) 120.6(7) 
C(22)-C(21)-C(20) 120.4(6) 
C(23)-C(22)-C(21) 119.3(7) 
C(24)-C(23)-C(22) 120.9(7) 
C(23)-C(24)-C(19) 120.7(6) 
F(1B)-C(1B)-C(2B) 105.0(5) 
F(1B)-C(1B)-C(12B) 105.4(5) 
F(1B)-C(1B)-C(19B) 107.9(5) 
C(12B)-C(1B)-C(2B) 112.6(5) 
C(19B)-C(1B)-C(2B) 112.2(5) 
C(19B)-C(1B)-C(12B) 113.1(5) 
O(1B)-C(2B)-C(1B) 104.9(5) 
O(1B)-C(2B)-C(3B) 108.3(5) 
O(1B)-C(2B)-C(9B) 108.3(5) 
C(3B)-C(2B)-C(1B) 113.0(5) 
C(3B)-C(2B)-C(9B) 112.1(5) 
C(9B)-C(2B)-C(1B) 109.9(4) 
C(4B)-C(3B)-C(2B) 122.2(5) 
C(4B)-C(3B)-C(8B) 117.3(5) 
C(8B)-C(3B)-C(2B) 120.5(6) 
C(5B)-C(4B)-C(3B) 121.8(6) 
C(4B)-C(5B)-C(6B) 120.5(7) 
C(7B)-C(6B)-C(5B) 119.3(6) 
C(6B)-C(7B)-C(8B) 120.7(6) 
C(7B)-C(8B)-C(3B) 120.3(6) 
C(10B)-C(9B)-C(2B) 112.8(5) 
C(11B)-C(10B)-C(9B) 124.3(6) 
C(13B)-C(12B)-C(1B) 115.4(5) 
C(14B)-C(13B)-C(12B) 121.1(7) 
C(18B)-C(13B)-C(12B) 120.9(6) 
C(18B)-C(13B)-C(14B) 118.0(6) 
C(15B)-C(14B)-C(13B) 120.1(7) 
C(16B)-C(15B)-C(14B) 122.1(7) 
C(15B)-C(16B)-C(17B) 118.4(6) 
C(16B)-C(17B)-C(18B) 120.6(7) 
C(13B)-C(18B)-C(17B) 120.8(7) 
C(20B)-C(19B)-C(1B) 120.7(5) 
C(24B)-C(19B)-C(1B) 121.7(5) 
C(24B)-C(19B)-C(20B) 117.6(6) 
C(21B)-C(20B)-C(19B) 121.0(6) 
C(22B)-C(21B)-C(20B) 120.5(6) 
C(21B)-C(22B)-C(23B) 119.4(7) 
C(22B)-C(23B)-C(24B) 120.4(6) 
C(19B)-C(24B)-C(23B) 121.1(6) 
_____________________________________________________________  
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Table 2.18. Anisotropic Displacement Parameters  (Å
2
 x 10
3
) for Crystal_004. The 
anisotropic displacement factor exponent takes the form:  -2π
2
[ h
2
 a*
2
U
11
 + ...  + 2 h k a* 
b* U
12
 ] 
________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________ 
F(1) 31(2)  19(2) 18(2)  -7(2) 7(2)  -2(2) 
O(1) 17(3)  20(2) 30(3)  -9(2) 8(2)  -7(2) 
C(1) 20(4)  17(3) 10(3)  -7(2) 3(3)  2(3) 
C(2) 15(4)  14(3) 18(3)  -7(2) 6(3)  -8(3) 
C(3) 23(4)  7(3) 12(3)  -3(2) 6(3)  -3(3) 
C(4) 28(4)  15(3) 14(3)  -1(2) 3(3)  -1(3) 
C(5) 28(4)  12(3) 22(3)  2(3) 12(3)  4(3) 
C(6) 44(5)  18(3) 16(3)  2(3) 17(3)  5(3) 
C(7) 32(4)  18(3) 12(3)  -2(2) 8(3)  -2(3) 
C(8) 25(4)  12(3) 12(3)  -1(2) 7(3)  -3(3) 
C(9) 30(4)  16(3) 14(3)  -1(2) 8(3)  -8(3) 
C(10) 37(4)  10(3) 19(3)  0(2) 13(3)  -3(3) 
C(11) 31(4)  9(3) 18(3)  2(2) 12(3)  -2(3) 
C(12) 33(5)  19(3) 16(3)  0(3) -6(3)  1(3) 
C(13) 22(4)  19(3) 15(3)  -4(3) -5(3)  -3(3) 
C(14) 38(5)  34(4) 22(4)  1(3) -1(3)  -3(4) 
C(15) 33(5)  31(4) 26(4)  0(3) 4(3)  7(3) 
C(16) 46(5)  17(3) 22(3)  5(3) -3(4)  4(3) 
C(17) 41(5)  26(4) 17(3)  4(3) 7(3)  3(3) 
C(18) 35(5)  24(4) 15(3)  8(3) -1(3)  7(3) 
C(19) 27(4)  5(3) 8(3)  3(2) -1(3)  1(3) 
C(20) 26(4)  19(3) 17(3)  -2(2) 2(3)  3(3) 
C(21) 29(5)  37(4) 19(3)  -14(3) 1(3)  5(3) 
C(22) 26(4)  23(4) 29(4)  -5(3) 3(3)  3(3) 
C(23) 26(4)  16(3) 25(3)  1(3) 10(3)  5(3) 
C(24) 37(5)  25(4) 8(3)  1(2) 4(3)  -8(3) 
F(1B) 20(2)  31(2) 14(2)  7(2) 8(2)  -6(2) 
O(1B) 13(3)  34(3) 17(2)  11(2) 3(2)  1(2) 
C(1B) 18(4)  19(3) 8(3)  1(2) 5(3)  -9(3) 
C(2B) 13(4)  26(3) 11(3)  6(2) 5(3)  -1(3) 
C(3B) 15(3)  17(3) 15(3)  2(2) 8(3)  0(3) 
C(4B) 23(4)  20(3) 19(3)  1(3) 14(3)  -1(3) 
C(5B) 37(4)  15(3) 29(4)  -13(3) 24(3)  -9(3) 
C(6B) 45(5)  19(3) 26(4)  -4(3) 20(4)  -12(3) 
C(7B) 38(5)  17(3) 13(3)  4(3) 10(3)  3(3) 
C(8B) 27(4)  17(3) 13(3)  -2(2) 11(3)  -3(3) 
C(9B) 20(4)  20(3) 11(3)  3(2) 6(3)  0(3) 
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C(10B) 28(4)  22(3) 12(3)  4(3) 7(3)  -1(3) 
C(11B) 73(7)  30(4) 64(5)  -31(4) 55(5)  -32(4) 
C(12B) 28(4)  26(4) 14(3)  9(3) 3(3)  -8(3) 
C(13B) 31(4)  22(3) 9(3)  5(2) 1(3)  -9(3) 
C(14B) 21(4)  29(4) 19(3)  10(3) 0(3)  -7(3) 
C(15B) 30(5)  32(4) 23(4)  9(3) -2(3)  -14(3) 
C(16B) 35(4)  17(3) 22(3)  8(3) 1(3)  1(3) 
C(17B) 28(4)  22(3) 18(3)  3(3) 2(3)  5(3) 
C(18B) 33(4)  20(3) 15(3)  5(3) 4(3)  -4(3) 
C(19B) 16(3)  11(3) 11(3)  -1(2) 6(2)  -4(2) 
C(20B) 23(4)  12(3) 10(3)  1(2) 5(3)  2(3) 
C(21B) 20(4)  12(3) 20(3)  4(2) -1(3)  3(3) 
C(22B) 23(4)  19(3) 45(4)  6(3) 12(4)  7(3) 
C(23B) 27(4)  20(4) 43(4)  3(3) 24(4)  6(3) 
C(24B) 33(4)  12(3) 15(3)  -4(2) 10(3)  0(3) 
________________________________________________________________________
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Table 2.19. Hydrogen Coordinates ( x 10
4
) and Isotropic Displacement Parameters (Å
2
 x 
10
3
) for Crystal_004. 
________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________ 
H(1) 195 129 -511 33 
H(4) 2936 -809 104 24 
H(5) 3537 -1551 -826 24 
H(6) 2745 -1829 -2346 29 
H(7) 1349 -1331 -2976 25 
H(8) 713 -628 -2045 19 
H(9A) 2315 -278 987 24 
H(9B) 1414 -61 1075 24 
H(10) 1846 -1797 608 25 
H(11A) 823 -1278 1585 22 
H(11B) 1049 -2301 1383 22 
H(12A) 1259 994 -1737 32 
H(12B) 392 1006 -1532 32 
H(14) 26 2439 -886 41 
H(15) -133 3972 -1146 38 
H(16) 636 4676 -1941 39 
H(17) 1617 3876 -2399 35 
H(18) 1762 2345 -2127 33 
H(20) 2345 1553 1314 27 
H(21) 3774 1950 1965 36 
H(22) 4671 1845 1114 33 
H(23) 4128 1333 -388 26 
H(24) 2705 960 -1057 29 
H(1B) -163 -2568 -4622 33 
H(4B) -2812 -3486 -4844 22 
H(5B) -3281 -4337 -3887 28 
H(6B) -2367 -4680 -2408 34 
H(7B) -954 -4218 -1925 27 
H(8B) -455 -3388 -2891 22 
H(9BA) -2287 -3010 -5848 21 
H(9BB) -1426 -2751 -6008 21 
H(10B) -1681 -4499 -5404 25 
H(11C) -937 -3967 -6656 57 
H(11D) -1041 -4991 -6346 57 
H(12C) -1117 -1617 -3157 28 
H(12D) -293 -1612 -3445 28 
H(14B) 14 -198 -4187 30 
H(15B) 55 1333 -4074 38 
H(16B) -724 2091 -3342 32 
H(17B) -1625 1295 -2780 29 
H(18B) -1713 -249 -2919 29 
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H(20B) -2466 -1094 -6129 18 
H(21B) -3913 -800 -6622 23 
H(22B) -4683 -1093 -5678 34 
H(23B) -3984 -1633 -4204 32 
H(24B) -2527 -1887 -3683 23 
________________________________________________________________________ 
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Relative and absolute stereochemistry of product from eq 2.11 (run with the 
product of a cross-coupling conducted with (4R,5S)-L1). (1R,2S)-1-(4-
Chlorophenyl)-2-fluoro-1,2,3-triphenylpropan-1-ol (for the sake of simplicity, 
disordered solvent molecules (CH2Cl2) have been omitted).  
 
A crystal of a solvate of C27H22Cl1F1O1 was selected and mounted in a nylon loop 
in immersion oil. All measurements were made on a Bruker Apex-II with filtered Mo-Kα 
radiation at a temperature of 100 K. Using Olex2 [1], the structure was solved with the 
ShelXS [2] structure solution program using Direct Methods and refined with the ShelXL 
[3] refinement package using Least Squares minimization. The disordered and partially 
occupied dichloromethane solvent was refined with similarity restraints placed on the 
appropriate atom bond lengths and displacement parameters. The occupancy of the 
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dichloromethane was also refined. The absolute stereochemistry was determined on the 
basis of the absolute structure parameter. 
 1. O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. 
Puschmann, OLEX2: a complete structure solution, refinement, and analysis program. J. 
Appl. Cryst. 2009, 42, 339–341. 
 2. SHELXS, G.M. Sheldrick, Acta Cryst. 2008, A64, 112–122. 
 3. SHELXL, G.M. Sheldrick, Acta Cryst. 2008, A64, 112–122. 
 
Table 2.20. Crystal Data and Structure Refinement for Crystal_005. 
Identification code  crystal_005 
Empirical formula  C27 H22 Cl1 F O · (0.58 CH2Cl2) 
Formula weight  466.24 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 11.4485(6) Å α = 90°. 
 b = 5.9142(3) Å β = 91.076(3) °. 
 c = 17.0352(8) Å γ = 90 °. 
Volume 1153.23(10) Å3 
Z 2 
Density (calculated) 1.343 Mg/m3 
Absorption coefficient 0.326 mm-1 
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F(000) 484.8 
Crystal size 0.3 x 0.1 x 0.05 mm3 
Theta range for data collection 1.779 to 37.564°. 
Index ranges -19<=h<=19, -9<=k<=10, -28<=l<=28 
Reflections collected 62094 
Independent reflections 11432 [R(int) = 0.0601] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 11432 / 68 / 321 
Goodness-of-fit on F2 0.957 
Final R indices [I>2sigma(I)] R1 = 0.0499, wR2 = 0.1202 
R indices (all data) R1 = 0.0773, wR2 = 0.1290 
Absolute structure parameter -0.005(18) 
Largest diff. peak and hole 0.818 and -0.637 e/Å-3 
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Table 2.21. Atomic Coordinates ( x 10
4
) and Equivalent Isotropic Displacement 
Parameters (Å
2
 x 10
3
) for Crystal_005. U(eq) is defined as one third of the trace of the 
orthogonalized U
ij
 tensor. 
________________________________________________________________________  
 x y z U(eq) Occ 
________________________________________________________________________ 
Cl(1) -3149(1) -8113(1) -3825(1) 33(1) 
F(1) -3173(1) -9003(2) -7865(1) 14(1) 
O(1) -3390(1) -3198(2) -7234(1) 16(1) 
C(1) -2872(2) -6682(3) -7856(1) 11(1) 
C(2) -3704(2) -5518(3) -7253(1) 12(1) 
C(3) -3090(2) -5802(3) -8686(1) 12(1) 
C(4) -2652(2) -3711(3) -8930(1) 16(1) 
C(5) -2846(2) -2956(4) -9698(1) 18(1) 
C(6) -3464(2) -4295(4) -10232(1) 21(1) 
C(7) -3910(2) -6353(4) -9993(1) 20(1) 
C(8) -3730(2) -7103(3) -9224(1) 15(1) 
C(9) -1579(2) -6523(3) -7607(1) 14(1) 
C(10) -804(2) -8115(4) -8052(1) 15(1) 
C(11) -491(2) -7697(4) -8830(1) 20(1) 
C(12) 216(2) -9199(5) -9226(1) 27(1) 
C(13) 629(2) -11144(4) -8862(1) 25(1) 
C(14) 347(2) -11570(4) -8090(1) 24(1) 
C(15) -371(2) -10072(4) -7688(1) 21(1) 
C(16) -3531(2) -6300(3) -6398(1) 13(1) 
C(17) -3843(2) -4760(3) -5813(1) 18(1) 
C(18) -3740(2) -5302(4) -5022(1) 22(1) 
C(19) -3313(2) -7411(4) -4810(1) 20(1) 
C(20) -3022(2) -8995(4) -5373(1) 19(1) 
C(21) -3140(2) -8431(3) -6168(1) 17(1) 
C(22) -4982(2) -5871(3) -7507(1) 13(1) 
C(23) -5592(2) -4212(3) -7925(1) 17(1) 
C(24) -6762(2) -4514(4) -8141(1) 21(1) 
C(25) -7343(2) -6478(4) -7942(1) 21(1) 
C(26) -6739(2) -8158(4) -7531(1) 20(1) 
C(27) -5575(2) -7861(3) -7317(1) 16(1) 
Cl(2) 762(3) -18036(7) -5767(2) 136(1) 0.581(3) 
Cl(3A) -738(8) -13650(20) -5696(6) 156(2) 0.235(3) 
C(28) 381(9) -15326(17) -5956(7) 141(2) 0.581(3) 
Cl(3B) 144(19) -12920(40) -5390(13) 158(3) 0.106(3) 
Cl(3C) -295(9) -15040(20) -5084(6) 169(3) 0.240(3) 
________________________________________________________________________
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Table 2.22. Bond Lengths [Å] and Angles [°] for Crystal_005. 
_____________________________________________________  
Cl(1)-C(19)  1.7347(19) 
F(1)-C(1)  1.416(2) 
O(1)-C(2)  1.419(2) 
C(1)-C(2)  1.573(2) 
C(1)-C(3)  1.522(2) 
C(1)-C(9)  1.535(2) 
C(2)-C(16)  1.537(2) 
C(2)-C(22)  1.533(3) 
C(3)-C(4)  1.400(3) 
C(3)-C(8)  1.394(3) 
C(4)-C(5)  1.397(3) 
C(5)-C(6)  1.389(3) 
C(6)-C(7)  1.384(3) 
C(7)-C(8)  1.394(3) 
C(9)-C(10)  1.508(3) 
C(10)-C(11)  1.402(3) 
C(10)-C(15)  1.399(3) 
C(11)-C(12)  1.386(3) 
C(12)-C(13)  1.386(4) 
C(13)-C(14)  1.383(3) 
C(14)-C(15)  1.397(3) 
C(16)-C(17)  1.402(3) 
C(16)-C(21)  1.392(3) 
C(17)-C(18)  1.387(3) 
C(18)-C(19)  1.386(3) 
C(19)-C(20)  1.386(3) 
C(20)-C(21)  1.399(3) 
C(22)-C(23)  1.393(3) 
C(22)-C(27)  1.399(3) 
C(23)-C(24)  1.393(3) 
C(24)-C(25)  1.384(3) 
C(25)-C(26)  1.392(3) 
C(26)-C(27)  1.386(3) 
Cl(2)-C(28)  1.691(10) 
Cl(3A)-C(28)  1.687(11) 
 
F(1)-C(1)-C(2) 106.29(13) 
F(1)-C(1)-C(3) 106.66(14) 
F(1)-C(1)-C(9) 107.18(14) 
C(3)-C(1)-C(2) 111.50(14) 
C(3)-C(1)-C(9) 112.15(14) 
C(9)-C(1)-C(2) 112.61(14) 
O(1)-C(2)-C(1) 106.35(14) 
O(1)-C(2)-C(16) 104.00(14) 
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O(1)-C(2)-C(22) 112.20(15) 
C(16)-C(2)-C(1) 114.78(14) 
C(22)-C(2)-C(1) 110.06(14) 
C(22)-C(2)-C(16) 109.34(14) 
C(4)-C(3)-C(1) 121.57(16) 
C(8)-C(3)-C(1) 119.78(16) 
C(8)-C(3)-C(4) 118.64(16) 
C(5)-C(4)-C(3) 120.55(18) 
C(6)-C(5)-C(4) 120.1(2) 
C(7)-C(6)-C(5) 119.63(18) 
C(6)-C(7)-C(8) 120.50(19) 
C(3)-C(8)-C(7) 120.55(19) 
C(10)-C(9)-C(1) 113.33(15) 
C(11)-C(10)-C(9) 121.90(18) 
C(15)-C(10)-C(9) 120.05(16) 
C(15)-C(10)-C(11) 118.05(18) 
C(12)-C(11)-C(10) 120.6(2) 
C(11)-C(12)-C(13) 120.8(2) 
C(14)-C(13)-C(12) 119.5(2) 
C(13)-C(14)-C(15) 120.1(2) 
C(14)-C(15)-C(10) 120.9(2) 
C(17)-C(16)-C(2) 116.65(16) 
C(21)-C(16)-C(2) 125.05(16) 
C(21)-C(16)-C(17) 118.23(17) 
C(18)-C(17)-C(16) 121.49(19) 
C(19)-C(18)-C(17) 119.00(19) 
C(18)-C(19)-Cl(1) 119.94(16) 
C(18)-C(19)-C(20) 121.06(18) 
C(20)-C(19)-Cl(1) 119.00(17) 
C(19)-C(20)-C(21) 119.28(19) 
C(16)-C(21)-C(20) 120.90(17) 
C(23)-C(22)-C(2) 121.02(17) 
C(23)-C(22)-C(27) 118.07(18) 
C(27)-C(22)-C(2) 120.91(16) 
C(22)-C(23)-C(24) 121.01(19) 
C(25)-C(24)-C(23) 120.45(19) 
C(24)-C(25)-C(26) 119.03(19) 
C(27)-C(26)-C(25) 120.6(2) 
C(26)-C(27)-C(22) 120.89(19) 
Cl(3A)-C(28)-Cl(2) 134.6(11) 
_____________________________________________________________  
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Table 2.23. Anisotropic Displacement Parameters (Å
2
 x 10
3
) for Crystal_005. The 
anisotropic displacement factor exponent takes the form:  -2π
2
[ h
2
 a*
2
U
11
 + ...  + 2 h k a* 
b* U
12
 ]. 
________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________ 
Cl(1) 60(1)  29(1) 9(1)  4(1) 0(1)  -10(1) 
F(1) 21(1)  7(1) 14(1)  0(1) 1(1)  -1(1) 
O(1) 28(1)  7(1) 13(1)  0(1) 3(1)  -1(1) 
C(1) 16(1)  7(1) 11(1)  0(1) 1(1)  0(1) 
C(2) 19(1)  7(1) 9(1)  0(1) 1(1)  0(1) 
C(3) 15(1)  11(1) 10(1)  1(1) 4(1)  2(1) 
C(4) 18(1)  14(1) 15(1)  2(1) 3(1)  0(1) 
C(5) 21(1)  18(1) 16(1)  6(1) 6(1)  3(1) 
C(6) 22(1)  29(1) 12(1)  6(1) 3(1)  5(1) 
C(7) 22(1)  27(1) 11(1)  0(1) 1(1)  0(1) 
C(8) 18(1)  16(1) 12(1)  0(1) 2(1)  -1(1) 
C(9) 17(1)  14(1) 12(1)  -1(1) 0(1)  0(1) 
C(10) 13(1)  17(1) 15(1)  -1(1) 0(1)  -1(1) 
C(11) 17(1)  26(1) 17(1)  2(1) 0(1)  4(1) 
C(12) 19(1)  43(1) 18(1)  -5(1) 2(1)  10(1) 
C(13) 16(1)  29(1) 31(1)  -9(1) -1(1)  5(1) 
C(14) 19(1)  18(1) 36(1)  0(1) 2(1)  2(1) 
C(15) 19(1)  20(1) 23(1)  3(1) 2(1)  1(1) 
C(16) 18(1)  11(1) 10(1)  0(1) 2(1)  -2(1) 
C(17) 27(1)  14(1) 13(1)  -2(1) 3(1)  1(1) 
C(18) 34(1)  20(1) 12(1)  -3(1) 5(1)  -1(1) 
C(19) 30(1)  20(1) 10(1)  3(1) 0(1)  -7(1) 
C(20) 31(1)  14(1) 13(1)  3(1) -1(1)  -2(1) 
C(21) 27(1)  12(1) 11(1)  0(1) 1(1)  -1(1) 
C(22) 17(1)  13(1) 8(1)  -1(1) 3(1)  2(1) 
C(23) 22(1)  16(1) 14(1)  3(1) 4(1)  4(1) 
C(24) 22(1)  24(1) 16(1)  1(1) 1(1)  9(1) 
C(25) 19(1)  27(1) 16(1)  -6(1) 1(1)  4(1) 
C(26) 21(1)  21(1) 18(1)  -3(1) 1(1)  -2(1) 
C(27) 21(1)  14(1) 15(1)  0(1) 1(1)  1(1) 
Cl(2) 132(2)  156(3) 116(2)  -63(2) -62(2)  26(2) 
Cl(3A) 136(4)  181(4) 150(4)  -49(4) -42(3)  3(4) 
C(28) 105(4)  181(5) 134(4)  -52(5) -65(4)  2(4) 
Cl(3B) 139(5)  183(5) 151(5)  -41(5) -49(4)  10(5) 
Cl(3C) 140(4)  189(5) 176(5)  -36(5) -37(4)  2(4) 
________________________________________________________________________
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Table 2.24. Hydrogen Coordinates ( x 10
4
) and Isotropic Displacement Parameters (Å
2
 x 
10
3
) for Crystal_005. 
________________________________________________________________________ 
 x  y  z  U(eq) Occ 
________________________________________________________________________ 
H(1) -3514 -2623 -7679 24 
H(4) -2218 -2799 -8569 19 
H(5) -2556 -1525 -9856 22 
H(6) -3580 -3801 -10758 25 
H(7) -4342 -7261 -10355 24 
H(8) -4045 -8513 -9066 18 
H(9A) -1306 -4954 -7689 17 
H(9B) -1504 -6860 -7039 17 
H(11) -765 -6370 -9088 24 
H(12) 418 -8893 -9754 32 
H(13) 1103 -12177 -9141 30 
H(14) 642 -12882 -7833 29 
H(15) -568 -10386 -7160 25 
H(17) -4133 -3313 -5961 22 
H(18) -3958 -4242 -4633 26 
H(20) -2745 -10447 -5221 23 
H(21) -2951 -9518 -6556 20 
H(23) -5205 -2853 -8064 21 
H(24) -7162 -3364 -8428 25 
H(25) -8143 -6676 -8084 25 
H(26) -7127 -9519 -7396 24 
H(27) -5174 -9025 -7038 20 
H(28A) 1081 -14455 -5790 169 0.581 
H(28B) 363 -15250 -6537 169 0.581 
________________________________________________________________________ 
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Absolute stereochemistry of product from eq 2.13 (run with the product of a 
cross-coupling conducted with (4R,5S)-L1). (S)-1-Fluoro-1,2-diphenylethyl benzoate.  
 
A crystal of C21H17F1O2 was selected and mounted in a nylon loop in immersion 
oil. All measurements were made on a Rigkau Saturn944+ with filtered Cu-Kα radiation 
at a temperature of 93 K. Using Olex2 [1], the structure was solved with the ShelXS [2] 
structure solution program using Direct Methods and refined with the ShelXL [3] 
refinement package using Least Squares minimization. The absolute stereochemistry was 
determined on the basis of the absolute structure parameter. 
 1. O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. 
Puschmann, OLEX2: a complete structure solution, refinement, and analysis program. J. 
Appl. Cryst. 2009, 42, 339–341. 
 2. SHELXS, G.M. Sheldrick, Acta Cryst. 2008, A64, 112–122. 
 3. SHELXL, G.M. Sheldrick, Acta Cryst. 2008, A64, 112–122. 
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Table 2.25.  Crystal Data and Structure Refinement for Crystal_003. 
Identification code  crystal_003 
Empirical formula  C21 H17 F1 O2  
Formula weight  320.36 
Temperature  93 K 
Wavelength  1.54187 Å 
Crystal system  Monoclinic 
Space group  C 1 2 1 
Unit cell dimensions a = 23.9583(4) Å α= 90°. 
 b = 5.74320(10) Å β= 98.352(7) °. 
 c = 11.8825(8) Å γ = 90 °. 
Volume 1617.66(12) Å3 
Z 4 
Density (calculated) 1.315 Mg/m3 
Absorption coefficient 0.743 mm-1 
F(000) 672 
Crystal size 0.3 x 0.15 x 0.1 mm3 
Theta range for data collection 3.730 to 68.193°. 
Index ranges -28<=h<=28, -6<=k<=6, -14<=l<=14 
Reflections collected 17522 
Independent reflections 2923 [R(int) = 0.0897] 
Completeness to theta = 67.687° 99.6 %  
Absorption correction Semi-empirical from equivalents 
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Max. and min. transmission 1.000 and 0.742 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2923 / 1 / 217 
Goodness-of-fit on F2 1.138 
Final R indices [I>2sigma(I)] R1 = 0.0427, wR2 = 0.1153 
R indices (all data) R1 = 0.0440, wR2 = 0.1173 
Absolute structure parameter 0.1(2) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.172 and -0.227 e/Å-3 
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Table 2.26. Atomic Coordinates  ( x 10
4
) and Equivalent Isotropic Displacement 
Parameters (Å
2
 x 10
3
) for Crystal_003. U(eq) is defined as one third of  the trace of the 
orthogonalized U
ij
 tensor. 
________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________  
F(1) 946(1) 3233(3) 6557(1) 32(1) 
O(1) 1179(1) 3964(3) 4361(2) 32(1) 
O(2) 827(1) 6566(3) 5507(2) 28(1) 
C(1) 928(1) 5744(5) 4476(2) 28(1) 
C(2) 1132(1) 5518(5) 6505(2) 27(1) 
C(3) 944(1) 6845(5) 7497(2) 29(1) 
C(4) 1242(1) 6041(5) 8638(2) 27(1) 
C(5) 1090(1) 3966(5) 9131(2) 31(1) 
C(6) 1386(1) 3197(5) 10155(2) 34(1) 
C(7) 1834(1) 4486(6) 10705(2) 34(1) 
C(8) 1985(1) 6552(6) 10225(2) 35(1) 
C(9) 1693(1) 7309(5) 9200(2) 31(1) 
C(10) 1762(1) 5559(5) 6497(2) 25(1) 
C(11) 2102(1) 3735(5) 6945(2) 28(1) 
C(12) 2684(1) 3855(5) 6969(2) 29(1) 
C(13) 2927(1) 5805(5) 6552(2) 29(1) 
C(14) 2589(1) 7632(5) 6101(2) 30(1) 
C(15) 2008(1) 7532(5) 6079(2) 28(1) 
C(16) 695(1) 7307(5) 3528(2) 26(1) 
C(17) 754(1) 6595(5) 2424(2) 32(1) 
C(18) 556(1) 8001(6) 1505(2) 34(1) 
C(19) 303(1) 10121(5) 1687(2) 34(1) 
C(20) 244(1) 10830(5) 2775(2) 32(1) 
C(21) 444(1) 9419(5) 3702(2) 29(1) 
________________________________________________________________________
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Table 2.27. Bond Lengths [Å] and Angles [°] for Crystal_003. 
_____________________________________________________  
F(1)-C(2)  1.390(3) 
O(1)-C(1)  1.204(3) 
O(2)-C(1)  1.367(3) 
O(2)-C(2)  1.432(3) 
C(1)-C(16)  1.484(4) 
C(2)-C(3)  1.526(4) 
C(2)-C(10)  1.512(3) 
C(3)-C(4)  1.511(4) 
C(4)-C(5)  1.399(4) 
C(4)-C(9)  1.391(4) 
C(5)-C(6)  1.389(4) 
C(6)-C(7)  1.387(4) 
C(7)-C(8)  1.387(5) 
C(8)-C(9)  1.384(4) 
C(10)-C(11)  1.385(4) 
C(10)-C(15)  1.401(4) 
C(11)-C(12)  1.391(4) 
C(12)-C(13)  1.387(4) 
C(13)-C(14)  1.385(4) 
C(14)-C(15)  1.390(4) 
C(16)-C(17)  1.401(4) 
C(16)-C(21)  1.382(4) 
C(17)-C(18)  1.384(4) 
C(18)-C(19)  1.390(5) 
C(19)-C(20)  1.383(4) 
C(20)-C(21)  1.395(4) 
 
C(1)-O(2)-C(2) 117.5(2) 
O(1)-C(1)-O(2) 123.4(2) 
O(1)-C(1)-C(16) 124.6(2) 
O(2)-C(1)-C(16) 112.0(2) 
F(1)-C(2)-O(2) 107.8(2) 
F(1)-C(2)-C(3) 107.7(2) 
F(1)-C(2)-C(10) 109.9(2) 
O(2)-C(2)-C(3) 104.9(2) 
O(2)-C(2)-C(10) 112.3(2) 
C(10)-C(2)-C(3) 113.9(2) 
C(4)-C(3)-C(2) 112.7(2) 
C(5)-C(4)-C(3) 121.2(2) 
C(9)-C(4)-C(3) 120.3(3) 
C(9)-C(4)-C(5) 118.5(2) 
C(6)-C(5)-C(4) 120.5(3) 
C(7)-C(6)-C(5) 120.3(3) 
C(8)-C(7)-C(6) 119.6(3) 
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C(9)-C(8)-C(7) 120.1(3) 
C(8)-C(9)-C(4) 121.1(3) 
C(11)-C(10)-C(2) 121.2(2) 
C(11)-C(10)-C(15) 119.7(2) 
C(15)-C(10)-C(2) 119.0(2) 
C(10)-C(11)-C(12) 120.1(2) 
C(13)-C(12)-C(11) 120.2(2) 
C(14)-C(13)-C(12) 119.8(2) 
C(13)-C(14)-C(15) 120.3(3) 
C(14)-C(15)-C(10) 119.8(2) 
C(17)-C(16)-C(1) 117.1(2) 
C(21)-C(16)-C(1) 122.8(2) 
C(21)-C(16)-C(17) 120.1(3) 
C(18)-C(17)-C(16) 119.9(3) 
C(17)-C(18)-C(19) 119.7(3) 
C(20)-C(19)-C(18) 120.6(3) 
C(19)-C(20)-C(21) 119.8(3) 
C(16)-C(21)-C(20) 119.9(3) 
_____________________________________________________________  
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Table 2.28. Anisotropic Displacement Parameters  (Å
2
 x 10
3
) for Crystal_003. The 
anisotropic displacement factor exponent takes the form:  -2π
2
[ h
2
 a*
2
U
11
 + ...  + 2 h k a* 
b* U
12
 ]. 
________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________ 
F(1) 30(1)  31(1) 34(1)  -1(1) 5(1)  -5(1) 
O(1) 32(1)  33(1) 31(1)  -4(1) 1(1)  4(1) 
O(2) 26(1)  36(1) 22(1)  -1(1) 3(1)  4(1) 
C(1) 22(1)  34(1) 28(1)  -5(1) 3(1)  -1(1) 
C(2) 28(1)  28(1) 25(1)  2(1) 2(1)  -1(1) 
C(3) 27(1)  35(2) 26(1)  -1(1) 6(1)  4(1) 
C(4) 25(1)  31(1) 25(1)  -1(1) 7(1)  3(1) 
C(5) 30(1)  36(2) 29(1)  0(1) 8(1)  -3(1) 
C(6) 40(2)  32(2) 31(1)  3(1) 10(1)  0(1) 
C(7) 35(2)  41(2) 25(1)  2(1) 4(1)  6(1) 
C(8) 34(1)  43(2) 28(1)  0(1) 4(1)  -3(1) 
C(9) 37(1)  31(1) 27(1)  -1(1) 7(1)  -2(1) 
C(10) 27(1)  29(1) 20(1)  -2(1) 3(1)  -1(1) 
C(11) 29(1)  29(1) 26(1)  2(1) 6(1)  0(1) 
C(12) 28(1)  34(2) 26(1)  1(1) 3(1)  4(1) 
C(13) 26(1)  33(1) 27(1)  -4(1) 4(1)  -2(1) 
C(14) 30(1)  33(2) 27(1)  0(1) 5(1)  -4(1) 
C(15) 32(1)  30(1) 23(1)  1(1) 1(1)  1(1) 
C(16) 21(1)  33(1) 26(1)  -1(1) 4(1)  -3(1) 
C(17) 29(1)  36(2) 31(1)  -6(1) 7(1)  -4(1) 
C(18) 36(1)  43(2) 24(1)  0(1) 6(1)  -2(1) 
C(19) 32(1)  39(2) 30(2)  5(1) 2(1)  -3(1) 
C(20) 26(1)  35(2) 33(2)  2(1) 3(1)  -2(1) 
C(21) 23(1)  39(2) 26(1)  -2(1) 4(1)  -5(1) 
________________________________________________________________________
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Table 2.29. Hydrogen Coordinates ( x 10
4
) and Isotropic Displacement Parameters (Å
2
 x 
10
3
) for crystal_003. 
________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________ 
H(3A) 1018 8526 7407 35 
H(3B) 532 6641 7475 35 
H(5) 782 3077 8762 38 
H(6) 1281 1781 10481 41 
H(7) 2036 3958 11406 41 
H(8) 2290 7447 10601 42 
H(9) 1803 8719 8875 38 
H(11) 1938 2399 7236 33 
H(12) 2916 2596 7273 35 
H(13) 3325 5887 6575 34 
H(14) 2755 8959 5806 36 
H(15) 1777 8799 5781 34 
H(17) 929 5150 2305 38 
H(18) 592 7519 755 41 
H(19) 170 11091 1057 41 
H(20) 68 12275 2892 38 
H(21) 408 9908 4451 35 
________________________________________________________________________ 
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2.6.7 1H NMR Spectra of Selected Compounds 
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CHAPTER 3 
Nickel-Catalyzed Negishi Alkylations of α-Halo-α-Perfluoroalkyl Electrophiles+ 
 
 
3.1 Introduction 
 Organic molecules bearing fluorine atoms usually exhibit unique properties, 
including biological activity, and have been found to have important applications in a 
variety of fields.1 Although significant progress has been made in the development of 
general methods for the synthesis of fluorinated aromatic molecules,2,3 current 
approaches to the preparation of compounds bearing a Csp3–RF moiety (RF = a 
perfluoroalkyl group) are still narrow in scope.4 
 Figure 3.1 shows a few interesting molecules wherein a perfluoroalkyl group is 
connected to an sp3-hybridized tertiary carbon.5 
 
Me OH
HO n-C6F13
estradiol derivative proline derivative
H
H
H
nucleoside analogue
N
H
F3C
COOH O
NHOH2C
F3C
N
N
N
NH2
 
Figure 3.1. Compounds Bearing Perfluoroalkyl-Substituted Tertiary Carbons 
																																																								
+ Portions of this chapter have appeared in the previous publication and the supporting 
information found therein: Liang, Y.; Fu, G. C. Angew. Chem. Int. Ed. 2015, 54, 9047–
9051. Copyright 2015 John Wiley & Sons, Inc.  
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 In order to construct this type of structure, one commonly employed strategy is to 
perform an alkyl-alkyl cross-coupling reaction with a perfluoroalkyl nucleophile (Scheme 
3.1a). However, only stoichiometric cross-coupling methods have been reported when 
unactivated alkyl electrophiles are used as substrates.6 Additionally, the reluctance of a 
fluoroalkyl group to participate in the reductive elimination step might also add 
difficulties to adopting this strategy.7 
 
Scheme 3.1. Two Types of Cross-Coupling Strategies 
a. Previous studies:
b. This study:
alkyl alkyl
X
RFM
stoichiometric cross-coupling
alkyl alkyl
RF
alkyl X
RF
alkylM
Ni-catalyzed cross-coupling
alkyl alkyl
RF
 
 
 We envisioned that an alternative approach in which an α-halo-α-perfluoroalkyl 
secondary alkyl electrophile is cross-coupled with an alkyl nucleophile can also be a 
promising strategy (Scheme 3.1b). Although success has been achieved in cross-coupling 
aryl, alkenyl, and alkynyl nucleophiles with primary alkyl electrophiles bearing a CF3 
group (specifically, CF3I and CF3OTs),8 to the best of our knowledge, secondary alkyl 
electrophiles with a perfluoroalkyl group have never been employed in such a method. In 
this chapter, we describe a nickel-catalyzed Negishi alkylation method with α-halo-α-
perfluoroalkyl secondary alkyl electrophiles as substrates. This new route provides a 
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versatile and practical approach for the generation of valuable building blocks bearing 
perfluoroalkyl-substituted tertiary carbons. 
 
3.2 Optimization 
 We chose to start our study by choosing alkylzinc reagents as the nucleophilic 
cross-coupling partners due to their ready accessibility and high functional-group 
tolerance.9 In 2003, our group reported the first Ni-catalyzed Negishi alkylation method 
with unactivated secondary alkyl electrophiles as substrates.10 Applying these conditions 
to the cross-coupling of an alkyl electrophile bearing a perfluoroalkyl group, we obtained 
promising results (eq 3.1). 
4% Ni(cod)2
8% s-Bu-Pybox
DMA, r.t.
NO
N N
O
s-Bu s-Bu
s-Bu-Pybox
RF
Br
Ph
PhO ZnBr
RF Ph
OPh
(3.1)
RF = CF3, 54% yield
RF = CF2CF3, 8% yield
1.6 equiv
 
 Although this catalytic system could deliver the CF3-substituted product in 
moderate yield, the efficiency of the reaction with the C2F5-substituted electrophile is 
very disappointing. In order to develop a general method that can cross-couple 
electrophiles bearing all kinds of perfluoroalkyl groups, we decided to optimize the 
reaction conditions using the C2F5-substituted alkyl bromide as model substrate. After 
extensive screening, we finally identified a suitable condition that can provide both cross-
coupling products in good yield (eq 3.2). From a practical point of view, both the nickel 
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source and ligand L2 shown in eq 3.2 are commercially available and can be handled in 
air.  
10% NiCl2  •  glyme
11% L2
1 equiv NaBr
DMA, r.t.
NO
N N
O
i-Pr i-PrL2
RF
Br
Ph
PhO ZnBr
RF Ph
OPh
(3.2)
RF = CF3, 80% yield
RF = CF2CF3, 79% yield
1.2 equiv
 
 As shown in Table 3.1, in the absence of nickel source, no product is formed 
(entry 2). Without the ligand L2, the cross-coupling product is generated in moderate 
yield (entry 3). The use of less alkylzinc reagent leads to only a small drop in yield (entry 
4). The employment of 5% catalyst affords a moderate decreased in efficiency (entry 5). 
The addition of small amount of water or the changes in temperature has no significant 
effect towards the outcome of the reaction, whereas performing the reaction under air 
leads to decreased yield (entries 6 to 9). 
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Table 3.1. Effect of Reaction Parametersa 
entry variation from the "standard" conditions yield (%)b
1
2
3
4
5
6
7
8
9
none
no NiCl2  •  glyme
no L2
1.0 equiv of organozinc reagent
5.0% NiCl2  •glyme, 5.5% L2
+ 0.1 equiv H2O
under air in a closed vial
40 ºC, instead of r.t.
0 ºC, instead of r.t.
aAll data are the average of two experiments. bThe yields were determined 
through analysis by 19F NMR spectroscopy with the aid of an internal standard.
79
<1
49
71
64
79
60
72
75
10% NiCl2  •  glyme
11% L2
1 equiv NaBr
DMA, r.t.
"standard" conditions
F3CF2C
Br
Ph
PhO ZnBr
F3CF2C Ph
OPh
1.2 equiv
 
 
The introducing of NaBr as additive is very crucial for this transformation. 
Several other related additives have been tested under the optimized conditions and NaBr 
turns out to be the best (Table 3.2). Possible explanations for the beneficial effects of 
NaBr include but are not restricted to an increase in the ionic strength of reaction medium 
and activation of alkylzinc reagents via the formation of ate complexes.11 
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Table 3.2. Effect of Additivea 
entry variation from the "standard" conditions yield (%)b
1
2
3
4
5
6
7
8
9
none
no NaBr
LiBr, instead of NaBr
KBr, instead of NaBr
CsBr, instead of NaBr
(n-Bu)4NBr, instead of NaBr
NaI, instead of NaBr
NaCl, instead of NaBr
NaF, instead of NaBr
aAll data are the average of two experiments. bThe yields were determined 
through analysis by 19F NMR spectroscopy with the aid of an internal standard.
79
28
75
66
61
74
59
66
27
10% NiCl2  •  glyme
11% L2
1 equiv NaBr
DMA, r.t.
"standard" conditions
F3CF2C
Br
Ph
PhO ZnBr
F3CF2C Ph
OPh
1.2 equiv
 
 
 Several tridentated and bidentated chiral or achiral ligands have been explored 
under our optimized conditions (Scheme 3.2). None of these previously employed ligands 
can even provide comparable results.  
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Scheme 3.2. Effect of Ligands 
N
N
OO
N
N
N
OO
N
Me Me Me Me
N
N N
N NN
N N N N
t-But-Bu
N N
Ph Ph
N
OO
N
Ph Ph
MeMe
NHMe HN Me
10% NiCl2  •  glyme
11% ligand
1 equiv NaBr
DMA, r.t.
F3CF2C
Br
Ph
PhO ZnBr
F3CF2C Ph
OPh
1.2 equiv
5% yield15% yield
<1% yield 4% yield 3% yield
7% yield 17% yield racemic<1% yield
NO
N N
O
i-Pr i-PrL2
79% yield
 
 
3.3 Scope 
 With the optimized conditions in hand, we started to explore the scope of this new 
method. A variety of alkylzinc reagents can be employed in this Negishi alkylation 
method (Table 3.3). Functional groups including an ether (entries 1, 2, and 8), an acetal 
(entry 3), an internal alkyne (entry 4), an ester (entry 5), a phosphonate (entry 6), a nitrile 
(entry 7), and a primary alkyl chloride (entry 8) can all be compatible with the optimized 
conditions. 
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Table 3.3. Negishi Alkylations to Generate Pentafluoroethyl-Substituted Products: 
Scopea  
entry R yield (%)b
1 74OPh
2
66
OEt
3 61
4
70P
OEt
5
77CN
O
O
O
O
OEt
R1
CH2CH2Ph
CH2CH2Ph
CH2CH2Ph
CH2CH2Ph
CH2CH2Ph
6
59
CH2CH2Ph
7
55
CH2CH2Ph
Ph
O
OPh8 Cl 64
aAll data are the average of two experiments. bYield of purified product.
10% NiCl2  •  glyme
11% L2
1 equiv NaBr
DMA, r.t.
F3CF2C
Br
R1
1.2 equiv
F3CF2C
R
R1
ZnBrR
 
  
 Next, we are delighted to observe that this method can also be applied to 
electrophiles bearing higher order perfluoroalkyl groups without any modifications 
(Table 3.4).  
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Table 3.4. Scope with Respect to the Perfluoroalkyl Groupa 
entry R yield (%)bRF
1 65OPh
2 54
OEt
3 51
4 69CN
O
n-C3F7
n-C3F7
n-C3F7
n-C3F7
5 67OPh
6 54
OEt
7 69CN
O
n-C4F9
n-C4F9
n-C4F9
8 66CNn-C9F19
aAll data are the average of two experiments. bYield of purified product.
P
OEt
O
OEt
10% NiCl2  •  glyme
11% L2
1 equiv NaBr
DMA, r.t.
RF
Br
1.2 equiv
ZnBrR
Ph RF
R
Ph
 
 
 Considering the unique properties of the trifluoromethyl (CF3) group, the 
construction of molecules bearing C–CF3 moieties has recently attracted much attention. 
Although a few methods have been developed in the generation of targets that include a 
trifluoromethyl group connected to a tertiary carbon, a general method that provides the 
products in good efficiency is still desirable.4,12 As shown in Table 3.5 and Table 3.6, our 
method can be directly used to access these targets and the functional-group tolerance is 
very satisfactory. 
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Table 3.5. Negishi Alkylations to Generate Trifluoromethyl-Substituted Products: Scope 
with Respect to the Nucleophilea 
entry R yield (%)b
1 79
2
83OPh3
83OEt
4
725
89
6
83CN
7
78Ph
8
67
9
74
O
O
O
Ph
O
aAll data are the average of two experiments.  bYield of purified product.
P
OEt
O
OEt
n-Bu
10% NiCl2  •  glyme
11% L2
1 equiv NaBr
DMA, r.t.
F3C
Br
1.2 equiv
ZnBrR
Ph F3C
R
Ph
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Table 3.6. Negishi Alkylations to Generate Trifluoromethyl-Substituted Products: Scope 
with Respect to the Electrophilea 
Br
OTs
OTBDPS
O
O
O
O
86
79
76
72
83
81
80
1
2
3
4c
5
6c
7
entry R1 yield (%)b
N
Boc
O
868 O
Me
I
aAll data are the average of two experiments. bYield of purified product. 
cNucleophile:  BrZnCH2CH2CH2CN.
n-Bu
10% NiCl2  •  glyme
11% L2
1 equiv NaBr
DMA, r.t.
F3C
Br
R1 1.2 equiv F3C R1
OPh
PhO ZnBr
 
  
 Our new method is not limited to cross-couplings of secondary alkyl bromides. 
Under the same conditions, a fluorinated alkyl iodide can also cross-couple with an 
alkylzinc reagent in moderate efficiency (eq 3.3). 
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10% NiCl2  •  glyme
11% L2
1 equiv NaBr
DMA, r.t.
F3CF2C
I
Ph
PhO ZnBr
F3CF2C Ph
OPh
1.2 equiv
62% yield
(3.3)
 
 
 To probe the scalability of this method, we perform a large-scale experiment 
using a trifluoromethyl-containing electrophile (eq 3.4). The cross-coupling reaction 
proceeds in good yield in the presence of only 5% catalyst. 
F3C Ph
CN
F3C
Br
Ph
1.22 g
80% yield
1.2 equiv
5% NiCl2  •  glyme
5.5% L2
1 equiv NaBr
DMA, r.t.
(3.4)ZnBrNC
6 mmol
 
 Although we initially optimized the reaction conditions with α-bromo-α-
perfluoroalkyl secondary electrophiles, we were also delighted to observe that an α-
bromo-α-difluoromethyl secondary electrophile can react with alkylzinc reagents under 
related conditions (eqs 3.5 and 3.6). Thus it provides us with an efficient way to generate 
difluoromethyl-substituted compounds, which is complementary to other strategies.13,14 
10% NiCl2  •  glyme
11% L2
1 equiv KBr
DMA/DMF, r.t.
HF2C
Br
1.2 equiv
(3.5)
Ph
PhO ZnBr
HF2C Ph
OPh
70% yield  
10% NiCl2  •  glyme
11% L2
1 equiv KBr
DMA/DMF, r.t.
HF2C
Br
1.2 equiv
(3.6)
Ph
P ZnBr
HF2C Ph
P
78% yield
O
EtO
EtO
O
OEt
OEt
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 A number of electrophiles that give low yield under our optimized conditions (eq 
3.2) are summarized in Figure 3.2. 
F3C
Br
Ph
<5% yield
F3C
Br
Ph
<1% yield
F3C
Br
Ph
<1% yield
F3C
Br
38% yield
F3CF2C
Cl
Ph F3CF2C
OTs
Ph
<5% yield <1% yield
F3C I
50% yield  
Figure 3.2. Unsuccessful Electrophiles. 
  
 Other features of this cross-coupling method are listed below. 
 A. A secondary alkylzinc reagent (cyclopentyl–ZnBr) is not suitable cross-
coupling partner. 
 B. The cross-coupling product is stable under our standard conditions. No C–F 
bond cleavage has been observed. 
 C. The major side reaction of this method is the debromodefluorination of the 
electrophile. 
 
3.4 Competition Experiments 
 From a practical perspective, we are delighted to observe that this cross-coupling 
reaction is typically very fast. Full conversion of electrophiles can be achieved even 
within a few minutes (less than 10 minutes for eq 3.2). We were curious about the unique 
reactivity of these perfluoroalkylated electrophiles and therefore subjected a few 
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structurally related fluorinated electrophiles to the reaction condition. These results are 
summarized in Table 3.7.  
 
Table 3.7. Differences in Reactivitya 
1.2 equiv R Ph
ZnBrPhO
OPh
R
Br
Ph
10% NiCl2  •  glyme
11% L2
1 equiv NaBr
DMA, r.t.
entry SM conversion (%)b Yield(%)breaction time
1 10 min 100 88
2
R
CF3
CF2H 5 h 85 44
3 CFH2 5 h 64 <1
4 CH3 5 h 31 13
aAll data are the average of two experiments. bYields and conversion are determined by 
19F NMR analysis and calibrated GC analysis versus internal standards.  
 
 As shown in Table 3.7, the trifluoromethyl-substituted electrophile is indeed more 
reactive than partially fluorinated electrophiles and non-fluorinated electrophile under our 
standard condition. Thus, we were wondering if this enhanced reactivity could lead to 
highly selective Negishi alkylations that might be synthetically useful. A series of 
competition experiments have been performed and the results are shown in Scheme 3.3. 
Highly chemoselective cross-coupling reactions can be achieved under the standard 
conditions. In each case, the less reactive electrophile can be recovered almost 
quantitatively. Although we are not sure about the origins of this selectivity, it is not 
uncommon for fluorine atoms to play important roles in determining the reacitivity of 
organofluorine compounds.15  
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Scheme 3.3. Competition Experiments (CF3, CF2H, CFH2 and CH3) 
HF2C
Br
Ph see eq 3.2
10 min
1.2 equiv
F3C Ph
ZnBrPhO OPh
F3C
Br
Ph HF2C Ph
OPh
1 equiv
100% conversion
1 equiv
97% recovery 88% yield 3% yield  
FH2C
Br
Ph see eq 3.2
10 min
1.2 equiv
F3C Ph
ZnBrPhO OPh
F3C
Br
Ph FH2C Ph
OPh
1 equiv
100% conversion
1 equiv
>99% recovery 87% yield <1% yield  
H3C
Br
Ph see eq 3.2
10 min
1.2 equiv
F3C Ph
ZnBrPhO OPh
F3C
Br
Ph H3C Ph
OPh
1 equiv
100% conversion
1 equiv
99% recovery 87% yield 1% yield  
 
 Additionally, we also performed a similar competition experiment using a 
pentafluoroethyl-substituted electrophile and a trifluoromethyl-substituted electrophile 
under the standard condition (eq 3.7). It turned out that the latter is less reactive. 
However, quantitative recovery of the less reactive substrate is not feasible at this stage. 
F3C
Br
Ph see eq 3.2
5 min
1.2 equiv
F3CF2C Ph
ZnBrPhO
OPh
F3CF2C
Br
Ph F3C Ph
OPh
1 equiv
87% conversion
1 equiv
25% recovery 68% yield 18% yield
(3.7)
 
 
3.5 Mechanistic Studies 
 Previously, for some nickel-catalyzed cross-couplings employing alkyl 
electrophiles, we have suggested that the electrophile may react to generate an alkyl 
	 164 
radical during the oxidative-addition step of the catalytic cycle.16 For this new method, 
we also obtained some evidence that is consistent with the existence of alkyl radicals as 
reaction intermediates. 
 This cross-coupling reaction can be inhibited by the addition of catalytic amount 
of 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO) as shown in eq 3.8. 
1.2 equiv F3C Ph
ZnBrPhO
OPh
F3C
Br
Ph
10% NiCl2  •  glyme
11% L2
1 equiv NaBr
DMA, r.t., 2 min
no TEMPO: 63% yield
15% TEMPO: <1% yield
(3.8)
 
The above cross-coupling reaction resumes after the TEMPO (15 mol%) has been 
consumed. After 15 minutes, the cross-coupling product is generated in 77% yield (eq 
3.9). We also identified a side product in this reaction. This side product can be 
independently synthesized and isolated according to conditions shown in eq 3.10. 
Presumably, this adduct is generated from the trapping of TEMPO with an alkyl radical.17 
1.2 equiv F3C Ph
ZnBrPhO
OPh
F3C
Br
Ph
10% NiCl2  •  glyme
11% L2
15% TEMPO
1 equiv NaBr
DMA, r.t., 15 min
(3.9)
F3C
O
Ph
N
Me
Me
Me
Me
10% yield77% yield
 
40% NiCl2  •  glyme
44% L2
40% TEMPO
1 equiv NaBr
DMA, r.t., 15 min
F3C
Br
1.2 equiv
Ph
n-Nonyl ZnBr (3.10)
F3C
O
Ph
N
Me
Me
Me
Me
71% yield  
 
3.6 Conclusions 
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 In summary, we have developed the first catalytic cross-coupling method 
employing α-bromo-α-perfluoroalkyl secondary electrophiles. Primary alkylzinc 
reagents can cross-couple with these electrophiles under mild conditions (at room 
temperature) in short reaction time (several minutes to hours) with the aid of 
commercially available catalyst components. Particularly, the catalytic system can be 
applied directly to α-bromo-α-trifluoromethyl electrophiles to generate products bearing 
trifluoromethyl-substituted tertiary carbons. Competition experiments and preliminary 
mechanistic studies reveal unique properties of these electrophiles and also provide 
evidence to support the existence of alkyl radical intermediates. 
 One remaining question within this project is whether or not an enantioselective 
Negishi alkylation protocol can be developed. Although ligand L2 leads to a quite 
efficient bond-formation process, the level of stereoinduction is quite low under our 
standard condition (eq 3.11). Extensive optimization has been conducted and a 
synthetically useful level of enantioselectivity could not be achieved under all conditions. 
10% NiCl2  •  glyme
11% (S)–L2
1 equiv NaBr
DMA, r.t.
F3C
Br
Ph
1.2 equiv F3C Ph
NO
N N
O
i-Pr i-Pr(S)–L2
EtO
O
ZnBr OEt
O
83% yield
24% ee
(3.11)
 
 At the same time, we also studied asymmetric Negishi arylations using these 
perfluoroalkyl-substituted electrophiles and quickly identified very promising results. 
Following these preliminary studies, we have successfully developed an asymmetric 
Negishi arylation method and it will be discussed in detail in the next chapter. 
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3.7 Experimental Section 
3.7.1 General Information 
1H NMR data and 13C NMR data were collected on a VARIAN 500 MHz 
spectrometer at ambient temperature. 19F NMR data and 31P NMR data were collected on 
a VARIAN 300 MHz spectrometer at ambient temperature. 
Anhydrous THF, CH2Cl2, and toluene were purified and dried using a solvent-
purification system that contained activated alumina. The following reagents were 
purchased and used as received: NiCl2•glyme (Strem), ligand L2 (Aldrich), DMA 
(Aldrich; anhydrous), DMF (Aldrich; anhydrous), zinc powder (Alfa-Aesar; ~100 mesh, 
99.9%), iodine (Alfa-Aesar; crystalline, 99.5%), NaBH4 (Oakwood), triphenyl phosphite 
(Aldrich), N-bromosuccinimide (Aldrich), N-iodosuccinimide (AK Scientific), oxalyl 
chloride (Aldrich), DMSO (Aldrich; ≥99.5%), Et3N (Aldrich), 
trifluoromethyltrimethylsilane (Oakwood), TBAF (Aldrich; 1.0 M in THF), 
triphenylphosphine (Oakwood), and tetrabromomethane (TCI). NaBr (Aldrich; ≥99%; 
granular) and KBr (Aldrich; ≥99%; granular) were dried at 140 °C for 12 h prior to use.  
All alkyl bromides were purchased (Aldrich, Alfa Aesar, TCI, and Oakwood) and used as 
received. 
All reactions were carried out in oven-dried glassware under an inert atmosphere.  
 
3.7.2 Preparation of Electrophiles 
These procedures have not been optimized. 
RF N
O
OMe
Me
RF R
O
RF R
OHNaBH4
RF R
BrP(OPh)3, NBSR–MgBr
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General Procedure A: Synthesis of Electrophiles with a Perfluoroalkyl 
Group 
Preparation of the ketone using a Grignard reagent. A solution of the 
Grignard reagent in THF (1.0 M, 40 mmol; 1.0 equiv) was added by syringe to a solution 
of the Weinreb amide18 (40 mmol) in THF (20 mL) at 0 °C. The reaction mixture was 
stirred at 0 °C for 15 min, and then it was allowed to warm to r.t. and stirred for 15 h.  
Next, water was added to quench the reaction at 0 °C. A solution of 1 N HCl (50 mL) 
was added, and then the mixture was extracted with CH2Cl2 (3 × 50 mL). The organic 
layers were combined, dried over Na2SO4, and concentrated. The crude product was 
purified by flash chromatography on silica gel. 
Reduction of the ketone to the alcohol. NaBH4 (2.3 g, 60 mmol; 3.0 equiv) was 
added in portions to a solution of the ketone (20 mmol) in Et2O (20 mL) and MeOH (20 
mL) at 0 °C (CAUTION: very exothermic). After the addition was complete, the mixture 
was stirred at 0 °C for 30 min, and then it was allowed to warm to r.t. and stirred for 30 
min. Next, Et2O (30 mL) was added to dilute the reaction mixture, the mixture was 
cooled to 0 °C, and then deionized water (30 mL) was added to quench the reaction. The 
mixture was extracted with CH2Cl2 (3 × 50 mL), and the combined organic layers were 
dried over Na2SO4 and concentrated. The crude product was purified by flash 
chromatography on silica gel. 
Bromination of the alcohol.19 Triphenylphosphite (4.0 g, 3.4 mL; 1.3 equiv) was 
added over 5 min to a solution of N-bromosuccinimide (2.3 g, 13 mmol; 1.3 equiv) in 
CH2Cl2 (10 mL) at 0 °C (CAUTION: exothermic). Next, a solution of the alcohol (10 
mmol) in CH2Cl2 (12 mL) was added to the mixture at 0 °C. The reaction mixture was 
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heated to 40 °C and then stirred at 40 °C for 12 h. Next, the solvent was evaporated, and 
the product was purified by flash chromatography on silica gel. 
 
HO R O R F3C R
OH
F3C R
BrDMSO, (COCl)2
1. TMSCF3, 
     cat. TBAF
2. HCl
P(OPh)3, NBS
Et3N  
General Procedure B: Synthesis of Electrophiles with a CF3 Group 
Swern oxidation of the alcohol. DMSO (2.9 mL, 40 mmol; 2.0 equiv) was added 
slowly to a solution of oxalyl chloride (2.0 mL, 24 mmol; 1.2 equiv) in CH2Cl2 (150 mL) 
at −78 °C. The resulting mixture was allowed to stir at −78 °C for 30 min. Next, a 
solution of the alcohol (20 mmol) in CH2Cl2 (30 mL) was added over 5 min to the 
mixture. The resulting mixture was stirred at −78 °C for 45 min, and then NEt3 (11 mL, 
80 mmol; 4.0 equiv) was added in one portion. The mixture was allowed to warm to r.t., 
and then it was stirred at r.t. for 2 h. Next, an aqueous saturated solution of NH4Cl (30 
mL) was added to quench the reaction. The resulting mixture was extracted with CH2Cl2 
(3 × 70 mL), and the combined organic layers were dried over Na2SO4 and concentrated.  
The crude product was purified by flash chromatography on silica gel. 
Trifluoromethylation of the aldehyde.20 A solution of TBAF (1.0 M in THF; 
0.20 mL, 0.20 mmol; 0.013 equiv) was added over 3 min to a solution of the aldehyde 
(15 mmol) and trifluoromethyltrimethylsilane (2.7 mL, 18 mmol; 1.2 equiv) in THF (20 
mL) at 0 °C (CAUTION: very exothermic). The reaction mixture was allowed to warm to 
r.t., and it was stirred for 1 h. Next, an aqueous solution of 1 N HCl (30 mL) was added, 
and the mixture was allowed to stir at r.t. for another 2 h. Then, the mixture was extracted 
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with CH2Cl2 (3 × 50 mL), and the combined organic layers were dried over Na2SO4 and 
concentrated. The crude product was purified by flash chromatography on silica gel. 
The bromination step is the same as in General Procedure A. 
 
HO R O R F3C R
OH
F3C R
BrDMSO, (COCl)2
1. TMSCF3, 
     cat. TBAF
2. HCl
PPh3, CBr4
Et3N  
General Procedure C: Synthesis of Electrophiles with a CF3 Group 
The first two steps are the same as in General Procedure B. 
Bromination of the alcohol.8e Triphenylphosphine (4.2 g, 16 mmol; 2.0 equiv) 
and tetrabromomethane (5.3 g, 16 mmol; 2.0 equiv) were added to a solution of the 
alcohol (8.0 mmol) in toluene (20 mL). The resulting mixture was heated to 110 °C and 
stirred at 110 °C for 3 h, at which time it had turned into a yellow suspension. Then, 
CH2Cl2 (50 mL) was added to the reaction mixture until it became a clear solution. The 
solvents were then evaporated, and the crude product was purified by flash 
chromatography on silica gel. 
 
HF2C OEt
O
HF2C R
O
HF2C R
OHNaBH4
HF2C R
BrP(OPh)3, NBSR–MgBr
 
General Procedure D: Synthesis of Electrophiles with a Difluoromethyl 
Group 
Preparation of the ketone using a Grignard reagent. A solution of the 
Grignard reagent in THF (1.0 M, 20 mmol; 1.0 equiv) was added by syringe to a solution 
of ethyl 2,2-difluoroacetate (40 mmol; 2.0 equiv) in THF (40 mL) at –78 ºC. The reaction 
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mixture was stirred at –78 °C for 1 hour. Next, aqueous NH4Cl solution (30 mL) was 
added to quench the reaction at –78 ºC. A solution of 1 N HCl (30 mL) was added, and 
then the mixture was extracted with CH2Cl2 (3 × 50 mL). The organic layers were 
combined, dried over Na2SO4, and concentrated. The crude product was purified by flash 
chromatography on silica gel. 
The next two steps are the same as in General Procedure A. 
 
F3CF2C
Br
Ph  
(3-Bromo-4,4,5,5,5-pentafluoropentyl)benzene. The title compound was 
synthesized according to General Procedure A, using 2,2,3,3,3-pentafluoro-N-methoxy-
N-methylpropanamide and a Grignard reagent prepared from (2-bromoethyl)benzene.  
The overall yield was 30% (3 steps). The title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 7.36 – 7.32 (m, 2H), 7.28 – 7.21 (m, 3H), 4.10 – 
4.01 (m, 1H), 3.10 – 3.02 (m, 1H), 2.82 – 2.75 (m, 1H), 2.42 – 2.34 (m, 1H), 2.25 – 2.15 
(m, 1H); 
13C NMR (126 MHz, CDCl3) δ 128.1, 117.8, 117.5, 115.7, 109.2 – 101.3 (m), 
35.3 – 34.3 (m), 21.6, 21.3; 
19F NMR (282 MHz, CDCl3) δ −80.0 (s, 3F), −114.2 (dd, 1F, J = 269.4, 12.4 Hz), 
−117.0 (dd, 1F, J = 269.4, 13.0 Hz); 
FT-IR (film) 3030, 1497, 1456, 1324, 1200, 1129, 1104, 1029, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C11H1079BrF5: 316, found: 316, 318 (M++2). 
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F3CF2C
Br
Cl
 
3-Bromo-8-chloro-1,1,1,2,2-pentafluorooctane. The title compound was 
synthesized according to General Procedure A, using 2,2,3,3,3-pentafluoro-N-methoxy-
N-methylpropanamide and a Grignard reagent prepared from 1-bromo-5-chloropentane.  
The overall yield was 9% (3 steps). The title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 4.20 – 4.10 (m, 1H), 3.55 (t, 2H, J = 6.6 Hz), 2.11 
– 2.01 (m, 1H), 1.95 – 1.69 (m, 4H), 1.60 – 1.43 (m, 3H); 
13C NMR (126 MHz, CDCl3) δ 120.5 – 111.9 (m), 46.5 (dd, J = 25.4, 23.7 Hz), 
44.7, 32.1, 30.5, 26.3, 25.9; 
19F NMR (282 MHz, CDCl3) δ −80.0 (s, 3F), −114.5 (dd, 1F, J = 269.3, 12.6 Hz), 
−117.2 (dd, 1F, J = 269.3, 12.7 Hz); 
FT-IR (film) 2944, 2867, 1196, 1022, 719 cm-1; 
GC-MS (EI) m/z (M+−HBr) calcd for C8H10ClF5: 236, found: 236. 
 
n-C3F7
Br
Ph  
(3-Bromo-4,4,5,5,6,6,6-heptafluorohexyl)benzene. The title compound was 
synthesized according to General Procedure A, using 2,2,3,3,4,4,4-heptafluoro-N-
methoxy-N-methylbutanamide and a Grignard reagent prepared from (2-
bromoethyl)benzene. The overall yield was 24% (3 steps). The title compound was 
isolated as a colorless oil. 
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1H NMR (500 MHz, CDCl3) δ 7.35 – 7.32 (m, 3H), 7.28 – 7.22 (m, 2H), 4.19 – 
4.08 (m, 1H), 3.06 (ddd, 1H, J = 13.3, 8.4, 4.4 Hz), 2.80 (dt, 1H, J = 13.9, 8.2 Hz), 2.43 – 
2.36 (m, 1H), 2.27 – 2.17 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 139.1, 128.8, 128.5, 126.7, 121.5 – 108.5 (m), 
46.5 (t, J = 24.5 Hz), 32.6, 32.3; 
19F NMR (282 MHz, CDCl3) δ −80.8 (t, 3F, J = 10.7 Hz), −109.2 – −115.5 (m, 
2F), –123.3 (dd, 2F, J = 20.0, 8.1 Hz); 
FT-IR (film) 3029, 2936, 1497, 1456, 1348, 1235, 1182, 1108, 964, 927, 750, 
724, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C12H1079BrF7: 366, found: 366, 368 (M++2). 
 
n-C4F9
Br
Ph  
(3-Bromo-4,4,5,5,6,6,7,7,7-nonafluoroheptyl)benzene. The title compound was 
synthesized according to General Procedure A, using 2,2,3,3,4,4,5,5,5-nonafluoro-N-
methoxy-N-methylpentanamide and a Grignard reagent prepared from (2-
bromoethyl)benzene. The overall yield was 31% (3 steps). The title compound was 
isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.31 (m, 2H), 7.27 – 7.21 (m, 3H), 4.20 – 
4.10 (m, 1H), 3.06 (ddd, 1H, J = 13.3, 8.4, 4.4 Hz), 2.79 (dt, 1H, J = 13.9, 8.2 Hz), 2.43 – 
2.35 (m, 1H), 2.21 (dddd, 1H, J =15.1, 11.1, 8.3, 4.4 Hz); 
13C NMR (126 MHz, CDCl3) δ 139.1, 128.8, 128.5, 126.7, 119.5 – 111.5 (m), 
47.0 – 46.4 (m), 32.7, 32.3; 
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19F NMR (282 MHz, CDCl3) δ −80.8 – −80.9 (m, 3F), −108.5 – −115.4 (m, 2F), 
−119.8 – −120.0  (m, 2F), −126.0 – −126.2 (m, 2F) 
FT-IR (film) 3030, 2929, 1497, 1456, 1353, 1238, 1136, 750, 717, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C13H1079BrF9: 416, found: 416, 418 (M++2). 
 
n-C9F19
Br
Ph  
(3-Bromo-4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-
nonadecafluorododecyl)benzene. The title compound was synthesized according to 
General Procedure A, using 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-nonadecafluoro-N-
methoxy-N-methyldecanamide and a Grignard reagent prepared from (2-
bromoethyl)benzene. The overall yield was 21% (3 steps). The title compound was 
isolated as a white solid. 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.30 (m, 2H), 7.27 – 7.20 (m, 3H), 4.20 – 
4.10 (m, 1H), 3.06 (ddd, 1H, J = 13.3, 8.4, 4.4 Hz), 2.79 (dt, 1H, J = 13.9, 8.2 Hz), 2.45 – 
2.35 (m, 1H), 2.25 – 2.17 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 139.1, 128.8, 128.5, 126.7, 115.7 – 103.7 (m), 
47.3 – 46.4 (m), 32.7, 32.3; 
19F NMR (282 MHz, CDCl3) δ −80.8 (m, 3F), −108.3 – −115.0 (m, 2F), −118.6 – 
−119.2 (m, 2F), −121.3 – −122.2 (m, 8F), −122.6 – −122.9 (m, 2F), −126.1 – −126.3 (m, 
2F); 
FT-IR (film) 3030, 2936, 1497, 1456, 1215, 1151, 1097, 700 cm-1; 
GC-MS (EI) m/z (M+−HBr−C9F19) calcd for C9H9: 117, found: 117. 
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PhF3C
Br
 
(3-Bromo-4,4,4-trifluorobutyl)benzene [136832-35-4]. The title compound was 
synthesized according to General Procedure A, using 2,2,2-trifluoro-N-methoxy-N-
methylacetamide and a Grignard reagent prepared from (2-bromoethyl)benzene. The 
overall yield was 34% (3 steps). The title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 7.37 – 7.32 (m, 2H), 7.29 – 7.22 (m, 3H), 4.03 – 
3.96 (m, 1H), 3.02 (ddd, 1H, J = 13.4, 8.3, 4.6 Hz), 2.81 – 2.75 (m, 1H), 2.40 – 2.33 (m, 
1H), 2.21 (dddd, 1H, J = 14.6, 11.0, 8.2, 4.6 Hz); 
13C NMR (126 MHz, CDCl3) δ 139.2, 128.8, 128.5, 126.7, 124.0 (q, J = 278.2 
Hz), 46.7 (q, J = 32.6 Hz), 32.9 (d, J = 1.4 Hz), 32.5; 
19F NMR (282 MHz, CDCl3) δ −72.1 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 3029, 1258, 1168, 1111, 750, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C10H1079BrF3: 266, found: 266, 268 (M++2). 
 
F3C
Br
n-Bu  
2-Bromo-1,1,1-trifluorodecane [1349717-60-7]. The title compound was 
synthesized according to General Procedure A, using 2,2,2-trifluoro-N-methoxy-N-
methylacetamide and a Grignard reagent prepared from 1-bromooctane. The overall yield 
was 30% (3 steps). The title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 4.06 (dqd, 1H, J = 10.5, 7.2, 3.3 Hz), 2.02 (dddd, 
1H, J = 14.6, 9.8, 6.1, 3.3 Hz), 1.91 – 1.81 (m, 1H), 1.43 – 1.21 (m, 12H), 0.89 (t, 3H, J = 
7.2 Hz); 
	 175 
13C NMR (126 MHz, CDCl3) δ 124.1 (q, J = 278.0 Hz), 47.7 (q, J = 32.3 Hz), 
31.8, 31.4 (d, J = 1.5 Hz), 29.23, 29.15, 28.6, 26.8, 22.6, 14.1; 
19F NMR (282 MHz, CDCl3) δ −72.4 (d, 3F, J = 7.2 Hz); 
FT-IR (film) 2956, 2928, 2857, 1266, 1173, 1124, 1105, 678 cm-1; 
GC-MS (EI) m/z (M+–C4H9) calcd for C6H979BrF3: 217, found: 217, 219 (M+–
C4H9+2). 
 
BrF3C
Br
 
2,10-Dibromo-1,1,1-trifluorodecane. The title compound was synthesized 
according to General Procedure B from 9-bromononan-1-ol. The overall yield was 50% 
(3 steps). The title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 4.06 (dqd, 1H, J = 10.5, 7.1, 3.3 Hz), 3.41 (t, 2H, J 
= 6.8 Hz), 2.02 (dddd, 1H, J = 14.5, 9.8, 6.1, 3.3 Hz), 1.89 – 1.82 (m, 3H), 1.47 – 1.28 
(m, 10H); 
13C NMR (126 MHz, CDCl3) δ 124.0 (q, J = 278.2 Hz), 47.7 (q, J = 32.4 Hz), 
33.9, 32.7, 31.3 (d, J = 1.5 Hz), 29.0, 28.56, 28.48, 28.0, 26.7; 
19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 2931, 2857, 1267, 1169, 1110, 677 cm-1; 
GC-MS (EI) m/z (M+–C3H6Br) calcd for C7H1179BrF3: 231, found: 231, 233 (M+–
C3H6Br+2). 
 
OTsF3C
Br
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6-Bromo-7,7,7-trifluoroheptyl 4-methylbenzenesulfonate. The title compound 
was synthesized according to General Procedure B from 6-hydroxyhexyl 4-
methylbenzenesulfonate.21 The overall yield was 52% (3 steps). The title compound was 
isolated as a colorless oil. 
1H NMR (500 MHz, CD3COCD3) δ 7.83 – 7.79 (m, 2H), 7.51 – 7.46 (m, 2H), 
4.55 (dqd, 1H, J = 10.7, 7.4, 3.3 Hz), 4.07 (t, 2H, J = 6.3 Hz), 2.46 (s, 3H), 2.04 – 1.99 
(m, 1H), 1.85 – 1.76 (m, 1H), 1.73 – 1.55 (m, 3H), 1.52 – 1.30 (m, 3H); 
13C NMR (126 MHz, CD3COCD3) δ 145.9, 134.5, 131.0, 128.8, 125.5 (q, J = 
277.2 Hz), 71.4, 48.4 (q, J = 32.0 Hz), 32.0 (d, J = 1.6 Hz), 29.3, 26.9, 25.2, 21.6; 
19F NMR (282 MHz, CD3COCD3) δ −72.9 (d, 3F, J = 7.4 Hz); 
FT-IR (film) 2948, 1598, 1359, 1189, 1176, 1117, 1098, 951, 815, 664 cm-1; 
GC-MS (EI) m/z (M+–OTs) calcd for C7H1179BrF3: 231, found: 231, 233 (M+–
OTs+2). 
 
OTBDPSF3C
Br
 
((6-Bromo-7,7,7-trifluoroheptyl)oxy)(tert-butyl)diphenylsilane. The title 
compound was synthesized according to General Procedure B from 6-((tert-
butyldiphenylsilyl)oxy)hexan-1-ol.22 The overall yield was 23% (3 steps). The title 
compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 7.70 – 7.66 (m, 4H), 7.46 – 7.37 (m, 6H), 4.04 
(dqd, 1H, J = 10.5, 7.2, 3.4 Hz), 3.69 (t, 2H, J = 6.3 Hz), 2.02 (dddd, 1H, J = 14.4, 9.8, 
5.6, 3.3 Hz), 1.90 – 1.81 (m, 1H), 1.69 – 1.54 (m, 3H), 1.49 – 1.35 (m, 3H), 1.07 (s, 9H); 
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13C NMR (126 MHz, CDCl3) δ 135.6, 134.0, 129.6, 127.6, 124.1 (q, J = 278.2 
Hz), 63.5, 47.6 (q, J = 32.4 Hz), 32.1, 31.4 (d, J = 1.4 Hz), 26.9, 26.5, 24.9, 19.2; 
19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 2932, 2858, 1428, 1259, 1171, 1113, 823, 701 cm-1; 
GC-MS (EI) m/z (M+–C4H9) calcd for C19H2179BrF3OSi: 429, found: 429. 
 
O
O
OBr
F3C
 
6-Bromo-7,7,7-trifluoroheptyl furan-2-carboxylate. The title compound was 
synthesized according to General Procedure B from 6-hydroxyhexyl furan-2-
carboxylate.23 The overall yield was 62% (3 steps). The title compound was isolated as a 
light-yellow oil (it should be stored in a refrigerator (~5 °C)). 
1H NMR (500 MHz, CDCl3) δ 7.57 (dd, 1H, J = 1.8, 0.9 Hz), 7.17 (dd, 1H, J = 
3.5, 0.9 Hz), 6.51 (dd, 1H, J = 3.5, 1.7 Hz), 4.31 (t, 2H, J = 6.6 Hz), 4.07 (dqd, 1H, J = 
10.5, 7.1, 3.4 Hz), 2.05 (dddd, 1H, J = 14.7, 10.3, 5.6, 3.3 Hz), 1.93 – 1.84 (m, 1H), 1.82 
– 1.68 (m, 3H), 1.55 – 1.42 (m, 3H); 
13C NMR (126 MHz, CDCl3) δ 158.7, 146.3, 144.7, 124.0 (q, J = 278.1 Hz), 
117.8, 111.8, 64.6, 47.4 (q, J = 32.5 Hz), 31.3 (d, J = 1.5 Hz), 28.4, 26.5, 25.1; 
19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.0 Hz); 
FT-IR (film) 2949, 2866, 1726, 1582, 1571, 1475, 1400, 1297, 1260, 1180, 1118, 
1014, 958, 885, 764, 677 cm-1; 
GC-MS (EI) m/z (M+) calcd for C12H1479BrF3O3: 342, found: 342, 344 (M++2). 
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O
Br
I
F3C
 
1-((6-Bromo-7,7,7-trifluoroheptyl)oxy)-4-iodobenzene. The title compound 
was synthesized according to General Procedure B from 6-(4-iodophenoxy)hexan-1-ol.24 
The overall yield was 33% (3 steps). The title compound was isolated as a colorless oil (it 
should be stored in a refrigerator (~5 °C)). 
1H NMR (500 MHz, CDCl3) δ 7.57 – 7.52 (m, 2H), 6.69 – 6.65 (m, 2H), 4.08 
(dqd, 1H, J = 10.5, 7.1, 3.4 Hz), 3.93 (t, 2H, J = 6.3 Hz), 2.07 (dddd, 1H, J = 14.3, 9.9, 
5.5, 3.4 Hz), 1.95 – 1.86 (m, 1H), 1.85 – 1.68 (m, 3H), 1.60 – 1.46 (m, 3H); 
13C NMR (126 MHz, CDCl3) δ 158.8, 138.2, 124.0 (q, J = 278.2 Hz), 116.9, 82.6, 
67.6, 47.5 (q, J = 32.5 Hz), 31.3 (d, J = 1.4 Hz), 28.8, 26.6, 25.2; 
19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 2944, 1587, 1487, 1473, 1283, 1245, 1175, 1117, 820 cm-1; 
GC-MS (EI) m/z (M+) calcd for C13H1579BrF3IO: 450, found: 450, 452 (M++2). 
 
F3C
Br N
Boc
 
tert-Butyl 4-(2-bromo-3,3,3-trifluoropropyl)piperidine-1-carboxylate. The 
title compound was synthesized according to General Procedure C from tert-butyl 4-(2-
hydroxyethyl)piperidine-1-carboxylate. The overall yield was 26% (3 steps). The title 
compound was isolated as a white solid. 
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1H NMR (500 MHz, CDCl3) δ 4.15 – 4.09 (m, 3H), 2.72 – 2.68 (m, 2H), 1.94 – 
1.85 (m, 1H), 1.85 – 1.72 (m, 2H), 1.68 – 1.63 (m, 2H), 1.44 (s, 9H), 1.23 (tdd, 1H, J = 
12.8, 11.0, 4.4 Hz), 1.03 (tdd, 1H, J = 12.7, 11.0, 4.5 Hz); 
13C NMR (126 MHz, CDCl3) δ 154.7, 124.1 (q, J = 278.1 Hz), 79.5, 44.8 (q, J = 
32.7 Hz), 37.6, 33.2, 32.4, 30.0, 28.4; 
19F NMR (282 MHz, CDCl3) δ −72.5 (d, 3F, J = 7.0 Hz); 
FT-IR (film) 2977, 2931, 2850, 1691, 1425, 1366, 1262, 1252, 1172, 1129, 1110, 
967, 685 cm-1; 
GC-MS (EI) m/z (M+–Boc) calcd for C8H1279BrF3N: 258, found: 258, 260 (M+–
Boc+2). 
 
O
O
Me
F3C
Br
 
1-(4-((6-Bromo-7,7,7-trifluoroheptyl)oxy)phenyl)ethan-1-one. The title 
compound was synthesized according to General Procedure C from 1-(4-((6-
hydroxyhexyl)oxy)phenyl)ethan-1-one.25 The overall yield was 57% (3 steps). The title 
compound was isolated as a light-yellow oil (it should be stored in a refrigerator (~5 °C)). 
1H NMR (500 MHz, CDCl3) δ 7.94 – 7.90 (m, 2H), 6.93 – 6.89 (m, 2H), 4.12 – 
4.05 (m, 1H), 4.03 (t, 2H, J = 6.3 Hz), 2.55 (s, 3H), 2.07 (dddd, 1H, J = 14.4, 10.1, 5.6, 
3.4 Hz), 1.94 – 1.80 (m, 3H), 1.78 – 1.68 (m, 1H), 1.62 – 1.47 (m, 3H); 
13C NMR (126 MHz, CDCl3) δ 196.7, 162.9, 130.6, 130.2, 124.0 (q, J = 278.2 
Hz), 114.0, 67.8, 47.4 (q, J = 32.4 Hz), 31.3 (d, J = 1.4 Hz), 28.7, 26.5, 26.3, 25.2; 
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19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 2946, 2867, 1676, 1602, 1576, 1509, 1358, 1257, 1172, 1117, 834 
cm-1; 
GC-MS (EI) m/z (M+–CH3) calcd for C14H1579BrF3O2: 351, found: 351, 353 (M+–
CH3+2). 
 
F3CF2C
I
Ph  
(4,4,5,5,5-Pentafluoro-3-iodopentyl)benzene. The title compound was 
synthesized according to General Procedure A, using 2,2,3,3,3-pentafluoro-N-methoxy-
N-methylpropanamide and a Grignard reagent prepared from (2-bromoethyl)benzene. N-
iodoosuccinimide, rather than N-bromosuccinimide, was used in the last step. The overall 
yield was 9% (3 steps). The title compound was isolated as a colorless oil (it should be 
stored in a refrigerator (~5 °C)). 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.30 (m, 2H), 7.27 – 7.20 (m, 3H), 4.18 – 
4.08 (m, 1H), 3.03 (dt, 1H, J = 13.3, 6.4 Hz), 2.72 (dt, 1H, J = 14.0, 8.2 Hz), 2.20 – 2.13 
(m, 2H); 
13C NMR (126 MHz, CDCl3) δ 139.0, 128.8, 128.5, 126.7, 121.6 – 112.0 (m), 
34.9, 33.6, 24.3 – 23.9 (m); 
19F NMR (282 MHz, CDCl3) δ −79.5 (s, 3F), −101.6 (dd, 1F, J = 265.8, 8.8 Hz), 
−114.8 (dd, 1F, J = 265.7, 19.6 Hz); 
FT-IR (film) 3029, 2934, 1497, 1455, 1318, 1207, 1120, 1019, 712, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C11H10F5I: 364, found: 364. 
 
	 181 
HF2C
Br
Ph  
(3-Bromo-4,4-difluorobutyl)benzene. The title compound was synthesized 
according to General Procedure D, using ethyl 2,2-difluoroacetate and a Grignard reagent 
prepared from (2-bromoethyl)benzene. The overall yield (3 steps) was 38%. The title 
compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.30 (m, 2H), 7.27 – 7.22 (m, 3H), 5.84 (td, 
1H, J = 55.9, 3.6 Hz), 3.94 – 3.85 (m, 1H), 2.99 (ddd, 1H, J = 13.5, 8.5, 4.8 Hz), 2.78 (dt, 
1H, J = 13.9, 8.2 Hz), 2.33 – 2.26 (m, 1H), 2.19 – 2.09 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 139.7, 128.7, 128.5, 126.5, 117.0 – 112.6 (m), 
49.8 (t, J = 24.0 Hz), 32.6, 32.3 (m); 
19F NMR (282 MHz, CDCl3) δ −117.4 (ddd, 1F, J = 277.0, 55.7, 10.8 Hz), −122.4 
(ddd, 1F, J = 277.0, 56.0, 13.1 Hz); 
FT-IR (neat) 3028, 2949, 1497, 1455, 1381, 1136, 1086, 1044, 752, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C10H1179BrF2: 248, found: 248, 250 (M++2); 
 
3.7.3 Nickel-Catalyzed Negishi Alkylations 
General procedure for the preparation of alkylzinc solutions (0.50 M).26  
In the air, zinc powder (589 mg, 9.00 mmol; 1.50 equiv) was added to an oven-
dried 20-mL vial equipped with a stir bar. The vial was heated at 80 °C under high 
vacuum for 30 min. After back-filling with nitrogen, iodine chips (76 mg, 0.30 mmol; 
0.050 equiv) were added to the vial. Then, the vial was evacuated and back-filled with 
nitrogen (three cycles). DMA (5 mL) was added to the mixture, and the mixture was 
stirred until the red color had faded. Next, the alkyl bromide (6.0 mmol; 1.0 equiv) was 
	 182 
added. The reaction mixture was stirred at 80 °C for 12 h, and then the mixture was 
allowed to cool to r.t. The gray solution was filtered under an inert atmosphere by 
injection through a syringe filter directly into a nitrogen-filled, 20-mL vial sealed with a 
PTFE septum cap. The alkylzinc solution was titrated using I2 according to Knochel’s 
method27 (the concentration was ~0.9 M). This solution was diluted into a 0.50 M 
solution by the addition of DMA. 
These solutions of organozinc bromides can be stored at r.t. under an inert 
atmosphere for several weeks without deterioration. 
 
General Procedure A: Negishi Alkylations of α-Halo-α-Perfluoroalkyl 
Electrophiles 
In the air, the electrophile (0.80 mmol) and NaBr (82 mg, 0.80 mmol; 1.0 equiv) 
were added to an oven-dried 20-mL vial equipped with a stir bar. The vial was closed 
with a PTFE septum cap and then evacuated and back-filled with nitrogen (three cycles). 
In the air, NiCl2•glyme (17.6 mg, 0.080 mmol) and ligand L2 (26.5 mg, 0.088 mmol) 
were added to an oven-dried 4-mL vial equipped with a stir bar. The vial was closed with 
a PTFE septum cap and then evacuated and back-filled with nitrogen (three cycles). 
DMA (2.0 mL) was added to the 4-mL vial, and the mixture was vigorously stirred at r.t. 
for 25 min. The resulting solution was transferred via syringe to the 20-mL reaction vial 
that contained the electrophile. The 4-mL vial was rinsed with DMA three times (0.7 mL, 
0.7 mL, and 0.6 mL), and the washings were transferred to the 20-mL reaction vial.  The 
resulting solution was allowed to stir at r.t. for 1 min. Then, the reaction vial was 
wrapped with electrical tape, and the alkylzinc solution (0.50 M; 1.9 mL, 0.95 mmol; 1.2 
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equiv) was added over 1 min. The mixture was stirred vigorously at r.t. for 5 h. Then, the 
reaction was quenched by the addition of MeOH (0.5 mL). The resulting mixture was 
allowed to stir for 1 min, and then it was diluted with Et2O (100 mL) and washed with 
deionized water (20 mL × 4). The organic layer was dried over Na2SO4 and then 
concentrated, and the residue was purified by flash chromatography. 
 
General Procedure B: Negishi Alkylations of α-Bromo-α-Difluoromethyl 
Electrophiles 
In the air, the electrophile (0.80 mmol) and KBr (95 mg, 0.80 mmol; 1.0 equiv) 
were added to an oven-dried 20-mL vial equipped with a stir bar. The vial was closed 
with a PTFE septum cap and then evacuated and back-filled with nitrogen (three cycles). 
In the air, NiCl2•glyme (17.6 mg, 0.080 mmol) and ligand L2 (26.5 mg, 0.088 mmol) 
were added to an oven-dried 4-mL vial equipped with a stir bar. The vial was closed with 
a PTFE septum cap and then evacuated and back-filled with nitrogen (three cycles). DMF 
(2.0 mL) was added to the 4-mL vial, and the mixture was vigorously stirred at r.t. for 25 
min. The resulting solution was transferred via syringe to the 20-mL reaction vial that 
contained the electrophile. The 4-mL vial was rinsed with DMF three times (0.7 mL, 0.7 
mL, and 0.6 mL), and the washings were transferred to the 20-mL reaction vial.  The 
resulting solution was allowed to stir at r.t. for 1 min. Then, the reaction vial was 
wrapped with electrical tape, and the alkylzinc solution in DMA (0.50 M; 1.9 mL, 0.95 
mmol; 1.2 equiv) was added over 1 min. The mixture was stirred vigorously at r.t. for 5 h. 
Then, the reaction was quenched by the addition of MeOH (0.5 mL). The resulting 
mixture was allowed to stir for 1 min, and then it was diluted with Et2O (100 mL) and 
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washed with deionized water (20 mL × 4). The organic layer was dried over Na2SO4 and 
then concentrated, and the residue was purified by flash chromatography. 
 
F3CF2C Ph
OPh
 
((5,5,6,6,6-Pentafluoro-4-phenethylhexyl)oxy)benzene (Table 3.3, Entry 1). 
The title compound was prepared according to the General Procedure A with (3-bromo-
4,4,5,5,5-pentafluoropentyl)benzene (254 mg, 0.80 mmol) and an alkylzinc bromide 
reagent prepared from (3-bromopropoxy)benzene. Solvent system for chromatography: 
10:1 → 3:1 hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 217 mg (73% yield); Run 2, 220 mg (74% yield). 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.29 (m, 4H), 7.25 – 7.17 (m, 3H), 6.99 – 
6.95 (m, 1H), 6.93 – 6.89 (m, 2H), 3.96 (t, 2H, J = 5.8 Hz), 2.81 – 2.67 (m, 2H), 2.30 – 
2.17 (m, 1H), 2.13 – 2.02 (m, 1H), 1.98 – 1.69 (m, 5H); 
13C NMR (126 MHz, CDCl3) δ 158.8, 141.0, 129.5, 128.6, 128.3, 126.2, 121.0 – 
115.1 (m), 120.8, 114.4, 67.1, 39.6 (t, J = 19.9 Hz), 32.9, 28.5, 26.3, 23.4; 
19F NMR (282 MHz, CDCl3) δ −81.7 (s, 3F), −117.0 (d, 2F, J = 16.1 Hz); 
FT-IR (film) 2960, 1601, 1587, 1497, 1472, 1246, 1203, 1171, 754, 700, 692 cm-
1; 
GC-MS (EI) m/z (M+) calcd for C20H21F5O: 372, found: 372. 
 
PhF3CF2C
O
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4-(3,3,4,4,4-Pentafluoro-2-phenethylbutyl)tetrahydro-2H-pyran (Table 3.3, 
Entry 2). The title compound was prepared according to the General Procedure A with 
(3-bromo-4,4,5,5,5-pentafluoropentyl)benzene (254 mg, 0.80 mmol) and an alkylzinc 
bromide reagent prepared from 4-(bromomethyl)tetrahydro-2H-pyran. Solvent system for 
chromatography: 15:1 → 12:1 hexane/ethyl acetate. The title compound was isolated as a 
colorless oil. 
Run 1, 147 mg (55% yield); Run 2, 144 mg (54% yield). 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.28 (m, 2H), 7.24 – 7.16 (m, 3H), 3.96 – 
3.87 (m, 2H), 3.38 – 3.30 (m, 1H), 3.28 – 3.19 (m, 1H), 2.76 – 2.64 (m, 2H), 2.26 – 2.14 
(m, 1H), 2.11 – 2.00 (m, 1H), 1.76 – 1.66 (m, 1H), 1.64 – 1.43 (m, 3H), 1.42 – 1.23 (m, 
3H), 1.20 – 1.09 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 141.0, 128.6, 128.4, 126.3, 121.6 – 114.0 (m), 
67.8, 67.7, 36.5 (t, J = 19.9 Hz), 34.5, 33.5, 33.2, 32.5, 32.3, 29.7; 
19F NMR (282 MHz, CDCl3) δ −81.4 (s, 3F), −116.2 – −118.3 (m, 2F); 
FT-IR (film) 2934, 2843, 1455, 1201, 1108, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H21F5O: 336, found: 336. 
 
F3CF2C Ph
OO
 
2-(4,4,5,5,5-Pentafluoro-3-phenethylpentyl)-1,3-dioxolane (Table 3.3, Entry 
3). The title compound was prepared according to the General Procedure A with (3-
bromo-4,4,5,5,5-pentafluoropentyl)benzene (254 mg, 0.80 mmol) and an alkylzinc 
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bromide reagent prepared from 2-(2-bromoethyl)-1,3-dioxolane. Solvent system for 
chromatography: 10:1 → 4:1 hexane/ethyl acetate. The title compound was isolated as a 
colorless oil. 
Run 1, 166 mg (61% yield); Run 2, 161 mg (60% yield). 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.28 (m, 2H), 7.24 – 7.17 (m, 3H), 4.86 (t, 
1H, J = 4.3 Hz), 4.02 – 3.94 (m, 2H), 3.91 – 3.83 (m, 2H), 2.75 (ddd, 1H, J = 13.8, 10.6, 
5.7 Hz), 2.67 (ddd, 1H, J = 13.7, 10.4, 6.2 Hz), 2.29 – 2.16 (m, 1H), 2.02 (ddt, 1H, J = 
19.6, 10.8, 5.1 Hz), 1.92 – 1.62 (m, 5H); 
13C NMR (126 MHz, CDCl3) δ 141.1, 128.5, 128.3, 126.2, 121.2 – 116.1 (m), 
103.9, 64.97, 64.94, 39.6 (t, J = 19.9 Hz), 32.8, 30.6, 28.5, 20.7; 
19F NMR (282 MHz, CDCl3) δ −81.7 (s, 3F), −117.1 (d, 2F, J = 16.1 Hz); 
FT-IR (film) 2958, 2885, 1203, 1143, 1096, 1008, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H19F5O2: 338, found: 338. 
 
PhF3CF2C
Ph
 
(6-(Perfluoroethyl)oct-1-yne-1,8-diyl)dibenzene (Table 3.3, Entry 4). The title 
compound was prepared according to the General Procedure A with (3-bromo-4,4,5,5,5-
pentafluoropentyl)benzene (254 mg, 0.80 mmol) and an alkylzinc bromide reagent 
prepared from (5-bromopent-1-yn-1-yl)benzene. Solvent system for chromatography: 
20:1 → 15:1 hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 173 mg (57% yield); Run 2, 183 mg (60% yield). 
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1H NMR (500 MHz, CDCl3) δ 7.43 – 7.38 (m, 2H), 7.33 – 7.28 (m, 5H), 7.25 – 
7.18 (m, 3H), 2.82 – 2.67 (m, 2H), 2.44 (t, 2H, J = 6.6 Hz), 2.27 – 2.14 (m, 1H), 2.06 
(dddd, 1H, J = 14.8, 10.7, 6.4, 4.4 Hz), 1.93 (ddt, 1H, J = 13.0, 8.2, 4.1 Hz), 1.86 – 1.62 
(m, 4H); 
13C NMR (126 MHz, CDCl3) δ 141.0, 131.5, 128.5, 128.3, 128.2, 127.7, 126.2, 
123.7, 121.5 – 115.0 (m), 89.1, 81.4, 39.5 (t, J = 20.0 Hz), 32.9, 28.5, 25.9, 25.7, 19.4; 
19F NMR (282 MHz, CDCl3) δ −81.7 (s, 3F), −117.0 (d, 2F, J = 16.2 Hz); 
FT-IR (film) 3028, 2959, 1490, 1454, 1202, 1171, 1122, 1094, 1008, 756, 692 
cm-1; 
GC-MS (EI) m/z (M+) calcd for C22H21F5: 380, found: 380. 
 
F3CF2C Ph
O
OEt
 
Ethyl 6,6,7,7,7-pentafluoro-5-phenethylheptanoate (Table 3.3, Entry 5). The 
title compound was prepared according to the General Procedure A with (3-bromo-
4,4,5,5,5-pentafluoropentyl)benzene (254 mg, 0.80 mmol) and an alkylzinc bromide 
reagent prepared from ethyl 4-bromobutanoate. Solvent system for chromatography: 2:1 
→ 1:1.5 hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 192 mg (68% yield); Run 2, 180 mg (64% yield). 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.28 (m, 2H), 7.24 – 7.17 (m, 3H), 4.15 (q, 
2H, J = 7.1 Hz), 2.78 – 2.64 (m, 2H), 2.31 (t, 2H, J = 6.8 Hz), 2.21 – 2.08 (m, 1H), 2.06 – 
1.99 (m, 1H), 1.85 – 1.51 (m, 5H), 1.27 (t, 3H, J = 7.1 Hz); 
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13C NMR (126 MHz, CDCl3) δ 173.0, 141.0, 128.5, 128.3, 126.2, 121.1 – 114.8 
(m), 60.4, 39.7 (t, J = 20.0 Hz), 34.1, 32.9, 28.5, 26.2, 22.0, 14.2; 
19F NMR (282 MHz, CDCl3) δ −81.7 (s, 3F), −117.1 (d, 2F, J = 16.2 Hz); 
FT-IR (film) 2963, 1735, 1201, 1123, 1095, 1007, 753, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H21F5O2: 352, found: 352. 
 
F3CF2C Ph
P
OEt
O
OEt
 
Diethyl (5,5,6,6,6-pentafluoro-4-phenethylhexyl)phosphonate (Table 3.3, 
Entry 6). The title compound was prepared according to the General Procedure A with 
(3-bromo-4,4,5,5,5-pentafluoropentyl)benzene (254 mg, 0.80 mmol) and an alkylzinc 
bromide reagent prepared from diethyl (3-bromopropyl)phosphonate. Solvent system for 
chromatography: 1:1 → 1:2.5 hexane/ethyl acetate. The title compound was isolated as a 
colorless oil. 
Run 1, 237 mg (71% yield); Run 2, 230 mg (69% yield). 
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 7.23 – 7.15 (m, 3H), 4.16 – 
4.03 (m, 4H), 2.75 – 2.63 (m, 2H), 2.17 – 2.07 (m, 1H), 2.05 – 1.96 (m, 1H), 1.84 – 1.56 
(m, 7H), 1.32 (t, 6H, J = 7.1 Hz); 
13C NMR (126 MHz, CDCl3) δ 140.9, 128.5, 128.3, 126.2, 121.2 – 114.7 (m), 
61.6 (d, J = 6.6 Hz), 39.7 (t, J = 20.0 Hz), 32.9, 28.5, 27.6 (d, J = 16.7 Hz), 25.7 (d, J = 
141.8 Hz), 20.0 (d, J = 4.9 Hz), 16.4 (d, J = 6.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −81.7 (s, 3F), −116.9 (t, 2F, J = 16.9 Hz); 
31P NMR (121 MHz, CDCl3) δ 31.2; 
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FT-IR (film) 2981, 1244, 1203, 1169, 1058, 1031, 960, 701 cm-1; 
GC-MS (EI) m/z (M+) calcd for C18H26F5O3P: 416, found: 416. 
 
F3CF2C Ph
CN
 
6,6,7,7,7-Pentafluoro-5-phenethylheptanenitrile (Table 3.3, Entry 7). The title 
compound was prepared according to the General Procedure A with (3-bromo-4,4,5,5,5-
pentafluoropentyl)benzene (254 mg, 0.80 mmol) and an alkylzinc bromide reagent 
prepared from 4-bromobutanenitrile. Solvent system for chromatography: 10:1 → 3:1 
hexane/ethyl acetate. The title compound was isolated as a yellow oil. 
Run 1, 190 mg (78% yield); Run 2, 183 mg (75% yield). 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.30 (m, 2H), 7.25 – 7.21 (m, 1H), 7.20 – 
7.17 (m, 2H), 2.80 – 2.64 (m, 2H), 2.35 – 2.29 (m, 2H), 2.22 – 2.02 (m, 2H), 1.90 – 1.64 
(m, 5H); 
13C NMR (126 MHz, CDCl3) δ 140.4, 128.6, 128.3, 126.4, 120.5 – 114.8 (m), 
118.9, 39.3 (t, J = 20.1 Hz), 32.8, 28.3, 26.0, 22.6, 17.3; 
19F NMR (282 MHz, CDCl3) δ −81.7 (s, 3F), −116.3 (dd, 1F, J = 274.0, 15.2 Hz), 
−117.6 (dd, 1F, J = 273.9, 16.4 Hz); 
FT-IR (film) 2952, 2247, 1497, 1455, 1335, 1203, 1173, 1124, 1096, 1007, 753, 
701 cm-1; 
GC-MS (EI) m/z (M+) calcd for C15H16F5N: 305, found: 305. 
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F3CF2C
Cl
OPh
 
((9-Chloro-4-(perfluoroethyl)nonyl)oxy)benzene (Table 3.3, Entry 8). The title 
compound was prepared according to the General Procedure with 3-bromo-8-chloro-
1,1,1,2,2-pentafluorooctane (254 mg, 0.80 mmol) and an alkylzinc bromide reagent 
prepared from (3-bromopropoxy)benzene. Solvent system for chromatography: 10:1 → 
8:1 hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 188 mg (63% yield); Run 2, 192 mg (64% yield). 
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 6.97 – 6.94 (m, 1H), 6.92 – 
6.88 (m, 2H), 4.01 – 3.94 (m, 2H), 3.53 (t, 2H, J = 6.6 Hz), 2.23 – 2.12 (m, 1H), 1.95 – 
1.62 (m, 7H), 1.56 – 1.33 (m, 5H); 
13C NMR (126 MHz, CDCl3) δ 158.8, 129.5, 120.8, 119.6 – 115.9 (m), 114.4, 
67.2, 44.9, 40.2 (t, J = 19.8 Hz), 32.3, 26.9, 26.6, 26.5, 26.1, 23.4; 
19F NMR (282 MHz, CDCl3) δ −81.7 (s, 3F), −117.2 (dd, 2F, J = 16.2, 13.2 Hz); 
FT-IR (film) 2954, 2871, 1601, 1587, 1498, 1471, 1246, 1202, 1018, 755, 692 
cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H22ClF5O: 372, found: 372. 
 
n-C3F7 Ph
OPh
 
(4,4,5,5,6,6,6-Heptafluoro-3-(3-phenoxypropyl)hexyl)benzene (Table 3.4, 
Entry 1). The title compound was prepared according to the General Procedure A with 
(3-bromo-4,4,5,5,6,6,6-heptafluorohexyl)benzene (294 mg, 0.80 mmol) and an alkylzinc 
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bromide reagent prepared from (3-bromopropoxy)benzene. Solvent system for 
chromatography: 10:1 → 3:1 hexane/dichloromethane. The title compound was isolated 
as a colorless oil. 
Run 1, 220 mg (65% yield); Run 2, 220 mg (65% yield). 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.28 (m, 4H), 7.25 – 7.17 (m, 3H), 6.99 – 
6.95 (m, 1H), 6.93 – 6.89 (m, 2H), 3.99 – 3.94 (m, 2H), 2.79 (ddd, 1H, J = 13.8, 10.4, 5.7 
Hz), 2.70 (ddd, 1H, J = 13.7, 10.2, 6.2 Hz), 2.39 – 2.24 (m, 1H), 2.14 – 2.04 (m, 1H), 
2.00 – 1.72 (m, 5H); 
13C NMR (126 MHz, CDCl3) δ 158.8, 141.0, 129.5, 128.6, 128.4, 126.2, 121.1 – 
109.7 (m), 120.8, 114.4, 67.2, 39.9 (t, J = 20.1 Hz), 32.9, 28.5, 26.3, 23.3; 
19F NMR (282 MHz, CDCl3) δ −80.7 (t, 3F, J = 11.0 Hz), −114.1 – −114.4 (m, 
2F), −124.6 – −124.8 (m, 2F); 
FT-IR (film) 3029, 2952, 1601, 1498, 1226, 1173, 1111, 753, 699, 692 cm-1; 
GC-MS (EI) m/z (M+) calcd for C21H21F7O: 422, found: 422. 
 
n-C3F7 Ph
O
OEt
 
Ethyl 6,6,7,7,8,8,8-heptafluoro-5-phenethyloctanoate (Table 3.4, Entry 2). 
The title compound was prepared according to the General Procedure A with (3-bromo-
4,4,5,5,6,6,6-heptafluorohexyl)benzene (294 mg, 0.80 mmol) and an alkylzinc bromide 
reagent prepared from ethyl 4-bromobutanoate. Solvent system for chromatography: 2:1 
→ 1:1.5 hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 174 mg (54% yield); Run 2, 174 mg (54% yield). 
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1H NMR (500 MHz, CDCl3) δ 7.33 – 7.28 (m, 2H), 7.24 – 7.17 (m, 3H), 4.15 (q, 
2H, J = 7.1 Hz), 2.79 – 2.64 (m, 2H), 2.31 (t, 2H, J = 6.7 Hz), 2.28 – 2.18 (m, 1H), 2.09 – 
2.00 (m, 1H), 1.86 – 1.53 (m, 5H), 1.27 (t, 3H, J = 7.1 Hz); 
13C NMR (126 MHz, CDCl3) δ 173.0, 141.0, 128.5, 128.3, 126.2, 121.9 – 107.1 
(m), 60.4, 40.1 (t, J = 20.0 Hz), 34.1, 32.9, 28.5, 26.1, 22.0, 14.2; 
19F NMR (282 MHz, CDCl3) δ −80.8 (t, 3F, J = 11.0 Hz), −114.1 – −114.4 (m, 
2F), −124.7 – −124.8 (m, 2F); 
FT-IR (film) 2963, 1736, 1225, 1178, 1107, 748, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C18H21F7O2: 402, found: 402. 
 
n-C3F7 Ph
P
OEt
O
OEt
 
Diethyl (5,5,6,6,7,7,7-heptafluoro-4-phenethylheptyl)phosphonate (Table 3.4, 
Entry 3). The title compound was prepared according to the General Procedure A with 
(3-bromo-4,4,5,5,6,6,6-heptafluorohexyl)benzene (294 mg, 0.80 mmol) and an alkylzinc 
bromide reagent prepared from diethyl (3-bromopropyl)phosphonate. Solvent system for 
chromatography: 1:1 → 1:2.5 hexane/ethyl acetate. The title compound was isolated as a 
colorless oil. 
Run 1, 186 mg (50% yield); Run 2, 190 mg (51% yield). 
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 7.23 – 7.15 (m, 3H), 4.16 – 
4.03 (m, 4H), 2.77 – 2.62 (m, 2H), 2.28 – 2.14 (m, 1H), 2.08 – 1.98 (m, 1H), 1.88 – 1.59 
(m, 7H), 1.32 (t, 6H, J = 7.1 Hz); 
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13C NMR (126 MHz, CDCl3) δ 140.9, 128.5, 128.3, 126.2, 121.7 – 107.0 (m), 
61.6 (d, J = 6.5 Hz), 40.1 (t, J = 20.0 Hz), 32.9, 28.5, 27.6 (d, J = 17.0 Hz), 25.7 (d, J = 
141.8 Hz), 19.9 (d, J = 4.8 Hz), 16.4 (d, J = 6.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −80.8 (t, 3F, J = 11.0 Hz), −114.0 – −114.3 (m, 
2F), −124.6 – −124.8 (m, 2F); 
31P NMR (121 MHz, CDCl3) δ 31.2; 
FT-IR (film) 2981, 1349, 1231, 1176, 1103, 1059, 1031, 958, 749, 701 cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H26F7O3P: 466, found: 466. 
 
n-C3F7 Ph
CN
 
6,6,7,7,8,8,8-Heptafluoro-5-phenethyloctanenitrile (Table 3.4, Entry 4). The 
title compound was prepared according to the General Procedure A with (3-bromo-
4,4,5,5,6,6,6-heptafluorohexyl)benzene (294 mg, 0.80 mmol) and an alkylzinc bromide 
reagent prepared from 4-bromobutanenitrile. Solvent system for chromatography: 10:1 → 
4:1 hexane/ethyl acetate. The title compound was isolated as a colorless oil. 
Run 1, 200 mg (70% yield); Run 2, 190 mg (67% yield). 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.29 (m, 2H), 7.27 – 7.16 (m, 3H), 2.81 – 
2.65 (m, 2H), 2.37 – 2.18 (m, 3H), 2.13 – 2.06 (m, 1H), 1.92 – 1.66 (m, 5H); 
13C NMR (126 MHz, CDCl3) δ 140.4, 128.6, 128.3, 126.4, 121.7 – 107.5 (m), 118.9, 39.6 
(t, J = 20.3 Hz), 32.9, 28.3, 26.0, 22.6, 17.3; 
19F NMR (282 MHz, CDCl3) δ −80.7 (t, 3F, J = 11.0 Hz), −114.0 – −114.4 (m, 
2F), −124.6 – −124.9 (m, 2F); 
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FT-IR (film) 2952, 2247, 1497, 1455, 1350, 1225, 1176, 1108, 748, 701 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H16F7N: 355, found: 355. 
 
n-C4F9 Ph
OPh
 
(4,4,5,5,6,6,7,7,7-Nonafluoro-3-(3-phenoxypropyl)heptyl)benzene (Table 3.4, 
Entry 5). The title compound was prepared according to the General Procedure A with 
(3-bromo-4,4,5,5,6,6,7,7,7-nonafluoroheptyl)benzene (334 mg, 0.80 mmol) and an 
alkylzinc bromide reagent prepared from (3-bromopropoxy)benzene. Solvent system for 
chromatography: hexane → 4:1 hexane/dichloromethane. The title compound was 
isolated as a colorless oil. 
Run 1, 255 mg (67% yield); Run 2, 250 mg (66% yield). 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.28 (m, 4H), 7.25 – 7.17 (m, 3H), 6.99 – 
6.95 (m, 1H), 6.93 – 6.89 (m, 2H), 4.00 – 3.94 (m, 2H), 2.81 – 2.67 (m, 2H), 2.39 – 2.28 
(m, 1H), 2.14 – 2.04 (m, 1H), 2.01 – 1.71 (m, 5H); 
13C NMR (126 MHz, CDCl3) δ 158.8, 141.0, 129.5, 128.6, 128.3, 126.2, 121.9 – 
116.0 (m), 120.8, 114.4, 67.2, 40.1 (t, J = 20.2 Hz), 32.9, 28.5, 26.3, 23.3; 
19F NMR (282 MHz, CDCl3) δ −80.8 – −81.0 (m, 3F), −113.5 – −113.8 (m, 2F), 
−121.3 – −121.6  (m, 2F), −126.0 – −126.2 (m, 2F); 
FT-IR (film) 3029, 2952, 1601, 1498, 1236, 1172, 1133, 752, 699, 692 cm-1; 
GC-MS (EI) m/z (M+) calcd for C22H21F9O: 472, found: 472. 
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n-C4F9 Ph
O
OEt
 
Ethyl 6,6,7,7,8,8,9,9,9-nonafluoro-5-phenethylnonanoate (Table 3.4, Entry 6). 
The title compound was prepared according to the General Procedure A with (3-bromo-
4,4,5,5,6,6,7,7,7-nonafluoroheptyl)benzene (334 mg, 0.80 mmol) and an alkylzinc 
bromide reagent prepared from ethyl 4-bromobutanoate. Solvent system for 
chromatography: hexane → 1:1.5 hexane/dichloromethane. The title compound was 
isolated as a colorless oil. 
Run 1, 200 mg (55% yield); Run 2, 188 mg (52% yield). 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.28 (m, 2H), 7.24 – 7.17 (m, 3H), 4.15 (q, 
2H, J = 7.2 Hz), 2.78 – 2.65 (m, 2H), 2.34 – 2.18 (m, 3H), 2.10 – 2.00 (m, 1H), 1.86 – 
1.54 (m, 5H), 1.27 (t, 3H, J = 7.1 Hz); 
13C NMR (126 MHz, CDCl3) δ 173.0, 141.0, 128.5, 128.3, 126.2, 121.8 – 115.4 
(m), 60.4, 40.3 (t, J = 20.2 Hz), 34.1, 32.9, 28.5, 26.1, 22.0, 14.2; 
19F NMR (282 MHz, CDCl3) δ −80.8 – −81.0 (m, 3F), −113.6 – −113.9 (m, 2F), 
−121.4 – −121.6  (m, 2F), −126.0 – −126.3 (m, 2F); 
FT-IR (film) 2963, 1735, 1235, 1133, 750, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H21F9O2: 452, found: 452. 
 
n-C4F9 Ph
CN
 
6,6,7,7,8,8,9,9,9-Nonafluoro-5-phenethylnonanenitrile (Table 3.4, Entry 7). 
The title compound was prepared according to the General Procedure A with (3-bromo-
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4,4,5,5,6,6,7,7,7-nonafluoroheptyl)benzene (334 mg, 0.80 mmol) and an alkylzinc 
bromide reagent prepared from 4-bromobutanenitrile. Solvent system for 
chromatography: hexane → 4:1 hexane/ethyl acetate. The title compound was isolated as 
a colorless oil. 
Run 1, 221 mg (68% yield); Run 2, 227 mg (70% yield). 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.30 (m, 2H), 7.26 – 7.21 (m, 1H), 7.21 – 
7.17 (m, 2H), 2.80 – 2.65 (m, 2H), 2.37 – 2.21 (m, 3H), 2.15 – 2.05 (m, 1H), 1.92 – 1.66 
(m, 5H); 
13C NMR (126 MHz, CDCl3) δ 140.4, 128.7, 128.3, 126.4, 121.6 – 116.0 (m), 
118.9, 39.8 (t, J = 20.3 Hz), 32.9, 28.3, 26.0, 22.6, 17.3; 
19F NMR (282 MHz, CDCl3) δ −80.8 – −81.0 (m, 3F), −113.4 – −113.8 (m, 2F), 
−121.3 – −121.6  (m, 2F), −126.0 – −126.2 (m, 2F); 
FT-IR (film) 2952, 2247, 1354, 1235, 1133, 1019, 750, 701 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H16F9N: 405, found: 405. 
 
n-C9F19 Ph
CN
 
6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-Nonadecafluoro-5-
phenethyltetradecanenitrile (Table 3.4, Entry 8). The title compound was prepared 
according to the General Procedure A with (3-bromo-
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-nonadecafluorododecyl)benzene (534 mg, 
0.80 mmol) and an alkylzinc bromide reagent prepared from 4-bromobutanenitrile. 
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Solvent system for chromatography: hexane → 4:1 hexane/ethyl acetate. The title 
compound was isolated as a colorless viscous oil. 
Run 1, 340 mg (65% yield); Run 2, 351 mg (67% yield). 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.29 (m, 2H), 7.25 – 7.17 (m, 3H), 2.81 – 
2.65 (m, 2H), 2.37 – 2.21 (m, 3H), 2.14 – 2.06 (m, 1H), 1.92 – 1.66 (m, 5H); 
13C NMR (126 MHz, CDCl3) δ 140.5, 128.7, 128.3, 126.4, 120.2 – 105.1 (m), 
118.9, 40.0 (t, J = 20.2 Hz), 32.9, 28.4, 26.0, 22.6, 17.3; 
19F NMR (282 MHz, CDCl3) δ −80.8 (t, 3F, J = 10.0 Hz), −113.2 – −113.6 (m, 
2F), −120.3 – −120.7 (m, 2F), −121.5 – −122.2 (m, 8F), −122.6 – −123.0 (m, 2F), −126.0 
– 126.4 (m, 2F); 
FT-IR (film) 2954, 2247, 1497, 1455, 1209, 1100, 739, 702, 658 cm-1; 
GC-MS (EI) m/z (M+−C9F19) calcd for C13H16N: 186, found: 186. 
 
PhF3C
n-Bu
 
(3-(Trifluoromethyl)dodecyl)benzene (Table 3.5, Entry 1). The title compound 
was prepared according to the General Procedure A with (3-bromo-4,4,4-
trifluorobutyl)benzene (214 mg, 0.80 mmol) and an alkylzinc bromide reagent prepared 
from 1-bromononane. Solvent system for chromatography: hexane. The title compound 
was isolated as a colorless oil. 
Run 1, 199 mg (79% yield); Run 2, 197 mg (78% yield). 
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1H NMR (500 MHz, CDCl3) δ 7.34 – 7.28 (m, 2H), 7.24 – 7.18 (m, 3H), 2.71 (t, 
2H, J = 8.2 Hz), 2.12 – 2.01 (m, 1H), 1.99 – 1.89 (m, 1H), 1.80 – 1.71 (m, 1H), 1.68 – 
1.59 (m, 1H), 1.52 – 1.22 (m, 15H), 0.90 (t, 3H, J = 6.9 Hz); 
13C NMR (126 MHz, CDCl3) δ 141.4, 128.7 (q, J = 280.4 Hz), 128.5, 128.4, 
126.1, 41.9 (q, J = 24.8 Hz), 33.1, 31.9, 29.64, 29.61, 29.5, 29.4, 29.3, 27.8 (q, J = 2.3 
Hz), 26.7, 22.7, 14.1; 
19F NMR (282 MHz, CDCl3) δ −69.9 (d, 3F, J = 9.5 Hz); 
FT-IR (film) 2926, 2855, 1455, 1260, 1153, 1129, 1104, 746, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H29F3: 314, found: 314. 
 
F3C Ph
Ph
 
(3-(Trifluoromethyl)pentane-1,5-diyl)dibenzene (Table 3.5, Entry 2). The title 
compound was prepared according to the General Procedure A with (3-bromo-4,4,4-
trifluorobutyl)benzene (214 mg, 0.80 mmol) and an alkylzinc bromide reagent prepared 
from (2-bromoethyl)benzene. Solvent system for chromatography: hexane. The title 
compound was isolated as a colorless oil. 
Run 1, 182 mg (78% yield); Run 2, 182 mg (78% yield). 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.29 (m, 4H), 7.26 – 7.21 (m, 2H), 7.19 – 
7.15 (m, 4H), 2.77 – 2.65 (m, 4H), 2.19 – 2.08 (m, 1H), 2.00 (dddd, 2H, J = 14.8, 9.2, 
6.8, 5.7 Hz), 1.82 (ddt, 2H, J = 13.7, 9.4, 6.7 Hz); 
13C NMR (126 MHz, CDCl3) δ 141.1, 128.58 (q, J = 281.1 Hz), 128.53, 128.4, 
126.2, 41.2 (q, J = 25.0 Hz), 32.9, 29.7 (d, J = 2.4 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.4 Hz); 
	 199 
FT-IR (film) 3027, 2937, 1497, 1454, 1260, 1145, 1113, 747, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C18H19F3: 292, found: 292. 
 
F3C Ph
OPh
 
(6-Phenoxy-3-(trifluoromethyl)hexyl)benzene (Table 3.5, Entry 3). The title 
compound was prepared according to the General Procedure A with (3-bromo-4,4,4-
trifluorobutyl)benzene (214 mg, 0.80 mmol) and an alkylzinc bromide reagent prepared 
from (3-bromopropoxy)benzene. Solvent system for chromatography: 6:1 → 5:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 213 mg (83% yield); Run 2, 213 mg (83% yield). 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.28 (m, 4H), 7.25 – 7.18 (m, 3H), 6.99 – 
6.96 (m, 1H), 6.93 – 6.89 (m, 2H), 3.96 (t, 2H, J = 5.9 Hz), 2.81 – 2.69 (m, 2H), 2.21 – 
2.13 (m, 1H), 2.01 (dddd, 1H, J = 14.2, 9.4, 6.7, 5.6 Hz), 1.93 – 1.69 (m, 5H); 
13C NMR (126 MHz, CDCl3) δ 158.8, 141.1, 129.5, 128.54 (q, J = 280.3 Hz), 
128.52, 128.4, 126.2, 120.7, 114.4, 67.2, 41.6 (q, J = 25.1 Hz), 32.9, 29.5 (q, J = 2.4 Hz), 
26.4, 24.4 (q, J = 2.5 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.8 (d, 3F, J = 9.4 Hz); 
FT-IR (film) 2953, 2874, 1601, 1497, 1246, 1152, 1120, 754, 700, 692 cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H21F3O: 322, found: 322. 
 
PhF3C
O
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4-(4-Phenyl-2-(trifluoromethyl)butyl)tetrahydro-2H-pyran (Table 3.5, Entry 
4). The title compound was prepared according to the General Procedure A with (3-
bromo-4,4,4-trifluorobutyl)benzene (214 mg, 0.80 mmol) and an alkylzinc bromide 
reagent prepared from 4-(bromomethyl)tetrahydro-2H-pyran. Solvent system for 
chromatography: 12:1 hexane/ethyl acetate. The title compound was isolated as a 
colorless oil. 
Run 1, 167 mg (73% yield); Run 2, 169 mg (74% yield). 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.28 (m, 2H), 7.24 – 7.17 (m, 3H), 3.97 – 
3.87 (m, 2H), 3.35 (td, 1H, J = 11.8, 2.1 Hz), 3.27 (td, 1H, J = 11.8, 2.3 Hz), 2.78 – 2.65 
(m, 2H), 2.19 – 2.09 (m, 1H), 1.98 (ddt, 1H, J = 14.3, 9.2, 6.2 Hz), 1.74 – 1.66 (m, 1H), 
1.59 – 1.51 (m, 3H), 1.40 – 1.12 (m, 4H); 
13C NMR (126 MHz, CDCl3) δ 141.0, 128.6 (q, J = 280.2 Hz), 128.5, 128.4, 
126.2, 67.82, 67.76, 38.4 (q, J = 25.0 Hz), 35.4 (q, J = 2.3 Hz), 33.2, 33.0, 32.7, 32.3, 
30.2 (q, J = 2.3 Hz); 
19F NMR (282 MHz, CDCl3) δ −70.3 (d, 3F, J = 9.2 Hz); 
FT-IR (film) 2935, 2842, 1261, 1239, 1160, 1134, 1105, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H21F3O: 286, found: 286. 
 
F3C Ph
OO
 
2-(5-Phenyl-3-(trifluoromethyl)pentyl)-1,3-dioxolane (Table 3.5, Entry 5). 
The title compound was prepared according to the General Procedure A with (3-bromo-
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4,4,4-trifluorobutyl)benzene (214 mg, 0.80 mmol) and an alkylzinc bromide reagent 
prepared from 2-(2-bromoethyl)-1,3-dioxolane. Solvent system for chromatography: 10:1 
→ 6:1 hexane/ethyl acetate. The title compound was isolated as a colorless oil. 
Run 1, 163 mg (71% yield); Run 2, 166 mg (72% yield). 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.28 (m, 2H), 7.23 – 7.17 (m, 3H), 4.85 (t, 
1H, J = 4.2 Hz), 4.01 – 3.93 (m, 2H), 3.90 – 3.82 (m, 2H), 2.78 – 2.66 (m, 2H), 2.21 – 
2.09 (m, 1H), 1.96 (dddd, 1H, J = 14.3, 9.5, 6.8, 5.7 Hz), 1.83 – 1.70 (m, 4H), 1.69 – 1.62 
(m, 1H); 
13C NMR (126 MHz, CDCl3) δ 141.1, 128.49, 128.48 (q, J = 280.5 Hz), 128.3, 
126.1, 103.9, 64.95, 64.92, 41.6 (q, J = 25.1 Hz), 32.8, 30.7, 29.5 (q, J = 2.3 Hz), 21.8 (q, 
J = 2.6 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.9 (d, 3F, J = 9.4 Hz); 
FT-IR (film) 2955, 2881, 1454, 1396, 1263, 1145, 1116, 1031, 749, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C15H19F3O2: 288, found: 288. 
 
F3C Ph
O
OEt
 
Ethyl 7-phenyl-5-(trifluoromethyl)heptanoate (Table 3.5, Entry 6). The title 
compound was prepared according to the General Procedure A with (3-bromo-4,4,4-
trifluorobutyl)benzene (214 mg, 0.80 mmol) and an alkylzinc bromide reagent prepared 
from ethyl 4-bromobutanoate. Solvent system for chromatography: 2:1 → 1:1.5 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 198 mg (82% yield); Run 2, 200 mg (83% yield). 
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1H NMR (500 MHz, CDCl3) δ 7.32 – 7.28 (m, 2H), 7.23 – 7.18 (m, 3H), 4.15 (q, 
2H, J = 7.1 Hz), 2.74 – 2.68 (m, 2H), 2.30 (t, 2H, J = 7.0 Hz), 2.13 – 2.04 (m, 1H), 2.01 – 
1.92 (m, 1H), 1.81 – 1.62 (m, 4H), 1.56 – 1.49 (m, 1H), 1.27 (t, 3H, J = 7.1 Hz); 
13C NMR (126 MHz, CDCl3) δ 173.0, 141.1, 128.5, 128.4 (q, J = 280.4 Hz), 
128.3, 126.2, 60.4, 41.7 (q, J = 25.0 Hz), 34.1, 32.9, 29.4 (q, J = 2.4 Hz), 27.2 (q, J = 2.5 
Hz), 22.0, 14.2; 
19F NMR (282 MHz, CDCl3) δ −69.9 (d, 3F, J = 9.4 Hz); 
FT-IR (film) 2942, 1734, 1262, 1184, 1147, 1114, 748, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H21F3O2: 302, found: 302. 
 
PhF3C
Ph
 
(6-(Trifluoromethyl)oct-1-yne-1,8-diyl)dibenzene (Table 3.5, Entry 7). The 
title compound was prepared according to the General Procedure A with (3-bromo-4,4,4-
trifluorobutyl)benzene (214 mg, 0.80 mmol) and an alkylzinc bromide reagent prepared 
from (5-bromopent-1-yn-1-yl)benzene. Solvent system for chromatography: 20:1 → 15:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 175 mg (66% yield); Run 2, 176 mg (67% yield). 
1H NMR (500 MHz, CDCl3) δ 7.43 – 7.39 (m, 2H), 7.33 – 7.27 (m, 5H), 7.24 – 
7.18 (m, 3H), 2.81 – 2.69 (m, 2H), 2.43 (t, 2H, J = 6.6 Hz), 2.21 – 2.08 (m, 1H), 2.00 
(dddd, 1H, J = 14.2, 9.5, 6.8, 5.6 Hz), 1.89 – 1.66 (m, 5H); 
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13C NMR (126 MHz, CDCl3) δ 141.1, 131.5, 128.52 (q, J = 280.4 Hz), 128.51, 
128.3, 128.2, 127.7, 126.2, 123.7, 89.2, 81.3, 41.5 (q, J = 25.0 Hz), 32.9, 29.5 (q, J = 2.4 
Hz), 26.9 (q, J = 2.4 Hz), 25.7, 19.4; 
19F NMR (282 MHz, CDCl3) δ −69.8 (d, 3F, J = 9.4 Hz); 
FT-IR (film) 2951, 1490, 1262, 1146, 1114, 756, 692 cm-1; 
GC-MS (EI) m/z (M+) calcd for C21H21F3: 330, found: 330. 
 
F3C Ph
CN
 
7-Phenyl-5-(trifluoromethyl)heptanenitrile (Table 3.5, Entry 8). The title 
compound was prepared according to the General Procedure A with (3-bromo-4,4,4-
trifluorobutyl)benzene (214 mg, 0.80 mmol) and an alkylzinc bromide reagent prepared 
from 4-bromobutanenitrile. Solvent system for chromatography: 10:1 → 4:1 hexane/ethyl 
acetate. The title compound was isolated as a colorless oil. 
Run 1, 170 mg (83% yield); Run 2, 170 mg (83% yield). 
This compound was also prepared on a 6.00 mmol scale (eq 3.4), using (3-bromo-
4,4,4-trifluorobutyl)benzene (1.60 g, 6.00 mmol) and an alkylzinc bromide reagent 
prepared from 4-bromobutanenitrile (0.50 M; 14.4 mL, 7.20 mmol; 1.20 equiv). 
Following the General Procedure A using 5.0% NiCl2⋅glyme (65.9 mg, 0.300 mmol) and 
5.5% ligand 1 (99.5 mg, 0.330 mmol), the title compound was isolated in 80% yield (1.22 
g). 
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1H NMR (500 MHz, CDCl3) δ 7.34 – 7.30 (m, 2H), 7.25 – 7.18 (m, 3H), 2.79 – 
2.68 (m, 2H), 2.32 (t, 2H, J = 6.8 Hz), 2.15 – 2.06 (m, 1H), 2.02 (dddd, 1H, J = 14.5, 8.9, 
6.9, 5.6 Hz), 1.82 – 1.62 (m, 5H); 
13C NMR (126 MHz, CDCl3) δ 140.6, 128.6, 128.3, 128.1 (q, J = 280.3 Hz), 
126.3, 119.0, 41.2 (q, J = 25.3 Hz), 32.8, 29.4 (q, J = 2.4 Hz), 26.9 (q, J = 2.5 Hz), 22.6, 
17.2; 
19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.1 Hz); 
FT-IR (film) 3028, 2946, 2877, 2247, 1497, 1462, 1455, 1396, 1263, 1195, 1149, 
1115, 1031, 751, 701 cm-1; 
GC-MS (EI) m/z (M+) calcd for C14H16F3N: 255, found: 255. 
 
F3C Ph
P
OEt
O
OEt
 
Diethyl (6-phenyl-4-(trifluoromethyl)hexyl)phosphonate (Table 3.5, Entry 9). 
The title compound was prepared according to the General Procedure A with (3-bromo-
4,4,4-trifluorobutyl)benzene (214 mg, 0.80 mmol) and an alkylzinc bromide reagent 
prepared from diethyl (3-bromopropyl)phosphonate. Solvent system for chromatography: 
4:1 → 1:3 hexane/ethyl acetate. The title compound was isolated as a colorless oil. 
Run 1, 258 mg (88% yield); Run 2, 260 mg (89% yield). 
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.26 (m, 2H), 7.22 – 7.15 (m, 3H), 4.15 – 
4.02 (m, 4H), 2.70 (t, 2H, J = 8.1 Hz), 2.10 – 2.02 (m, 1H), 1.94 (dddd, 1H, J = 14.4, 8.7, 
7.3, 5.8 Hz), 1.78 – 1.52 (m, 7H), 1.31 (t, 6H, J = 7.1 Hz); 
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13C NMR (126 MHz, CDCl3) δ 140.9, 128.5, 128.34 (q, J = 280.3 Hz), 128.28, 
126.2, 61.5 (d, J = 6.5 Hz), 41.6 (q, J = 25.4 Hz), 32.9, 29.4 (d, J = 2.3 Hz), 28.6 (dd, J = 
16.7, 2.4 Hz), 25.6 (d, J = 141.8 Hz), 19.9 (d, J = 4.8 Hz), 16.4 (d, J = 5.9 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.8 (d, 3F, J = 9.3 Hz); 
31P NMR (121 MHz, CDCl3) δ 31.3; 
FT-IR (film) 2981, 2940, 1257, 1161, 1107, 1058, 1030, 960, 701 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H26F3O3P: 366, found: 366. 
 
F3C
OPh
n-Bu  
((4-(Trifluoromethyl)dodecyl)oxy)benzene (Table 3.6, Entry 1). The title 
compound was prepared according to the General Procedure A with 2-bromo-1,1,1-
trifluorodecane (220 mg, 0.80 mmol) and an alkylzinc bromide reagent prepared from (3-
bromopropoxy)benzene. Solvent system for chromatography: hexane → 10:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 225 mg (85% yield); Run 2, 230 mg (87% yield). 
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.26 (m, 2H), 6.97 – 6.93 (m, 1H), 6.92 – 
6.88 (m, 2H), 3.97 (t, 2H, J = 6.1 Hz), 2.10 (dddd, 1H, J = 15.7. 9.6, 6.4, 3.6 Hz), 1.94 – 
1.84 (m, 2H), 1.83 – 1.73 (m, 1H), 1.71 – 1.59 (m, 2H), 1.50 – 1.23 (m, 13H), 0.90 (t, 3H, 
J = 6.9 Hz); 
13C NMR (126 MHz, CDCl3) δ 158.9, 129.4, 128.6 (q, J = 280.4 Hz), 120.7, 
114.4, 67.4, 42.3 (q, J = 24.8 Hz), 31.8, 29.7, 29.4, 29.2, 27.8 (q, J = 2.4 Hz), 26.8, 26.6, 
24.5 (q, J = 2.3 Hz), 22.7, 14.1; 
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19F NMR (282 MHz, CDCl3) δ −70.1 (d, 3F, J = 9.5 Hz); 
FT-IR (film) 2927, 2856, 1601, 1498, 1245, 1160, 1133, 753, 691 cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H29F3O: 330, found: 330. 
 
BrF3C
OPh
 
((12-Bromo-4-(trifluoromethyl)dodecyl)oxy)benzene (Table 3.6, Entry 2). The 
title compound was prepared according to the General Procedure A with 2,10-dibromo-
1,1,1-trifluorodecane (283 mg, 0.80 mmol) and an alkylzinc bromide reagent prepared 
from (3-bromopropoxy)benzene. Solvent system for chromatography: 10:1 → 6:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 259 mg (79% yield); Run 2, 260 mg (79% yield). 
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 6.97 – 6.93 (m, 1H), 6.92 – 
6.88 (m, 2H), 3.97 (t, 2H, J = 6.1 Hz), 3.41 (t, 2H, J = 6.8 Hz), 2.11 (ddtd, 1H, J = 15.6, 
9.6, 5.9, 3.4 Hz), 1.92 – 1.73 (m, 5H), 1.71 – 1.59 (m, 2H), 1.51 – 1.25 (m, 11H); 
13C NMR (126 MHz, CDCl3) δ 158.8, 129.4, 128.6 (q, J = 280.5 Hz), 120.7, 
114.4, 67.3, 42.3 (q, J = 24.8 Hz), 34.0, 32.8, 29.5, 29.2, 28.7, 28.1, 27.8 (q, J = 2.5 Hz), 
26.7, 26.6, 24.4 (q, J = 2.5 Hz); 
19F NMR (282 MHz, CDCl3) δ −70.1 (d, 3F, J = 9.5 Hz); 
FT-IR (film) 2931, 2856, 1601, 1498, 1245, 1162, 1121, 754, 691 cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H2879BrF3O: 408, found: 408, 410 (M++2). 
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OTsF3C
OPh
 
9-Phenoxy-6-(trifluoromethyl)nonyl 4-methylbenzenesulfonate (Table 3.6, 
Entry 3). The title compound was prepared according to the General Procedure A with 6-
bromo-7,7,7-trifluoroheptyl 4-methylbenzenesulfonate (322 mg, 0.80 mmol) and an 
alkylzinc bromide reagent prepared from (3-bromopropoxy)benzene. Solvent system for 
chromatography: 10:1 hexane/ethyl acetate. The title compound was isolated as a 
colorless oil. 
Run 1, 275 mg (75% yield); Run 2, 278 mg (76% yield). 
1H NMR (500 MHz, CDCl3) δ 7.81 – 7.76 (m, 2H), 7.36 – 7.32 (m, 2H), 7.31 – 
7.25 (m, 2H), 6.96 – 6.92 (m, 1H), 6.91 – 6.86 (m, 2H), 4.03 – 3.92 (m, 4H), 2.44 (s, 3H), 
2.15 – 2.00 (m, 1H), 1.90 – 1.80 (m, 2H), 1.79 – 1.71 (m, 1H), 1.69 – 1.53 (m, 4H), 1.46 
– 1.25 (m, 5H); 
13C NMR (126 MHz, CDCl3) δ 158.8, 144.7, 133.1, 129.8, 129.4, 128.4 (q, J = 
281.0 Hz), 127.8, 120.7, 114.4, 70.3, 67.2, 42.2 (q, J = 24.8 Hz), 28.6, 27.6 (d, J = 2.7 
Hz), 26.5, 26.1, 25.5, 24.4 (d, J = 2.7 Hz), 21.6; 
19F NMR (282 MHz, CDCl3) δ −70.0 (d, 3F, J = 9.5 Hz); 
FT-IR (film) 2946, 1600, 1498, 1360, 1246, 1189, 1177, 1157, 955, 815, 756, 664 
cm-1; 
LC-MS (ESI) m/z (M+H+) calcd for C23H30F3O4S: 459, found: 459. 
 
OTBDPSF3C
CN
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10-((tert-Butyldiphenylsilyl)oxy)-5-(trifluoromethyl)decanenitrile (Table 3.6, 
Entry 4). The title compound was prepared according to the General Procedure A with 
((6-bromo-7,7,7-trifluoroheptyl)oxy)(tert-butyl)diphenylsilane (390 mg, 0.80 mmol) and 
an alkylzinc bromide reagent prepared from 4-bromobutanenitrile. Solvent system for 
chromatography: 10:1 → 8:1 hexane/ethyl acetate. The title compound was isolated as a 
colorless oil. 
Run 1, 268 mg (70% yield); Run 2, 281 mg (74% yield). 
1H NMR (500 MHz, CDCl3) δ 7.70 – 7.66 (m, 4H), 7.46 – 7.37 (m, 6H), 3.68 (t, 
2H, J = 6.3 Hz), 2.38 – 2.33 (m, 2H), 2.08 – 2.01 (m, 1H), 1.83 – 1.68 (m, 3H), 1.68 – 
1.54 (m, 4H), 1.44 – 1.33 (m, 5H), 1.06 (s, 9H); 
13C NMR (126 MHz, CDCl3) δ 135.5, 134.0, 129.5, 128.2 (q, J = 280.3 Hz), 
127.6, 119.0, 63.7, 42.1 (q, J = 25.2 Hz), 32.2, 27.7 (q, J = 2.4 Hz), 27.1 (q, J = 2.4 Hz), 
26.8, 26.5, 25.8, 22.8, 19.2, 17.3; 
19F NMR (282 MHz, CDCl3) δ −69.9 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 2933, 2858, 2247, 1428, 1258, 1153, 1112, 703 cm-1; 
GC-MS (EI) m/z (M+−C4H9) calcd for C23H27F3NOSi: 418, found: 418. 
 
O
O
O
F3C
OPh
 
9-Phenoxy-6-(trifluoromethyl)nonyl furan-2-carboxylate (Table 3.6, Entry 5). 
The title compound was prepared according to the General Procedure A with 6-bromo-
7,7,7-trifluoroheptyl furan-2-carboxylate (274 mg, 0.80 mmol) and an alkylzinc bromide 
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reagent prepared from (3-bromopropoxy)benzene. Solvent system for chromatography: 
20:1 hexane/ethyl acetate. The title compound was isolated as a colorless oil. 
Run 1, 267 mg (84% yield); Run 2, 258 mg (81% yield). 
1H NMR (500 MHz, CD3COCD3) δ 7.80 (dd, 1H, J = 1.8, 0.8 Hz), 7.30 – 7.25 
(m, 2H), 7.22 (dd, 1H, J = 3.5, 0.9 Hz), 6.96 – 6.89 (m, 3H), 6.63 (dd, 1H, J = 3.5, 1.8 
Hz), 4.27 (t, 2H, J = 6.6 Hz), 4.03 (t, 2H, J = 6.1 Hz), 2.38 – 2.25 (m, 1H), 1.94 – 1.64 
(m, 7H), 1.60 – 1.43 (m, 5H); 
13C NMR (126 MHz, CD3COCD3) δ 160.1, 159.1, 147.9, 146.0, 130.4, 130.1 (q, J 
= 279.8 Hz), 121.5, 118.7, 115.5, 112.9, 68.2, 65.4, 43.0 (q, J = 24.6 Hz), 29.4, 28.6 (q, J 
= 2.5 Hz), 27.4, 27.3, 26.9, 25.3 (q, J = 2.7 Hz); 
19F NMR (282 MHz, CD3COCD3) δ −70.6 (d, 3F, J = 9.9 Hz); 
FT-IR (film) 2948, 2871, 1722, 1601, 1586, 1498, 1475, 1398, 1297, 1246, 1180, 
1120, 1078, 755, 692 cm-1; 
GC-MS (EI) m/z (M+) calcd for C21H25F3O4: 398, found: 398. 
 
O
I
F3C
CN
 
10-(4-Iodophenoxy)-5-(trifluoromethyl)decanenitrile (Table 3.6, Entry 6). 
The title compound was prepared according to the General Procedure A with 1-((6-
bromo-7,7,7-trifluoroheptyl)oxy)-4-iodobenzene (361 mg, 0.80 mmol) and an alkylzinc 
bromide reagent prepared from 4-bromobutanenitrile. Solvent system for 
chromatography: 10:1 → 4:1 hexane/ethyl acetate. The title compound was isolated as a 
white solid. 
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Run 1, 283 mg (81% yield); Run 2, 285 mg (81% yield). 
1H NMR (500 MHz, CDCl3) δ 7.56 – 7.52 (m, 2H), 6.69 – 6.64 (m, 2H), 3.92 (t, 
2H, J = 6.3 Hz), 2.40 – 2.35 (m, 2H), 2.14 – 2.02 (m, 1H), 1.84 – 1.59 (m, 7H), 1.51 – 
1.41 (m, 5H); 
13C NMR (126 MHz, CDCl3) δ 158.8, 138.1, 128.1 (q, J = 280.3 Hz), 119.0, 
116.9, 82.5, 67.7, 42.1 (q, J = 25.3 Hz), 28.9, 27.7 (q, J = 2.4 Hz), 27.1 (q, J = 2.4 Hz), 
26.5, 26.1, 22.8, 17.4; 
19F NMR (282 MHz, CDCl3) δ −69.9 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 2943, 2246, 1586, 1487, 1244, 1174, 1153, 1125, 821 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H21F3INO: 439, found: 439. 
 
F3C
OPh
N
Boc
 
tert-Butyl 4-(5-phenoxy-2-(trifluoromethyl)pentyl)piperidine-1-carboxylate 
(Table 3.6, Entry 7). The title compound was prepared according to the General 
Procedure A with tert-butyl 4-(2-bromo-3,3,3-trifluoropropyl)piperidine-1-carboxylate 
(288 mg, 0.80 mmol) and an alkylzinc bromide reagent prepared from (3-
bromopropoxy)benzene. Solvent system for chromatography: 25:1 → 15:1 hexane/ethyl 
acetate. The title compound was isolated as a colorless oil. 
Run 1, 267 mg (80% yield); Run 2, 265 mg (80% yield). 
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.26 (m, 2H), 6.97 – 6.93 (m, 1H), 6.90 – 
6.86 (m, 2H), 4.16 – 4.02 (m, 2H), 3.99 – 3.95 (m, 2H), 2.73 – 2.57 (m, 2H), 2.27 – 2.16 
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(m, 1H), 1.94 – 1.75 (m, 3H), 1.71 – 1.61 (m, 3H), 1.60 – 1.50 (m, 2H), 1.46 (s, 9H), 1.38 
– 1.30 (m, 1H), 1.15 – 1.01 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 158.7, 154.7, 129.5, 128.5 (q, J = 280.0 Hz), 
120.8, 114.4, 79.3, 67.1, 39.2 (q, J = 25.1 Hz), 34.9, 33.4, 32.3, 31.9, 28.4, 26.4, 25.1 (d, 
J = 2.5 Hz); 
19F NMR (282 MHz, CDCl3) δ −70.4 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 2973, 2933, 2870, 1692, 1498, 1424, 1366, 1246, 1171, 1138, 755, 
692 cm-1; 
GC-MS (EI) m/z (M+−Boc) calcd for C17H23F3NO: 314, found: 314. 
 
O
O
Me
F3C
OPh
 
1-(4-((9-Phenoxy-6-(trifluoromethyl)nonyl)oxy)phenyl)ethan-1-one (Table 
3.6, Entry 8). The title compound was prepared according to the General Procedure A 
with 1-(4-((6-bromo-7,7,7-trifluoroheptyl)oxy)phenyl)ethan-1-one (294 mg, 0.80 mmol) 
and an alkylzinc bromide reagent prepared from (3-bromopropoxy)benzene. Solvent 
system for chromatography: 10:1 → 4:1 hexane/ethyl acetate. The title compound was 
isolated as a yellow oil. 
Run 1, 291 mg (86% yield); Run 2, 287 mg (85% yield). 
1H NMR (500 MHz, CDCl3) δ 7.95 – 7.90 (m, 2H), 7.31 – 7.25 (m, 2H), 6.98 – 
6.86 (m, 5H), 4.01 (t, 2H, J = 6.4 Hz), 3.96 (t, 2H, J = 6.0 Hz), 2.55 (s, 3H), 2.13 (dddd, 
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1H, J = 14.7, 8.8, 5.8, 3.1 Hz), 1.93 – 1.74 (m, 5H), 1.72 – 1.62 (m, 2H), 1.57 – 1.42 (m, 
5H); 
13C NMR (126 MHz, CDCl3) δ 196.7, 163.0, 158.8, 130.6, 130.2, 129.4, 128.5 (q, 
J = 280.4 Hz), 120.7, 114.4, 114.1, 67.9, 67.3, 42.2 (q, J = 25.0 Hz), 28.9, 27.7 (d, J = 2.3 
Hz), 26.6, 26.5, 26.3, 26.1, 24.5 (d, J = 2.5 Hz); 
19F NMR (282 MHz, CDCl3) δ −70.0 (d, 3F, J = 9.5 Hz); 
FT-IR (film) 2945, 1676, 1601, 1254, 1172, 1158, 1124, 834, 755, 692 cm-1; 
LC-MS (ESI) m/z (M+H+) calcd for C24H30F3O3: 423, found: 423. 
 
F3CF2C Ph
OPh
 
((5,5,6,6,6-Pentafluoro-4-phenethylhexyl)oxy)benzene (eq 3.3). The title 
compound was prepared according to the General Procedure A with (4,4,5,5,5-
pentafluoro-3-iodopentyl)benzene (291 mg, 0.80 mmol) and an alkylzinc bromide 
reagent prepared from (3-bromopropoxy)benzene. Solvent system for chromatography: 
10:1 → 3:1 hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 186 mg (62% yield); Run 2, 183 mg (61% yield). 
For the characterization data, see Table 3.3, Entry 1 (above). 
 
HF2C Ph
OPh
 
(3-(Difluoromethyl)-6-phenoxyhexyl)benzene (eq 3.5). The title compound was 
prepared according to General Procedure B with (3-bromo-4,4-difluorobutyl)benzene 
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(199 mg, 0.80 mmol) and an alkylzinc bromide reagent prepared from (3-
bromopropoxy)benzene. Solvent system for chromatography: 6:1 → 4:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 170 mg (70% yield); Run 2, 168 mg (69% yield). 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.28 (m, 4H), 7.24 – 7.18 (m, 3H), 6.97 (tt, 
1H, J = 7.3, 1.1 Hz), 6.93 – 6.89 (m, 2H), 5.80 (td, 1H, J = 56.7, 3.3 Hz), 3,96 (t, 2H, J = 
6.2 Hz), 2.73 (t, 2H, J = 7.9 Hz), 1.97 – 1.83 (m, 4H), 1.79 – 1.70 (m, 2H), 1.67 – 1.60 
(m, 1H); 
13C NMR (126 MHz, CDCl3) δ 158.8, 141.6, 129.4, 128.5, 128.3, 126.0, 120.7, 
118.8 (t, J = 242.6 Hz), 114.4, 67.4, 41.1 (t, J = 18.6 Hz), 33.0, 29.5 (t, J = 4.4 Hz), 26.5, 
24.3 (t, J = 4.6 Hz); 
19F NMR (282 MHz, CDCl3) δ −122.4 (dd, 2F, J = 56.6, 15.5 Hz); 
FT-IR (neat) 2948, 1600, 1586, 1497, 1246, 1081, 1037, 754, 692 cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H22F2O: 304, found: 304; 
 
HF2C Ph
P
O
OEtOEt
 
Diethyl (4-(difluoromethyl)-6-phenylhexyl)phosphonate (eq 3.6). The title 
compound was prepared according to General Procedure B with 3-bromo-4,4-
difluorobutyl)benzene (199 mg, 0.80 mmol) and an alkylzinc bromide reagent prepared 
from diethyl (3-bromopropyl)phosphonate. Solvent system for chromatography: 1:2 → 
1:3 hexane/ethyl acetate. The title compound was isolated as a colorless oil. 
Run 1, 215 mg (77% yield); Run 2, 217 mg (78% yield). 
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1H NMR (500 MHz, CDCl3) δ 7.30 – 7.25 (m, 2H), 7.21 – 7.15 (m, 3H), 5.74 (td, 
1H, J = 56.6, 3.2 Hz), 4.15 – 4.02 (m, 4H), 2.67 (t, 2H, J = 7.9 Hz), 1.88 – 1.75 (m, 2H), 
1.74 – 1.58 (m, 6H), 1.54 – 1.44 (m, 1H), 1.32 (t, 6H, J = 7.1 Hz); 
13C NMR (126 MHz, CDCl3) δ 141.4, 128.4, 128.3, 126.0, 118.5 (t, J = 242.6 
Hz), 61.5 (d, J = 6.5 Hz), 41.2 (td, J = 18.8, 1.8 Hz), 33.0, 29.4 (t, J = 4.3 Hz), 28.6 (dt, J 
= 16.9, 4.5 Hz), 25.8 (d, J = 141.3 Hz), 19.9 (d, J = 5.0 Hz), 16.4 (d, J = 6.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −122.4 – −122.7 (m, 2F); 
31P NMR (121 MHz, CDCl3) δ 31.6; 
FT-IR (neat) 2981, 2938, 1241, 1054, 1030, 961, 701 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H27F2O3P: 348, found: 348; 
 
Competition Experiments (Scheme 3.3 and eq 3.7).  
In a nitrogen-filled glovebox, NiCl2•glyme (2.2 mg, 0.010 mmol), ligand L2 (3.3 
mg, 0.011 mmol), and NaBr (10.3 mg, 0.10 mmol) were added to an oven-dried 4-mL 
vial equipped with a stir bar.  DMA (0.25 mL) was added to the 4-mL vial, and the vial 
was closed with a PTFE septum cap.  The mixture was vigorously stirred at r.t. for 25 
min. Then, a solution in DMA of each of the two alkyl electrophiles (0.10 mmol in 0.25 
mL of DMA) was added in turn to the 4-mL vial. The combined mixture was allowed to 
stir at r.t. for 1 min. Next, the solution of the alkylzinc reagent (0.50 M; 0.24 mL, 0.12 
mmol; 1.2 equiv) was added in one portion. The reaction mixture was stirred vigorously 
at r.t. for 10 min, and then the reaction was quenched with MeOH (0.2 mL). A solution of 
PhCF3 (0.20 M; 0.50 mL, 0.10 mmol; 1.0 equiv) in CDCl3 was added to the vial as an 
internal standard, and the reaction mixture was analyzed by 19F NMR spectroscopy. 
	 215 
When (3-bromobutyl)benzene was used as the electrophile, n-tetradecane (26 µL) was 
added to the vial as another internal standard, and the reaction mixture was also analyzed 
by GC. 
 
Study of the effect of TEMPO: 
Eq 3.8, without TEMPO: In a nitrogen-filled glovebox, NiCl2•glyme (2.2 mg, 
0.010 mmol), ligand L2 (3.3 mg, 0.011 mmol), and NaBr (10.3 mg, 0.10 mmol) were 
added to an oven-dried 4-mL vial equipped with a stir bar. DMA (0.25 mL) was added to 
the 4-mL vial, and the vial was closed with a PTFE septum cap. The mixture was stirred 
vigorously at r.t. for 25 min. Then, a solution of the alkyl electrophile in DMA (0.10 
mmol in 0.25 mL of DMA) was added to this solution. The resulting solution was 
allowed to stir at r.t. for 1 min. Next, a solution of the alkylzinc reagent (0.50 M; 0.24 
mL, 0.12 mmol; 1.2 equiv) was added in one portion. The mixture was stirred vigorously 
at r.t. for 2 min, and then the reaction was quenched with MeOH (0.2 mL). A solution of 
PhCF3 (0.20 M; 0.50 mL, 0.10 mmol; 1.0 equiv) in CDCl3 was added to the vial as an 
internal standard, and the reaction mixture was analyzed by 19F NMR spectroscopy. 
 
Eq 3.8, with TEMPO: In a nitrogen-filled glovebox, (3-bromo-4,4,4-
trifluorobutyl)benzene (26.7 mg, 0.10 mmol) and NaBr (10.3 mg, 0.10 mmol) were added 
to an oven-dried 4-mL vial equipped with a stir bar. DMA (0.25 mL) was added to this 
vial, and then a solution of TEMPO in DMA (0.15 M; 0.10 mL, 0.015 mmol; 0.15 equiv) 
and a solution of the alkylzinc reagent (0.50 M; 0.24 mL, 0.12 mmol; 1.2 equiv). 
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In a nitrogen-filled glove box, NiCl2•glyme (6.6 mg, 0.030 mmol) and ligand L2 
(9.9 mg, 0.033 mmol) were added to a second oven-dried 4-mL vial equipped with a stir 
bar. DMA (0.75 mL) was added to this vial, and the vial was closed with a PTFE septum 
cap. The mixture was vigorously stirred at r.t. for 25 min. Next, 0.25 mL of this catalyst 
stock solution was added to the 4-mL reaction vial in one portion. The resulting mixture 
was stirred vigorously at r.t. for 2 min, and then the reaction was quenched with MeOH 
(0.2 mL). A solution of PhCF3 (0.20 M; 0.50 mL, 0.10 mmol; 1.0 equiv) in CDCl3 was 
added to the vial as an internal standard, and the reaction mixture was analyzed by 19F 
NMR spectroscopy. 
 
Eq 3.9: In a nitrogen-filled glovebox, (3-bromo-4,4,4-trifluorobutyl)benzene 
(26.7 mg, 0.10 mmol) and NaBr (10.3 mg, 0.10 mmol) were added to an oven-dried 4-
mL vial equipped with a stir bar. DMA (0.25 mL) was added to this vial, and then a 
solution of TEMPO in DMA (0.15 M; 0.10 mL, 0.015 mmol; 0.15 equiv) and a solution 
of the alkylzinc reagent (0.50 M; 0.24 mL, 0.12 mmol; 1.2 equiv). 
In a nitrogen-filled glove box, NiCl2•glyme (6.6 mg, 0.030 mmol) and ligand L2 
(9.9 mg, 0.033 mmol) were added to a second oven-dried 4-mL vial equipped with a stir 
bar. DMA (0.75 mL) was added to this vial, and the vial was closed with a PTFE septum 
cap. The mixture was vigorously stirred at r.t. for 25 min. Next, 0.25 mL of this catalyst 
stock solution was added to the 4-mL reaction vial in one portion. The resulting mixture 
was stirred vigorously at r.t. for 15 min, and then the reaction was quenched with MeOH 
(0.2 mL). A solution of PhCF3 (0.20 M; 0.50 mL, 0.10 mmol; 1.0 equiv) in CDCl3 was 
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added to the vial as an internal standard, and the reaction mixture was analyzed by 19F 
NMR spectroscopy. 
 
F3C
O
Ph
N
Me
Me
Me
Me
 
2,2,6,6-Tetramethyl-1-((1,1,1-trifluoro-4-phenylbutan-2-yl)oxy)piperidine (eq 
3.10; preparation of an authentic sample). The title compound was prepared according 
to the General Procedure A with (3-bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 
mmol) and an alkylzinc bromide reagent prepared from 1-bromononane, in the presence 
of TEMPO (94 mg, 0.40 mmol), NiCl2•glyme (88 mg, 0.40 mmol), and ligand L2 (133 
mg, 0.44 mmol). Solvent system for chromatography: hexane → 7:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil (98 mg, 71% 
yield). 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.28 (m, 2H), 7.24 – 7.19 (m, 3H), 4.32 – 
4.24 (m, 1H), 2.84 (ddd, 1H, J = 16.2, 11.4, 5.0 Hz), 2.75 (ddd, 1H, J = 14.0, 10.6, 6.5 
Hz), 2.49 – 2.40 (m, 1H), 2.07 – 1.97 (m, 1H), 1.67 – 1.40 (m, 5H), 1.37 – 1.28 (m, 1H), 
1.21 – 1.06 (m, 12H); 
13C NMR (126 MHz, CDCl3) δ 141.3, 128.44, 128.36, 126.0, 125.3 (q, J = 283.3 
Hz), 79.5 (q, J = 27.5 Hz), 61.1, 60.2, 40.5, 33.9, 33.4, 31.6 (d, J = 1.7 Hz), 29.8 (d, J = 
1.3 Hz), 20.3, 17.1; 
19F NMR (282 MHz, CDCl3) δ −73.3 (d, 3F, J = 6.9 Hz); 
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FT-IR (film) 2976, 2933, 2873, 1457, 1378, 1363, 1264, 1189, 1159, 1132, 1090, 
748, 698 cm-1; 
HRMS (ESI) m/z (M+H+) calcd for C19H29F3NO: 344.2201, found: 344.2194. 
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3.7.4 1H NMR Spectra of Selected Compounds 
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CHAPTER 4 
Nickel-Catalyzed Asymmetric Negishi Arylations of  
α-Halo-α-Trifluoromethyl Electrophiles+ 
 
 
4.1 Introduction 
In Chapter 3, we describe our effort towards the development of a Negishi 
alkylation method using trifluoromethyl-substituted secondary electrophiles. Although 
the new method is quite versatile and practical, the attempt to extend it into an 
enatioselective alkylation method did not yield very positive results. We were still quite 
interested in exploring the possibility of providing such an approach to the construction 
of tertiary stereocenters bearing a trifluoromethyl (CF3) group. Examples in the literature 
of catalytic enantioselective reactions that can generate this type of structures include the 
α-trifluoromethylation of aldehydes,1 the hydrogenation of CF3-containing olefins,2 the 
nucleophilic trifluoromethylation of allylic electrophiles,3 and the conjugate addition of 
CF3-substituted electron-poor alkenes.4 Many of these methods often require adjacent 
directing and/or activating groups (such as an aryl, alkenyl and carbonyl substituent) to 
achieve the bond formation and high levels of enantioselectivity. Therefore, the 
development of a general strategy without the need of pre-installed functional groups 
could complement existing methods. Our desired nickel-catalyzed cross-couplings of α-
halo-α-trifluoromethyl electrophiles can be considered as a promising candidate to 																																																								
+ Portions of this chapter have appeared in the previous publication and the supporting 
information found therein: Liang, Y.; Fu, G. C. J. Am. Chem. Soc. 2015, 137, 9523–9526. 
Copyright 2015 American Chemical Society.  
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achieve these goals. If a chiral catalyst can distinguish a trifluoromethyl (CF3) group and 
an alkyl group effectively, high enantioselectivity can be obtained without the help from 
adjacent functional groups. 
 Our group has already reported a series of enantioselective arylation methods 
employing a variety of secondary alkyl electrophiles (Scheme 4.1a). One common feature 
of these reactions is that a halogen atom and an electron-withdrawing group are 
connected to the same carbon. Although the detailed conditions for each family of 
electrophiles may vary, to date, we have shown that secondary electrophiles including α-
haloesters,5 α-haloketones,6 α-halonitriles,7 α-halosulfones8 and α-halosulfonamides8 can 
all be suitable cross-coupling partners for enantioselective arylations. Considering the 
electron-withdrawing nature of a CF3 group, it might be possible to achieve asymmetric 
arylations with α-halo-α-trifluoromethyl electrophiles when suitable catalysts are chosen 
(Scheme 4.1b). Therefore, this new method will provide a unique approach for the 
generation of tertiary trifluoromethyl-substituted stereocenters and at the same time 
expand the territory our nickel-catalyzed cross-coupling chemistry. 
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Scheme 4.1. Design of the Project 
Ar M
racemic
alkylEWG
X chiral nickel catalyst
alkylEWG
Ar
M: Zn, Mg, B, Si
NC alkyl
X
S alkyl
X
N
O O
R
R1
S alkyl
X
R
O O
alkyl
X
R
O
alkyl
X
RO
O
a. Previous studies:
b. This study:
Ar M
racemic
alkylF3C
X chiral nickel catalyst
alkylF3C
Ar
enantioenriched
enantioenriched  
 
4.2 Optimization 
 We decided to start this study by examining arylzinc reagents as the nucleophiles 
and quickly identified a very promising result. In the presence of a commercially 
available bis(oxazoline) ligand L3, the Negishi arylation reaction provides the product in 
good yield and excellent enantioselectivity (eq 4.1).  
10% NiCl2  •  glyme
13% (S,S)–L3
THF, −20 °CF3C
Br
Ph
2.0 equiv
F3C
Ph
Ph
O
N N
O
MeMe
Ph Ph
Ph ZnCl
(S,S)-L3
racemic 84% yield
95% ee
(4.1)
 
 Further optimization based on this promising result led to a more general and 
practical condition (Table 4.1, entry 1). The impact of various reaction parameters on the 
outcome of this method is shown in Table 4.1. 
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Table 4.1. Effect of Parametersa 
entry variation from the "standard" conditions ee (%) yield (%)b
1
2
3
4
5
6
7
8
none
no NiCl2 •  glyme
no (S,S)-L3
1.1 equiv Ph−ZnCl
3.0% NiCl2 •  glyme, 3.9% (S,S)-1
THF only
r.t., instead of −20 °C
0.1 equiv H2O added
aAll data are the average of two experiments. bThe yields were determined through 
analysis by 19F NMR spectroscopy with the aid of an internal standard.
95
–
–
95
94
95
86
95
89
<2
3
78
72
82
15
88
6% NiCl2  •  glyme
7.8% (S,S)–L3
THF/diglyme
−20 °C
"standard" conditions
F3C
Br
Ph
1.5 equiv
F3C
Ph
Ph
Ph ZnCl
racemic
 
 
 Both the nickel source and the chiral ligand L3 are important for this 
transformation (entries 2 and 3). When less amount of nucleophile or catalyst is 
employed, the product is generated in decreased yield but the enantioselectivity still 
maintained (entries 4 and 5). Diglyme serves as a co-solvent to increase the efficiency of 
the reaction (entry 6). At room temperature, the efficiency and stereoselectivity drop 
significantly (entry 7). Finally, the reaction condition is not sensitive to a small amount of 
water (entry 8).  
 A number of structurally related or previously employed chiral ligands have been 
surveyed under our optimized conditions and the results are displayed in Scheme 4.2. All 
of these ligands provide the product in lower yields and ee values. From a practical 
perspective, both enantiomers of ligand L3 are commercially available. 
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Scheme 4.2. Effect of Ligands 
NO
N N
O
i-Pr i-Pr
<2% yield
O
N N
O
Ph Ph
NH
PhPh
HNMe Me
O
N N
O
i-Pr i-Pr
Me Me
26% yield
33% ee
27% yield
40% ee
4% yield
11% ee
O
N N
O
MeMe
Ph Ph
(S,S)–L3
89% yield
95% ee
6% NiCl2  •  glyme
7.8% ligand
THF/diglyme
−20 °C
F3C
Br
Ph
1.5 equiv
F3C
Ph
Ph
Ph ZnCl
racemic
 
 
 Additionally, similar to the trend we observed for the project described in Chapter 
2, the nucleophilic arylating reagent also plays a very crucial role in this transformation 
(Scheme 4.3). Arylzinc reagents that are derived from aryllithium nucleophiles give the 
best results. However, arylzinc reagents prepared from aryl Grignard reagents and aryl 
Grignard reagents themselves can also be employed to deliver the cross-coupling 
products in good enantioselectivity with moderate yields. 
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Scheme 4.3. Effect of Nucleophiles 
Ph ZnCl
from Ph–Li + ZnCl2
89% yield
95% ee
Ph ZnCl
from Ph–MgBr + ZnCl2
79% yield
95% ee
Ph MgCl
57% yield
95% ee
<2% yield
6% NiCl2  •  glyme
7.8% (S,S)–L3
THF/diglyme
−20 °C
F3C
Br
Ph
1.5 equiv
F3C
Ph
Ph
nucleophile
racemic
Ph Li
 
 
4.3 Scope 
 With the optimized conditions in hand, we decided to explore the scope of this 
new method. As shown in Table 4.2, a variety of ortho-, meta- and para-substituted 
arylzinc reagents are compatible nucleophilic cross-coupling partners. Both electron-rich 
and electron-poor nucleophiles can generate the products in good yields and 
enantioselectivity. Functional groups such as an aryl ether (entries 1 and 2), an aryl halide 
(entries 5, 6, 10, and 11), an aryl thioether (entry 9) can all be tolerated. 
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Table 4.2. Scope with Respect to the Nucleophilea 
6% NiCl2  •  glyme
7.8% (S,S)–L3
THF/diglyme
−20 °C
F3C
Br
Ph
1.5 equiv
F3C
Ar
Ph
Ar ZnCl
racemic
entry Ar ee (%) yield (%)b
aAll data are the average of two experiments. bYield of purified product.
cReaction temperature: –15 ºC.
X
X = H
Me
SMe
F
Br
95
95
94
96
95
2
3
4c
5c
6c
86
89
52
84
87
X
X = OMe
Me
CF3
F
Cl
96
95
97
96
96
90
90
87
79
86
7
8
9
10c
11c
OMe
87 501
 
 
 Arylzinc reagents with an oxygen heterocycle and a nitrogen heterocycle are also 
feasible nucleophiles for this transformation (eqs 4.2 and 4.3). 
6% NiCl2  •  glyme
7.8% (S,S)–L3
THF/diglyme
−20 °C
F3C
Br
Ph
1.5 equiv F3C Phracemic
O
ZnCl
O
60% yield
94% ee
(4.2)
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N
ZnCl
Me
F3C Ph
N
Me
68% yield
94% ee
6% NiCl2  •  glyme
7.8% (S,S)–L3
THF/diglyme
−20 °C
F3C
Br
Ph
racemic 1.5 equiv
(4.3)
 
 The scope with regard to the electrophilic cross-coupling partners is also fairly 
broad (Table 4.3). Synthetically useful functional groups including a silyl ether protecting 
group (entry 4), a primary alkyl chloride (entry 5), a primary alkyl bromide (entry 6), a 
primary alkyl tosylate (entry 7), an aromatic ketone (entry 8), an aryl iodide (entry 9), a 
carbamate (entry 10), and a furan-containing ester (entry 11) can all be compatible with 
our standard conditions. Also, the chiral catalyst can even effectively distinguish between 
a CF3 group and a CH3 group (entry 1) to provide the product in good stereoselectivity.9 
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Table 4.3. Scope with Respect to the Electrophilea 
entry R ee (%) yield (%)b
aAll data are the average of two experiments. bYield of purified product.
Cl
Br
OTs
OTBDPS
O
O
O
O
95 88
96 89
96 80
97 91
94 77
96 81
95 60
96 81
97 82
2
5
6
7
4
11
9
3
10 N
Boc
O
96 898 O
Me
1 Me 91 81
I
n-Oct
MeO ZnCl
6% NiCl2  •  glyme
7.8% (S,S)–L3
THF/diglyme
−20 °C
F3C
Br
R
1.5 equiv F3C Rracemic
OMe
 
 
 Although we initially optimized the reactions using alkyl bromides as substrates, 
we are delighted to observe that an alkyl iodide can also be a suitable electrophile for this 
new method (eq 4.4). 
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1.5 equivracemic
F3C
I
F3C
OMe
Ph
Ph
94% yield
96% ee
(4.4)
ZnClMeO
6% NiCl2  •  glyme
7.8% (S,S)–L3
THF/diglyme
−20 °C
 
 To demonstrate the scalability of this method, we performed a Negishi arylation 
reaction at a larger scale and the product was still generated in good yield and 
enantioselectivity (eq 4.5). Moreover, conducting the cross-coupling reaction in a closed 
vial under air led to similar efficiency (eq 4.6).  
1.5 equivracemic
5.0 mmol
F3C
Br
F3C
OMe
Ph
Ph
1.34 g
91% yield
96% ee
(4.5)
ZnClMeO
6% NiCl2  •  glyme
7.8% (S,S)–L3
THF/diglyme
−20 °C
 
1.5 equivracemic
F3C
Br
F3C
OMe
Ph
Ph
87% yield
96% ee
(4.6)
ZnClMeO
6% NiCl2  •  glyme
7.8% (R,R)–L3
THF/diglyme
−20 °C
In a capped vial under air
 
 This method is not without limitations. Figure 4.1 summarizes a few electrophiles 
and nucleophiles that are not suitable cross-coupling partners under our optimized 
conditions (Table 4.1, entry 1). 
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F3C
Cl
Ph F3C
OTs
Ph
<5% yield <2% yield
Me
ZnCl
30% yield
96% ee
S ZnCl
<2% yield
S
<2% yield
ZnCl
ZnCl
<15% yield
ZnCl
<15% yield
Me
F3C
Br
<2% yield
F3C Ph
Br
<2% yield
F3C
OTf
Ph
<2% yield
 
Figure 4.1. Unsuccessful Electrophiles and Nucleophiles 
 
 Other features of this method are provided below: 
 A. During the course of these cross-couplings, no kinetic resolution of the 
electrophile (<5% ee) was observed. 
 B. The ee value stays constant in the course of the reaction.  
 C. The cross-coupling product is stable under our reaction system. No C–F bond 
cleavage has been observed. 
 D. Major side reaction of this method is the hydrodebromination of the 
electrophile. 
 
4.4 Scope of Other Fluorinated Electrophiles 
 This cross-coupling method can also be applied to substrates bearing an electron-
withdrawing group other than CF3. Electrophiles with a perfluoroalkyl group, a 
chlorodifluoromethyl group, a CF2COPh substituent and a CF2COOEt substituent can all 
undergo Negishi arylations to provide the products in good yield and excellent 
enantioselectivity (eqs 4.7, 4.8, 4.9, and 4.10). To the best of our knowledge, our method 
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serves as the first method for the asymmetric of tertiary stereocenters containing these 
fluoroalkyl groups.10 
n-C3F7 Ph
92% yield
99% ee
OMe
n-C3F7 Ph
Br MeO ZnCl
1.5 equiv
(4.7)
6% NiCl2  •  glyme
7.8% (S,S)–L3
THF/diglyme
−20 °Cracemic
 
ClF2C Ph
89% yield
96% ee
ClF2C Ph
Br
1.5 equiv
OMe
(4.8)MeO ZnCl
racemic
6% NiCl2  •  glyme
7.8% (S,S)–L3
THF/diglyme
−20 °C
 
Ph
Ph
81% yield
98% ee
Ph ZnCl
1.5 equiv F F
Ph
OBr
Ph
F F
Ph
O
(4.9)
racemic
6% NiCl2  •  glyme
7.8% (S,S)–L3
THF/diglyme
−20 °C
 
Ph
79% yield
98% ee
ZnCl
1.5 equiv F F
EtO
O
Br
Ph
F F
EtO
O
OMe
MeO
(4.10)
racemic
6% NiCl2  •  glyme
7.8% (S,S)–L3
THF/diglyme
−20 °C
 
 However, despite this success, our method still cannot be applied to any kinds of 
fluoroalkyl-containing electrophiles. A few unsuccessful cases are shown in Figure 4.2 
(see entry 1 of Table 4.1 for reaction condition). 
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HF2C
Br
Ph
52% yield
17% ee
Br
PhF3C
20% yield
17% ee
Br
PhEtOOCF COOEt
3% yield
Br
Ph
F F
<2% yield
Ph
 
Figure 4.2. Problematic Fluoroalkyl-Containing Electrophiles 
 
4.5 Conclusions 
 In summary, a highly enantioselective and versatile nickel-catalyzed Negishi 
arylation protocol has been developed employing α-halo-α-trifluoromethyl secondary 
electrophiles. This method not only provides a unique approach for the construction of 
tertiary CF3-containing stereocenters without the necessity to pre-install directing or 
activating groups, but also expands our asymmetric Negishi arylation system to 
previously unknown substrates. Additionally, the ability to apply these conditions directly 
to substrates bearing a variety of fluoroalkyl groups also makes it a valuable strategy for 
the synthesis of potentially interesting fluorine-containing chiral building blocks. 
 After our method was published in early 2015, Zhang and co-workers reported a 
nickel-catalyzed non-asymmetric reductive cross-coupling method using the same type of 
electrophiles that we developed and aryl halides.11 
 
4.6 Experimental Section 
4.6.1 General Information 
The following reagents were purchased and used as received: NiCl2•glyme 
(Strem), ligand (R,R)–L3 (Aldrich), ligand (S,S)–L3 (Aldrich), ZnCl2 (Aldrich; reagent 
grade, ≥98%), diglyme (Aldrich; anhydrous), n-BuLi (Aldrich; 2.5 M in hexanes). All 
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aryl bromides were purchased (Aldrich, Alfa Aesar, TCI, and Oakwood) and used as 
received. Anhydrous THF was purified and dried using a solvent-purification system that 
contained activated alumina. 
All reactions were carried out in oven-dried glassware under an inert atmosphere. 
HPLC analyses were carried out on an Agilent 1100 Series system, using Daicel 
CHIRALCEL® columns or Daicel CHIRALPAK® columns (internal diameter 4.6 mm, 
column length 250 mm, particle size 5 µm). 
1H NMR data and 13C NMR data were collected on a Varian 500 MHz 
spectrometer at ambient temperature. 19F NMR data were collected on a Varian 300 MHz 
spectrometer at ambient temperature. 
 
4.6.2 Preparation of Electrophiles 
These procedures have not been optimized. 
RF N
O
Me
RF R
O
RF R
OHNaBH4
RF R
BrP(OPh)3, NBSR–MgBrOMe
 
General Procedure A 
Preparation of the ketone using a Grignard reagent. A solution of the 
Grignard reagent in THF (1.0 M, 40 mmol; 1.0 equiv) was added by syringe to a solution 
of the Weinreb amide12 (40 mmol) in THF (20 mL) at 0 °C. The reaction mixture was 
stirred at 0 °C for 15 min, and then it was allowed to warm to r.t. and stirred for 15 h.  
Next, water was added to quench the reaction at 0 °C. A solution of 1 N HCl (50 mL) 
was added, and then the mixture was extracted with CH2Cl2 (3 × 50 mL). The organic 
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layers were combined, dried over Na2SO4, and concentrated. The crude product was 
purified by flash chromatography on silica gel. 
Reduction of the ketone to the alcohol. NaBH4 (2.3 g, 60 mmol; 3.0 equiv) was 
added in portions to a solution of the ketone (20 mmol) in Et2O (20 mL) and MeOH (20 
mL) at 0 °C (CAUTION: very exothermic). After the addition was complete, the mixture 
was stirred at 0 °C for 30 min, and then it was allowed to warm to r.t. and stirred for 30 
min. Next, Et2O (30 mL) was added to dilute the reaction mixture, the mixture was 
cooled to 0 °C, and then deionized water (30 mL) was added to quench the reaction. The 
mixture was extracted with CH2Cl2 (3 × 50 mL), and the combined organic layers were 
dried over Na2SO4 and concentrated. The crude product was purified by flash 
chromatography on silica gel. 
Bromination of the alcohol.13 Triphenylphosphite (4.0 g, 3.4 mL; 1.3 equiv) was 
added over 5 min to a solution of N-bromosuccinimide (2.3 g, 13 mmol; 1.3 equiv) in 
CH2Cl2 (10 mL) at 0 °C (CAUTION: exothermic). Next, a solution of the alcohol (10 
mmol) in CH2Cl2 (12 mL) was added to the mixture at 0 °C. The reaction mixture was 
heated to 40 °C and then stirred at 40 °C for 12 h. Next, the solvent was evaporated, and 
the product was purified by flash chromatography on silica gel. 
 
HO R O R F3C R
OH
F3C R
BrDMSO, (COCl)2
1. TMSCF3, 
     cat. TBAF
2. HCl
P(OPh)3, NBS
Et3N  
General Procedure B 
Swern oxidation of the alcohol. DMSO (2.9 mL, 40 mmol; 2.0 equiv) was added 
slowly to a solution of oxalyl chloride (2.0 mL, 24 mmol; 1.2 equiv) in CH2Cl2 (150 mL) 
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at −78 °C. The resulting mixture was allowed to stir at −78 °C for 30 min. Next, a 
solution of the alcohol (20 mmol) in CH2Cl2 (30 mL) was added over 5 min to the 
mixture. The resulting mixture was stirred at −78 °C for 45 min, and then NEt3 (11 mL, 
80 mmol; 4.0 equiv) was added in one portion. The mixture was allowed to warm to r.t., 
and then it was stirred at r.t. for 2 h. Next, an aqueous saturated solution of NH4Cl (30 
mL) was added to quench the reaction. The resulting mixture was extracted with CH2Cl2 
(3 × 70 mL), and the combined organic layers were dried over Na2SO4 and concentrated.  
The crude product was purified by flash chromatography on silica gel. 
Trifluoromethylation of the aldehyde.14 A solution of TBAF (1.0 M in THF; 
0.20 mL, 0.20 mmol; 0.013 equiv) was added over 3 min to a solution of the aldehyde 
(15 mmol) and trifluoromethyltrimethylsilane (2.7 mL, 18 mmol; 1.2 equiv) in THF (20 
mL) at 0 °C (CAUTION: very exothermic). The reaction mixture was allowed to warm to 
r.t., and it was stirred for 1 h. Next, an aqueous solution of 1 N HCl (30 mL) was added, 
and the mixture was allowed to stir at r.t. for another 2 h. Then, the mixture was extracted 
with CH2Cl2 (3 × 50 mL), and the combined organic layers were dried over Na2SO4 and 
concentrated. The crude product was purified by flash chromatography on silica gel. 
The bromination step is the same as in General Procedure A. 
 
HO R O R F3C R
OH
F3C R
BrDMSO, (COCl)2
1. TMSCF3, 
     cat. TBAF
2. HCl
PPh3, CBr4
Et3N  
General Procedure C 
The first two steps are the same as in General Procedure B. 
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Bromination of the alcohol.15 Triphenylphosphine (4.2 g, 16 mmol; 2.0 equiv) 
and tetrabromomethane (5.3 g, 16 mmol; 2.0 equiv) were added to a solution of the 
alcohol (8.0 mmol) in toluene (20 mL). The resulting mixture was heated to 110 °C and 
stirred at 110 °C for 3 h, at which time it had turned into a yellow suspension. Then, 
CH2Cl2 (50 mL) was added to the reaction mixture until it became a clear solution. The 
solvents were then evaporated, and the crude product was purified by flash 
chromatography on silica gel. 
 
PhF3C
Br
 
(3-Bromo-4,4,4-trifluorobutyl)benzene [136832-35-4]. The title compound was 
synthesized according to General Procedure A, using 2,2,2-trifluoro-N-methoxy-N-
methylacetamide and a Grignard reagent prepared from (2-bromoethyl)benzene. The 
overall yield was 34% (3 steps). The title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 7.37 – 7.32 (m, 2H), 7.29 – 7.22 (m, 3H), 4.03 – 
3.96 (m, 1H), 3.02 (ddd, 1H, J = 13.4, 8.3, 4.6 Hz), 2.81 – 2.75 (m, 1H), 2.40 – 2.33 (m, 
1H), 2.21 (dddd, 1H, J = 14.6, 11.0, 8.2, 4.6 Hz); 
13C NMR (126 MHz, CDCl3) δ 139.2, 128.8, 128.5, 126.7, 124.0 (q, J = 278.2 
Hz), 46.7 (q, J = 32.6 Hz), 32.9 (d, J = 1.4 Hz), 32.5; 
19F NMR (282 MHz, CDCl3) δ −72.1 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 3029, 1258, 1168, 1111, 750, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C10H1079BrF3: 266, found: 266, 268 (M++2). 
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MeF3C
Br
 
2-Bromo-1,1,1-trifluoropropane [421-46-5]. The title compound was 
synthesized from 1,1,1-trifluoropropan-2-ol according to a literature procedure16 in 68% 
yield (colorless oil; it should be stored in a refrigerator (~5 °C)). 
1H NMR (500 MHz, CDCl3) δ 4.21 (hept, 1H, J = 7.0 Hz), 1.81 (d, 3H, J = 7.0 
Hz); 
The NMR spectral data are in agreement with literature data.17 
 
F3C
Br
 
(2-Bromo-3,3,3-trifluoropropyl)cyclohexane. The title compound was 
synthesized according to General Procedure B, using 3-cyclohexyl-1,1,1-trifluoropropan-
2-ol, in 46% yield (colorless oil). 
1H NMR (500 MHz, CDCl3) δ 4.16 (dqd, 1H, J = 3.7, 7.1, 10.8 Hz), 1.88 – 1.65 
(m, 7H), 1.65 – 1.56 (m, 1H), 1.35 – 1.24 (m, 2H), 1.23 – 1.11 (m, 1H), 1.08 – 1.00 (m, 
1H), 0.87 – 0.79 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 124.3 (q, J = 277.8 Hz), 45.5 (q, J = 32.4 Hz), 
38.4, 34.5, 33.7, 31.0, 26.3, 26.1, 25.7; 
19F NMR (282 MHz, CDCl3) δ −72.5 (d, 3F, J = 7.0 Hz); 
FT-IR (film) 2925, 2854, 1450, 1314, 1291, 1271, 1258, 1180, 1157, 1128, 1109, 
681 cm-1; 
GC-MS (EI) m/z (M+) calcd for C9H1479BrF3: 258, found: 258, 260 (M++2). 
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F3C
Br
n-Oct  
2-Bromo-1,1,1-trifluorodecane [1349717-60-7]. The title compound was 
synthesized according to General Procedure A, using 2,2,2-trifluoro-N-methoxy-N-
methylacetamide and a Grignard reagent prepared from 1-bromooctane. The overall yield 
was 30% (3 steps). The title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 4.06 (dqd, 1H, J = 10.5, 7.2, 3.3 Hz), 2.02 (dddd, 
1H, J = 14.6, 9.8, 6.1, 3.3 Hz), 1.91 – 1.81 (m, 1H), 1.43 – 1.21 (m, 12H), 0.89 (t, 3H, J = 
7.2 Hz); 
13C NMR (126 MHz, CDCl3) δ 124.1 (q, J = 278.0 Hz), 47.7 (q, J = 32.3 Hz), 
31.8, 31.4 (d, J = 1.5 Hz), 29.23, 29.15, 28.6, 26.8, 22.6, 14.1; 
19F NMR (282 MHz, CDCl3) δ −72.4 (d, 3F, J = 7.2 Hz); 
FT-IR (film) 2956, 2928, 2857, 1266, 1173, 1124, 1105, 678 cm-1; 
GC-MS (EI) m/z (M+–C4H9) calcd for C6H979BrF3: 217, found: 217, 219 (M+–
C4H9+2). 
 
OTBDPSF3C
Br
 
((6-Bromo-7,7,7-trifluoroheptyl)oxy)(tert-butyl)diphenylsilane. The title 
compound was synthesized according to General Procedure B from 6-((tert-
butyldiphenylsilyl)oxy)hexan-1-ol.18 The overall yield was 23% (3 steps). The title 
compound was isolated as a colorless oil. 
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1H NMR (500 MHz, CDCl3) δ 7.70 – 7.66 (m, 4H), 7.46 – 7.37 (m, 6H), 4.04 
(dqd, 1H, J = 10.5, 7.2, 3.4 Hz), 3.69 (t, 2H, J = 6.3 Hz), 2.02 (dddd, 1H, J = 14.4, 9.8, 
5.6, 3.3 Hz), 1.90 – 1.81 (m, 1H), 1.69 – 1.54 (m, 3H), 1.49 – 1.35 (m, 3H), 1.07 (s, 9H); 
13C NMR (126 MHz, CDCl3) δ 135.6, 134.0, 129.6, 127.6, 124.1 (q, J = 278.2 
Hz), 63.5, 47.6 (q, J = 32.4 Hz), 32.1, 31.4 (d, J = 1.4 Hz), 26.9, 26.5, 24.9, 19.2; 
19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 2932, 2858, 1428, 1259, 1171, 1113, 823, 701 cm-1; 
GC-MS (EI) m/z (M+–C4H9) calcd for C19H2179BrF3OSi: 429, found: 429. 
 
ClF3C
Br
 
2-Bromo-6-chloro-1,1,1-trifluorohexane. The title compound was synthesized 
according to General Procedure B from using 6-chloro-1,1,1-trifluorohexan-2-ol. The 
overall yield was 44% yield (3 steps). The title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 4.08 (dqd, 1H, J = 3.3, 7.1, 10.5 Hz), 3.58 – 3.55 
(m, 2H), 2.11 – 2.04 (m, 1H), 1.94 – 1.78 (m, 4H), 1.66 – 1.57 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 123.9 (q, J = 278.1 Hz), 47.2 (q, J = 32.6 Hz), 
44.3, 31.5, 30.8 (d, J = 1.5 Hz), 24.3; 
19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 2957, 1330, 1259, 1167, 1111, 677 cm-1; 
GC-MS (EI) m/z (M+−HBr) calcd for C6H8ClF3: 172, found: 172. 
 
BrF3C
Br
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2,10-Dibromo-1,1,1-trifluorodecane. The title compound was synthesized 
according to General Procedure B from 9-bromononan-1-ol. The overall yield was 50% 
(3 steps). The title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 4.06 (dqd, 1H, J = 10.5, 7.1, 3.3 Hz), 3.41 (t, 2H, J 
= 6.8 Hz), 2.02 (dddd, 1H, J = 14.5, 9.8, 6.1, 3.3 Hz), 1.89 – 1.82 (m, 3H), 1.47 – 1.28 
(m, 10H); 
13C NMR (126 MHz, CDCl3) δ 124.0 (q, J = 278.2 Hz), 47.7 (q, J = 32.4 Hz), 
33.9, 32.7, 31.3 (d, J = 1.5 Hz), 29.0, 28.56, 28.48, 28.0, 26.7; 
19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 2931, 2857, 1267, 1169, 1110, 677 cm-1; 
GC-MS (EI) m/z (M+–C3H6Br) calcd for C7H1179BrF3: 231, found: 231, 233 (M+–
C3H6Br+2). 
 
OTsF3C
Br
 
6-Bromo-7,7,7-trifluoroheptyl 4-methylbenzenesulfonate. The title compound 
was synthesized according to General Procedure B from 6-hydroxyhexyl 4-
methylbenzenesulfonate.19 The overall yield was 52% (3 steps). The title compound was 
isolated as a colorless oil. 
1H NMR (500 MHz, CD3COCD3) δ 7.83 – 7.79 (m, 2H), 7.51 – 7.46 (m, 2H), 
4.55 (dqd, 1H, J = 10.7, 7.4, 3.3 Hz), 4.07 (t, 2H, J = 6.3 Hz), 2.46 (s, 3H), 2.04 – 1.99 
(m, 1H), 1.85 – 1.76 (m, 1H), 1.73 – 1.55 (m, 3H), 1.52 – 1.30 (m, 3H); 
13C NMR (126 MHz, CD3COCD3) δ 145.9, 134.5, 131.0, 128.8, 125.5 (q, J = 
277.2 Hz), 71.4, 48.4 (q, J = 32.0 Hz), 32.0 (d, J = 1.6 Hz), 29.3, 26.9, 25.2, 21.6; 
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19F NMR (282 MHz, CD3COCD3) δ −72.9 (d, 3F, J = 7.4 Hz); 
FT-IR (film) 2948, 1598, 1359, 1189, 1176, 1117, 1098, 951, 815, 664 cm-1; 
GC-MS (EI) m/z (M+–OTs) calcd for C7H1179BrF3: 231, found: 231, 233 (M+–
OTs+2). 
 
O
O
Me
F3C
Br
 
1-(4-((6-Bromo-7,7,7-trifluoroheptyl)oxy)phenyl)ethan-1-one. The title 
compound was synthesized according to General Procedure C from 1-(4-((6-
hydroxyhexyl)oxy)phenyl)ethan-1-one.20 The overall yield was 57% (3 steps). The title 
compound was isolated as a light-yellow oil (it should be stored in a refrigerator (~5 °C)). 
1H NMR (500 MHz, CDCl3) δ 7.94 – 7.90 (m, 2H), 6.93 – 6.89 (m, 2H), 4.12 – 
4.05 (m, 1H), 4.03 (t, 2H, J = 6.3 Hz), 2.55 (s, 3H), 2.07 (dddd, 1H, J = 14.4, 10.1, 5.6, 
3.4 Hz), 1.94 – 1.80 (m, 3H), 1.78 – 1.68 (m, 1H), 1.62 – 1.47 (m, 3H); 
13C NMR (126 MHz, CDCl3) δ 196.7, 162.9, 130.6, 130.2, 124.0 (q, J = 278.2 
Hz), 114.0, 67.8, 47.4 (q, J = 32.4 Hz), 31.3 (d, J = 1.4 Hz), 28.7, 26.5, 26.3, 25.2; 
19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 2946, 2867, 1676, 1602, 1576, 1509, 1358, 1257, 1172, 1117, 834 
cm-1; 
GC-MS (EI) m/z (M+–CH3) calcd for C14H1579BrF3O2: 351, found: 351, 353 (M+–
CH3+2). 
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Br
I
F3C
 
1-((6-Bromo-7,7,7-trifluoroheptyl)oxy)-4-iodobenzene. The title compound 
was synthesized according to General Procedure B from 6-(4-iodophenoxy)hexan-1-ol.21 
The overall yield was 33% (3 steps). The title compound was isolated as a colorless oil (it 
should be stored in a refrigerator (~5 °C)). 
1H NMR (500 MHz, CDCl3) δ 7.57 – 7.52 (m, 2H), 6.69 – 6.65 (m, 2H), 4.08 
(dqd, 1H, J = 10.5, 7.1, 3.4 Hz), 3.93 (t, 2H, J = 6.3 Hz), 2.07 (dddd, 1H, J = 14.3, 9.9, 
5.5, 3.4 Hz), 1.95 – 1.86 (m, 1H), 1.85 – 1.68 (m, 3H), 1.60 – 1.46 (m, 3H); 
13C NMR (126 MHz, CDCl3) δ 158.8, 138.2, 124.0 (q, J = 278.2 Hz), 116.9, 82.6, 
67.6, 47.5 (q, J = 32.5 Hz), 31.3 (d, J = 1.4 Hz), 28.8, 26.6, 25.2; 
19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 2944, 1587, 1487, 1473, 1283, 1245, 1175, 1117, 820 cm-1; 
GC-MS (EI) m/z (M+) calcd for C13H1579BrF3IO: 450, found: 450, 452 (M++2). 
 
F3C
Br N
Boc
 
tert-Butyl 4-(2-bromo-3,3,3-trifluoropropyl)piperidine-1-carboxylate. The 
title compound was synthesized according to General Procedure C from tert-butyl 4-(2-
hydroxyethyl)piperidine-1-carboxylate. The overall yield was 26% (3 steps). The title 
compound was isolated as a white solid. 
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1H NMR (500 MHz, CDCl3) δ 4.15 – 4.09 (m, 3H), 2.72 – 2.68 (m, 2H), 1.94 – 
1.85 (m, 1H), 1.85 – 1.72 (m, 2H), 1.68 – 1.63 (m, 2H), 1.44 (s, 9H), 1.23 (tdd, 1H, J = 
12.8, 11.0, 4.4 Hz), 1.03 (tdd, 1H, J = 12.7, 11.0, 4.5 Hz); 
13C NMR (126 MHz, CDCl3) δ 154.7, 124.1 (q, J = 278.1 Hz), 79.5, 44.8 (q, J = 
32.7 Hz), 37.6, 33.2, 32.4, 30.0, 28.4; 
19F NMR (282 MHz, CDCl3) δ −72.5 (d, 3F, J = 7.0 Hz); 
FT-IR (film) 2977, 2931, 2850, 1691, 1425, 1366, 1262, 1252, 1172, 1129, 1110, 
967, 685 cm-1; 
GC-MS (EI) m/z (M+–Boc) calcd for C8H1279BrF3N: 258, found: 258, 260 (M+–
Boc+2). 
 
O
O
OBr
F3C
 
6-Bromo-7,7,7-trifluoroheptyl furan-2-carboxylate. The title compound was 
synthesized according to General Procedure B from 6-hydroxyhexyl furan-2-
carboxylate.22 The overall yield was 62% (3 steps). The title compound was isolated as a 
light-yellow oil (it should be stored in a refrigerator (~5 °C)). 
1H NMR (500 MHz, CDCl3) δ 7.57 (dd, 1H, J = 1.8, 0.9 Hz), 7.17 (dd, 1H, J = 
3.5, 0.9 Hz), 6.51 (dd, 1H, J = 3.5, 1.7 Hz), 4.31 (t, 2H, J = 6.6 Hz), 4.07 (dqd, 1H, J = 
10.5, 7.1, 3.4 Hz), 2.05 (dddd, 1H, J = 14.7, 10.3, 5.6, 3.3 Hz), 1.93 – 1.84 (m, 1H), 1.82 
– 1.68 (m, 3H), 1.55 – 1.42 (m, 3H); 
13C NMR (126 MHz, CDCl3) δ 158.7, 146.3, 144.7, 124.0 (q, J = 278.1 Hz), 
117.8, 111.8, 64.6, 47.4 (q, J = 32.5 Hz), 31.3 (d, J = 1.5 Hz), 28.4, 26.5, 25.1; 
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19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.0 Hz); 
FT-IR (film) 2949, 2866, 1726, 1582, 1571, 1475, 1400, 1297, 1260, 1180, 1118, 
1014, 958, 885, 764, 677 cm-1; 
GC-MS (EI) m/z (M+) calcd for C12H1479BrF3O3: 342, found: 342, 344 (M++2). 
 
F3C
I
Ph  
(4,4,4-Trifluoro-3-iodobutyl)benzene. The title compound was synthesized 
according to General Procedure A, using 1,1,1-trifluoro-4-phenylbutan-2-ol, in 48% yield 
(colorless oil; it should be stored in a refrigerator (~5 °C)); N-iodosuccinimide, rather 
than N-bromosuccinimide, was used. 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.31 (m, 2H), 7.28 – 7.22 (m, 3H), 4.09 – 
4.00 (m, 1H), 3.00 (dt, 1H, J = 6.4, 13.4 Hz), 2.71 (dt, 1H, J = 8.2, 13.9 Hz), 2.23 – 2.16 
(m, 2H); 
13C NMR (126 MHz, CDCl3) δ 139.1, 128.8, 128.5, 126.7, 124.6 (q, J = 276.5 
Hz), 34.4, 34.2 (d, J = 1.6 Hz), 23.6 (q, J = 31.1 Hz); 
19F NMR (282 MHz, CDCl3) δ −68.8 (d, 3F, J = 8.0 Hz); 
FT-IR (film) 3028, 1455, 1257, 1161, 1094, 1075, 749 cm-1; 
GC-MS (EI) m/z (M+) calcd for C10H10F2I: 314, found: 314. 
 
n-C3F7
Br
Ph  
(3-Bromo-4,4,5,5,6,6,6-heptafluorohexyl)benzene. The title compound was 
synthesized according to General Procedure A, using 2,2,3,3,4,4,4-heptafluoro-N-
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methoxy-N-methylbutanamide and a Grignard reagent prepared from (2-
bromoethyl)benzene. The overall yield was 24% (3 steps). The title compound was 
isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.32 (m, 3H), 7.28 – 7.22 (m, 2H), 4.19 – 
4.08 (m, 1H), 3.06 (ddd, 1H, J = 13.3, 8.4, 4.4 Hz), 2.80 (dt, 1H, J = 13.9, 8.2 Hz), 2.43 – 
2.36 (m, 1H), 2.27 – 2.17 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 139.1, 128.8, 128.5, 126.7, 121.5 – 108.5 (m), 
46.5 (t, J = 24.5 Hz), 32.6, 32.3; 
19F NMR (282 MHz, CDCl3) δ −80.8 (t, 3F, J = 10.7 Hz), −109.2 – −115.5 (m, 
2F), –123.3 (dd, 2F, J = 20.0, 8.1 Hz); 
FT-IR (film) 3029, 2936, 1497, 1456, 1348, 1235, 1182, 1108, 964, 927, 750, 
724, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C12H1079BrF7: 366, found: 366, 368 (M++2). 
 
ClF2C
Br
Ph  
(3-Bromo-4-chloro-4,4-difluorobutyl)benzene. The title compound was 
synthesized according to General Procedure A, using 1-chloro-1,1-difluoro-4-
phenylbutan-2-ol, in 48% yield (colorless oil). 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.32 (m, 2H), 7.27 – 7.23 (m, 3H), 4.12 
(tdd, 1H, J = 2.6, 5.6, 11.1 Hz), 3.04 (ddd, 1H, J = 4.5, 8.3, 13.3 Hz), 2.78 (dt, 1H, J = 
8.3, 13.9 Hz), 2.50 – 2.43 (m, 1H), 2.22 (dddd, 1H, J = 4.4, 8.1, 11.0, 14.5 Hz); 
13C NMR (126 MHz, CDCl3) δ 139.3, 128.7, 128.5, 127.6 (dd, J = 292.5, 294.2 
Hz), 126.7, 53.7 (t, J = 27.0 Hz), 34.2, 32.6; 
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19F NMR (282 MHz, CDCl3) δ −53.7 (dd, 1F, J = 5.7, 162.3 Hz), −57.5 (dd, 1F, J 
= 11.1, 162.4 Hz); 
FT-IR (film) 3029, 2929, 1497, 1455, 1256, 1203, 1169, 1116, 1080, 1031, 947, 
751, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C10H1079BrClF2: 282, found: 282, 284 (M++2); 
 
Br
Ph
F F
Ph
O
 
3-Bromo-2,2-difluoro-1,5-diphenylpentan-1-one. The title compound was 
synthesized according to General Procedure B, using 2,2-difluoro-3-hydroxy-1,5-
diphenylpentan-1-one,23 in 44% yield (colorless oil). 
1H NMR (500 MHz, CDCl3) δ 8.07 – 8.05 (m, 2H), 7.67 – 7.64 (m, 1H), 7.52 – 
7.48 (m, 2H), 7.34 – 7.30 (m, 2H), 7.27 – 7.22 (m, 3H), 4.46 (dtd, 1H, J = 2.6, 11.1, 14.9 
Hz), 3.08 (ddd, 1H, J = 4.5, 8.7, 13.5 Hz), 2.80 (dt, 1H, J = 8.3, 13.9 Hz), 2.45 – 2.38 (m, 
1H), 2.30 – 2.22 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 188.3 (dd, J = 28.9, 30.6 Hz), 139.6, 134.4, 132.2 
(t, J = 2.3 Hz), 130.0 (dd, J = 2.7, 4.1 Hz), 128.7, 128.6, 128.5, 126.4, 116.1 (dd, J = 
256.9, 261.0 Hz), 49.6 (dd, J = 24.1, 26.9 Hz), 32.8, 32.2 (t, J = 2.2 Hz); 
19F NMR (282 MHz, CDCl3) δ −101.1 (dd, 1F, J = 11.1, 275.8 Hz), −105.7 (dd, 
1F, J = 14.9, 275.7 Hz); 
FT-IR (film) 3063, 3028, 2930, 1702, 1598, 1497, 1449, 1281, 1251, 1203, 1185, 
1046, 923, 898, 754, 717, 700, 687 cm-1; 
GC-MS (EI) m/z (M+−Br) calcd for C17H15F2O: 273, found: 273. 
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Br
PhEtO
F F
O
 
Ethyl 3-bromo-2,2-difluoro-5-phenylpentanoate. The title compound was 
synthesized according to General Procedure B, using ethyl 2,2-difluoro-3-hydroxy-5-
phenylpentanoate,24 in 87% yield (colorless oil). 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.31 (m, 2H), 7.26 – 7.21 (m, 3H), 4.35 (q, 
2H, J = 7.1 Hz), 4.23 – 4.15 (m, 1H), 3.03 (ddd, 1H, J = 4.6, 8.5, 13.5 Hz), 2.76 (dt, 1H, J 
= 8.3, 13.9 Hz), 2.36 – 2.29 (m, 1H), 2.20 (dddd, 1H, J = 4.6, 8.5, 11.1, 14.8 Hz), 1.34 (t, 
3H, J = 7.1 Hz); 
13C NMR (126 MHz, CDCl3) δ 162.2 (t, J = 32.3 Hz), 139.6, 128.7, 128.5, 126.5, 
113.5 (dd, J = 253.1, 258.0 Hz), 63.4, 49.2 (dd, J = 25.5, 28.0 Hz), 32.7, 31.9, 13.8; 
19F NMR (282 MHz, CDCl3) δ −105.1 (dd, 1F, J = 9.0, 255.8 Hz), −114.4 (dd, 
1F, J = 15.9, 255.8 Hz); 
FT-IR (film) 3028, 2984, 1776, 1760, 1497, 1455, 1373, 1311, 1251, 1218, 1102, 
1061, 753, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C13H1579BrF2O2: 320, found: 320, 322 (M++2).		 	 	 	 	 	 	 	 	  
4.6.3 Stereoconvergent Negishi Cross-Couplings 
General procedure for the preparation of a solution of the arylzinc reagent 
(0.30 M): ZnCl2 (Aldrich; reagent grade, ≥98%) was fused through drying with a heat 
gun under high vacuum for 20 min before use. n-BuLi (Aldrich; ~2.5 M in hexanes) was 
titrated using diphenylacetic acid, according to Kofron’s method.25 
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In the air, ZnCl2 (1.43 g, 10.5 mmol) was added quickly to an oven-dried 20 mL 
vial equipped with a stir bar. The vial was closed with a PTFE septum cap, and then it 
was evacuated and back-filled with nitrogen (three cycles). THF (6.0 mL) was added to 
the vial, and the resulting mixture was stirred vigorously until the ZnCl2 had completely 
dissolved. THF (0.5 mL) was then added, thereby providing a 1.50 M solution of ZnCl2. 
Next, an oven-dried 40 mL vial equipped with a stir bar was charged with the aryl 
bromide (9.00 mmol), and then it was closed with a PTFE septum cap. The vial was next 
evacuated and back-filled with nitrogen (three cycles), and then THF (6.5 mL) was added 
to this vial. The vial that contained the solution of the aryl bromide was cooled to −78 °C. 
A solution of n-BuLi in hexanes (2.57 M; 3.50 mL, 9.00 mmol; 1.00 equiv) was added 
over ~4 min to the solution of the aryl bromide. After the addition was complete, the 
resulting mixture was stirred at −78 °C for 7 min. Next, the solution of ZnCl2 (1.50 M; 
6.00 mL, 9.00 mmol; 1.00 equiv) was added to the vial. The resulting mixture was 
allowed to warm to r.t., and then it was stirred for 45 min at r.t. The solution of the 
arylzinc reagent was titrated using I2, according to Knochel’s method26 (the concentration 
was typically ~0.4 M). This solution was then diluted to a 0.30 M solution using THF. 
These solutions of organozinc reagents can be stored at r.t. under an inert 
atmosphere for several weeks without deterioration. 
 
General Procedure for stereoconvergent Negishi arylations: In the air, an 
oven-dried 20 mL vial equipped with a stir bar was charged with the electrophile (1.00 
mmol). The vial was closed with a PTFE septum cap, and then it was evacuated and 
back-filled with nitrogen (three cycles). In the air, NiCl2⋅glyme (13.2 mg, 0.060 mmol) 
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and (R,R)–L3 (26.1 mg, 0.078 mmol) were added to an oven-dried 4 mL vial equipped 
with a stir bar. The vial was closed with a PTFE septum cap, and then it was evacuated 
and back-filled with nitrogen (three cycles). Diglyme (1.5 mL) was added to the vial, and 
the mixture was vigorously stirred at r.t. for 30 min. The resulting solution was 
transferred via syringe to the 20 mL reaction vial that contained the electrophile. The 4 
mL vial was rinsed with THF three times (0.8 mL, 0.8 mL, and 0.7 mL), and the 
washings were transferred to the reaction vial. The resulting solution was stirred at r.t. for 
3 min. Then, the joint of the reaction vial was wrapped with electrical tape, and the vial 
was cooled to −20 °C. Meanwhile, an oven-dried 40 mL vial that contained the solution 
of the arylzinc reagent was also cooled to −20 °C. Nitrogen-filled balloons were attached 
to both of the vials. To the vigorously stirred solution of catalyst and electrophile was 
added the solution of the arylzinc reagent (0.30 M; 5.0 mL, 1.5 mmol; 1.5 equiv) over 3 
min, leading to an orange reaction mixture. The balloon was removed, and the puncture 
hole in the septum cap was covered with grease. The mixture was stirred vigorously at 
−20 °C for 14 h, and then the reaction was quenched by the addition of MeOH (2 mL). 
The resulting mixture was allowed to warm to r.t., and then it was diluted with Et2O (100 
mL) and washed with deionized water (20 mL × 4). The organic layer was dried over 
Na2SO4, filtered, and then concentrated, and the residue was purified by flash 
chromatography. 
A second run was performed with (S,S)–L3. 	
PhF3C
OMe
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(R)-1-Methoxy-2-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 4.2, 
Entry 1). (3-Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc 
chloride reagent prepared from 1-bromo-2-methoxybenzene were used. The reaction was 
run at −20 °C for 40 h. Solvent system for chromatography: 15:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 150 mg (51% yield, 88% ee); Run 2, 140 mg (48% yield, 86% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (R,R)-L3: 15.5 min (minor), 16.4 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.41 – 7.39 (m, 1H), 7.33 (ddd, 1H, J = 1.7, 7.4, 
8.2 Hz), 7.30 – 7.26 (m, 2H), 7.22 – 7.18 (m, 1H), 7.11 – 7.09 (m, 2H), 7.03 (td, 1H, J = 
1.1, 7.5 Hz), 6.95 (dd, 1H, J = 1.1, 8.3 Hz), 4.08 (dqd, 1H, J = 4.2, 9.7, 11.2 Hz), 3.82 (s, 
3H), 2.57 – 2.44 (m, 2H), 2.33 (dddd, 1H, J = 4.2, 7.1, 9.8, 13.4 Hz), 2.18 (dddd, 1H, J = 
5.1, 9.5, 11.0, 13.5 Hz); 
13C NMR (126 MHz, CDCl3) δ 158.0, 141.1, 129.0, 128.4, 128.3, 128.2, 127.2 (q, 
J = 280.9 Hz), 126.0, 123.1, 120.8, 110.9, 55.6, 39.8 (q, J = 27.2 Hz), 32.6, 30.4 (d, J = 
2.5 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.5 (d, 3F, J = 9.6 Hz); 
FT-IR (film) 2941, 1603, 1496, 1464, 1246, 1148, 1118, 1030, 753, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H17F3O: 294, found: 294; 
[α]25D = +12° (c = 1.01, CHCl3); 86% ee, from (S,S)-L3. 
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(R)-1-Methoxy-3-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 4.2, 
Entry 2). (3-Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc 
chloride reagent prepared from 1-bromo-3-methoxybenzene were used. Solvent system 
for chromatography: 5:1 → 4:1 hexane/dichloromethane. The title compound was 
isolated as a colorless oil. 
Run 1, 268 mg (91% yield, 96% ee); Run 2, 260 mg (88% yield, 96% ee). 
This compound was also prepared on a 5.00 mmol scale (eq 4.5), using (3-bromo-
4,4,4-trifluorobutyl)benzene (1.34 g, 5.00 mmol) and an arylzinc chloride reagent 
prepared from 1-bromo-3-methoxybenzene (0.30 M; 25 mL, 7.5 mmol; 1.5 equiv). 
Following the General Procedure, the title compound was isolated in 91% yield (1.34 g) 
and 96% ee. 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (S,S)-L3: 20.4 min (minor), 32.2 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.27 (m, 3H), 7.24 – 7.20 (m, 1H), 7.13 – 
7.10 (m, 2H), 6.93 – 6.89 (m, 2H), 6.87 – 6.84 (m, 1H), 3.84 (s, 3H), 3.21 (dqd, 1H, J = 
3.9, 9.3, 11.1 Hz), 2.61 (ddd, 1H, J = 4.9, 9.1, 13.9 Hz), 2.44 (ddd, 1H, J = 7.8, 8.9, 13.8 
Hz), 2.34 (dddd, 1H, J = 3.9, 7.7, 9.1, 13.2 Hz), 2.21 (dddd, 1H, J = 4.9, 9.0, 11.2, 13.8 
Hz); 
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13C NMR (126 MHz, CDCl3) δ 159.8, 140.6, 135.9 (d, J = 2.0 Hz), 129.7, 128.5, 
128.4, 126.9 (q, J = 280.6 Hz), 126.2, 121.5, 115.2, 113.3, 55.2, 49.2 (q, J = 26.5 Hz), 
32.5, 30.2 (d, J = 2.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.6 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 3028, 2956, 1603, 1586, 1496, 1454, 1258, 1157, 1110, 1044, 781, 
700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H17F3O: 294, found: 294; 
[α]25D = +48° (c = 0.97, CHCl3); 96% ee, from (R,R)-L3. 
 
PhF3C
Me
 
(R)-1-Methyl-3-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 4.2, Entry 
3). (3-Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride 
reagent prepared from 1-bromo-3-methylbenzene were used. Solvent system for 
chromatography: hexane. The title compound was isolated as a colorless oil. 
Run 1, 247 mg (89% yield, 95% ee); Run 2, 252 mg (91% yield, 95% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (S,S)-L3: 12.4 min (minor), 13.5 
min (major). 
1H NMR (500 MHz, CD3COCD3) δ 7.35 – 7.12 (m, 9H), 3.48 – 3.37 (m, 1H), 
2.58 – 2.44 (m, 2H), 2.37 (s, 3H), 2.35 – 2.21 (m, 2H); 
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13C NMR (126 MHz, CD3COCD3) δ 142.0, 139.3, 135.4 (d, J = 2.1 Hz), 130.9, 
129.9, 129.6, 129.4, 129.3, 128.4 (q, J = 279.9 Hz), 127.3, 127.1, 49.8 (q, J = 26.1 Hz), 
33.4, 31.1 (d, J = 2.2 Hz), 21.5; 
19F NMR (282 MHz, CD3COCD3) δ −70.2 (d, 3F, J = 9.7 Hz); 
FT-IR (film) 3028, 2955, 1496, 1454, 1259, 1171, 1147, 1110, 785, 708, 699 cm-
1; 
GC-MS (EI) m/z (M+) calcd for C17H17F3: 278, found: 278; 
[α]25D = −46° (c = 0.97, CHCl3); 95% ee, from (S,S)-L3. 
 
PhF3C
CF3
 
(R)-1-(1,1,1-Trifluoro-4-phenylbutan-2-yl)-3-(trifluoromethyl)benzene (Table 
4.2, Entry 4). (3-Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an 
arylzinc chloride reagent prepared from 1-bromo-3-(trifluoromethyl)benzene were used. 
The reaction was run at −15 °C for 14 h. Solvent system for chromatography: hexane. 
The title compound was isolated as a colorless oil. 
Run 1, 287 mg (86% yield, 96% ee); Run 2, 288 mg (87% yield, 97% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (S,S)-L3: 14.6 min (minor), 17.4 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.66 – 7.63 (m, 1H), 7.56 – 7.48 (m, 3H), 7.33 – 
7.27 (m, 2H), 7.26 – 7.20 (m, 1H), 7.10 – 7.05 (m, 2H), 3.30 (dqd, 1H, J = 3.6, 9.0, 10.8 
Hz), 2.65 – 2.56 (m, 1H), 2.47 – 2.36 (m, 2H), 2.30 – 2.20 (m, 1H); 
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13C NMR (126 MHz, CDCl3) δ 140.0, 135.5 (d, J = 2.2 Hz), 132.5, 131.2 (q, J = 
32.5 Hz), 129.3, 128.6, 128.3, 126.5 (q, J = 280.7 Hz), 126.4, 126.1 (q, J = 3.9 Hz), 125.2 
(q, J = 3.7 Hz), 123.9 (q, J = 271.4 Hz), 49.0 (q, J = 26.9 Hz), 32.4, 29.9 (d, J = 2.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −62.7 (s, 3F), −69.7 (d, 3F, J = 9.1 Hz); 
FT-IR (film) 3029, 2958, 1497, 1454, 1332, 1258, 1169, 1115, 1077, 802, 711, 
698 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H14F6: 332, found: 332; 
[α]25D = +42° (c = 0.98, CHCl3); 96% ee, from (R,R)-L3. 
 
PhF3C
F
 
(R)-1-Fluoro-3-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 4.2, Entry 
5). (3-Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride 
reagent prepared from 1-bromo-3-fluorobenzene were used. The reaction was run at −15 
°C for 14 h. Solvent system for chromatography: hexane. The title compound was 
isolated as a colorless oil. 
Run 1, 225 mg (80% yield, 96% ee); Run 2, 220 mg (78% yield, 96% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (S,S)-L3: 16.7 min (minor), 19.7 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.40 – 7.34 (m, 1H), 7.32 – 7.28 (m, 2H), 7.25 – 
7.20 (m, 1H), 7.13 – 7.01 (m, 5H), 3.29 – 3.17 (m, 1H), 2.61 (ddd, 1H, J = 4.9, 8.8, 13.5 
Hz), 2.47 – 2.32 (m, 2H), 2.20 (dddd, 1H, J = 4.9, 8.6, 11.2, 13.7 Hz); 
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13C NMR (126 MHz, CDCl3) δ 162.9 (d, J = 246.6 Hz), 140.2, 136.9 (m), 130.2 
(d, J = 8.3 Hz), 128.6, 128.4, 126.6 (q, J = 280.6 Hz), 126.3, 125.1 (d, J = 2.9 Hz), 116.0 
(d, J = 22.0 Hz), 115.3 (d, J = 21.0 Hz), 48.9 (qd, J = 1.9, 26.9 Hz), 32.4, 30.1 (d, J = 2.0 
Hz); 
19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.2 Hz), −112.4 (m, 1F); 
FT-IR (film) 3029, 2957, 1616, 1593, 1491, 1454, 1258, 1174, 1157, 1143, 1112, 
787, 709, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H14F4: 282, found: 282; 
[α]25D = +49° (c = 0.97, CHCl3); 96% ee, from (R,R)-L3. 
 
PhF3C
Cl
 
(R)-1-Chloro-3-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 4.2, Entry 
6). (3-Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride 
reagent prepared from 1-bromo-3-chlorobenzene were used. The reaction was run at −15 
°C for 14 h. Solvent system for chromatography: hexane. The title compound was 
isolated as a colorless oil. 
Run 1, 260 mg (87% yield, 96% ee); Run 2, 255 mg (85% yield, 96% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (S,S)-L3: 18.0 min (minor), 23.3 
min (major). 
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1H NMR (500 MHz, CDCl3) δ 7.38 – 7.28 (m, 5H), 7.25 – 7.17 (m, 2H), 7.12 – 
7.08 (m, 2H), 3.21 (dqd, 1H, J = 3.9, 9.2, 11.0 Hz), 2.61 (ddd, 1H, J = 4.9, 8.8, 13.5 Hz), 
2.47 – 2.32 (m, 2H), 2.20 (dddd, 1H, J = 4.9, 8.5, 11.1, 13.7 Hz); 
13C NMR (126 MHz, CDCl3) δ 140.2, 136.4 (d, J = 2.0 Hz), 134.7, 130.0, 129.3, 
128.6, 128.5, 128.3, 127.4, 126.6 (q, J = 280.7 Hz), 126.4, 48.9 (q, J = 26.9 Hz), 32.4, 
30.0 (d, J = 2.1 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.6 (d, 3F, J = 9.1 Hz); 
FT-IR (film) 3028, 2957, 1599, 1576, 1497, 1479, 1454, 1434, 1257, 1170, 1157, 
1113, 786, 713, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H14ClF3: 298, found: 298; 
[α]25D = +54° (c = 1.01, CHCl3); 96% ee, from (R,R)-L3. 
 
PhF3C
Ph
 
(R)-(4,4,4-Trifluorobutane-1,3-diyl)dibenzene (Table 4.2, Entry 7). (3-Bromo-
4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride reagent 
prepared from bromobenzene were used. Solvent system for chromatography: hexane. 
The title compound was isolated as a colorless oil. 
Run 1, 230 mg (87% yield, 95% ee); Run 2, 225 mg (85% yield, 95% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (S,S)-L3: 15.6 min (minor), 16.6 
min (major). 
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1H NMR (500 MHz, CDCl3) δ 7.44 – 7.36 (m, 3H), 7.34 – 7.28 (m, 4H), 7.25 – 
7.20 (m, 1H), 7.13 – 7.09 (m, 2H), 3.24 (dqd, 1H, J = 3.9, 9.4, 11.0 Hz), 2.61 (ddd, 1H, J 
= 4.9, 8.9, 13.6 Hz), 2.49 – 2.32 (m, 2H), 2.25 (dddd, 1H, J = 4.8, 8.7, 11.1, 13.8 Hz); 
13C NMR (126 MHz, CDCl3) δ 140.6, 134.4 (d, J = 2.0 Hz), 129.2, 128.7, 128.5, 
128.4, 128.2, 126.9 (q, J = 280.6 Hz), 126.2, 49.2 (q, J = 26.5 Hz), 32.5, 30.1 (d, J = 2.0 
Hz); 
19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 3030, 2956, 1496, 1455, 1258, 1148, 1109, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H15F3: 264, found: 264; 
[α]25D = −47° (c = 0.99, CHCl3); 95% ee, from (S,S)-L3. 
 
PhF3C
Me
 
(R)-1-Methyl-4-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 4.2, Entry 
8). (3-Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride 
reagent prepared from 1-bromo-4-methylbenzene were used. Solvent system for 
chromatography: hexane. The title compound was isolated as a colorless oil. 
Run 1, 246 mg (88% yield, 95% ee); Run 2, 250 mg (90% yield, 94% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (S,S)-L3: 12.1 min (minor), 13.1 
min (major). 
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1H NMR (500 MHz, CDCl3) δ 7.33 – 7.27 (m, 2H), 7.24 – 7.19 (m, 5H), 7.13 – 
7.10 (m, 2H), 3.20 (dqd, 1H, J = 3.9, 9.4, 11.2 Hz), 2.61 (ddd, 1H, J = 4.9, 9.1, 13.8 Hz), 
2.47 – 2.41 (m, 1H), 2.40 (s, 3H), 2.35 (dddd, 1H, J = 3.9, 7.7, 9.1, 13.2 Hz), 2.22 (dddd, 
1H, J = 4.9, 9.0, 11.2, 13.7 Hz); 
13C NMR (126 MHz, CDCl3) δ 140.7, 138.0, 131.3 (d, J = 2.0 Hz), 129.5, 129.0, 
128.5, 128.4, 127.0 (q, J = 280.5 Hz), 126.2, 48.7 (q, J = 26.5 Hz), 32.5, 30.1 (d, J = 2.1 
Hz), 21.2; 
19F NMR (282 MHz, CDCl3) δ −69.9 (d, 3F, J = 9.4 Hz); 
FT-IR (film) 3028, 2955, 1517, 1496, 1454, 1259, 1169, 1148, 1108, 814, 699 
cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H17F3: 278, found: 278; 
[α]25D = +52° (c = 0.99, CHCl3); 95% ee, from (R,R)-L3. 
 
PhF3C
SMe
 
(R)-Methyl(4-(1,1,1-trifluoro-4-phenylbutan-2-yl)phenyl)sulfane (Table 4.2, 
Entry 9). (3-Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc 
chloride reagent prepared from (4-bromophenyl)(methyl)sulfane were used. Solvent 
system for chromatography: 15:1 → 5:1 hexane/dichloromethane. The title compound 
was isolated as a colorless oil. 
Run 1, 162 mg (52% yield, 94% ee); Run 2, 160 mg (52% yield, 93% ee). 
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The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (R,R)-L3: 19.4 min (minor), 20.6 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.27 (m, 4H), 7.24 – 7.20 (m, 3H), 7.12 – 
7.07 (m, 2H), 3.23 – 3.14 (m, 1H), 2.60 (ddd, 1H, J = 4.9, 8.9, 13.7 Hz), 2.52 (s, 3H), 
2.46 – 2.29 (m, 2H), 2.20 (dddd, 1H, J = 4.8, 8.7, 11.2, 13.7 Hz); 
13C NMR (126 MHz, CDCl3) δ 140.5, 138.7, 131.0 (d, J = 2.3 Hz), 129.6, 128.5, 
128.4, 126.8 (q, J = 280.6 Hz), 126.6, 126.2, 48.6 (q, J = 26.6 Hz), 32.4, 30.0 (d, J = 2.1 
Hz), 15.5; 
19F NMR (282 MHz, CDCl3) δ −69.9 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 3027, 2922, 1601, 1496, 1256, 1169, 1149, 1109, 816, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H17F3S: 310, found: 310; 
[α]25D = +68° (c = 0.98, CHCl3); 94% ee, from (R,R)-L3. 
 
PhF3C
F
 
(R)-1-Fluoro-4-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 4.2, Entry 
10). (3-Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc 
chloride reagent prepared from 1-bromo-4-fluorobenzene were used. The reaction was 
run at −15 °C for 14 h. Solvent system for chromatography: hexane. The title compound 
was isolated as a colorless oil. 
Run 1, 235 mg (83% yield, 96% ee); Run 2, 241 mg (85% yield, 96% ee). 
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The ee was determined on an OD-H column (hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (R,R)-L3: 26.3 min (minor), 29.8 min 
(major). 
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.26 (m, 4H), 7.25 – 7.20 (m, 1H), 7.13 – 
7.07 (m, 4H), 3.22 (dqd, 1H, J = 3.7, 9.2, 11.0 Hz), 2.60 (ddd, 1H, J = 4.6, 8.0, 12.2 Hz), 
2.46 – 2.32 (m, 2H), 2.24 – 2.14 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 162.6 (d, J = 247.3 Hz), 140.3, 130.8 (d, J = 8.0 
Hz), 130.1 (d, J = 1.7 Hz), 128.5, 128.4, 126.7 (q, J = 280.4 Hz), 126.3, 115.7 (d, J = 
21.5 Hz), 48.4 (q, J = 26.8 Hz), 32.4, 30.1 (d, J = 2.1 Hz); 
19F NMR (282 MHz, CDCl3) δ −70.0 (d, 3F, J = 9.2 Hz), −113.9 (m, 1F); 
FT-IR (film) 3028, 2956, 1609, 1513, 1497, 1455, 1258, 1230, 1163, 1111, 831, 
699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H14F4: 282, found: 282; 
[α]25D = −45° (c = 1.04, CHCl3); 96% ee, from (S,S)-L3. 
 
PhF3C
Br
 
(R)-1-Bromo-4-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 4.2, Entry 
11). (3-Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc 
chloride reagent prepared from 1,4-dibromobenzene were used. The reaction was run at 
−15 °C for 14 h. Solvent system for chromatography: hexane. The title compound was 
isolated as a colorless oil. 
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Run 1, 296 mg (86% yield, 95% ee); Run 2, 300 mg (87% yield, 95% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (S,S)-L3: 20.0 min (minor), 22.6 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.56 – 7.52 (m, 2H), 7.32 – 7.27 (m, 2H), 7.25 – 
7.16 (m, 3H), 7.10 – 7.07 (m, 2H), 3.20 (dqd, 1H, J = 3.8, 9.2, 10.9 Hz), 2.60 (ddd, 1H, J 
= 4.5, 7.8, 11.8 Hz), 2.46 – 2.31 (m, 2H), 2.24 – 2.13 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 140.2, 133.4 (d, J = 1.9 Hz), 132.0, 130.8, 128.6, 
128.3, 126.5 (q, J = 280.6 Hz), 126.3, 122.4, 48.6 (q, J = 26.7 Hz), 32.3, 29.9 (d, J = 2.0 
Hz); 
19F NMR (282 MHz, CDCl3) δ −69.8 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 3028, 2956, 1491, 1454, 1256, 1170, 1156, 1114, 1076, 1012, 819, 
699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H1479BrF3: 342, found: 342, 344 (M++2); 
[α]25D = +61° (c = 0.99, CHCl3); 95% ee, from (R,R)-L3. 
 
F3C
O
Ph  
(R)-5-(1,1,1-Trifluoro-4-phenylbutan-2-yl)benzofuran (eq 4.2). (3-Bromo-
4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride reagent 
prepared from 5-bromobenzofuran were used. Solvent system for chromatography: 20:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
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Run 1, 184 mg (61% yield, 94% ee); Run 2, 178 mg (59% yield, 94% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (S,S)-L3: 21.8 min (minor), 22.6 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.67 (d, 1H, J = 2.2 Hz), 7.57 – 7.53 (m, 2H), 7.32 
– 7.28 (m, 2H), 7.26 – 7.20 (m, 2H), 7.13 – 7.09 (m, 2H), 6.80 (dd, 1H, J = 1.0, 2.2 Hz), 
3.35 (dqd, 1H, J = 3.7, 9.3, 11.1 Hz), 2.66 – 2.57 (m, 1H), 2.50 – 2.38 (m, 2H), 2.34 – 
2.24 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 154.7, 145.7, 140.6, 128.8 (q, J = 2.1 Hz), 128.5, 
128.4, 127.8, 127.0 (q, J = 280.7 Hz), 126.2, 125.3, 121.8, 111.6, 106.6, 49.0 (q, J = 26.6 
Hz), 32.5, 30.4 (d, J = 2.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.8 (d, 3F, J = 9.4 Hz); 
FT-IR (film) 3028, 2955, 1471, 1454, 1259, 1157, 1127, 1107, 1031, 742, 699 
cm-1; 
GC-MS (EI) m/z (M+) calcd for C18H15F3O: 304, found: 304; 
[α]25D = +56° (c = 1.00, CHCl3); 94% ee, from (R,R)-L3. 
 
F3C
N
Me
Ph  
(R)-1-Methyl-5-(1,1,1-trifluoro-4-phenylbutan-2-yl)-1H-indole (eq 4.3). (3-
Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride 
reagent prepared from 5-bromo-1-methyl-1H-indole were used. Solvent system for 
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chromatography: 20:1 → 12:1 hexane/dichloromethane. The title compound was isolated 
as a light-green color solid. 
Run 1, 209 mg (66% yield, 94% ee); Run 2, 222 mg (70% yield, 94% ee). 
The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (R,R)-L3: 23.0 min (major), 24.8 
min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.61 – 7.59 (m, 1H), 7.37 (d, 1H J = 8.4 Hz), 7.33 
– 7.29 (m, 2H), 7.25 – 7.18 (m, 2H), 7.15 – 7.10 (m, 3H), 6.54 (dd, 1H, J = 0.9, 3.1 Hz), 
3.83 (s, 3H), 3.35 (dqd, 1H, J = 3.6, 9.3, 11.0 Hz), 2.66 – 2.60 (m, 1H), 2.51 – 2.29 (m, 
3H); 
13C NMR (126 MHz, CDCl3) δ 141.0, 136.5, 129.5, 128.6, 128.43, 128.40, 127.3 
(q, J = 280.5 Hz), 126.1, 125.0 (q, J = 2.0 Hz), 122.4, 121.7, 109.4, 101.0, 49.2 (q, J = 
26.3 Hz), 32.9, 32.5, 30.5 (d, J = 2.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.8 (d, 3F, J = 9.4 Hz); 
FT-IR (film) 3027, 2951, 1514, 1495, 1453, 1336, 1258, 1138, 1103, 799, 724, 
700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H18F3N: 317, found: 317; 
[α]25D = +63° (c = 1.00, CHCl3); 94% ee, from (R,R)-L3. 
 
PhF3C
Ph
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(R)-4-(1,1,1-Trifluoro-4-phenylbutan-2-yl)-1,1'-biphenyl (for determination 
of absolute stereochemistry). (3-Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 
mmol) and an arylzinc chloride reagent prepared from 4-bromo-1,1'-biphenyl were used. 
Solvent system for chromatography: hexane → 10:1 hexane/dichloromethane. The title 
compound was isolated as a white solid. 
Run 1, 160 mg (47% yield, 94% ee); Run 2, 158 mg (46% yield, 93% ee). 
The ee was determined on an OD-H column (1.0% i-PrOH/hexane, flow rate 1.0 
mL/min); retention times for compound obtained using (R,R)-L3: 7.0 min (minor), 11.1 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.65 – 7.62 (m, 4H), 7.50 – 7.45 (m, 2H), 7.42 – 
7.36 (m, 3H), 7.33 – 7.29 (m, 2H), 7.25 – 7.20 (m, 1H), 7.15 – 7.11 (m, 2H), 3.29 (dqd, 
1H, J = 3.9, 9.3, 11.0 Hz), 2.65 (ddd, 1H, J = 4.9, 9.0, 13.8 Hz), 2.53 – 2.35 (m, 2H), 2.27 
(dddd, 1H, J = 4.9, 8.8, 11.1, 13.8 Hz); 
13C NMR (126 MHz, CDCl3) δ 141.1, 140.6, 140.5, 133.4 (d, J = 2.0 Hz), 129.6, 
128.8, 128.5, 128.4, 127.5, 127.4, 127.1, 126.9 (q, J = 280.6 Hz), 126.2, 48.8 (q, J = 26.5 
Hz), 32.5, 30.1 (d, J = 2.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.6 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 3061, 3030, 2955, 1496, 1487, 1454, 1256, 1168, 1148, 1108, 1009, 
833, 765, 737, 698 cm-1; 
GC-MS (EI) m/z (M+) calcd for C22H19F3: 340, found: 340; 
[α]25D = −69° (c = 0.96, CHCl3); 93% ee, from (S,S)-L3. 
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MeF3C
OMe
 
(R)-1-Methoxy-3-(1,1,1-trifluoropropan-2-yl)benzene (Table 4.3, Entry 1). 2-
Bromo-1,1,1-trifluoropropane (177 mg, 1.00 mmol) and an arylzinc chloride reagent 
prepared from 1-bromo-3-methoxybenzene were used. Solvent system for 
chromatography: 15:1 hexane/dichloromethane. The title compound was isolated as a 
colorless oil. 
Run 1, 166 mg (81% yield, 92% ee); Run 2, 164 mg (80% yield, 90% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (S,S)-L3: 19.5 min (minor), 29.0 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.30 – 7.26 (m, 1H), 6.93 – 6.91 (m, 1H), 6.89 – 
6.87 (m, 2H), 3.82 (s, 3H), 3.40 (qq, 1H, J = 7.2, 9.2 Hz), 1.51 (d, 3H, J = 7.3 Hz); 
13C NMR (126 MHz, CDCl3) δ 159.6, 137.9, 129.5, 127.1 (q, J = 280.5 Hz), 
120.8, 114.6, 113.1, 55.2, 44.2 (q, J = 27.5 Hz), 14.6 (d, J = 2.8 Hz); 
19F NMR (282 MHz, CDCl3) δ −71.4 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 2992, 2948, 2839, 1604, 1588, 1496, 1465, 1291, 1261, 1237, 1172, 
1126, 1041, 991, 781, 703 cm-1; 
GC-MS (EI) m/z (M+) calcd for C10H11F3O: 204, found: 204; 
[α]25D = −9.8° (c = 1.04, CHCl3); 90% ee, from (S,S)-L3. 
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n-OctF3C
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(R)-1-Methoxy-3-(1,1,1-trifluorodecan-2-yl)benzene (Table 4.3, Entry 2). 2-
Bromo-1,1,1-trifluorodecane (275 mg, 1.00 mmol) and an arylzinc chloride reagent 
prepared from 1-bromo-3-methoxybenzene were used. Solvent system for 
chromatography: 15:1 hexane/dichloromethane. The title compound was isolated as a 
colorless oil. 
Run 1, 265 mg (88% yield, 94% ee); Run 2, 263 mg (87% yield, 96% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (S,S)-L3: 10.8 min (minor), 15.5 
min (major). 
1H NMR (500 MHz, CD3CN) δ 7.31 – 7.27 (m, 1H), 6.93 – 6.87 (m, 3H), 3.78 (s, 
3H), 3.43 – 3.32 (m, 1H), 1.99 – 1.84 (m, 2H), 1.35 – 1.06 (m, 12H), 0.86 (t, 3H, J = 7.0 
Hz); 
13C NMR (126 MHz, CD3CN) δ 160.9, 137.6 (d, J = 2.1 Hz), 130.7, 128.5 (q, J = 
279.2 Hz), 122.3, 116.1, 114.2, 56.0, 50.2 (q, J = 25.9 Hz), 32.6, 30.0, 29.9, 29.8, 29.1 (q, 
J = 2.3 Hz), 27.3, 23.4, 14.4; 
19F NMR (282 MHz, CD3CN) δ −70.3 (d, 3F, J = 9.7 Hz); 
FT-IR (film) 2926, 2856, 1603, 1587, 1496, 1456, 1436, 1259, 1161, 1125, 1104, 
1047, 708 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H25F3O: 302, found: 302; 
[α]25D = −42° (c = 1.04, CHCl3); 96% ee, from (S,S)-L3. 
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F3C
OMe
 
(R)-1-(3-Cyclohexyl-1,1,1-trifluoropropan-2-yl)-3-methoxybenzene (Table 
4.3, Entry 3). (2-Bromo-3,3,3-trifluoropropyl)cyclohexane (259 mg, 1.00 mmol) and an 
arylzinc chloride reagent prepared from 1-bromo-3-methoxybenzene were used. Solvent 
system for chromatography: 25:1 hexane/dichloromethane. The title compound was 
isolated as a colorless oil. 
Run 1, 230 mg (80% yield, 96% ee); Run 2, 231 mg (81% yield, 96% ee). 
The ee was determined on an OJ-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (R,R)-L3: 9.1 min (minor), 9.7 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.30 – 7.25 (m, 1H), 6.90 – 6.81 (m, 3H), 3.82 (s, 
3H), 3.33 (dqd, 1H, J = 4.0, 9.4, 11.2 Hz), 1.86 – 1.71 (m, 3H), 1.68 – 1.54 (m, 4H), 1.18 
– 1.02 (m, 4H), 1.00 – 0.82 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 159.6, 136.6 (d, J = 2.0 Hz), 129.5, 127.2 (q, J = 
280.5 Hz), 121.5, 115.2, 112.9, 55.2, 47.2 (q, J = 26.2 Hz), 36.0 (d, J = 2.0 Hz), 34.2, 
33.9, 31.8, 26.4, 26.0, 25.8; 
19F NMR (282 MHz, CDCl3) δ −69.8 (d, 3F, J = 9.4 Hz); 
FT-IR (film) 2926, 2852, 1604, 1587, 1490, 1452, 1261, 1183, 1155, 1113, 1050, 
779, 710 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H21F3O: 286, found: 286; 
[α]25D = +52° (c = 1.00, CHCl3); 96% ee, from (R,R)-L3. 
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OTBDPSF3C
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(R)-tert-Butyldiphenyl((7,7,7-trifluoro-6-(3-methoxyphenyl)heptyl)oxy)silane 
(Table 4.3, Entry 4). ((6-Bromo-7,7,7-trifluoroheptyl)oxy)(tert-butyl)diphenylsilane 
(487 mg, 1.00 mmol) and an arylzinc chloride reagent prepared from 1-bromo-3-
methoxybenzene were used. Solvent system for chromatography: 4:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 390 mg (76% yield, 94% ee); Run 2, 395 mg (77% yield, 94% ee). 
The ee was determined on an OD-H column (1.0% i-PrOH/hexane, flow rate 1.0 
mL/min); retention times for compound obtained using (S,S)-L3: 4.7 min (minor), 7.8 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.69 – 7.64 (m, 4H), 7.46 – 7.35 (m, 6H), 7.30 – 
7.23 (m, 1H), 6.90 – 6.81 (m, 3H), 3.82 (s, 3H), 3.65 – 3.59 (m, 2H), 3.17 (dqd, 1H, J = 
4.0, 9.3, 11.0 Hz), 2.03 – 1.92 (m, 1H), 1.90 – 1.79 (m, 1H), 1.57 – 1.27 (m, 4H), 1.23 – 
1.14 (m, 2H), 1.06 (s, 9H); 
13C NMR (126 MHz, CDCl3) δ 159.7, 136.4 (d, J = 2.0 Hz), 135.5, 134.0 (d, J = 
1.4 Hz), 129.6, 129.5, 127.6, 126.9 (q, J = 280.7 Hz), 121.4, 115.0, 113.0, 63.7, 55.2, 
50.0 (q, J = 26.3 Hz), 32.2, 28.7 (d, J = 2.2 Hz), 26.9, 26.5, 25.5, 19.2; 
19F NMR (282 MHz, CDCl3) δ −69.6 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 2933, 2858, 1603, 1587, 1490, 1472, 1428, 1260, 1161, 1113, 702 
cm-1; 
GC-MS (EI) m/z (M+−C4H9) calcd for C26H28F3O2Si: 457, found: 457; 
[α]25D = +24° (c = 1.03, CHCl3); 94% ee, from (R,R)-L3. 
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ClF3C
OMe
 
(R)-1-(6-Chloro-1,1,1-trifluorohexan-2-yl)-3-methoxybenzene (Table 4.3, 
Entry 5). 2-Bromo-6-chloro-1,1,1-trifluorohexane (253 mg, 1.00 mmol) and an arylzinc 
chloride reagent prepared from 1-bromo-3-methoxybenzene were used. Solvent system 
for chromatography: 15:1 → 12:1 → 10:1 hexane/dichloromethane. The title compound 
was isolated as a colorless oil. 
Run 1, 250 mg (89% yield, 96% ee); Run 2, 248 mg (88% yield, 96% ee). 
The ee was determined on an OJ-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (R,R)-L3: 26.1 min (minor), 27.5 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.30 – 7.26 (m, 1H), 6.89 – 6.86 (m, 2H), 6.83 – 
6.82 (m, 1H), 3.82 (s, 3H), 3.52 – 3.42 (m, 2H), 3.19 (dqd, 1H, J = 4.1, 9.2 ,11.0 Hz), 
2.05 – 1.96 (m, 1H), 1.94 – 1.68 (m, 3H), 1.43 – 1.28 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 159.7, 136.0 (d, J = 2.3 Hz), 129.7, 126.8 (q, J = 
280.7 Hz), 121.3, 115.0, 113.2, 55.2, 50.0 (q, J = 26.6 Hz), 44.4, 32.1, 28.1 (d, J = 2.2 
Hz), 24.1; 
19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 2954, 1603, 1490, 1456, 1257, 1159, 1109, 1043, 781, 707 cm-1; 
GC-MS (EI) m/z (M+) calcd for C13H16ClF3O: 280, found: 280; 
[α]25D = +51° (c = 0.99, CHCl3); 96% ee, from (R,R)-L3. 
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BrF3C
OMe
 
(R)-1-(10-Bromo-1,1,1-trifluorodecan-2-yl)-3-methoxybenzene (Table 4.3, 
Entry 6). 2,10-Dibromo-1,1,1-trifluorodecane (354 mg, 1.00 mmol) and an arylzinc 
chloride reagent prepared from 1-bromo-3-methoxybenzene were used. Solvent system 
for chromatography: 15:1 → 12:1 → 10:1 hexane/dichloromethane. The title compound 
was isolated as a colorless oil. 
Run 1, 309 mg (81% yield, 96% ee); Run 2, 300 mg (79% yield, 95% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 1.0 
mL/min); retention times for compound obtained using (S,S)-L3: 14.9 min (minor), 25.4 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.25 (m, 1H), 6.88 – 6.86 (m, 2H), 6.83 – 
6.82 (m, 1H), 3.82 (s, 3H), 3.39 (t, 2H, J = 6.8 Hz), 3.18 (dqd, 1H, J = 4.0, 9.3, 11.1 Hz), 
1.97 (dddd, 1H, J = 4.1, 7.7, 9.2, 13.4 Hz), 1.89 – 1.78 (m, 3H), 1.45 – 1.13 (m, 10H); 
13C NMR (126 MHz, CDCl3) δ 159.6, 136.5 (d, J = 2.2 Hz), 129.5, 126.9 (q, J = 
280.7 Hz), 121.4, 115.1, 113.0, 55.2, 50.1 (q, J = 26.3 Hz), 33.9, 32.7, 29.1, 29.0, 28.64 
(d, J = 2.0 Hz), 28.57, 28.0, 26.6; 
19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 2929, 2856, 1603, 1490, 1457, 1437, 1257, 1158, 1109, 1050, 780, 
708 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H2479BrF3O: 380, found: 380, 382 (M++2); 
[α]25D = +33° (c = 0.99, CHCl3); 96% ee, from (R,R)-L3. 
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OTsF3C
OMe
 
(R)-7,7,7-Trifluoro-6-(3-methoxyphenyl)heptyl 4-methylbenzenesulfonate 
(Table 4.3, Entry 7). 6-Bromo-7,7,7-trifluoroheptyl 4-methylbenzenesulfonate (403 mg, 
1.00 mmol) and an arylzinc chloride reagent prepared from 1-bromo-3-methoxybenzene 
were used. Solvent system for chromatography: 1:1 → 1:1.5 → 1:2 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 391 mg (91% yield, 97% ee); Run 2, 393 mg (91% yield, 97% ee). 
The ee was determined on an OJ-H column (10% i-PrOH/hexane, flow rate 1.0 
mL/min); retention times for compound obtained using (R,R)-L3: 32.0 min (minor), 34.7 
min (major). 
1H NMR (500 MHz, CD3COCD3) δ 7.80 – 7.76 (m, 2H), 7.48 – 7.44 (m, 2H), 
7.33 – 7.28 (m, 1H), 6.95 – 6.90 (m, 3H), 3.99 (td, 2H, J = 1.1, 6.4 Hz), 3.80 (s, 3H), 3.46 
– 3.37 (m, 1H), 2.45 (s, 3H), 1.96 – 1.83 (m, 2H), 1.63 – 1.50 (m, 2H), 1.40 – 1.06 (m, 
4H); 
13C NMR (126 MHz, CD3COCD3) δ 160.9, 145.8, 137.3 (d, J = 2.1 Hz), 134.5, 
130.9, 130.6, 128.7, 128.3 (q, J = 279.9 Hz), 122.1, 116.1, 114.1, 71.4, 55.6, 50.2 (q, J = 
26.1 Hz), 29.2, 29.0 (d, J = 2.2 Hz), 26.8, 25.7, 21.6; 
19F NMR (282 MHz, CD3COCD3) δ −70.2 (d, 3F, J = 9.6 Hz); 
FT-IR (film) 2945, 1600, 1496, 1457, 1358, 1258, 1176, 1118, 956, 815, 708, 663 
cm-1; 
GC-MS (EI) m/z (M+−OTs) calcd for C14H18F3O: 259, found: 259; 
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[α]25D = +25° (c = 0.99, CHCl3); 97% ee, from (R,R)-L3. 
 
O
O
Me
F3C
OMe
 
(R)-1-(4-((7,7,7-Trifluoro-6-(3-methoxyphenyl)heptyl)oxy)phenyl)ethan-1-one 
(Table 4.3, Entry 8). 1-(4-((6-Bromo-7,7,7-trifluoroheptyl)oxy)phenyl)ethan-1-one (367 
mg, 1.00 mmol) and an arylzinc chloride reagent prepared from 1-bromo-3-
methoxybenzene were used. Solvent system for chromatography: 15:1 → 10:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 357 mg (91% yield, 95% ee); Run 2, 342 mg (87% yield, 96% ee). 
The ee was determined on an AD-H column (5% i-PrOH/hexane, flow rate 1.0 
mL/min); retention times for compound obtained using (R,R)-L3: 14.4 min (minor), 17.4 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.93 – 7.89 (m, 2H), 7.28 – 7.25 (m, 1H), 6.89 – 
6.82 (m, 5H), 3.97 – 3.94 (m, 2H), 3.81 (s, 3H), 3.19 (dqd, 1H, J = 4.1, 9.3, 11.0 Hz), 
2.55 (s, 3H), 2.05 – 1.97 (m, 1H), 1.92 – 1.84 (m, 1H), 1.79 – 1.69 (m, 2H), 1.54 – 1.38 
(m, 2H), 1.31 – 1.23 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 196.7, 162.9, 159.7, 136.3 (d, J = 2.0 Hz), 130.5, 
130.2, 129.6, 126.9 (q, J = 280.6 Hz), 121.3, 115.1, 114.1, 113.0, 67.9, 55.2, 50.0 (q, J = 
26.4 Hz), 28.7, 28.6 (d, J = 2.2 Hz), 26.4, 26.3, 25.7; 
19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.3 Hz); 
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FT-IR (film) 2943, 1675, 1601, 1255, 1170, 1117, 834, 708 cm-1; 
GC-MS (EI) m/z (M+) calcd for C22H25F3O3: 394, found: 394; 
[α]25D = +34° (c = 0.97, CHCl3); 95% ee, from (R,R)-L3. 
 
O
I
F3C
OMe
 
(R)-1-Methoxy-3-(1,1,1-trifluoro-7-(4-iodophenoxy)heptan-2-yl)benzene 
(Table 4.3, Entry 9). 1-((6-Bromo-7,7,7-trifluoroheptyl)oxy)-4-iodobenzene (451 mg, 
1.00 mmol) and an arylzinc chloride reagent prepared from 1-bromo-3-methoxybenzene 
were used. Solvent system for chromatography: 10:1 → 5:1 → 4:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 282 mg (59% yield, 95% ee); Run 2, 292 mg (61% yield, 95% ee). 
The ee was determined on an OD-H column (10% i-PrOH/hexane, flow rate 1.0 
mL/min); retention times for compound obtained using (R,R)-L3: 12.6 min (minor), 22.9 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.56 – 7.51 (m, 2H), 7.30 – 7.24 (m, 1H), 6.90 – 
6.81 (m, 3H), 6.66 – 6.61 (m, 2H), 3.85 (t, 2H, J = 6.4 Hz), 3.81 (s, 3H), 3.19 (dqd, 1H, J 
= 4.1, 9.3, 11.0 Hz), 2.07 – 1.96 (m, 1H), 1.93 – 1.83 (m, 1H), 1.78 – 1.63 (m, 2H), 1.54 
– 1.36 (m, 2H), 1.32 – 1.19 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 159.7, 158.8, 138.1, 136.3 (d, J = 2.1 Hz), 129.6, 
126.9 (q, J = 280.7 Hz), 121.3, 116.9, 115.1, 113.0, 82.5, 67.7, 55.2, 50.0 (q, J = 26.4 
Hz), 28.8, 28.6 (d, J = 2.1 Hz), 26.4, 25.7; 
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19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 2942, 1586, 1486, 1472, 1244, 1174, 1118, 820, 708 cm-1; 
GC-MS (EI) m/z (M+) calcd for C20H22F3IO2: 478, found: 478; 
[α]25D = +28° (c = 0.98, CHCl3); 95% ee, from (R,R)-L3. 
 
F3C
OMe
N
Boc
 
tert-Butyl (R)-4-(3,3,3-trifluoro-2-(3-methoxyphenyl)propyl)piperidine-1-
carboxylate (Table 4.3, Entry 10). tert-Butyl 4-(2-bromo-3,3,3-
trifluoropropyl)piperidine-1-carboxylate (360 mg, 1.00 mmol) and an arylzinc chloride 
reagent prepared from 1-bromo-3-methoxybenzene were used. Solvent system for 
chromatography: 15:1 → 10:1 hexane/dichloromethane. The title compound was isolated 
as a light-yello solid. 
Run 1, 320 mg (83% yield, 96% ee); Run 2, 315 mg (81% yield, 97% ee). 
The ee was determined on an OJ-H column (2.0% i-PrOH/hexane, flow rate 1.0 
mL/min); retention times for compound obtained using (S,S)-L3: 8.5 min (minor), 13.0 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.29 – 7.25 (m, 1H), 6.89 – 6.81 (m, 3H), 4.02 (br, 
2H), 3.81 (s, 3H), 3.36 – 3.27 (m, 1H), 2.54 (br, 2H), 1.90 (ddd, 1H, J = 4.4, 11.4, 13.8 
Hz), 1.78 (ddd, 1H, J = 4.0, 9.4, 13.7 Hz), 1.68 – 1.64 (m, 1H), 1.52 – 1.48 (m, 1H), 1.43 
(s, 9H), 1.27 – 1.04 (m, 3H); 
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13C NMR (126 MHz, CDCl3) δ 159.7, 154.7, 136.0 (d, J = 1.9 Hz), 129.7, 126.9 
(q, J = 280.7 Hz), 121.3, 115.1, 113.0, 79.3, 55.2, 47.1 (q, J = 26.5 Hz), 35.2 (d, J = 1.9 
Hz), 32.7, 32.5, 30.8, 28.4; 
19F NMR (282 MHz, CDCl3) δ −69.9 (d, 3F, J = 9.2 Hz); 
FT-IR (film) 2932, 1690, 1456, 1424, 1366, 1259, 1162, 1118, 1098, 969, 711 
cm-1; 
GC-MS (EI) m/z (M+–Boc) calcd for C15H19F3NO: 286, found: 286; 
[α]25D = −49° (c = 0.99, CHCl3); 97% ee, from (S,S)-L3. 
 
O
O
O
F3C
OMe
 
(R)-7,7,7-Trifluoro-6-(3-methoxyphenyl)heptyl furan-2-carboxylate (Table 
4.3, Entry 11). 6-Bromo-7,7,7-trifluoroheptyl furan-2-carboxylate (343 mg, 1.00 mmol) 
and an arylzinc chloride reagent prepared from 1-bromo-3-methoxybenzene were used. 
Solvent system for chromatography: 1:1 → 1:1.2 → 1:1.5 hexane/dichloromethane. The 
title compound was isolated as a yellow oil. 
Run 1, 298 mg (81% yield, 96% ee); Run 2, 298 mg (81% yield, 96% ee). 
The ee was determined on an OJ-H column (5% i-PrOH/hexane, flow rate 1.0 
mL/min); retention times for compound obtained using (R,R)-L3: 25.6 min (minor), 33.0 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.57 (dd, 1H, J = 0.9, 1.8 Hz), 7.29 – 7.24 (m, 1H), 
7.14 (dd, 1H, J = 0.8, 3.5 Hz), 6.89 – 6.80 (m, 3H), 6.50 (dd, 1H, J = 1.7, 3.5 Hz), 4.24 (t, 
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2H, J = 6.6 Hz), 3.80 (s, 3H), 3.18 (dqd, 1H, J = 4.1, 9.3, 11.0 Hz), 1.99 (dddd, 1H, J = 
4.1, 7.1, 9.7, 13.7 Hz), 1.91 – 1.81 (m, 1H), 1.76 – 1.61 (m, 2H), 1.50 – 1.32 (m, 2H), 
1.29 – 1.21 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 159.7, 158.7, 146.2, 144.7, 136.3 (d, J = 2.2 Hz), 
129.6, 126.9 (q, J = 280.6 Hz), 121.3, 117.7, 115.0, 113.0, 111.8, 64.7, 55.2, 50.0 (q, J = 
26.4 Hz), 28.6 (d, J = 2.0 Hz), 28.4, 26.4, 25.6; 
19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.2 Hz); 
FT-IR (film) 2947, 1727, 1603, 1584, 1473, 1297, 1259, 1180, 1119, 765, 709 
cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H21F3O4: 370, found: 370; 
[α]25D = +32° (c = 0.94, CHCl3); 96% ee, from (R,R)-L3. 
 
PhF3C
OMe
 
(R)-1-Methoxy-3-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (eq 4.4). (4,4,4-
Trifluoro-3-iodobutyl)benzene (314 mg, 1.00 mmol) and an arylzinc chloride reagent 
prepared from 1-bromo-3-methoxybenzene were used. Solvent system for 
chromatography: 5:1 → 4:1 hexane/dichloromethane. The title compound was isolated as 
a colorless oil. 
Run 1, 277 mg (94% yield, 96% ee); Run 2, 277 mg (94% yield, 96% ee). 
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The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
ml/min); retention times for compound obtained using (S,S)-L3: 20.2 min (minor), 32.3 
min (major). 
For the characterization data, see Table 4.2, Entry 2 (above). 
 
n-C3F7 Ph
OMe
 
(R)-1-(4,4,5,5,6,6,6-Heptafluoro-1-phenylhexan-3-yl)-3-methoxybenzene (eq 
4.7). (3-Bromo-4,4,5,5,6,6,6-heptafluorohexyl)benzene (367 mg, 1.00 mmol) and an 
arylzinc chloride reagent prepared from 1-bromo-3-methoxybenzene were used. Solvent 
system for chromatography: 15:1 → 12:1 → 10:1 hexane/dichloromethane. The title 
compound was isolated as a colorless oil. 
Run 1, 363 mg (92% yield, 99% ee); Run 2, 361 mg (92% yield, 99% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (S,S)-L3: 12.8 min (minor), 15.6 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.28 (m, 3H), 7.24 – 7.20 (m, 1H), 7.11 – 
7.09 (m, 2H), 6.93 – 6.90 (m, 2H), 6.86 – 6.85 (m, 1H), 3.84 (s, 3H), 3.34 – 3.25 (m, 1H), 
2.60 – 2.53 (m, 1H), 2.45 – 2.34 (m, 2H), 2.26 – 2.17 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 159.7, 140.5, 135.5 (d, J = 5.4 Hz), 129.6, 128.5, 
128.4, 126.2, 122.0, 119.5 – 115.2 (m), 115.6, 113.2, 112.1 – 107.0 (m), 55.2, 47.1 (t, J = 
21.0 Hz), 32.4, 29.3; 
	 308 
19F NMR (282 MHz, CDCl3) δ −80.7 (dd, 3F, J = 10.2, 11.9 Hz), −112.9 – −116.8 
(m, 2F), −122.6 – −125.6 (m, 2F); 
FT-IR (film) 2961, 1603, 1587, 1496, 1456, 1348, 1219, 1174, 1116, 1045, 933, 
728, 698 cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H17F7O: 394, found: 394; 
[α]25D = +40° (c = 0.93, CHCl3); 99% ee, from (R,R)-L3. 
 
ClF2C Ph
OMe
 
(R)-1-(1-Chloro-1,1-difluoro-4-phenylbutan-2-yl)-4-methoxybenzene (eq 4.8). 
(3-Bromo-4-chloro-4,4-difluorobutyl)benzene (283 mg, 1.00 mmol) and an arylzinc 
chloride reagent prepared from 1-bromo-4-methoxybenzene were used. Solvent system 
for chromatography: 6:1 → 4:1 hexane/dichloromethane. The title compound was 
isolated as a colorless oil. 
Run 1, 274 mg (88% yield, 96% ee); Run 2, 278 mg (89% yield, 96% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (R,R)-L3: 29.1 min (minor), 34.4 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.19 (m, 5H), 7.11 – 7.08 (m, 2H), 6.96 – 
6.92 (m, 2H), 3.85 (s, 3H), 3.30 (qd, 1H, J = 3.1, 11.5 Hz), 2.63 – 2.57 (m, 1H), 2.45 – 
2.36 (m, 2H), 2.27 – 2.19 (m, 1H); 
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13C NMR (126 MHz, CDCl3) δ 159.5, 140.7, 131.2 (t, J = 296.2 Hz), 130.6, 
128.5, 128.4, 126.8 (t, J = 2.5 Hz), 126.2, 114.0, 55.2, 54.8 (t, J = 22.3 Hz), 32.6, 30.8 (t, 
J = 2.2 Hz); 
19F NMR (282 MHz, CDCl3) δ −53.9 (dd, 1F, J = 10.9, 160.5 Hz), −54.7 (dd, 1F, 
J = 11.9, 160.7 Hz); 
FT-IR (film) 3026, 2956, 1612, 1515, 1496, 1454, 1306, 1251, 1180, 1114, 1034, 
947, 826, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H17ClF2O: 310, found: 310; 
[α]25D = +43° (c = 0.93, CHCl3); 96% ee, from (R,R)-L3. 
 
Ph
PhPh
F F
O
 
(R)-2,2-Difluoro-1,3,5-triphenylpentan-1-one (eq 4.9). 3-Bromo-2,2-difluoro-
1,5-diphenylpentan-1-one (353 mg, 1.00 mmol) and an arylzinc chloride reagent prepared 
from bromobenzene were used. Solvent system for chromatography: 10:1 → 5:1 → 2:1 
hexane/dichloromethane. The title compound was isolated as a white solid. 
Run 1, 283 mg (81% yield, 98% ee); Run 2, 280 mg (80% yield, 97% ee). 
The ee was determined on an AD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (R,R)-L3: 20.1 min (minor), 20.9 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.88 – 7.85 (m, 2H), 7.59 – 7.55 (m, 1H), 7.43 – 
7.39 (m, 2H), 7.35 – 7.24 (m, 7H), 7.20 – 7.17 (m, 1H), 7.10 – 7.07 (m, 2H), 3.62 – 3.52 
(m, 1H), 2.58 (ddd, 1H, J = 4.7, 9.3, 13.6 Hz), 2.46 – 2.33 (m, 2H), 2.29 – 2.22 (m, 1H); 
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13C NMR (126 MHz, CDCl3) δ 190.1 (t, J = 30.0 Hz), 141.0, 135.02, 134.98, 
133.9, 132.8, 129.84, 129.79 (t, J = 3.5 Hz), 128.6, 128.5, 128.4, 127.9, 126.0, 119.4 (t, J 
= 258.1 Hz), 49.2 (t, J = 21.5 Hz), 32.8, 29.6 (t, J = 3.6 Hz); 
19F NMR (282 MHz, CDCl3) δ −103.1 (dd, 1F, J = 15.4, 272.5 Hz), −105.4 (dd, 
1F, J = 17.3, 272.5 Hz); 
FT-IR (film) 3028, 1701, 1598, 1496, 1454, 1161, 1089, 1065, 912, 698 cm-1; 
GC-MS (EI) m/z (M+) calcd for C23H20F2O: 350, found: 350; 
[α]25D = −9.7° (c = 0.94, CHCl3); 97% ee, from (S,S)-L3. 
 
PhEtO
F F
O
OMe
 
Ethyl (R)-2,2-difluoro-3-(3-methoxyphenyl)-5-phenylpentanoate (eq 4.10). 
Ethyl 3-bromo-2,2-difluoro-5-phenylpentanoate (321 mg, 1.00 mmol) and an arylzinc 
chloride reagent prepared from 1-bromo-3-methoxybenzene were used. Solvent system 
for chromatography: 2:1 → 1.5:1 hexane/dichloromethane. The title compound was 
isolated as a colorless oil. 
Run 1, 271 mg (78% yield, 98% ee); Run 2, 278 mg (80% yield, 98% ee). 
The ee was determined on an AD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
mL/min); retention times for compound obtained using (R,R)-L3: 22.9 min (minor), 28.8 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.29 – 7.25 (m, 3H), 7.21 – 7.18 (m, 1H), 7.11 – 
7.09 (m, 2H), 6.89 – 6.82 (m, 3H), 4.13 (qd, 2H, J = 1.1, 7.2 Hz), 3.82 (s, 3H), 3.30 
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(dddd, 1H, J = 3.6, 11.3, 12.9, 19.6 Hz), 2.58 (ddd, 1H, J = 4.8, 9.3, 14.0 Hz), 2.42 (ddd, 
1H, J = 7.5, 9.3, 13.9 Hz), 2.28 (dddd, 1H, J = 3.6, 7.6, 9.3, 13.1 Hz), 2.19 (dddd, 1H, J = 
4.9, 9.2, 11.3, 13.9 Hz), 1.13 (t, 3H, J = 7.1 Hz); 
13C NMR (126 MHz, CDCl3) δ 163.8 (t, J = 32.8 Hz), 159.7, 141.0, 136.3 (d, J = 
6.3 Hz), 129.6, 128.39, 128.38, 126.1, 121.9, 116.5 (dd, J = 254.4, 257.5 Hz), 115.4, 
113.3, 62.5, 55.2, 49.4 (dd, J = 21.2, 23.0 Hz), 32.7, 29.2 (dd, J = 1.8, 4.6 Hz), 13.7; 
19F NMR (282 MHz, CDCl3) δ −107.1 (dd, 1F, J = 12.9, 252.1 Hz), −113.7 (dd, 
1F, J = 19.6, 252.1 Hz); 
FT-IR (film) 2940, 1771, 1602, 1490, 1456, 1257, 1103, 1064, 774, 751, 698 cm-
1; 
GC-MS (EI) m/z (M+) calcd for C20H22F2O3: 348, found: 348; 
[α]25D = +27° (c = 1.05, CHCl3); 98% ee, from (R,R)-L3. 
 
4.6.4 Determination of the Absolute Configuration of the Cross-Coupling Products 
PhF3C
Ph
 
  (S)-4-(1,1,1-Trifluoro-4-phenylbutan-2-yl)-1,1'-biphenyl. This compound was 
prepared according to the General Procedure using (3-bromo-4,4,4-
trifluorobutyl)benzene and an arylzinc chloride reagent prepared from 4-bromo-1,1'-
biphenyl (run with (R,R)-L3). 
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A suitable crystal of C22H19F3 was selected for analysis. All measurements were 
made on a Bruker APEX-II CCD with filtered Cu-Kα radiation at a temperature of 120 
K.  Using Olex2,1 the structure was solved with the ShelXS2 structure solution program 
using Direct Methods and refined with the ShelXL2 refinement package using Least 
Squares minimization. The absolute stereochemistry was determined on the basis of the 
absolute structure parameter. 
1. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, 
H. J. Appl. Crystallogr. 2009, 42, 339. 
2. Sheldrick, G. M. Acta Crystallogr. A 2008, 64, 112. 
 
Table 4.4. Crystal Data and Structure Refinement for Crystal01. 
Identification code  crystal01 
Empirical formula  C22H19F3 
Formula weight  340.37 
Temperature  120 K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21 
	 313 
Unit cell dimensions a = 11.0486(3) Å α = 90°. 
 b = 5.4958(2) Å β = 96.3784(11) °. 
 c = 14.1940(4) Å γ = 90 °. 
Volume 856.54(5) Å3 
Z 2 
Density (calculated) 1.320 Mg/m3 
Absorption coefficient 0.814 mm-1 
F(000) 356 
Crystal size 0.161 x 0.036 x 0.031 mm3 
Theta range for data collection 3.133 to 71.808°. 
Index ranges -13<=h<=13, -6<=k<=6, -17<=l<=17 
Reflections collected 16914 
Independent reflections 3123 [R(int) = 0.0295] 
Completeness to theta = 67.679° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8644 and 0.7825 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3123 / 1 / 226 
Goodness-of-fit on F2 1.033 
Final R indices [I>2sigma(I)] R1 = 0.0282, wR2 = 0.0776 
R indices (all data) R1 = 0.0286, wR2 = 0.0780 
Absolute structure parameter (Flack) 0.05(4) 
Largest diff. peak and hole 0.218 and -0.180 e/Å-3 
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Table 4.5. Atomic Coordinates ( x 10
4
) and Equivalent Isotropic Displacement 
Parameters (Å
2
 x 10
3
) for Crystal01. U(eq) is defined as one third of the trace of the 
orthogonalized U
ij
 tensor. 
________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________ 
F(1) 4828(1) 5608(2) 2905(1) 36(1) 
F(2) 5550(1) 3642(2) 1786(1) 35(1) 
F(3) 5939(1) 7458(2) 1980(1) 33(1) 
C(1) 6808(2) 3676(4) 5793(1) 28(1) 
C(2) 6772(2) 5381(4) 6511(1) 30(1) 
C(3) 7706(2) 7058(4) 6688(1) 28(1) 
C(4) 8678(2) 7010(4) 6150(1) 28(1) 
C(5) 8705(2) 5311(4) 5426(1) 25(1) 
C(6) 7767(1) 3635(3) 5235(1) 21(1) 
C(7) 7762(2) 1825(3) 4432(1) 24(1) 
C(8) 6759(2) 2328(3) 3621(1) 22(1) 
C(9) 6939(1) 4755(3) 3122(1) 21(1) 
C(10) 5822(2) 5359(4) 2446(1) 25(1) 
C(11) 8076(1) 4830(3) 2603(1) 20(1) 
C(12) 8296(2) 3054(3) 1948(1) 26(1) 
C(13) 9316(2) 3184(3) 1457(1) 26(1) 
C(14) 10156(1) 5072(3) 1603(1) 20(1) 
C(15) 9940(2) 6825(3) 2277(1) 27(1) 
C(16) 8915(2) 6704(3) 2764(1) 26(1) 
C(17) 11251(2) 5188(3) 1073(1) 22(1) 
C(18) 11495(2) 3363(4) 441(2) 35(1) 
C(19) 12520(2) 3444(4) -43(2) 38(1) 
C(20) 13331(2) 5346(4) 96(1) 32(1) 
C(21) 13103(2) 7173(5) 713(2) 38(1) 
C(22) 12072(2) 7101(4) 1195(1) 34(1) 
________________________________________________________________________
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Table 4.6. Bond Lengths [Å] and Angles [°] for Crystal01. 
_____________________________________________________  
F(1)-C(10)  1.3449(19) 
F(2)-C(10)  1.340(2) 
F(3)-C(10)  1.343(2) 
C(1)-C(2)  1.388(3) 
C(1)-C(6)  1.392(2) 
C(2)-C(3)  1.386(3) 
C(3)-C(4)  1.386(2) 
C(4)-C(5)  1.391(3) 
C(5)-C(6)  1.390(3) 
C(6)-C(7)  1.512(2) 
C(7)-C(8)  1.533(2) 
C(8)-C(9)  1.533(2) 
C(9)-C(10)  1.513(2) 
C(9)-C(11)  1.526(2) 
C(11)-C(12)  1.388(2) 
C(11)-C(16)  1.387(2) 
C(12)-C(13)  1.391(2) 
C(13)-C(14)  1.392(2) 
C(14)-C(15)  1.397(2) 
C(14)-C(17)  1.496(2) 
C(15)-C(16)  1.391(2) 
C(17)-C(18)  1.392(3) 
C(17)-C(22)  1.387(3) 
C(18)-C(19)  1.389(3) 
C(19)-C(20)  1.377(3) 
C(20)-C(21)  1.373(3) 
C(21)-C(22)  1.392(3) 
 
C(2)-C(1)-C(6) 120.97(16) 
C(3)-C(2)-C(1) 120.03(16) 
C(2)-C(3)-C(4) 119.65(17) 
C(3)-C(4)-C(5) 120.10(17) 
C(6)-C(5)-C(4) 120.80(15) 
C(1)-C(6)-C(7) 120.04(15) 
C(5)-C(6)-C(1) 118.43(15) 
C(5)-C(6)-C(7) 121.52(15) 
C(6)-C(7)-C(8) 112.91(14) 
C(7)-C(8)-C(9) 112.59(14) 
C(10)-C(9)-C(8) 110.19(14) 
C(10)-C(9)-C(11) 110.23(13) 
C(11)-C(9)-C(8) 113.71(13) 
F(1)-C(10)-C(9) 111.55(14) 
F(2)-C(10)-F(1) 106.19(15) 
F(2)-C(10)-F(3) 106.70(13) 
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F(2)-C(10)-C(9) 113.11(14) 
F(3)-C(10)-F(1) 106.23(15) 
F(3)-C(10)-C(9) 112.58(15) 
C(12)-C(11)-C(9) 121.26(15) 
C(16)-C(11)-C(9) 120.77(14) 
C(16)-C(11)-C(12) 117.96(15) 
C(11)-C(12)-C(13) 120.75(16) 
C(12)-C(13)-C(14) 121.83(16) 
C(13)-C(14)-C(15) 116.98(15) 
C(13)-C(14)-C(17) 121.35(15) 
C(15)-C(14)-C(17) 121.65(15) 
C(16)-C(15)-C(14) 121.17(16) 
C(11)-C(16)-C(15) 121.28(16) 
C(18)-C(17)-C(14) 121.23(16) 
C(22)-C(17)-C(14) 121.62(15) 
C(22)-C(17)-C(18) 117.14(16) 
C(19)-C(18)-C(17) 121.47(19) 
C(20)-C(19)-C(18) 120.45(19) 
C(21)-C(20)-C(19) 118.95(17) 
C(20)-C(21)-C(22) 120.7(2) 
C(17)-C(22)-C(21) 121.30(19) 
_____________________________________________________________  
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Table 4.7. Anisotropic Displacement Parameters (Å
2
 x 10
3
) for Crystal01. The 
anisotropic displacement factor exponent takes the form: -2π
2
[ h
2
 a*
2
U
11
 + ... + 2 h k a* b* 
U
12
 ] 
________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________ 
F(1) 26(1)  48(1) 37(1)  3(1) 10(1)  10(1) 
F(2) 32(1)  39(1) 33(1)  -11(1) -7(1)  4(1) 
F(3) 35(1)  32(1) 32(1)  8(1) 2(1)  6(1) 
C(1) 29(1)  30(1) 25(1)  -3(1) 5(1)  -5(1) 
C(2) 28(1)  37(1) 25(1)  -4(1) 7(1)  1(1) 
C(3) 33(1)  28(1) 20(1)  -4(1) -1(1)  5(1) 
C(4) 29(1)  29(1) 26(1)  -1(1) -2(1)  -4(1) 
C(5) 24(1)  30(1) 21(1)  2(1) 2(1)  0(1) 
C(6) 26(1)  20(1) 18(1)  2(1) 0(1)  4(1) 
C(7) 31(1)  19(1) 22(1)  0(1) 4(1)  3(1) 
C(8) 27(1)  21(1) 21(1)  -2(1) 4(1)  -1(1) 
C(9) 24(1)  20(1) 19(1)  -3(1) 4(1)  1(1) 
C(10) 26(1)  25(1) 25(1)  -1(1) 5(1)  4(1) 
C(11) 23(1)  20(1) 17(1)  0(1) 2(1)  2(1) 
C(12) 27(1)  25(1) 27(1)  -8(1) 5(1)  -4(1) 
C(13) 31(1)  24(1) 25(1)  -10(1) 6(1)  -2(1) 
C(14) 24(1)  20(1) 16(1)  4(1) 0(1)  3(1) 
C(15) 31(1)  19(1) 32(1)  -5(1) 8(1)  -4(1) 
C(16) 33(1)  19(1) 27(1)  -7(1) 8(1)  0(1) 
C(17) 24(1)  24(1) 16(1)  6(1) 0(1)  4(1) 
C(18) 41(1)  27(1) 39(1)  -6(1) 17(1)  -3(1) 
C(19) 46(1)  33(1) 40(1)  -3(1) 22(1)  3(1) 
C(20) 26(1)  43(1) 27(1)  10(1) 6(1)  8(1) 
C(21) 30(1)  47(1) 38(1)  -1(1) 7(1)  -9(1) 
C(22) 32(1)  37(1) 32(1)  -8(1) 8(1)  -5(1) 
________________________________________________________________________
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Table 4.8. Hydrogen Coordinates ( x 10
4
) and Isotropic Displacement Parameters (Å
2
 x 
10
3
) for Crystal01. 
________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________   
H(1) 6168 2521 5681 33 
H(2) 6107 5397 6882 36 
H(3) 7679 8236 7175 33 
H(4) 9327 8138 6276 34 
H(5) 9372 5296 5058 30 
H(7A) 7650 168 4682 28 
H(7B) 8563 1872 4182 28 
H(8A) 5960 2345 3875 27 
H(8B) 6747 993 3151 27 
H(9) 7027 6050 3619 25 
H(12) 7744 1734 1834 31 
H(13) 9442 1952 1009 32 
H(15) 10502 8122 2406 33 
H(16) 8787 7929 3214 32 
H(18) 10947 2033 337 42 
H(19) 12663 2177 -472 46 
H(20) 14037 5395 -229 38 
H(21) 13654 8499 811 46 
H(22) 11929 8388 1615 40 
________________________________________________________________________ 
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Ph
PhPh
F F
O
 
(S)-2,2-Difluoro-1,3,5-triphenylpentan-1-one (eq 4.9). This compound was 
prepared with (R,R)-L3. 
 
A suitable crystal of C23H20F2O was selected for analysis.  All measurements 
were made on a Bruker APEX-II CCD with filtered Cu-Kα radiation at a temperature of 
120 K.  Using Olex2,1 the structure was solved with the ShelXS2 structure solution 
program using Direct Methods and refined with the ShelXL2 refinement package using 
Least Squares minimization.  The absolute stereochemistry was determined on the basis 
of the absolute structure parameter. 
1. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, 
H. J. Appl. Crystallogr. 2009, 42, 339. 
2. Sheldrick, G. M. Acta Crystallogr. A 2008, 64, 112. 
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Table 4.9. Crystal Data and Structure Refinement for Crystal02. 
Identification code  crystal02 
Empirical formula  C23H20F2O 
Formula weight  350.39 
Temperature  120 K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 5.66013(10) Å α = 90°. 
 b = 13.3182(2) Å β = 90 °. 
 c = 23.7538(4) Å γ = 90 °. 
Volume 1790.63(5) Å3 
Z 4 
Density (calculated) 1.300 Mg/m3 
Absorption coefficient 0.755 mm-1 
F(000) 736 
Crystal size 0.133 x 0.057 x 0.012 mm3 
Theta range for data collection 3.721 to 71.834°. 
Index ranges -6<=h<=6, -16<=k<=16, -28<=l<=29 
Reflections collected 21566 
Independent reflections 3486 [R(int) = 0.0407] 
Completeness to theta = 67.679° 99.8 %  
Absorption correction Semi-empirical from equivalents 
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Max. and min. transmission 0.7535 and 0.6828 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3486 / 0 / 235 
Goodness-of-fit on F2 1.061 
Final R indices [I>2sigma(I)] R1 = 0.0280, wR2 = 0.0726 
R indices (all data) R1 = 0.0290, wR2 = 0.0734 
Absolute structure parameter (Flack) 0.04(4) 
Largest diff. peak and hole 0.158 and -0.181 e/Å-3 
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Table 4.10. Atomic Coordinates ( x 10
4
) and Equivalent Isotropic Displacement 
Parameters (Å
2
 x 10
3
) for Crystal02. U(eq) is defined as one third of the trace of the 
orthogonalized U
ij
 tensor. 
________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________ 
F(1) 1883(2) 3098(1) -253(1) 23(1) 
F(2) 4614(2) 3949(1) 181(1) 23(1) 
O(1) 4293(2) 5356(1) -544(1) 25(1) 
C(1) -1167(3) 4179(1) -1024(1) 21(1) 
C(2) -2795(3) 4277(1) -1456(1) 25(1) 
C(3) -2562(3) 5041(2) -1850(1) 27(1) 
C(4) -679(4) 5708(1) -1815(1) 27(1) 
C(5) 975(3) 5605(1) -1391(1) 23(1) 
C(6) 749(3) 4842(1) -989(1) 18(1) 
C(7) 2613(3) 4794(1) -546(1) 18(1) 
C(8) 2411(3) 4046(1) -52(1) 18(1) 
C(9) 621(3) 4361(1) 396(1) 17(1) 
C(10) 977(3) 5461(1) 551(1) 16(1) 
C(11) 2992(3) 5781(1) 839(1) 19(1) 
C(12) 3298(3) 6793(1) 964(1) 21(1) 
C(13) 1600(3) 7492(1) 810(1) 21(1) 
C(14) -401(3) 7179(1) 524(1) 22(1) 
C(15) -717(3) 6166(1) 394(1) 19(1) 
C(16) 719(3) 3646(1) 903(1) 20(1) 
C(17) -1172(3) 3896(1) 1344(1) 23(1) 
C(18) -1094(3) 3172(1) 1833(1) 20(1) 
C(19) -2859(3) 2457(1) 1908(1) 25(1) 
C(20) -2738(4) 1764(1) 2343(1) 30(1) 
C(21) -835(4) 1774(1) 2711(1) 30(1) 
C(22) 919(4) 2488(2) 2645(1) 28(1) 
C(23) 796(3) 3182(1) 2210(1) 24(1) 
________________________________________________________________________ 
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Table 4.11.  Bond Lengths [Å] and Angles [°] for Crystal02. 
_____________________________________________________  
F(1)-C(8)  1.3822(18) 
F(2)-C(8)  1.3698(18) 
O(1)-C(7)  1.211(2) 
C(1)-C(2)  1.386(2) 
C(1)-C(6)  1.401(2) 
C(2)-C(3)  1.388(3) 
C(3)-C(4)  1.390(3) 
C(4)-C(5)  1.382(3) 
C(5)-C(6)  1.400(2) 
C(6)-C(7)  1.491(2) 
C(7)-C(8)  1.545(2) 
C(8)-C(9)  1.527(2) 
C(9)-C(10)  1.524(2) 
C(9)-C(16)  1.536(2) 
C(10)-C(11)  1.396(2) 
C(10)-C(15)  1.393(2) 
C(11)-C(12)  1.391(2) 
C(12)-C(13)  1.389(2) 
C(13)-C(14)  1.384(3) 
C(14)-C(15)  1.396(2) 
C(16)-C(17)  1.535(2) 
C(17)-C(18)  1.511(2) 
C(18)-C(19)  1.392(2) 
C(18)-C(23)  1.394(2) 
C(19)-C(20)  1.387(3) 
C(20)-C(21)  1.388(3) 
C(21)-C(22)  1.383(3) 
C(22)-C(23)  1.389(3) 
 
C(2)-C(1)-C(6) 119.93(16) 
C(1)-C(2)-C(3) 120.33(17) 
C(2)-C(3)-C(4) 120.08(17) 
C(5)-C(4)-C(3) 119.95(17) 
C(4)-C(5)-C(6) 120.49(16) 
C(1)-C(6)-C(7) 124.17(15) 
C(5)-C(6)-C(1) 119.21(16) 
C(5)-C(6)-C(7) 116.62(15) 
O(1)-C(7)-C(6) 122.16(15) 
O(1)-C(7)-C(8) 116.94(15) 
C(6)-C(7)-C(8) 120.84(14) 
F(1)-C(8)-C(7) 109.98(12) 
F(1)-C(8)-C(9) 110.34(13) 
F(2)-C(8)-F(1) 104.46(12) 
F(2)-C(8)-C(7) 107.49(13) 
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F(2)-C(8)-C(9) 110.44(12) 
C(9)-C(8)-C(7) 113.69(13) 
C(8)-C(9)-C(16) 110.57(13) 
C(10)-C(9)-C(8) 110.17(13) 
C(10)-C(9)-C(16) 113.65(13) 
C(11)-C(10)-C(9) 121.34(14) 
C(15)-C(10)-C(9) 119.48(14) 
C(15)-C(10)-C(11) 119.17(15) 
C(12)-C(11)-C(10) 120.19(15) 
C(13)-C(12)-C(11) 120.46(16) 
C(14)-C(13)-C(12) 119.58(16) 
C(13)-C(14)-C(15) 120.33(15) 
C(10)-C(15)-C(14) 120.27(15) 
C(17)-C(16)-C(9) 112.08(13) 
C(18)-C(17)-C(16) 111.50(13) 
C(19)-C(18)-C(17) 120.90(15) 
C(19)-C(18)-C(23) 118.43(16) 
C(23)-C(18)-C(17) 120.63(15) 
C(20)-C(19)-C(18) 120.97(17) 
C(19)-C(20)-C(21) 120.07(18) 
C(22)-C(21)-C(20) 119.53(17) 
C(21)-C(22)-C(23) 120.38(18) 
C(22)-C(23)-C(18) 120.61(17) 
_____________________________________________________________  
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Table 4.12. Anisotropic Displacement Parameters (Å
2
 x 10
3
) for Crystal02. The 
anisotropic displacement factor exponent takes the form: -2π
2
[ h
2
 a*
2
U
11
 + ... + 2 h k a* b* 
U
12
 ] 
________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________ 
F(1) 27(1)  13(1) 29(1)  -4(1) 1(1)  0(1) 
F(2) 15(1)  24(1) 29(1)  0(1) -1(1)  5(1) 
O(1) 22(1)  24(1) 28(1)  -2(1) 3(1)  -7(1) 
C(1) 22(1)  20(1) 22(1)  -3(1) 3(1)  -1(1) 
C(2) 22(1)  27(1) 26(1)  -7(1) 0(1)  0(1) 
C(3) 28(1)  30(1) 24(1)  -4(1) -4(1)  8(1) 
C(4) 35(1)  22(1) 24(1)  2(1) 1(1)  5(1) 
C(5) 25(1)  18(1) 25(1)  -1(1) 4(1)  0(1) 
C(6) 19(1)  17(1) 20(1)  -4(1) 3(1)  2(1) 
C(7) 18(1)  16(1) 21(1)  -5(1) 5(1)  0(1) 
C(8) 14(1)  15(1) 24(1)  -4(1) -1(1)  0(1) 
C(9) 14(1)  17(1) 20(1)  -1(1) 0(1)  1(1) 
C(10) 14(1)  18(1) 17(1)  -1(1) 2(1)  1(1) 
C(11) 17(1)  20(1) 21(1)  -2(1) -3(1)  4(1) 
C(12) 20(1)  23(1) 22(1)  -2(1) -1(1)  -1(1) 
C(13) 25(1)  16(1) 22(1)  -2(1) 3(1)  0(1) 
C(14) 22(1)  19(1) 25(1)  0(1) 0(1)  6(1) 
C(15) 16(1)  20(1) 21(1)  -1(1) -1(1)  2(1) 
C(16) 19(1)  17(1) 22(1)  1(1) 1(1)  1(1) 
C(17) 21(1)  25(1) 24(1)  2(1) 2(1)  4(1) 
C(18) 19(1)  20(1) 21(1)  -2(1) 4(1)  2(1) 
C(19) 21(1)  25(1) 29(1)  -5(1) 3(1)  -1(1) 
C(20) 30(1)  22(1) 39(1)  -2(1) 14(1)  -5(1) 
C(21) 43(1)  24(1) 24(1)  3(1) 11(1)  5(1) 
C(22) 35(1)  31(1) 20(1)  -1(1) -2(1)  4(1) 
C(23) 24(1)  24(1) 25(1)  -3(1) 0(1)  -5(1) 
________________________________________________________________________
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Table 4.13.  Hydrogen Coordinates ( x 10
4
) and Isotropic Displacement Parameters (Å
2
 x 
10
3
) for Crystal02. 
________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________ 
H(1) -1351 3663 -751 25 
H(2) -4076 3818 -1484 30 
H(3) -3692 5109 -2143 33 
H(4) -527 6233 -2083 33 
H(5) 2274 6055 -1372 28 
H(9) -987 4298 225 20 
H(11) 4158 5307 948 23 
H(12) 4679 7006 1158 26 
H(13) 1810 8182 899 25 
H(14) -1565 7656 417 27 
H(15) -2092 5957 197 23 
H(16A) 488 2948 771 23 
H(16B) 2300 3688 1079 23 
H(17A) -918 4588 1485 28 
H(17B) -2753 3869 1167 28 
H(19) -4165 2443 1657 30 
H(20) -3961 1282 2389 36 
H(21) -736 1293 3005 36 
H(22) 2214 2503 2899 34 
H(23) 2010 3669 2169 29 
________________________________________________________________________ 
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4.6.5 1H NMR Spectra of Selected Compounds 
 
 
 
 
 
 
 
 
 
 
 
 
	 328 
	 329 
	 330 
 
	 331 
	 332 
	 333 
	 334 
	 335 
	 336 
	 337 
	 338 
	 339 
	 340 
	 341 
	 342 
	 343 
	 344 
	 345 
 
 
 
 
 
 
 
 
 
 
 
 
	 346 
4.7 Notes and References 
(1) For examples, see: (a) Nagib, D. A.; Scott, M. E.; MacMillan, D. W. C. J. Am. 
Chem. Soc. 2009, 131, 10875–10877. (b) Allen, A. E.; MacMillan, D. W. C. J. Am. 
Chem. Soc. 2010, 132, 4986–4987. 
(2) For examples, see: (a) Engman, M.; Cheruku, P.; Tolstoy P.; Bergquist, J.; 
Völker, S. F.; Andersson, P. G. Adv. Synth. Catal. 2009, 351, 375–378. (b) Dong, K.; Li, 
Y.; Wang, Z.; Ding, K. Angew. Chem. Int. Ed. 2013, 52, 14191–14195. 
(3) For examples, see: (a) Furukawa, T.; Nishimine, T.; Tokunaga, E.; Hasegawa, K.; 
Shiro, M.; Shibata, N. Org. Lett. 2011, 13, 3972–3975. (b) Li, Y.; Liang, F.; Li, Q.; Xu, 
Y.-c.; Wang, Q.-R.; Jiang, L. Org. Lett. 2011, 13, 6082–6085. (c) Nishimine, T.; Fukushi, 
K.; Shibata, N.; Taira, H.; Tokunaga, E.; Yamano, A.; Shiro, M.; Shibata, N. Angew. 
Chem. Int. Ed. 2014, 53, 517–520. 
(4) For examples, see: (a) Konno, T.; Tanaka, T.; Miyabe, T.; Morigaki, A.; Ishihara, 
T. Tetrahedron Lett. 2008, 49, 2106–2010. (b) Ogawa, S.; Yasui, H.; Tokunaga, E.; 
Nakamuna, S.; Shibata, N. Chem. Lett. 2009, 38, 1006–1007. (c) Huang, Y.; Tokunaga, 
E.; Suzuki, S.; Shiro, M.; Shibata, N. Org. Lett. 2010, 12, 1136–1138. (d) Wen, L.; Shen, 
Q.; Lu, L. Org. Lett. 2010, 12, 4655–4657. (e) Blay, G.; Fernández, I.; Muñoz, M. C.; 
Pedro, J. R.; Vila, C. Chem. Eur. J. 2010, 16, 9117–9122. (f) Huang, Y.; Suzuki, S.; Liu, 
G.; Tokunaga, E.; Shiro, M.; Shibata, N. New J. Chem. 2011, 35, 2614–2621. (g) Wen, 
L.; Shen, Q.; Wan, X.; Lu, L. J. Org. Chem. 2011, 76, 2282–2285. (h) Wang, W.; Lian, 
X.; Chen, D.; Liu, X.; Lin, L.; Feng, X. Chem. Commun. 2011, 47, 7821–7823. (i) Deng, 
H.-P.; Wei, Y.; Shi, M. Adv. Synth. Catal. 2012, 354, 783–789. (j) Kawai, H.; Sugita, Y.; 
Tokunaga, E.; Sato, H.; Shiro, M.; Shibata, N. Chem. Commun. 2012, 48, 3632–3634. (k) 
	 347 
Shibatomi, K.; Narayama, A.; Abe, Y.; Iwasa, S. Chem. Commun. 2012, 48, 7380–7382. 
(l) Morigaki, A.; Tanaka, T.; Miyabe, T.; Ishihara, T.; Konno, T. Org. Biomol. Chem. 
2013, 11, 586–595.  (m) Wen, L.; Yin, L.; Shen, Q.; Lu, L. ACS Catal. 2013, 3, 502–506. 
(n) Martinelli, E.; Vicini, A. C.; Mancinelli, M.; Mazzanti, A.; Zani, P.; Bernardi, L.; 
Fochi, M. Chem. Commun. 2015, 51, 658–660. (o) Massolo, E.; Benaglia, M.; Orlandi, 
M.; Rossi, S.; Celentano, G. Chem. Eur. J. 2015, 21, 3589–3595. 
(5) Dai, X.; Strotman, N. A.; Fu, G. C. J. Am. Chem. Soc. 2008, 130, 3302–3303. 
(6) Lou, S.; Fu, G. C. J. Am. Chem. Soc. 2010, 132, 1264–1266. 
(7) Choi, J.; Fu, G. C. J. Am. Chem. Soc. 2012, 134, 9102–9105. 
(8) Choi, J.; Martín-Gago, P.; Fu, G. C. J. Am. Chem. Soc. 2014, 136, 12161–12165. 
(9) For examples of enantioselective reactions wherein differentiation between a CF3 
and a CH3 group is achieved, see: (a) Feigl, D. M.; Mosher, H. S. Chem. Commun. 1965, 
615–616. (b) Ramachandran, P. V.; Teodorović, A. V.; Brown, H. C. Tetrahedron 1993, 
49, 1725–1738. (c) Ramachandran, P. V.; Gong, B.; Teodorović, A. V. J. Fluorine Chem. 
2007, 128, 844–850. (d) Jolley, K. E.; Zanotti-Gerosa, A.; Hancock, F.; Dyke, A.; 
Grainger, D. M.; Medlock, J. A.; Nedden, H. G.; Le Paih, J. J. M.; Roseblade, S. J.; 
Seger, A.; Sivakumar, V.; Prokes, I.; Morris, D. J.; Wills, M. Adv. Synth. Catal. 2012, 
354, 2545–2555. 
(10) For recent examples on the synthesis and utility of chlorodifluoromethyl- and 
difluorocarbonyl-containing compounds, see: (a) Salomon, P.; Zard, S. Z. Org. Lett. 
2014, 16, 2926–2929. (b) Han, C.; Salyer, A. E.; Kim, E. H.; Jiang, X.; Jarrard, R. E.; 
Powers, M. S.; Kirchhoff, A. M.; Salvador, T. K.; Chester, J. A.; Hockerman, G. H.; 
	 348 
Colby, D. A. J. Med. Chem. 2013, 56, 2456–2465. (c) Ge, S.; Arlow, S. I.; Mormino, M. 
G.; Hartwig, J. F. J. Am. Chem. Soc. 2014, 136, 14401–14404. 
(11) Li, X.; Feng, Z.; Jiang, Z.-X.; Zhang, X. Org. Lett. 2015, 17, 5570–5573. 
(12) Prepared from the corresponding acid anhydride, acid chloride, or ester, based on 
published procedures: (a) Regan, J. et al. J. Med. Chem. 2006, 49, 7887–7896. (b) 
Bergeron, M.; Johnson, T.; Paquin, J.-F. Angew. Chem. Int. Ed. 2011, 50, 11112–11116. 
(13) Bose, A. K.; Lal, B. Tetrahedron Lett. 1973, 14, 3937–3940. 
(14) Krishnamurti, R.; Bellew, D. R.; Prakash, G. K. S. J. Org. Chem. 1991, 56, 
984−989. 
(15) Lin, X.; Zheng, F.; Qing, F.-L. Organometallics 2012, 31, 1578–1582. 
(16) Ullmann, J.; Hanack, M. Synthesis 1989, 685–687. 
(17) Hanack, M.; Ullmann, J. J. Org. Chem. 1989, 54, 1432–1435. 
(18) Prepared according to a literature procedure: Yuan, H.; He, R.; Wan, B.; Wang, 
Y.; Pauli, G. F.; Franzblau, S. G.; Kozikowski, A. P. Bioorg. Med. Chem. Lett. 2008, 18, 
5311–5315. 
(19) Prepared according to a literature procedure: Shaikh, T. M.; Sudalai, A. Eur. J. 
Org. Chem. 2010, 3437–3444. 
(20) Prepared from 6-chlorohexan-1-ol and 1-(4-hydroxyphenyl)ethan-1-one. 
(21) Prepared from 6-chlorohexan-1-ol and 4-iodophenol. 
(22) Prepared from hexane-1,6-diol and furan-2-carbonyl chloride. 
(23) Prepared in two steps based on literature procedures: (a) Ammi, H.; Kobayashi, 
T.; Hatamoto, Y.; Uneyama, K. Chem. Commun. 1999, 1323–1324.  (b) Lefebvre, O.; 
Brigaud, T.; Portella, C. J. Org. Chem. 2001, 66, 1941–1946. 
	 349 
(24) Prepared according to a literature procedure: Welch, M.; Dutton, J. M.; 
Glansdorp, F. G.; Thomas, G. L.; Smith, D. S.; Coulthurst, S. J.; Barnard, A. M. L.; 
Salmond, G. P. C.; Spring, D. R. Bioorg. Med. Chem. Lett. 2005, 15, 4235–4238. 
(25) Kofron, W. G.; Baclawski, L. M. J. Org. Chem. 1976, 41, 1879−1880. 
(26) Krasovskiy, A.; Knochel, P. Synthesis 2006, 890−891. 
 
 
	 350 
CHAPTER 5 
Nickel-Catalyzed Asymmetric Suzuki Alkynylations of  
α-Halo-α-Trifluoromethyl Electrophiles 
 
 
5.1 Introduction 
In the last decade, our group has developed a series of enantioselective cross-
coupling methods of racemic secondary alkyl electrophiles with different families of 
nucleophiles. To date, we have demonstrated that sp3-hybridized nucleophiles, including 
primary alkyl and symmetrical secondary alkyl nucleophiles, and sp2-hybridized 
nucleophiles, including aryl and alkenyl nucleophiles, are suitable substrates for this type 
of reactions (Scheme 5.1a). One of the new directions in our group’s chemistry is to 
explore new types of nucleophilic cross-coupling partners. In this chapter, our effort 
towards the development of an enantioselective cross-coupling method employing a new 
class of nucleophiles, namely sp-hybridized alkynyl organoboron reagents, is described 
(Scheme 5.1b).  
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Scheme 5.1. Enantioselective Cross-Couplings with Alkynyl Nucleophiles 
R M
racemic
R2R1
X chiral nickel catalyst
R2R1
R
a. Previous studies:
b. This study:
enantioenriched
M R3
primary alkyl
M
secondary alkyl
M
aryl
M
R3
alkenyl
M
racemic
R2R1
X chiral nickel catalyst
R2R1
enantioenriched
R
alkynyl
R
 
 
 Chiral molecules bearing an alkynyl-substituted tertiary stereocenter are valuable 
building blocks due to the versatility of the alkynyl functional groups.1 Cross-couplings 
of a secondary alkyl electrophile and an alkynyl organometallic reagent is one of the most 
straightforward approaches to construct such a stereocenter (Scheme 5.1b). However, 
although non-asymmetric cross-coupling methods using secondary alkyl electrophiles and 
alkynyl nucleophiles have been reported with a number of different transition-metal 
catalysts2 (including nickel catalysts3), the enantioselective version of this transformation 
has been largely underdeveloped. In 2008, Sestelo, Sarandeses, and co-workers reported 
an nickel-catalyzed asymmetric alkynylation method employing secondary benzylic 
bromides and alkynylindium reagents (eq 5.1).4 The yield and enantioselectivity of this 
method are moderate and the scope with respect to the electrophiles is quite limited. 
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Additionally, the cross-coupling conditions used by these researchers are actually first 
disclosed by our group in 2005 for an enantioselective Negishi alkylation method.5 
In Ph 3
10% NiBr2•diglyme
13% (S)-(i-Pr)-Pybox
DMA/THF, r.t.
140 h0.4 equiv
O
N
N
N
O
i-Pr i-Pr
(S)-(i-Pr)-Pybox
Br
Me Me
Ph
racemic 70% yield
84% ee
(5.1)
 
 
 Despite these drawbacks, this study is still the only reported method using an 
alkynyl nucleophile in enantioselective cross-coupling reactions. In order to investigate 
the field of asymmetric alkynylation cross-coupling and also further explore the utilities 
of fluorine-containing electrophiles, we decided to start our studies by choosing α-
bromo-α-trifluoromethyl secondary electrophiles as our model substrates. The success of 
such a transformation will provide a convenient approach for the synthesis of chiral 
building blocks bearing a trifluoromethyl-substituted propargylic stereocenter.6 
M
racemic
R1F3C
Br chiral nickel catalyst
R1F3C
enantioenriched
R
R
(5.2)
 
 
5.2 Optimization 
 We started our journey by conducting a variety of screenings using alkynyllzinc 
and alkynyl Grignard reagents as nucleophiles. Unfortunately, we cannot identify a 
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suitable condition (>20% yield) to continue further optimization. By switching the 
nucleophilic cross-coupling partner to an alkynylboron reagent which is in situ generated 
from the corresponding alkynyllithium reagent and B(OMe)3, we quickly obtained a 
promising lead. In a ligand screening, we observed that performing the reaction with a 
chiral cyano-substituted bis(oxazoline) ligand L4 generates the cross-coupling product in 
low yield but moderate enantioselectivity (Scheme 5.2). 
 
Scheme 5.2. Preliminary Results from a Ligand Screening 
1.0 equiv
10% NiCl2•glyme
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N N
O
Ph Ph
PhPh
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N N
O
MeMe
Ph Ph
MeHN
Ph Ph
NHMe
O
N HN
O
Ph Ph
CN
O
N N
O
i-Pr i-Pr
4% yield
–9% ee
5% yield
–2% ee
15% yield
–59% ee
<1% yield
(S,S)–L4
12% yield
72% ee
6% yield
30% ee
B(OMe)3Li
Ph
A negative ee value signifies that the major product of the reaction is the 
opposite (S) enantiomer.  
 
 Further optimization was performed to increase the efficiency and 
stereoselectivity based on these results. Finally, we identified a suitable condition to 
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deliver the cross-coupling product in good yield and enantioselectivity (Table 5.1, entry 
1). The impact of reaction parameters on the efficiency of this transformation is provided 
in Table 5.1. 
 
Table 5.1. Effect of Reaction Parametersa 
entry variation from the "standard" conditions ee (%) yield (%)b
1
2
3
4
5
6
7
8
9
10
none
no NiCl2•glyme
no (S,S)–L4
no LiCl
no DMA
1.0 equiv of nucleophile
1% NiCl2•glyme, 1.2% (S,S)–1
r.t., instead of 0 ºC
+ 0.1 equiv H2O
in a closed vial under air
aAll data are the average of two experiments. bYields determined by 19F NMR analysis 
versus an internal standard.
92
–
–
91
92
92
92
90
92
92
88
<2
3
67
68
75
78
79
88
87
Ph
B(OMe)3Li
5% NiCl2•glyme
6% (S,S)–L4
1 equiv LiCl
20 equiv DMA
DME, 0 ºC
"standard conditions"
F3C
Br
Ph
F3C Ph
1.2 equiv
Ph
racemic
 
 
 Essentially no bond-formation can be observed without the nickel source or the 
ligand L4 (entries 2 and 3). The addition of both LiCl and DMA leads to increased yield 
for the transformation without any changes in enantioselectivity (entries 4 and 5). The use 
of a smaller amount of nucleophile or catalyst or performing the reaction at room 
temperature leads to slightly decreased efficiency (entries 6, 7, and 8). To our delight, the 
optimized condition is not very sensitive to a small amount of water or air (entries 9 and 
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10). From a practical perspective, both the nickel source and the ligand L4 are 
commercially available and air-stable. 
 The chiral ligand L4 is very crucial for the success of this transformation. A 
number of other bidentated and tridentated chiral ligands have been surveyed under the 
optimized conditions and none of them can provide comparable efficiency (Scheme 5.3). 
Previously, we have never employed this family of chiral bis(oxazoline) ligands in any of 
our asymmetric nickel-catalyzed cross-coupling methods.7 Thus, this study introduced 
this new family of ligand to our system. 
 
Scheme 5.3. Effect of Ligands 
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	 356 
5.3 Scope 
 With the optimized conditions in hand, we started to explore the scope of this new 
method. As shown in Table 5.2, it is delighted that a number of alkyl-substituted alkynyl 
nucleophiles are suitable substrates for this transformation (entries 1 to 5). Functional 
groups including a primary alkyl chloride (entry 3) and a tertiary amine (entry 4) can both 
be tolerated. Also, a nucleophile bearing a terminal silyl protecting group is able to 
deliver the product in good yield and enantioselectivity (entry 6).  
 
Table 5.2. Scope with Respect to the Nucleophile: Part Ia 
R1 B(OMe)3Li
5% NiCl2•glyme
6% (S,S)–L4
1 equiv LiCl
20 equiv DMA
DME, 0 ºC
F3C
Br
F3C
R1
1.2 equivracemic
entry R1 ee (%) yield (%)b
Ph
Ph
Cl
92 86
92 86
93 81
Me2N 91 80
94 78
TIPS 93 93
Ph
Ph
1
2
3
4c
5
6d
aAll data are the average of two experiments. b  Yield of purified product.
c10% NiCl2•glyme, 12% (S,S)–L4. dReaction temperature: r.t.  
 
 Moreover, the current method can also be applied to aryl- and alkenyl-substituted 
alkynyl nucleophiles (Table 5.3). High enantioselectivity and yield are uniformly 
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obtained whether the aromatic ring is para- (entries 2 to 4), meta- (entries 5 and 6), and 
ortho-substituted (entry 7), and whether it is electron-poor or electron-rich. Nucleophiles 
containing a naphthalene ring (entry 8) and a thiophene ring (entry 9) are both applicable 
under our optimized conditions.  
 
Table 5.3. Scope with Respect to the Nucleophile: Part IIa 
R1 B(OMe)3Li
5% NiCl2•glyme
6% (S,S)–L4
1 equiv LiCl
20 equiv DMA
DME, 0 ºC
F3C
Br
R
F3C R
R1
1.2 equivracemic
entry R1 ee (%) yield (%)bR
CH2CH2Ph
CH2CH2Ph
CH2CH2Ph
CH2CH2Ph
CH2CH2Ph
CH2CH2Ph
CH2CH2Ph
n-Oct
Ph 94 98
X
94 94
94 99
93 92
X
X = Cl
OMe
NMe2
CH2CH2Ph
CH2CH2Ph
X = F
OMe
94 80
95 99
MeO 94 97
S
94 62
95 91
MeO
Me
93 97
1
2c
5c
6
8
10
7
9d
3
4
aAll data are the average of two experiments. b  Yield of purified product.
cReaction temperature: 10 ºC. d10% NiCl2•glyme, 12% (S,S)–L4.  
 
	 358 
Table 5.4. Scope with Respect to the Electrophilea 
R1 B(OMe)3Li
5% NiCl2•glyme
6% (S,S)–L4
1 equiv LiCl
20 equiv DMA
DME, 0 ºC
F3C
Br
R
F3C R
R1
1.2 equivracemic
entry R1 ee (%) yield (%)bR
n-Oct MeO
aAll data are the average of two experiments. b  Yield of purified product. 
c10% NiCl2•glyme, 12% (S,S)–L4.
92 94
OTBDPS
Cl
O
O
Me
O
I
O
O
O
N Boc
PhCH2CH2
PhCH2CH2
MeO
Ph
MeO
MeO
91 78
92 84
93 97
94 87
97 97
94 87
1
2
3
4
5c
6
7c
 
 
 The scope with respect to the electrophile is also fairly broad (Table 5.4). An 
array of synthetically useful functional groups including a silyl ether (entry 2), a primary 
alkyl chloride (entry 3), an aromatic ketone (entry 4), an aryl iodide (entry 5), a 
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carbamate (entry 6), a furan ring (entry 7), and an ester (entry 7) can all be compatible 
with our conditions. 
 Although initially we optimized the reactions using an alkyl bromide as 
electrophile, we are glad that an alkyl iodide is also a suitable substrate for this 
transformation (eq 5.3). 
Ph
B(OMe)3Li
5% NiCl2•glyme
6% (S,S)–L4
1 equiv LiCl
20 equiv DMA
DME, 0 ºC
F3C
I
Ph
F3C Ph
1.2 equiv
Ph
racemic
86% yield
92% ee
(5.3)
 
 The scalability of this method is quite satisfactory. As shown in eq 5.4, a 4.5-
mmol scale cross-coupling reaction is performed in the presence of 3% catalyst. More 
than 1 gram of product can still be generated in good yield and enantioselectivity. 
Ph
B(OMe)3Li
3% NiCl2•glyme
3.6% (S,S)–L4
1 equiv LiCl
20 equiv DMA
DME, 0 ºC
F3C
Br
Ph
F3C Ph
1.2 equiv
Ph
racemic
4.5 mmol
1.21 g
85% yield
93% ee
(5.4)
 
 Similar to the findings in Chapter 4, the current method is not limited to cross-
couple CF3-substituted electrophiles. Racemic secondary electrophiles bearing a 
perfluoroethyl group (eq 5.5), a perfluoropropyl group (eq 5.6), and a CF2COPh group 
(eq 5.7) can all be suitable substrates for this transformation under our standard 
conditions. 
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Ph
B(OMe)3Li
5% NiCl2•glyme
6% (S,S)–L4
1 equiv LiCl
20 equiv DMA
DME, 0 ºC
F3CF2C
Br
Ph
F3CF2C Ph
1.2 equiv
Ph
racemic
87% yield
99% ee
(5.5)
 
Ph
B(OMe)3Li
5% NiCl2•glyme
6% (S,S)–L4
1 equiv LiCl
20 equiv DMA
DME, 0 ºC
n-C3F7
Br
Ph
n-C3F7 Ph
1.2 equiv
Ph
racemic
84% yield
98% ee
(5.6)
 
Ph B(OMe)3Li
10% NiCl2•glyme
12% (S,S)–L4
1 equiv LiCl
20 equiv DMA
DME, 0 ºC
Br
Ph
1.2 equiv
racemic
95% yield
98% ee
F F
Ph
O
Ph
F F
Ph
O
Ph
(5.7)
 
 
5.4 Preliminary Results of Asymmetric Alkynylations of Other Alkyl Electrophiles 
 Serving as a proof-of-concept, the current Suzuki alkynylation protocol 
successfully demonstrates that alkynyl nucleophiles can be employed in nickel-catalyzed 
asymmetric cross-coupling processes. However, we are more interested in developing 
asymmetric alkynylations methods using other families of electrophiles. Some of our 
preliminary results are presented in Table 5.5. 
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Table 5.5. Scope with Respect to Other Alkyl Electrophilesa 
5% NiCl2•glyme
6% (S,S)–L4
1 equiv LiCl
20 equiv DMA
DME, 0 ºC
R
Br
R1
1.2 equivracemic
entry electrophile ee (%) yield (%)b
98 89
93 85
85 88
97 80
87 93
91 83
1
2
3c
4c
5
6c
aAll data are the average of two experiments. b  Yield of purified product.
cNo LiCl. d10% NiCl2•glyme, 12% (S,S)–L4.
Ph
B(OMe)3Li
R R1
Ph
O
Br
EtEtO
O
Br
EtO Me
Me
N
O
BrPh
O
Br
EtN
H
St-Bu
O O
I
S n-Bu
Br
N
O O
Me
Me
S n-Bu
Br
Ph
O O
7c,d 86 96
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We were very delighted to observe that our standard conditions can be applied to 
cross-couple an α-bromo sulfone (entry 1) and an α-bromo sulfonamide (entry 2). α-
Bromo esters (entries 3 and 4) are also feasible substrates under slightly modified 
conditions (without the addition of LiCl). A sterically more hindered electrophile also 
cross-couples in good efficiency and excellent enantioselectivity (entry 4).8 Moreover, an 
α-bromo secondary amide (entry 5) and an α-bromo lactam can also cross-couple with 
the nucleophile in good yield and enatioselectivity. This is the first time that we apply an 
asymmetric cross-coupling protocol to these families of electrophiles. Finally, it is even 
more surprising to observe that the current method can cross-couple an unactivated 
secondary alkyl iodide. This is also the first time in our studies that an asymmetric cross-
coupling method can be applied to both activated and unactivated racemic secondary 
alkyl electrophiles. 
 
5.5 Conclusions 
 In summary, the first enantioselective Suzuki alkynylation method of secondary 
alkyl electrophiles has been described in this chapter. In the presence of commercially 
available catalysts and nucleophiles that can be easily prepared from readily available 
terminal alkynes, an array of α-bromo-α-trifluoromethyl secondary electrophiles cross-
couple with a variety of alkynylboron nucleophiles to generate products in good 
efficiency and excellent stereoselectivity. Furthermore, the generality of this protocol has 
been examined using other alkyl electrophiles. Our preliminary studies have shown that 
the current method is quite general for the construction of a variety of tertiary 
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stereocenters bearing an alkynyl group. Further studies to disclose the full scope of this 
method and also examine the mechanism of these transformations are underway.  
 
5.6 Experimental Section 
5.6.1 General Information 
The following reagents were purchased and used as received: NiCl2•glyme 
(Strem), B(OMe)3 (Aldrich; ≥99.5%), DMA (Aldrich; anhydrous), LiCl (Alfa Aesar; 
ultra dry, ≥99.995%), n-BuLi (Aldrich; ~2.5 M in hexanes; titrated using diphenylacetic 
acid according to Kofron’s method9). All terminal alkynes were purchased (Aldrich, Alfa 
Aesar, TCI, Oakwood, Ak Scintific and Combi-Blocks) and used as received. Anhydrous 
DME was purified and dried using a solvent-purification system that contained activated 
alumina. Ligand (S,S)–L4 was purchased from Aldrich and used as received. Ligand 
(R,R)–L4 was synthesized according to a literature procedure.10 
All reactions were carried out in oven-dried glassware under an inert atmosphere. 
HPLC analyses were carried out on an Agilent 1100 Series system, using Daicel 
CHIRALCEL® columns or Daicel CHIRALPAK® columns (internal diameter 4.6 mm, 
column length 250 mm, particle size 5 µm). 
1H NMR data and 13C NMR data were collected on a Varian 500 MHz 
spectrometer at ambient temperature. 19F NMR data were collected on a Varian 300 MHz 
spectrometer at ambient temperature. 
 
5.6.2 Preparation of Electrophiles 
These procedures have not been optimized. 
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 All of the fluorinated electrophiles are prepared according to literature 
procedures.11 
 All of the electrophiles shown in Table 5.5 are prepared according to literature 
procedures12 or purchased and used as received. 	 	 	 	 	  
5.6.3 Enantioselective Suzuki Cross-Couplings 
Preparation of alkynylboron reagents (0.47 M):  
In the air, an oven-dried 20 mL vial equipped with a stir bar was charged with the 
alkyne (2.0 mmol) and closed with a PTFE septum cap. The vial was evacuated and 
back-filled with nitrogen (three cycles), and then DME (2 mL) was added to this vial. 
A solution of n-BuLi (2.54 M; 0.79 mL, 2.0 mmol; 1.0 equiv) was added over 1 
min to this 20-mL vial, which had been cooled to 0 °C for 10 min. The mixture was 
allowed to stir at 0 °C for another 5 min and then warmed to room temperature. After 
stirring at room temperature for 10 min, DME was added to produce a total volume of 4.0 
mL (0.5 M). Next, B(OMe)3 (0.25 mL; 2.2 mmol; 1.1 equiv) was added to the 
alkynyllithium solution to provide an alkynylboron solution (0.47 M). The mixture was 
allowed to stir for 30 min at room temperature and used directly in the cross-coupling 
reaction. 
 
General procedure for asymmetric alkynylation:  
Preparation of a catalyst–ligand stork solution. 
In the air, NiCl2⋅glyme (6.6 mg, 0.060 mmol) and (R,R)–L4 (12 mg, 0.072 mmol) 
were added to an oven-dried 4 mL vial equipped with a stir bar. The vial was closed with 
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a PTFE septum cap and the evacuated and back-filled with nitrogen three times. DME 
(1.5 mL) was added to the 4 mL vial and the mixture was vigorously stirred at room 
temperature for 30 min. 
Asymmetric Suzuki alkynylation. 
In the air, the electrophile (0.50 mmol) and LiCl (21 mg, 0.50 mmol; 1.0 equiv) 
were added to an oven-dried 20 mL vial equipped with a stir bar. The vial was closed 
with a PTFE septum cap and then evacuated and back-filled with nitrogen three times. 
DMA (0.93 mL, 10 mmol; 20 equiv) and DME (1.25 mL) were added to this 20 mL vial. 
The catalyst–ligand stork solution (1.25 mL; 0.050 mmol NiCl2⋅glyme and 0.060 mmol 
(R,R)–L4) was added to the same vial and the mixture was allowed to stir at room 
temperature for 1 min. Next, this 20 mL vial was wrapped with electrical tape and cooled 
to 0 °C. Meanwhile, a 20 mL vial that contained the solution of the alkynylboron reagent 
was also cooled to 0 °C. Nitrogen-filled balloons were attached to both of the vials. To 
the vigorously stirred solution of catalyst and electrophile was added the solution of the 
alkynylboron reagent (0.47 M; 1.3 mL, 0.60 mmol; 1.2 equiv) over 1 min. The balloons 
were removed and the puncture hole in the septum cap was covered with grease. The 
mixture was stirred vigorously at 0 °C for 4 to 24 hours, and then MeOH (1 mL) was 
added to the reaction mixture. The resulting mixture was allowed to warm to room 
temperature, and then it was diluted with Et2O (100 mL) and washed with deionized 
water (20 mL × 3). The organic layer was dried over Na2SO4, filtered, and then 
concentrated, and the crude material was purified by flash chromatography. 
A second run was performed with (S,S)–L4. 
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F3C Ph
Ph
 
(R)-(5-(Trifluoromethyl)hept-3-yne-1,7-diyl)dibenzene (Table 5.2, entry 1). 
(3-Bromo-4,4,4-trifluorobutyl)benzene (134 mg, 0.50 mmol) and an alkynylboron 
reagent prepared from but-3-yn-1-ylbenzene were used. The reaction was run at 0 ºC for 
4 h. Solvent system for chromatography: 10:1 hexane/dichloromethane. The title 
compound was isolated as a colorless oil. 
Run 1, 135 mg (85% yield, 92% ee); Run 2, 137 mg (87% yield, 92% ee). 
This compound was also prepared on a 4.5 mmol scale (eq 5.4), using (3-Bromo-
4,4,4-trifluorobutyl)benzene (1.2 g, 4.5 mmol) and an alkynylboron reagent prepared 
from but-3-yn-1-ylbenzene (0.47 M; 11.5 mL, 5.4 mmol; 1.2 equiv). Following the 
General Procedure using 3.0% NiCl2⋅glyme (30 mg, 0.14 mmol) and 3.6% (S,S)–L4 (54 
mg, 0.16 mmol), the title compound was isolated in 85% yield (1.21 g) and 93% ee. 
The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 9.4 min (major), 13.6 
min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.37 – 7.31 (m, 4H), 7.31 – 7.23 (m, 4H), 7.20 – 
7.16 (m, 2H), 3.04 – 2.86 (m, 1H), 2.93 – 2.85 (m, 3H), 2.66 (dt, 1H, J = 13.8, 8.5 Hz), 
2.60 (td, 1H, J = 7.4, 2.3 Hz), 2.06 – 1.98 (m, 1H), 1.97 – 1.88 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 140.38, 140.37, 128.50, 128.49, 128.47, 128.4, 
126.3, 126.2, 125.5 (q, J = 280.3 Hz), 85.0, 73.6 (q, J = 3.5 Hz), 37.0 (q, J = 30.2 Hz), 
34.8, 32.4, 30.1 (d, J = 1.7 Hz), 20.8; 
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19F NMR (282 MHz, CDCl3) δ −71.3 (d, 3F, J = 8.0 Hz); 
FT-IR (film) 3028, 2932, 2243, 1604, 1497, 1454, 1260, 1165, 1118, 750, 698 
cm-1; 
GC-MS (EI) m/z (M+) calcd for C20H19F3: 316, found: 316; 
[α]25D = +86° (c = 1.0, CHCl3); 92% ee, from (R,R)-L4. 
 
F3C Ph
Ph
 
(R)-(3-(Trifluoromethyl)oct-4-yne-1,8-diyl)dibenzene (Table 5.2, entry 2). (3-
Bromo-4,4,4-trifluorobutyl)benzene (134 mg, 0.50 mmol) and an alkynylboron reagent 
prepared from pent-4-yn-1-ylbenzene were used. The reaction was run at 0 ºC for 16 h. 
Solvent system for chromatography: 10:1 hexane/dichloromethane. The title compound 
was isolated as a colorless oil. 
Run 1, 140 mg (85% yield, 92% ee); Run 2, 143 mg (87% yield, 92% ee). 
The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 7.2 min (minor), 7.9 min 
(major). 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.29 (m, 4H), 7.27 – 7.20 (m, 6H), 3.10 – 
2.95 (m, 2H), 2.81 – 2.73 (m, 3H), 2.28 (td, 2H, J = 7.0, 2.3 Hz), 2.10 – 1.85 (m, 4H); 
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13C NMR (126 MHz, CDCl3) δ 141.4, 140.4, 128.55, 128.51, 128.46, 128.38, 
126.3, 125.9, 125.5 (q, J = 280.1 Hz), 85.4, 73.4 (q, J = 3.5 Hz), 37.0 (q, J = 30.2 Hz), 
34.7, 32.5, 30.22, 30.16, 18.0; 
19F NMR (282 MHz, CDCl3) δ −71.4 (d, 3F, J = 8.0 Hz); 
FT-IR (film) 3063, 3027, 2940, 2862, 2242, 1603, 1497, 1454, 1259, 1165, 1117, 
747, 698 cm-1; 
GC-MS (EI) m/z (M+) calcd for C21H21F3: 330, found: 330; 
[α]25D = −60° (c = 1.0, CHCl3); 92% ee, from (S,S)-L4. 
 
F3C Ph
Cl
 
(R)-(9-Chloro-3-(trifluoromethyl)non-4-yn-1-yl)benzene (Table 5.2, entry 3). 
(3-Bromo-4,4,4-trifluorobutyl)benzene (134 mg, 0.50 mmol) and an alkynylboron 
reagent prepared from 6-chlorohex-1-yne were used. The reaction was run at 0 ºC for 12 
h. Solvent system for chromatography: 10:1 hexane/dichloromethane. The title 
compound was isolated as a colorless oil. 
Run 1, 123 mg (81% yield, 93% ee); Run 2, 121 mg (80% yield, 93% ee). 
The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 6.6 min (minor), 7.5 min 
(major). 
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1H NMR (500 MHz, CDCl3) δ 7.34 – 7.29 (m, 2H), 7.25 – 7.20 (m, 3H), 3.60 (t, 
2H, J = 6.5 Hz), 3.05 – 2.91 (m, 2H), 2.73 (dt, 1H, J = 13.8, 8.5 Hz), 2.31 (td, 2H, J = 
7.0, 2.3 Hz), 2.07 – 1.98 (m, 1H), 1.98 – 1.89 (m, 3H), 1.76 – 1.69 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 140.3, 128.6, 128.4, 126.3, 125.5 (q, J = 280.1 
Hz), 84.9, 73.5 (q, J = 3.6 Hz), 44.5, 37.0 (q, J = 30.2 Hz), 32.5, 31.4, 30.1, 25.7, 17.9; 
19F NMR (282 MHz, CDCl3) δ −71.4 (d, 3F, J = 8.0 Hz); 
FT-IR (film) 2942, 2243, 1455, 1259, 1164, 1117, 751, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H18ClF3: 302, found: 302; 
[α]25D = −76° (c = 1.0, CHCl3); 93% ee, from (S,S)-L4. 
 
F3C Ph
N
Me
Me
 
(R)-N,N-Dimethyl-6-phenyl-4-(trifluoromethyl)hex-2-yn-1-amine (Table 5.2, 
entry 4). (3-Bromo-4,4,4-trifluorobutyl)benzene (134 mg, 0.50 mmol) and an 
alkynylboron reagent prepared from N,N-dimethylprop-2-yn-1-amine were used. 10% 
NiCl2⋅glyme (11 mg, 0.050 mmol) and 12% L4 (20 mg, 0.060 mmol) were used. The 
reaction was run at 0 ºC for 16 h. Solvent system for chromatography: 1:1 hexane/ethyl 
acetate. The title compound was isolated as a yellow oil. 
Run 1, 107 mg (79% yield, 91% ee); Run 2, 110 mg (81% yield, 91% ee). 
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The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 12.5 min (minor), 18.6 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.29 (m, 2H), 7.25 – 7.20 (m, 3H), 3.34 (d, 
2H, J = 2.0 Hz), 3.12 – 3.02 (m, 1H), 2.97 (ddd, 1H, J = 13.8, 8.8, 4.9 Hz), 2.75 (dt, 1H, J 
= 13.8, 8.5 Hz), 2.33 (s, 6H), 2.10 – 1.93 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 140.2, 128.6, 128.4, 126.4, 125.4 (q, J = 280.1 
Hz), 80.3, 77.9 (q, J = 3.4 Hz), 47.9, 44.0, 37.0 (q, J = 30.3 Hz), 32.5, 30.0; 
19F NMR (282 MHz, CDCl3) δ −71.2 (d, 3F, J = 7.9 Hz); 
FT-IR (film) 2941, 2860, 2823, 2778, 1604, 1497, 1454, 1259, 1164, 1118, 1035, 
698 cm-1; 
GC-MS (EI) m/z (M+) calcd for C15H18F3N: 269, found: 269; 
[α]25D = +74° (c = 1.0, CHCl3); 91% ee, from (R,R)-L4. 
 
F3C Ph  
(R)-(5-Cyclohexyl-3-(trifluoromethyl)pent-4-yn-1-yl)benzene (Table 5.2, 
entry 5). (3-Bromo-4,4,4-trifluorobutyl)benzene (134 mg, 0.50 mmol) and an 
alkynylboron reagent prepared from ethynylcyclohexane were used. The reaction was run 
at 0 ºC for 17 h. Solvent system for chromatography: hexane. The title compound was 
isolated as a colorless oil. 
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Run 1, 113 mg (77% yield, 93% ee); Run 2, 116 mg (79% yield, 94% ee). 
The ee was determined on an OD-H column (hexane, flow rate 0.3 ml/min); 
retention times for compound obtained using (S,S)-L4: 18.5 min (minor), 19.4 min 
(major). 
1H NMR (500 MHz, CD3CN) δ 7.33 – 7.29 (m, 2H), 7.26 – 7.20 (m, 3H), 3.20 – 
3.10 (m, 1H), 2.93 (ddd, 1H, J = 13.9, 9.3, 4.7 Hz), 2.78 – 2.70 (m, 1H), 2.52 – 2.44 (m, 
1H), 2.02 (dddd, 1H, J = 13.2, 9.3, 7.8, 4.0 Hz), 1.90 – 1.76 (m, 3H), 1.75 – 1.66 (m, 2H), 
1.55 – 1.42 (m, 3H), 1.42 – 1.31 (m, 3H); 
13C NMR (126 MHz, CD3CN) δ 141.7, 129.5, 129.4, 127.2, 126.9 (q, J = 279.1 
Hz), 91.0, 73.7, 37.6 (q, J = 29.9 Hz), 33.2, 33.1, 31.1 (d, J = 1.6 Hz), 29.5, 26.5, 25.3; 
19F NMR (282 MHz, CD3CN) δ −72.1 (d, 3F, J = 8.3 Hz); 
FT-IR (film) 2931, 2855, 2242, 1497, 1450, 1260, 1165, 1118, 698 cm-1; 
GC-MS (EI) m/z (M+) calcd for C18H21F3: 294, found: 294; 
[α]25D = −83° (c = 1.0, CHCl3); 94% ee, from (S,S)-L4. 
 
F3C Ph
TIPS
 
(R)-Triisopropyl(5-phenyl-3-(trifluoromethyl)pent-1-yn-1-yl)silane (Table 
5.2, entry 6). (3-Bromo-4,4,4-trifluorobutyl)benzene (134 mg, 0.50 mmol) and an 
alkynylboron reagent prepared from ethynyltriisopropylsilane were used. The reaction 
was run at r.t. for 4 h. Solvent system for chromatography: hexane. The title compound 
was isolated as a colorless oil. 
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Run 1, 170 mg (92% yield, 92% ee); Run 2, 174 mg (94% yield, 93% ee). 
The ee was determined on an OD-H column (hexane, flow rate 0.3 ml/min); 
retention times for compound obtained using (S,S)-L4: 14.2 min (minor), 15.1 min 
(major). 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.29 (m, 2H), 7.26 – 7.21 (m, 3H), 3.12 – 
2.96 (m, 2H), 2.79 (dt, 1H, J = 13.8, 8.6 Hz), 2.10 – 1.94 (m, 2H), 1.13 – 1.11 (m, 21H); 
13C NMR (126 MHz, CDCl3) δ 140.3, 128.6, 128.5, 126.4, 125.3 (q, J = 280.0 
Hz), 100.1 (q, J = 3.3 Hz), 86.9, 37.9 (q, J = 30.4 Hz), 32.5, 30.2 (d, J = 1.7 Hz), 18.5, 
11.1; 
19F NMR (282 MHz, CDCl3) δ −71.2 (d, 3F, J = 7.9 Hz); 
FT-IR (film) 2944, 2892, 2866, 2184, 1462, 1259, 1167, 1121, 883, 701, 679, 666 
cm-1; 
GC-MS (EI) m/z (M+−C3H7) calcd for C18H24F3Si: 325, found: 325; 
[α]25D = −80° (c = 1.0, CHCl3); 93% ee, from (S,S)-L4. 
 
F3C Ph
Ph
 
(R)-(3-(Trifluoromethyl)pent-1-yne-1,5-diyl)dibenzene (Table 5.3, entry 1). 
(3-Bromo-4,4,4-trifluorobutyl)benzene (134 mg, 0.50 mmol) and an alkynylboron 
reagent prepared from ethynylbenzene were used. The reaction was run at 0 ºC for 12 h. 
Solvent system for chromatography: 50:1 hexane/dichloromethane. The title compound 
was isolated as a colorless oil. 
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Run 1, 140 mg (97% yield, 94% ee); Run 2, 141 mg (98% yield, 94% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
ml/min); retention times for compound obtained using (S,S)-L4: 14.0 min (minor), 15.6 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.55 – 7.51 (m, 2H), 7.40 – 7.33 (m, 5H), 7.30 – 
7.25 (m, 2H), 3.34 – 3.23 (m, 1H), 3.06 (ddd, 1H, J = 13.7, 8.6, 5.0 Hz), 2.86 (dt, 1H, J = 
13.9, 8.5 Hz), 2.22 – 2.06 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 140.2, 131.9, 128.7, 128.6, 128.5, 128.3, 126.4, 
125.3 (q, J = 280.4 Hz), 122.3, 85.3, 81.9 (q, J = 3.5 Hz), 37.6 (q, J = 30.5 Hz), 32.5, 
30.0; 
19F NMR (282 MHz, CDCl3) δ −70.9 (d, 3F, J = 7.9 Hz); 
FT-IR (film) 3028, 2939, 1600, 1491, 1444, 1256, 1163, 1118, 755, 690 cm-1; 
GC-MS (EI) m/z (M+) calcd for C18H15F3: 288, found: 288; 
[α]25D = +140° (c = 1.0, CHCl3); 94% ee, from (R,R)-L4. 
 
F3C Ph
Cl
 
(R)-1-Chloro-4-(5-phenyl-3-(trifluoromethyl)pent-1-yn-1-yl)benzene (Table 
5.3, entry 2). (3-Bromo-4,4,4-trifluorobutyl)benzene (134 mg, 0.50 mmol) and an 
alkynylboron reagent prepared from 1-chloro-4-ethynylbenzene were used. The reaction 
	 374 
was run at 10 ºC for 16 h. Solvent system for chromatography: 50:1 
hexane/dichloromethane. The title compound was isolated as a light-yellow oil. 
Run 1, 150 mg (93% yield, 94% ee); Run 2, 151 mg (94% yield, 94% ee). 
The ee was determined on an OD-H column (hexane, flow rate 0.5 ml/min); 
retention times for compound obtained using (S,S)-L4: 34.6 min (major), 38.1 min 
(minor). 
1H NMR (500 MHz, CDCl3) δ 7.46 – 7.42 (m, 2H), 7.37 – 7.32 (m, 4H), 7.28 – 
7.24 (m, 3H), 3.30 – 3.24 (m, 1H), 3.04 (ddd, 1H, J = 13.7, 8.6, 5.0 Hz), 2.83 (dt, 1H, J = 
13.9, 8.4 Hz), 2.22 – 2.06 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 140.1, 134.1, 133.1, 128.7, 128.6, 128.5, 126.4, 
125.2 (q, J = 280.3 Hz), 120.7, 84.2, 82.9 (q, J = 3.5 Hz), 37.6 (q, J = 30.5 Hz), 32.5, 
29.9; 
19F NMR (282 MHz, CDCl3) δ −70.8 (d, 3F, J = 7.9 Hz); 
FT-IR (film) 3028, 2939, 1490, 1257, 1163, 1120, 1092, 1015, 828, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C18H14ClF3: 322, found: 322; 
[α]25D = −141° (c = 1.0, CHCl3); 94% ee, from (S,S)-L4. 
 
F3C Ph
OMe
 
(R)-1-Methoxy-4-(5-phenyl-3-(trifluoromethyl)pent-1-yn-1-yl)benzene (Table 
5.3, entry 3). (3-Bromo-4,4,4-trifluorobutyl)benzene (134 mg, 0.50 mmol) and an 
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alkynylboron reagent prepared from 1-ethynyl-4-methoxybenzene were used. The 
reaction was run at 0 ºC for 12 h. Solvent system for chromatography: 6:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 156 mg (98% yield, 94% ee); Run 2, 157 mg (99% yield, 94% ee). 
The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 10.9 min (major), 12.5 
min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.46 – 7.42 (m, 2H), 7.35 – 7.31 (m, 2H), 7.28 – 
7.22 (m, 3H), 6.89 – 6.86 (m, 2H), 3.83 (s, 3H), 3.29 – 3.20 (m, 1H), 3.03 (ddd, 1H, J = 
13.7, 8.6, 5.0 Hz), 2.83 (dt, 1H, J = 13.9, 8.5 Hz), 2.18 – 2.04 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 159.8, 140.3, 133.3, 128.6, 128.5, 126.4, 125.4 (q, 
J = 280.4 Hz), 114.3, 113.9, 85.2, 80.4 (q, J = 3.7 Hz), 55.3, 37.6 (q, J = 30.4 Hz), 32.6, 
30.1; 
19F NMR (282 MHz, CDCl3) δ −70.9 (d, 3F, J = 7.9 Hz); 
FT-IR (film) 2937, 2237, 1607, 1510, 1457, 1292, 1251, 1172, 1119, 1037, 832, 
701 cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H17F3O: 318, found: 318; 
[α]25D = −155° (c = 1.0, CHCl3); 94% ee, from (S,S)-L4. 
 
F3C Ph
NMe2
 
	 376 
(R)-N,N-Dimethyl-4-(5-phenyl-3-(trifluoromethyl)pent-1-yn-1-yl)aniline 
(Table 5.3, entry 4). (3-Bromo-4,4,4-trifluorobutyl)benzene (134 mg, 0.50 mmol) and an 
alkynylboron reagent prepared from 4-ethynyl-N,N-dimethylaniline were used. The 
reaction was run at 0 ºC for 12 h. Solvent system for chromatography: 3:1 
hexane/dichloromethane. The title compound was isolated as a pink oil. 
Run 1, 150 mg (90% yield, 93% ee); Run 2, 155 mg (93% yield, 93% ee). 
The ee was determined on an OD-H column (1.0% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (R,R)-L4: 5.9 min (minor), 7.6 
min (major). 
1H NMR (500 MHz, CD3COCD3) δ 7.36 – 7.29 (m, 6H), 7.25 – 7.20 (m, 1H), 
6.74 – 6.69 (m, 2H), 3.49 (dqd, 1H, J = 10.7, 8.3, 4.0 Hz), 3.03 (ddd, 1H, J = 14.0, 9.4, 
4.9 Hz), 2.98 (s, 6H), 2.90 – 2.79 (m, 1H), 2.14 (dddd, 1H, J = 12.9, 9.4, 7.6, 4.1 Hz), 
2.04 – 1.96 (m, 1H); 
13C NMR (126 MHz, CD3COCD3) δ 151.7, 141.8, 133.8, 129.6, 129.5, 127.3, 
127.0 (q, J = 279.4 Hz), 112.8, 109.7, 87.4, 80.2 (q, J = 3.7 Hz), 40.4, 38.5 (q, J = 29.9 
Hz), 33.4, 31.4 (d, J = 1.7 Hz); 
19F NMR (282 MHz, CD3COCD3) δ −71.7 (d, 3F, J = 8.2 Hz); 
FT-IR (film) 2922, 2231, 1609, 1523, 1359, 1257, 1160, 1116, 816, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C20H20F3N: 331, found: 331; 
[α]25D = −146° (c = 1.0, CHCl3); 93% ee, from (S,S)-L4. 
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F3C Ph
F
 
(R)-1-Fluoro-3-(5-phenyl-3-(trifluoromethyl)pent-1-yn-1-yl)benzene (Table 
5.3, entry 5). (3-Bromo-4,4,4-trifluorobutyl)benzene (134 mg, 0.50 mmol) and an 
alkynylboron reagent prepared from 1-ethynyl-3-fluorobenzene were used. The reaction 
was run at 10 ºC for 16 h. Solvent system for chromatography: 50:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 120 mg (78% yield, 94% ee); Run 2, 124 mg (81% yield, 93% ee). 
The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 6.2 min (minor), 6.9 min 
(major). 
1H NMR (500 MHz, CDCl3) δ 7.38 – 7.24 (m, 7H), 7.23 – 7.19 (m, 1H), 7.12 – 
7.06 (m, 1H), 3.32 – 3.22 (m, 1H), 3.04 (ddd, 1H, J = 13.7, 8.5, 5.0 Hz), 2.84 (dt, 1H, J = 
13.9, 8.4 Hz), 2.22 – 2.06 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 162.3 (d, J = 246.6 Hz), 140.0, 129.9 (d, J = 8.6 
Hz), 128.6, 128.5, 127.8 (d, J = 2.8 Hz), 126.5, 124.0 (d, J = 9.3 Hz), 125.2 (q, J = 280.3 
Hz), 118.7 (d, J = 22.6 Hz), 116.1 (d, J = 21.1 Hz), 84.1 (d, J = 3.4 Hz), 82.9 (q, J = 3.5 
Hz), 37.5 (q, J = 30.5 Hz), 32.5, 29.9; 
19F NMR (282 MHz, CDCl3) δ −70.8 (d, 3F, J = 7.9 Hz), −112.8 (m, 1F); 
FT-IR (film) 3028, 2942, 1608, 1582, 1488, 1435, 1258, 1172, 1151, 1119, 875, 
784, 699, 680 cm-1; 
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GC-MS (EI) m/z (M+) calcd for C18H14F4: 306, found: 306; 
[α]25D = +131° (c = 1.0, CHCl3); 94% ee, from (R,R)-L4. 
 
F3C Ph
OMe
 
(R)-1-Methoxy-3-(5-phenyl-3-(trifluoromethyl)pent-1-yn-1-yl)benzene (Table 
5.3, entry 6). (3-Bromo-4,4,4-trifluorobutyl)benzene (134 mg, 0.50 mmol) and an 
alkynylboron reagent prepared from 1-ethynyl-3-methoxybenzene were used. The 
reaction was run at 0 ºC for 12 h. Solvent system for chromatography: 5:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 158 mg (99% yield, 95% ee); Run 2, 158 mg (99% yield, 95% ee). 
The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 12.4 min (minor), 16.1 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.36 – 7.32 (m, 2H), 7.29 – 7.23 (m, 4H), 7.11 
(ddd, 1H, J = 7.6, 1.5, 1.0 Hz), 7.03 (dd, 1H, J = 2.6, 1.4 Hz), 6.93 (ddd, 1H, J = 8.3, 2.6, 
1.0 Hz), 3.84 (s, 3H), 3.32 – 3.22 (m, 1H), 3.04 (ddd, 1H, J = 13.7, 8.5, 5.1 Hz), 2.84 (dt, 
1H, J = 13.9, 8.5 Hz), 2.20 – 2.05 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 159.3, 140.2, 129.4, 128.6, 128.5, 126.4, 125.3 (q, 
J = 280.4 Hz), 124.4, 123.2, 116.7, 115.2, 85.3, 81.7 (q, J = 3.6 Hz), 55.3, 37.6 (q, J = 
30.4 Hz), 32.5, 30.0; 
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19F NMR (282 MHz, CDCl3) δ −70.8 (d, 3F, J = 7.9 Hz); 
FT-IR (film) 3027, 2940, 1598, 1576, 1490, 1455, 1319, 1287, 1258, 1161, 1118, 
1046, 700, 686 cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H17F3O: 318, found: 318; 
[α]25D = −54° (c = 1.0, CHCl3); 95% ee, from (S,S)-L4. 
 
F3C Ph
OMe
Me
 
(R)-4-Methoxy-2-methyl-1-(5-phenyl-3-(trifluoromethyl)pent-1-yn-1-
yl)benzene (Table 5.3, entry 7). (3-Bromo-4,4,4-trifluorobutyl)benzene (134 mg, 0.50 
mmol) and an alkynylboron reagent prepared from 1-ethynyl-4-methoxy-2-
methylbenzene were used. The reaction was run at 0 ºC for 12 h. Solvent system for 
chromatography: 5:1 hexane/dichloromethane. The title compound was isolated as a 
colorless oil. 
Run 1, 161 mg (97% yield, 94% ee); Run 2, 160 mg (96% yield, 92% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
ml/min); retention times for compound obtained using (R,R)-L4: 22.2 min (minor), 22.9 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.40 (d, 1H, J = 8.5 Hz), 7.36 – 7.31 (m, 2H), 7.28 
– 7.22 (m, 3H), 6.79 – 6.77 (m, 1H), 6.74 – 6.68 (m, 1H), 3.82 (s, 3H), 3.29 (dtt, 1H, J = 
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15.7, 7.9, 3.9 Hz), 3.05 (ddd, 1H, J = 13.7, 8.7, 4.9 Hz), 2.85 (dt, 1H, J = 13.8, 8.5 Hz), 
2.46 (s, 3H), 2.19 – 2.04 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 159.7, 142.3, 140.3, 133.4, 128.6, 128.5, 126.4, 
125.5 (q, J = 280.3 Hz), 115.0, 114.3, 111.2, 84.3 (q, J = 3.6 Hz), 84.2, 55.2, 37.7 (q, J = 
30.4 Hz), 32.6, 30.2, 20.9; 
19F NMR (282 MHz, CDCl3) δ −71.1 (d, 3F, J = 7.9 Hz); 
FT-IR (film) 3028, 2941, 2235, 1606, 1497, 1455, 1297, 1258, 1236, 1162, 1118, 
1043, 750, 701 cm-1; 
GC-MS (EI) m/z (M+) calcd for C20H19F3O: 332, found: 332; 
[α]25D = −91° (c = 1.0, CHCl3); 92% ee, from (S,S)-L4. 
 
F3C Ph
OMe
 
(R)-2-Methoxy-6-(5-phenyl-3-(trifluoromethyl)pent-1-yn-1-yl)naphthalene 
(Table 5.3, entry 8). (3-Bromo-4,4,4-trifluorobutyl)benzene (134 mg, 0.50 mmol) and an 
alkynylboron reagent prepared from 2-ethynyl-6-methoxynaphthalene were used. The 
reaction was run at 0 ºC for 17 h. Solvent system for chromatography: 6:1 
hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 178 mg (97% yield, 94% ee); Run 2, 178 mg (97% yield, 94% ee). 
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The ee was determined on an OD-H column (1.0% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 7.8 min (major), 14.2 
min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.98 – 7.95 (m, 1H), 7.74 – 7.69 (m, 2H), 7.52 (dd, 
1H, J = 8.4, 1.6 Hz), 7.38 – 7.33 (m, 2H), 7.31 – 7.25 (m, 3H), 7.21 – 7.17 (m, 1H), 7.14 
– 7.11 (m, 1H), 3.94 (s, 3H), 3.35 – 3.29 (m, 1H), 3.09 (ddd, 1H, J = 13.7, 8.5, 5.2 Hz), 
2.89 (dt, 1H, J = 13.9, 8.4 Hz), 2.24 – 2.10 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 158.4, 140.2, 134.3, 131.7, 129.3, 129.0, 128.6, 
128.5, 128.3, 126.8, 126.4, 125.4 (q, J = 280.3 Hz), 119.5, 117.1, 105.7, 85.8, 81.4 (q, J = 
3.6 Hz), 55.3, 37.7 (q, J = 30.4 Hz), 32.6, 30.1; 
19F NMR (282 MHz, CDCl3) δ −70.8 (d, 3F, J = 7.9 Hz); 
FT-IR (film) 3027, 2937, 2236, 1630, 1602, 1498, 1484, 1390, 1258, 1198, 1162, 
1118, 1031, 854, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C23H19F3O: 368, found: 368; 
[α]25D = −144° (c = 1.0, CHCl3); 94% ee, from (S,S)-L4. 
 
F3C n-Oct
S
 
(R)-2-(3-(Trifluoromethyl)undec-1-yn-1-yl)thiophene (Table 5.3, entry 9). 2-
Bromo-1,1,1-trifluorodecane (138 mg, 0.50 mmol) and an alkynylboron reagent prepared 
from 2-ethynylthiophene were used. 10% NiCl2⋅glyme (11 mg, 0.050 mmol) and 12% L4 
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(20 mg, 0.060 mmol) were used. The reaction was run at 0 ºC for 16 h. Solvent system 
for chromatography: hexane. The title compound was isolated as a light yellow oil. 
Run 1, 90 mg (60% yield, 94% ee); Run 2, 96 mg (64% yield, 94% ee). 
The ee was determined on an OD-H column (hexane, flow rate 0.3 ml/min); 
retention times for compound obtained using (R,R)-L4: 17.2 min (minor), 19.4 min 
(major). 
1H NMR (500 MHz, CDCl3) δ 7.26 (dd, 1H, J = 5.2, 1.2 Hz), 7.23 (dd, 1H, J = 
3.7, 1.2 Hz), 6.97 (dd, 1H, J = 5.2, 3.6 Hz), 3.30 (dqd, 1H, J = 10.4, 8.0, 4.3 Hz), 1.87 – 
1.60 (m, 3H), 1.52 – 1.43 (m, 1H), 1.41 – 1.23 (m, 10H), 0.89 (t, 3H, J = 6.7 Hz); 
13C NMR (126 MHz, CDCl3) δ 132.5, 127.2, 126.9, 125.3 (q, J = 280.5 Hz), 
122.3, 86.3 (q, J = 3.6 Hz), 77.9, 38.6 (q, J = 30.3 Hz), 31.8, 29.2, 29.1, 29.0, 28.3, 26.7, 
22.7, 14.1; 
19F NMR (282 MHz, CDCl3) δ −70.9 (d, 3F, J = 8.0 Hz); 
FT-IR (film) 2955, 2927, 2856, 2234, 1261, 1168, 1132, 1107, 852, 831, 700 cm-
1; 
GC-MS (EI) m/z (M+) calcd for C16H21F3S: 302, found: 302; 
[α]25D = +42° (c = 1.0, CHCl3); 94% ee, from (R,R)-L4. 
 
F3C Ph  
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(R)-(5-(Cyclohex-1-en-1-yl)-3-(trifluoromethyl)pent-4-yn-1-yl)benzene (Table 
5.3, entry 10). (3-Bromo-4,4,4-trifluorobutyl)benzene (134 mg, 0.50 mmol) and an 
alkynylboron reagent prepared from 1-ethynylcyclohex-1-ene were used. The reaction 
was run at 0 ºC for 12 h. Solvent system for chromatography: hexane. The title compound 
was isolated as a light-yellow oil. 
Run 1, 133 mg (91% yield, 95% ee); Run 2, 133 mg (91% yield, 95% ee). 
The ee was determined on an OD-H column (hexane, flow rate 0.3 ml/min); 
retention times for compound obtained using (S,S)-L4: 23.2 min (minor), 24.9 min 
(major). 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.29 (m, 2H), 7.25 – 7.21 (m, 3H), 6.21 – 
6.17 (m, 1H), 3.13 (dqd, 1H, J = 12.0, 8.0, 4.1 Hz), 2.96 (ddd, 1H, J = 13.7, 8.8, 4.9 Hz), 
2.75 (dt, 1H, J = 13.8, 8.5 Hz), 2.20 – 1.93 (m, 6H), 1.70 – 1.57 (m, 4H); 
13C NMR (126 MHz, CDCl3) δ 140.4, 135.8, 128.54, 128.49, 126.3, 125.4 (q, J = 
280.3 Hz), 119.9, 87.2, 79.0 (q, J = 3.7 Hz), 37.4 (q, J = 30.1 Hz), 32.5, 30.1, 29.1, 25.6, 
22.2, 21.4; 
19F NMR (282 MHz, CDCl3) δ −71.2 (d, 3F, J = 7.9 Hz); 
FT-IR (film) 2934, 2227, 1455, 1259, 1161, 1119, 919, 750, 698 cm-1; 
GC-MS (EI) m/z (M+) calcd for C18H19F3: 292, found: 292; 
[α]25D = −114° (c = 1.0, CHCl3); 95% ee, from (S,S)-L4. 
 
 
	 384 
F3C n-Oct
OMe
 
(R)-1-Methoxy-4-(3-(trifluoromethyl)undec-1-yn-1-yl)benzene (Table 5.4, 
entry 1). 2-Bromo-1,1,1-trifluorodecane (138 mg, 0.50 mmol) and an alkynylboron 
reagent prepared from 1-ethynyl-4-methoxybenzene were used. The reaction was run at 0 
ºC for 12 h. Solvent system for chromatography: 12:1 hexane/dichloromethane. The title 
compound was isolated as a colorless oil. 
Run 1, 152 mg (93% yield, 92% ee); Run 2, 154 mg (94% yield, 92% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
ml/min); retention times for compound obtained using (S,S)-L4: 10.4 min (major), 12.4 
min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.40 – 7.37 (m, 2H), 6.85 – 6.82 (m, 2H), 3.81 (s, 
3H), 3.30 – 3.22 (m, 1H), 1.85 – 1.62 (m, 3H), 1.53 – 1.43 (m, 1H), 1.42 – 1.22 (m, 10H), 
0.89 (t, 3H, J = 6.7 Hz); 
13C NMR (126 MHz, CDCl3) δ 159.7, 133.3, 125.5 (q, J = 280.4 Hz), 114.5, 
113.8, 84.5, 80.9 (q, J = 3.5 Hz), 55.3, 38.3 (q, J = 30.1 Hz), 31.8, 29.3, 29.2, 29.1, 28.4, 
26.7, 22.7, 14.1; 
19F NMR (282 MHz, CDCl3) δ −71.2 (d, 3F, J = 8.0 Hz); 
FT-IR (film) 2955, 2927, 2856, 2238, 1608, 1511, 1466, 1291, 1250, 1172, 1132, 
1106, 1034, 831 cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H25F3O: 326, found: 326; 
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[α]25D = −26° (c = 1.0, CHCl3); 92% ee, from (S,S)-L4. 
 
F3C
OTBDPS
Ph
 
(R)-tert-Butyldiphenyl((10-phenyl-6-(trifluoromethyl)dec-7-yn-1-yl)oxy)silane 
(Table 5.4, entry 2). ((6-Bromo-7,7,7-trifluoroheptyl)oxy)(tert-butyl)diphenylsilane (244 
mg, 0.50 mmol) and an alkynylboron reagent prepared from but-3-yn-1-ylbenzene were 
used. The reaction was run at 0 ºC for 9 h. Solvent system for chromatography: 15:1 to 
10:1 to 5:1 hexane/dichloromethane. The title compound was isolated as a colorless oil. 
Run 1, 210 mg (78% yield, 91% ee); Run 2, 210 mg (78% yield, 91% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 
ml/min); retention times for compound obtained using (S,S)-L4: 19.4 min (major), 25.5 
min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.71 – 7.67 (m, 4H), 7.46 – 7.38 (m, 6H), 7.32 – 
7.27 (m, 2H), 7.24 – 7.19 (m, 3H), 3.68 (t, 2H, J = 6.4 Hz), 3.02 – 2.94 (m, 1H), 2.82 (t, 
2H, J = 7.4 Hz), 2.50 (td, 2H, J = 7.4, 2.2 Hz), 1.71 – 1.64 (m, 1H), 1.63 – 1.46 (m, 4H), 
1.45 – 1.26 (m, 3H), 1.08 (s, 9H); 
13C NMR (126 MHz, CDCl3) δ 140.4, 135.5, 134.0, 129.5, 128.5, 128.3, 127.6, 
126.3, 125.6 (q, J = 280.2 Hz), 84.3, 73.9 (q, J = 3.6 Hz), 63.7, 37.7 (q, J = 29.9 Hz), 
34.9, 32.2, 28.4, 26.9, 26.3, 25.3, 20.8, 19.2; 
19F NMR (282 MHz, CDCl3) δ −71.4 (d, 3F, J = 8.1 Hz); 
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FT-IR (film) 3070, 3028, 2932, 2858, 1472, 1463, 1454, 1428, 1262, 1169, 1145, 
1125, 1112, 823, 741, 700 cm-1; 
GC-MS (EI) m/z (M+−TBDPS) calcd for C17H20F3O: 297, found: 297; 
[α]25D = −16° (c = 1.0, CHCl3); 91% ee, from (S,S)-L4. 
 
ClF3C
Ph
 
(R)-(9-Chloro-5-(trifluoromethyl)non-3-yn-1-yl)benzene (Table 5.4, entry 3). 
2-Bromo-6-chloro-1,1,1-trifluorohexane (127 mg, 0.50 mmol) and an alkynylboron 
reagent prepared from but-3-yn-1-ylbenzene were used. The reaction was run at 0 ºC for 
12 h. Solvent system for chromatography: 15:1 to 10:1 hexane/dichloromethane. The title 
compound was isolated as a light-yellow oil. 
Run 1, 127 mg (84% yield, 92% ee); Run 2, 127 mg (84% yield, 92% ee). 
The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 6.5 min (major), 7.7 min 
(minor). 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.28 (m, 2H), 7.25 – 7.20 (m, 3H), 3.56 – 
3.48 (m, 2H), 3.05 – 2.97 (m, 1H), 2.83 (t, 2H, J = 7.4 Hz), 2.51 (td, 2H, J = 7.4, 2.2 Hz), 
1.84 – 1.42 (m, 6H); 
13C NMR (126 MHz, CDCl3) δ 140.4, 128.5, 128.3, 126.3, 125.4 (q, J = 280.2 
Hz), 84.7, 73.5 (q, J = 3.7 Hz), 44.5, 37.6 (q, J = 30.1 Hz), 34.8, 32.0, 27.8, 23.9, 20.8; 
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19F NMR (282 MHz, CDCl3) δ −71.5 (d, 3F, J = 8.3 Hz); 
FT-IR (film) 2957, 2870, 2246, 1455, 1263, 1170, 1153, 1117, 749, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H18ClF3: 302, found: 302; 
[α]25D = −29° (c = 1.0, CHCl3); 92% ee, from (S,S)-L4. 
 
O
O
Me
F3C
OMe
 
(R)-1-(4-((8-(4-Methoxyphenyl)-6-(trifluoromethyl)oct-7-yn-1-
yl)oxy)phenyl)ethan-1-one (Table 5.4, entry 4). 1-(4-((6-Bromo-7,7,7-
trifluoroheptyl)oxy)phenyl)ethan-1-one (184 mg, 0.50 mmol) and an alkynylboron 
reagent prepared from 1-ethynyl-4-methoxybenzene were used. The reaction was run at 0 
ºC for 12 h. Solvent system for chromatography: 10:1 to 5:1 hexane/ethyl acetate. The 
title compound was isolated as a yellow solid. It should be stored in a refrigerator (~5 
ºC). 
Run 1, 199 mg (95% yield, 93% ee); Run 2, 205 mg (98% yield, 92% ee). 
The ee was determined on an AD-H column (5.0% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 16.2 min (major), 17.4 
min (minor). 
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1H NMR (500 MHz, CDCl3) δ 7.93 – 7.89 (m, 2H), 7.38 – 7.34 (m, 2H), 6.93 – 
6.88 (m, 2H), 6.84 – 6.79 (m, 2H), 4.03 (t, 2H, J = 6.3 Hz), 3.80 (s, 3H), 3.34 – 3.24 (m, 
1H), 2.55 (s, 3H), 1.91 – 1.71 (m, 5H), 1.64 – 1.50 (m, 3H); 
13C NMR (126 MHz, CDCl3) δ 196.8, 162.9, 159.7, 133.2, 130.5, 130.1, 125.4 (q, 
J = 280.2 Hz), 114.3, 114.1, 113.8, 84.7, 80.6 (q, J = 3.5 Hz), 67.9, 55.3, 38.2 (q, J = 30.2 
Hz), 28.8, 28.3, 26.4, 26.3, 25.5; 
19F NMR (282 MHz, CDCl3) δ −71.1 (d, 3F, J = 8.0 Hz); 
FT-IR (film) 2938, 2869, 2234, 1674, 1602, 1510, 1358, 1253, 1172, 1127, 1031, 
833 cm-1; 
LC-MS (ESI) m/z (M+H+) calcd for C24H26F3O3: 419, found: 419; 
[α]25D = −44° (c = 1.0, CHCl3); 92% ee, from (S,S)-L4. 
 
O
I
F3C
Ph
 
(R)-1-Iodo-4-((8-phenyl-6-(trifluoromethyl)oct-7-yn-1-yl)oxy)benzene (Table 
5.4, entry 5). 1-((6-Bromo-7,7,7-trifluoroheptyl)oxy)-4-iodobenzene (226 mg, 0.50 
mmol) and an alkynylboron reagent prepared from ethynylbenzene were used. 10% 
NiCl2⋅glyme (11 mg, 0.050 mmol) and 12% L4 (20 mg, 0.060 mmol) were used. The 
reaction was run at 0 ºC for 17 h. Solvent system for chromatography: 10:1 to 8:1 
hexane/dichloromethane. The title compound was isolated as a light-yellow oil. It should 
be stored in a refrigerator (~5 ºC). 
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Run 1, 207 mg (88% yield, 94% ee); Run 2, 200 mg (85% yield, 94% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 17.4 min (major), 19.8 
min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.55 – 7.51 (m, 2H), 7.46 – 7.41 (m, 2H), 7.36 – 
7.28 (m, 3H), 6.69 – 6.64 (m, 2H), 3.93 (t, 2H, J = 6.3 Hz), 3.35 – 3.27 (m, 1H), 1.91 – 
1.72 (m, 5H), 1.64 – 1.49 (m, 3H); 
13C NMR (126 MHz, CDCl3) δ 158.5, 138.1, 131.8, 128.6, 128.3, 125.3 (q, J = 
280.5 Hz), 122.2, 116.8, 84.8, 82.5, 82.1 (q, J = 3.6 Hz), 67.7, 38.3 (q, J = 30.3 Hz), 28.8, 
28.3, 26.4, 25.6; 
19F NMR (282 MHz, CDCl3) δ −71.0 (d, 3F, J = 7.9 Hz); 
FT-IR (film) 2940, 2868, 1587, 1486, 1471, 1283, 1244, 1174, 1127, 819, 756, 
691 cm-1; 
GC-MS (EI) m/z (M+) calcd for C21H20F3IO: 472, found: 472; 
[α]25D = −36° (c = 1.0, CHCl3); 94% ee, from (S,S)-L4. 
 
F3C
N Boc
OMe
 
tert-butyl (R)-4-(4-(4-methoxyphenyl)-2-(trifluoromethyl)but-3-yn-1-
yl)piperidine-1-carboxylate (Table 5.4, entry 6). tert-Butyl 4-(2-bromo-3,3,3-
trifluoropropyl)piperidine-1-carboxylate (180 mg, 0.50 mmol) and an alkynylboron 
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reagent prepared from 1-ethynyl-4-methoxybenzene were used. The reaction was run at 0 
ºC for 17 h. Solvent system for chromatography: 20:1 to 15:1 hexane/ethyl acetate. The 
title compound was isolated as a yellow oil. 
Run 1, 196 mg (95% yield, 97% ee); Run 2, 201 mg (98% yield, 97% ee). 
The ee was determined on an OD-H column (3.0% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 7.7 min (major), 12.5 
min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.39 – 7.35 (m, 2H), 6.86 – 6.81 (m, 2H), 4.25 – 
3.97 (m, 2H), 3.81 (s, 3H), 3.36 (dqd, 1H, J = 11.9, 7.8, 4.1 Hz), 2.85 – 2.60 (m, 2H), 
1.85 – 1.68 (m, 4H), 1.65 – 1.57 (m, 1H), 1.45 (s, 9H), 1.30 – 1.18 (m, 1H), 1.13 – 1.04 
(m, 1H); 
13C NMR (126 MHz, CDCl3) δ 159.8, 154.8, 133.3, 114.2, 113.9, 125.5 (q, J = 
280.3 Hz), 84.8, 80.3 (q, J = 3.5 Hz), 79.4, 55.3, 35.8 (q, J = 30.5 Hz), 34.8, 33.2, 32.6, 
30.7, 28.4; 
19F NMR (282 MHz, CDCl3) δ −71.4 (d, 3F, J = 7.8 Hz); 
FT-IR (film) 2975, 2930, 2848, 2237, 1692, 1607, 1511, 1425, 1366, 1285, 1250, 
1172, 1128, 833 cm-1; 
GC-MS (EI) m/z (M+ −Boc) calcd for C17H19F3NO: 310, found: 310; 
[α]25D = +62° (c = 1.0, CHCl3); 97% ee, from (R,R)-L4. 
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O
O
F3C
OMe
 
(R)-8-(4-Methoxyphenyl)-6-(trifluoromethyl)oct-7-yn-1-yl furan-2-
carboxylate (Table 5.4, entry 7). 6-Bromo-7,7,7-trifluoroheptyl furan-2-carboxylate 
(172 mg, 0.50 mmol) and an alkynylboron reagent prepared from 1-ethynyl-4-
methoxybenzene were used. 10% NiCl2⋅glyme (11 mg, 0.050 mmol) and 12% L4 (20 mg, 
0.060 mmol) were used. The reaction was run at 0 ºC for 17 h. Solvent system for 
chromatography: 10:1 hexane/ethyl acetate. The title compound was isolated as a light-
yellow oil. It should be stored in a refrigerator (~5 ºC). 
Run 1, 171 mg (87% yield, 94% ee); Run 2, 171 mg (87% yield, 93% ee). 
The ee was determined on an OD-H column (1.0% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 18.6 min (major), 23.1 
min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.57 (dd, 1H, J = 1.8, 0.9 Hz), 7.39 – 7.35 (m, 2H), 
7.17 (dd, 1H, J = 3.5, 0.9 Hz), 6.85 – 6.80 (m, 2H), 6.49 (dd, 1H, J = 3.5, 1.7 Hz), 4.32 (t, 
2H, J = 6.6 Hz), 3.80 (s, 3H), 3.32 – 3.23 (m, 1H), 1.88 – 1.69 (m, 5H), 1.60 – 1.43 (m, 
3H); 
13C NMR (126 MHz, CDCl3) δ 159.7, 158.8, 146.2, 144.7, 133.3, 125.4 (q, J = 
280.4 Hz), 117.8, 114.3, 113.8, 111.8, 84.7, 80.6 (q, J = 3.7 Hz), 64.7, 55.2, 38.2 (q, J = 
30.2 Hz), 28.5, 28.3, 26.4, 25.5; 
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19F NMR (282 MHz, CDCl3) δ −71.1 (d, 3F, J = 8.0 Hz); 
FT-IR (film) 2953, 2234, 1725, 1607, 1511, 1475, 1296, 1250, 1172, 1125, 1032, 
1014, 833, 764 cm-1; 
GC-MS (EI) m/z (M+) calcd for C21H21F3O4: 394, found: 394; 
[α]25D = −37° (c = 1.0, CHCl3); 93% ee, from (S,S)-L4. 
 
F3C Ph
Ph
 
(R)-(5-(Trifluoromethyl)hept-3-yne-1,7-diyl)dibenzene (eq 5.3). (4,4,4-
trifluoro-3-iodobutyl)benzene (157 mg, 0.50 mmol) and an alkynylboron reagent 
prepared from but-3-yn-1-ylbenzene were used. The reaction was run at 0 ºC for 5 h. 
Solvent system for chromatography: 10:1 hexane/dichloromethane. The title compound 
was isolated as a colorless oil. 
Run 1, 139 mg (88% yield, 92% ee); Run 2, 131 mg (83% yield, 92% ee). 
The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 7.9 min (major), 10.5 
min (minor). 
For the characterization data, see Table 5.2, entry 1 (above). 
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F3CF2C Ph
Ph
 
(R)-(5-(Perfluoroethyl)hept-3-yne-1,7-diyl)dibenzene (eq 5.5). (3-Bromo-
4,4,5,5,5-pentafluoropentyl)benzene (159 mg, 0.50 mmol) and an alkynylboron reagent 
prepared from but-3-yn-1-ylbenzene were used. The reaction was run at 0 ºC for 5 h. 
Solvent system for chromatography: 10:1 hexane/dichloromethane. The title compound 
was isolated as a colorless oil. 
Run 1, 161 mg (88% yield, 99% ee); Run 2, 155 mg (85% yield, 99% ee). 
The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 6.2 min (major), 7.3 min 
(minor). 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.29 (m, 4H), 7.28 – 7.22 (m, 4H), 7.18 – 
7.14 (m, 2H), 3.05 – 2.95 (m, 1H), 2.94 – 2.85 (m, 3H), 2.64 (dt, 1H, J =13.8, 8.5 Hz), 
2.57 (td, 1H, J = 7.4, 2.3 Hz), 2.05 (dtd, 1H, J = 12.4, 8.5, 3.7 Hz), 1.92 (dddd, 1H, J = 
13.3, 11.1, 8.9, 4.7 Hz); 
13C NMR (126 MHz, CDCl3) δ 140.37, 140.36, 128.51, 128.46, 128.42, 128.38, 
126.33, 126.27, 120.8 – 109.5 (m), 85.8, 72.9 (dd, J = 9.6, 3.1 Hz), 34.8, 34.7 (dd, J = 
26.5, 22.8 Hz), 32.5, 29.0, 20.7; 
19F NMR (282 MHz, CDCl3) δ −81.5 (s, 3F), −117.0 (dd, J = 265.3, 8.6 Hz), 
−121.0 (dd, J = 265.3, 19.0 Hz); 
FT-IR (film) 3028, 2931, 2238, 1497, 1455, 1194, 1119, 1068, 1031, 750, 698 
cm-1; 
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GC-MS (EI) m/z (M+) calcd for C21H19F5: 366, found: 366; 
[α]25D = +68° (c = 1.0, CHCl3); 99% ee, from (R,R)-L4. 
 
n-C3F7 Ph
Ph
 
(R)-(5-(Perfluoropropyl)hept-3-yne-1,7-diyl)dibenzene (eq 5.6). (3-Bromo-
4,4,5,5,6,6,6-heptafluorohexyl)benzene (184 mg, 0.50 mmol) and an alkynylboron 
reagent prepared from but-3-yn-1-ylbenzene were used. The reaction was run at 0 ºC for 
12 h. Solvent system for chromatography: 20:1 to 10:1 hexane/dichloromethane. The title 
compound was isolated as a colorless oil. 
Run 1, 175 mg (84% yield, 98% ee); Run 2, 172 mg (83% yield, 98% ee). 
The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 6.0 min (major), 7.7 min 
(minor). 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.29 (m, 4H), 7.28 – 7.21 (m, 4H), 7.18 – 
7.15 (m, 2H), 3.11 – 3.00 (m, 1H), 2.95 – 2.85 (m, 3H), 2.64 (dt, 1H, J = 13.8, 8.5 Hz), 
2.57 (td, 1H, J = 7.4, 2.3 Hz), 2.06 (dtd, 1H, J = 12.4, 8.5, 3.7 Hz), 1.93 (dddd, 1H, J = 
13.3, 11.0, 9.0, 4.7 Hz); 
13C NMR (126 MHz, CDCl3) δ 140.39, 140.37, 128.51, 128.46, 128.42, 128.37, 
126.33, 126.27, 119.5 – 106.2 (m), 85.8, 72.9 (d, J = 10.0 Hz), 34.9 (dd, J = 26.8, 22.7 
Hz), 34.8, 32.5, 28.9, 20.8; 
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19F NMR (282 MHz, CDCl3) δ −80.8 (dd, 3F, J = 11.8, 9.1 Hz), −113.7 – −118.1 
(m, 2F), −122.9 – −126.1 (m, 2F); 
FT-IR (film) 3064, 3029, 2930, 2863, 1604, 1497, 1455, 1349, 1224, 1185, 1117, 
750, 698 cm-1; 
GC-MS (EI) m/z (M+) calcd for C22H19F7: 416, found: 416; 
[α]25D = +59° (c = 1.0, CHCl3); 98% ee, from (R,R)-L4. 
 
Ph
F
Ph
O
F
Ph
 
(R)-2,2-Difluoro-3-phenethyl-1,5-diphenylpent-4-yn-1-one (eq 5.7). 3-Bromo-
2,2-difluoro-1,5-diphenylpentan-1-one (177 mg, 0.50 mmol) and an alkynylboron reagent 
prepared from ethynylbenzene were used. 10% NiCl2⋅glyme (11 mg, 0.050 mmol) and 
12% L4 (20 mg, 0.060 mmol) were used. The reaction was run at 0 ºC for 17 h. Solvent 
system for chromatography: 4:1 to 2:1 hexane/dichloromethane. The title compound was 
isolated as a colorless oil. It should be stored in a refrigerator (~5 ºC). 
Run 1, 178 mg (95% yield, 98% ee); Run 2, 178 mg (95% yield, 98% ee). 
The ee was determined on an AD-H column (0.25% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 6.6 min (minor), 7.2 min 
(major). 
1H NMR (500 MHz, CD3COCD3) δ 8.12 – 8.08 (m, 2H), 7.77 – 7.72 (m, 1H), 
7.63 – 7.57 (m, 2H), 7.42 – 7.28 (m, 9H), 7.25 – 7.19 (m, 1H), 3.67 (dtd, 1H, J = 17.6, 
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10.9, 3.8 Hz), 3.08 (ddd, 1H, J = 13.9, 9.2, 4.8 Hz), 2.89 (ddd, 1H, J = 13.7, 9.1, 7.8 Hz), 
2.24 – 2.16 (m, 1H), 2.11 – 2.06 (m, 1H); 
13C NMR (126 MHz, CD3COCD3) δ 190.0 (t, J = 28.7 Hz), 141.9, 135.6, 133.6, 
132.6, 130.8 (t, J = 3.5 Hz), 130.0, 129.7, 129.55, 129.53, 129.51, 127.2, 123.5, 119.2 
(dd, J = 259.6, 257.2 Hz), 86.9, 84.8 (dd, J = 9.4, 2.8 Hz), 38.5 (dd, J = 27.3, 23.1 Hz), 
33.7, 30.3f; 
19F NMR (282 MHz, CD3COCD3) δ −103.6 (dd, 1F, J = 266.6, 10.9 Hz), −107.1 
(dd, 1F, J = 266.6, 17.5 Hz); 
FT-IR (film) 3062, 3027, 2940, 1704, 1598, 1491, 1449, 1275, 1185, 1129, 1070, 
916, 757, 720, 690, 664 cm-1; 
GC-MS (EI) m/z (M+) calcd for C25H20F2O: 374, found: 374; 
[α]25D = +92° (c = 1.0, CHCl3); 98% ee, from (R,R)-L4. 
 
S n-BuN
O O
Me
Me
Ph
 
N,N-Dimethyl-1-phenylnon-3-yne-5-sulfonamide (Table 5.5, entry 1). 1-
Bromo-N,N-dimethylpentane-1-sulfonamide (129 mg, 0.50 mmol) and an alkynylboron 
reagent prepared from but-3-yn-1-ylbenzene were used. The reaction was run at 0 ºC for 
22 h. Solvent system for chromatography: 5:1 to 4:1 hexane/ethyl acetate. The title 
compound was isolated as a colorless oil. 
Run 1, 138 mg (90% yield, 98% ee); Run 2, 136 mg (88% yield, 98% ee). 
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The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (R,R)-L4: 37.0 min (major), 40.8 
min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 7.24 – 7.19 (m, 3H), 3.79 
(ddt, 1H, J = 10.7, 4.2, 2.2 Hz), 2.89 (s, 6H), 2.86 – 2.79 (m, 2H), 2.58 – 2.52 (m, 2H), 
2.03 – 1.94 (m, 1H), 1.85 – 1.75 (m, 1H), 1.57 – 1.47 (m, 1H), 1.40 – 1.28 (m, 3H), 0.91 
(t, 3H, J = 7.2 Hz); 
13C NMR (126 MHz, CDCl3) δ 140.1, 128.43, 128.37, 126.4, 87.0, 73.6, 54.4, 
38.5, 34.6, 29.8, 28.7, 22.1, 20.9, 13.8; 
FT-IR (film) 3027, 2953, 2918, 2859, 2359, 2235, 1456, 1336, 1280, 1142, 964, 
746, 697 cm-1; 
LC-MS (ESI) m/z (M+Na+) calcd for C17H25NNaO2S: 330, found: 330; 
[α]25D = –29° (c = 1.0, CHCl3); 98% ee, from (R,R)-L4. 
 
S n-BuPh
O O
Ph
 
((1-Phenylnon-3-yn-5-yl)sulfonyl)benzene (Table 5.5, entry 2). ((1-
Bromopentyl)sulfonyl)benzene (146 mg, 0.50 mmol) and an alkynylboron reagent 
prepared from but-3-yn-1-ylbenzene were used. The reaction was run at 0 ºC for 22 h. 
Solvent system for chromatography: 10:1 hexane/ethyl acetate. The title compound was 
isolated as a light-yellow oil. 
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Run 1, 143 mg (84% yield, 93% ee); Run 2, 144 mg (85% yield, 93% ee). 
The ee was determined on an AD-H column (5.0% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (R,R)-L4: 10.9 min (major), 14.3 
min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.90 – 7.87 (m, 2H), 7.67 – 7.63 (m, 1H), 7.54 – 
7.50 (m, 2H), 7.30 – 7.25 (m, 2H), 7.23 – 7.18 (m, 1H), 7.15 – 7.11 (m, 2H), 3.78 (ddt, 
1H, J = 11.1, 3.8, 2.3 Hz), 2.73 (t, 2H, J = 7.4 Hz), 2.45 (td, 2H, J = 7.4, 2.3 Hz), 2.07 
(dddd, 1H, J = 12.6, 9.6, 5.5, 3.8 Hz), 1.63 (dddd, 1H, J = 12.6, 11.0, 9.5, 4.4 Hz), 1.54 – 
1.43 (m, 1H), 1.35 – 1.26 (m, 3H), 0.88 (t, 3H, J = 7.2 Hz); 
13C NMR (126 MHz, CDCl3) δ 140.1, 136.8, 133.8, 129.5, 128.6, 128.35, 128.33, 
126.3, 88.2, 73.1, 59.6, 34.5, 28.8, 28.3, 22.1, 20.9, 13.8; 
FT-IR (film) 3062, 3027, 2957, 2930, 2870, 2236, 1453, 1447, 1319, 1308, 1148, 
1084, 750, 699, 689 cm-1; 
LC-MS (ESI) m/z (M+Na+) calcd for C21H24NaO2S: 363, found: 363; 
[α]25D = +0.63° (c = 1.0, CHCl3); 93% ee, from (S,S)-L4. 
 
O
EtEtO
Ph
 
Ethyl 2-ethyl-6-phenylhex-3-ynoate (Table 5.5, entry 3). Ethyl 2-
bromobutanoate (98 mg, 0.50 mmol) and an alkynylboron reagent prepared from but-3-
yn-1-ylbenzene were used. LiCl was not added for this reaction. The reaction was run at 
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0 ºC for 24 h. Solvent system for chromatography: 1:1 hexane/dichloromethane. The title 
compound was isolated as a colorless oil. It should be stored in a freezer (–20 ºC). 
Run 1, 105 mg (86% yield, 85% ee); Run 2, 109 mg (89% yield, 85% ee). 
The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (R,R)-L4: 11.4 min (minor), 17.4 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.27 (m, 2H), 7.24 – 7.18 (m, 3H), 4.19 (q, 
2H, J = 7.1 Hz), 3.21 (ddt, 1H, J = 7.8, 6.1, 2.3 Hz), 2.83 (t, 2H, J = 7.6 Hz), 2.53 – 2.47 
(m, 2H), 1.87 – 1.68 (m, 2H), 1.28 (t, 3H, J = 7.1 Hz), 0.97 (t, 3H, J = 7.4 Hz); 
13C NMR (126 MHz, CDCl3) δ 171.5, 140.7, 128.5, 128.2, 126.2, 83.0, 77.1, 61.2, 
39.6, 35.2, 26.1, 21.0, 14.1, 11.5; 
FT-IR (film) 3027, 2970, 2934, 2875, 1741, 1496, 1454, 1250, 1181, 1024, 750, 
699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H20O2: 244, found: 244; 
[α]25D = +10° (c = 1.0, CHCl3); 85% ee, from (S,S)-L4. 
 
O
EtO Me
Me
Ph
 
Ethyl 2-isopropyl-6-phenylhex-3-ynoate (Table 5.5, entry 4). Ethyl 2-bromo-3-
methylbutanoate (105 mg, 0.50 mmol) and an alkynylboron reagent prepared from but-3-
yn-1-ylbenzene were used. LiCl was not added for this reaction. The reaction was run at 
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0 ºC for 12 h. Solvent system for chromatography: 1:1 hexane/dichloromethane. The title 
compound was isolated as a light-yellow oil. It should be stored in a freezer (–20 ºC). 
Run 1, 100 mg (78% yield, 97% ee); Run 2, 105 mg (81% yield, 97% ee). 
The ee was determined on an OD-H column (1.0% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (R,R)-L4: 5.0 min (minor), 7.3 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.26 (m, 2H), 7.24 – 7.18 (m, 3H), 4.19 (q, 
2H, J = 7.1 Hz), 3.11 (dt, 1H, J = 6.5, 2.3 Hz), 2.84 (t, 2H, J = 7.5 Hz), 2.55 – 2.49 (m, 
2H), 2.21 – 2.08 (m, 1H), 1.28 (t, 3H, J = 7.1 Hz), 0.97 (d, 3H, J = 1.5 Hz), 0.96 (d, 3H, J 
= 1.6 Hz); 
13C NMR (126 MHz, CDCl3) δ 171.2, 140.7, 128.5, 128.3, 126.1, 83.9, 75.8, 61.1, 
45.7, 35.2, 31.1, 21.0, 20.7, 19.0, 14.2; 
FT-IR (film) 3027, 2963, 2930, 2872, 1741, 1454, 1253, 1180, 1156, 1031, 748, 
699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H22O2: 258, found: 258; 
[α]25D = −7.3° (c = 1.0, CHCl3); 97% ee, from (R,R)-L4. 
 
O
EtN
H
Ph
 
N-Cyclohexyl-2-ethyl-6-phenylhex-3-ynamide (Table 5.5, entry 5). 2-Bromo-
N-cyclohexylbutanamide (124 mg, 0.50 mmol) and an alkynylboron reagent prepared 
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from but-3-yn-1-ylbenzene were used. The reaction was run at 0 ºC for 22 h. Solvent 
system for chromatography: 5:1 hexane/ethyl acetate. The title compound was isolated as 
a white solid. 
Run 1, 138 mg (93% yield, 87% ee); Run 2, 138 mg (93% yield, 86% ee). 
The ee was determined on an AD-H column (2.0% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 10.2 min (major), 11.3 
min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.19 (m, 5H), 6.33 – 6.26 (m, 1H), 3.73 – 
3.65 (m, 1H), 3.13 – 3.08 (m, 1H), 2.85 (t, 2H, J = 7.3 Hz), 2.62 – 2.53 (m, 2H), 1.91 – 
1.54 (m, 7H), 1.41 – 1.27 (m, 2H), 1.22 – 0.99 (m, 3H), 0.94 (t, 3H, J = 7.4 Hz); 
13C NMR (126 MHz, CDCl3) δ 169.2, 140.3, 128.4, 128.3, 126.4, 85.9, 78.6, 48.0, 
41.0, 35.0, 32.9, 32.6, 26.1, 25.5, 24.70, 24.68, 20.6, 11.0; 
FT-IR (film) 3276, 2925, 2852, 1641, 1550, 1449, 1379, 1314, 1245, 1219, 1154, 
1103, 1076, 981, 753, 732, 694 cm-1; 
GC-MS (EI) m/z (M+) calcd for C20H27NO: 297, found: 297; 
[α]25D = −3.3° (c = 1.0, CHCl3); 86% ee, from (S,S)-L4. 
 
N
O
Ph Ph
 
1-Phenyl-3-(4-phenylbut-1-yn-1-yl)pyrrolidin-2-one (Table 5.5, entry 6). 3-
Bromo-1-phenylpyrrolidin-2-one (120 mg, 0.50 mmol) and an alkynylboron reagent 
prepared from but-3-yn-1-ylbenzene were used. LiCl was not added for this reaction. The 
	 402 
reaction was run at 0 ºC for 22 h. Solvent system for chromatography: 7:1 to 6:1 
hexane/ethyl acetate. The title compound was isolated as a white solid. 
Run 1, 120 mg (83% yield, 91% ee); Run 2, 120 mg (83% yield, 91% ee). 
The ee was determined on an AD-H column (20% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (R,R)-L4: 11.5 min (minor), 14.7 
min (major). 
1H NMR (500 MHz, CDCl3) δ 7.65 – 7.61 (m, 2H), 7.41 – 7.35 (m, 2H), 7.31 – 
7.25 (m, 2H), 7.24 – 7.15 (m, 4H), 3.86 – 3.75 (m, 2H), 3.53 (tt, 1H, J = 8.5, 2.3 Hz), 
2.85 (t, 2H, J = 7.7 Hz), 2.52 (td, 2H, J = 7.6, 2.3 Hz), 2.45 (dddd, 1H, J = 12.9, 8.6, 7.1, 
4.5 Hz), 2.21 – 2.12 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 170.9, 140.7, 139.2, 128.8, 128.5, 128.3, 126.2, 
124.7, 119.8, 83.0, 77.0, 46.7, 36.6, 35.1, 26.8, 21.1; 
FT-IR (film) 3061, 3028, 2928, 1683, 1600, 1497, 1454, 1398, 1315, 1225, 1208, 
757, 745, 701, 690 cm-1; 
LC-MS (ESI) m/z (M+H+) calcd for C20H20NO: 290, found: 290; 
[α]25D = +79° (c = 1.0, CHCl3); 91% ee, from (S,S)-L4. 
 
St-Bu
O O
Ph
 
(7-(tert-Butylsulfonyl)-5-(cyclohexylmethyl)hept-3-yn-1-yl)benzene (Table 
5.5, entry 7). (4-(tert-butylsulfonyl)-2-iodobutyl)cyclohexane (193 mg, 0.50 mmol) and 
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an alkynylboron reagent prepared from but-3-yn-1-ylbenzene were used. LiCl was not 
added for this reaction. 10% NiCl2⋅glyme (11 mg, 0.050 mmol) and 12% L4 (20 mg, 
0.060 mmol) were used. The reaction was run at 0 ºC for 20 h. Solvent system for 
chromatography: 6:1 hexane/ethyl acetate. The title compound was isolated as a yellow 
oil. 
Run 1, 185 mg (95% yield, 87% ee); Run 2, 186 mg (96% yield, 85% ee). 
The ee was determined on an AD-H column (1.0% i-PrOH/hexane, flow rate 1.0 
ml/min); retention times for compound obtained using (S,S)-L4: 10.5 min (major), 12.2 
min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.27 (m, 2H), 7.23 – 7.18 (m, 3H), 3.11 
(ddd, 1H, J = 13.0, 11.1, 4.9 Hz), 2.90 (ddd, 1H, J = 13.0, 11.0, 5.0 Hz), 2.79 (t, 2H, J = 
7.4 Hz), 2.57 – 2.50 (m, 1H), 2.47 (td, 2H, J = 7.4, 2.2 Hz), 2.07 – 1.98 (m, 1H), 1.84 – 
1.76 (m, 1H), 1.76 – 1.60 (m, 6H), 1.39 (s, 9H), 1.30 – 1.11 (m, 5H), 0.95 – 0.74 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 140.7, 128.4, 128.3, 126.2, 82.3, 82.0, 58.9, 44.0, 
43.2, 35.3, 35.1, 33.7, 32.4, 28.4, 26.5, 26.4, 26.2, 26.1, 23.4, 20.8; 
FT-IR (film) 2921, 2849, 1449, 1300, 1270, 1116, 750, 699, 664 cm-1; 
LC-MS (ESI) m/z (M+H+) calcd for C24H36NaO2S: 411, found: 411; 
[α]25D = +11° (c = 1.0, CHCl3); 87% ee, from (R,R)-L4. 
 
5.6.4 Assignments of the Absolute Stereochemistry of the Cross-Coupling Products 
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O
O
Me
F3C
OMe
 
 Absolute stereochemistry of product from entry 4 of Table 5.4 (run with 
(R,R)–L4). (S)-1-(4-((8-(4-Methoxyphenyl)-6-(trifluoromethyl)oct-7-yn-1-
yl)oxy)phenyl)ethan-1-one 
 
A suitable crystal of C24H25F3O3 was selected for analysis. All Measurements 
were made on a Bruker APEX-II CCD diffractometer. The crystal was kept at 100.0 K 
during data collection. Using Olex2 [1], the structure was solved with the ShelXS [2] 
structure solution program using Direct Methods and refined with the ShelXL [3] 
refinement package using Least Squares minimisation. The absolute stereochemistry was 
determined on the basis of the absolute structure parameter. 
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 1. O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. 
Puschmann, OLEX2: a complete structure solution, refinement and analysis program. J. 
Appl. Cryst. 2009, 42, 339–341. 
 2. SHELXS, G.M. Sheldrick, Acta Cryst. 2008, A64, 112–122. 
 3. SHELXL, G.M. Sheldrick, Acta Cryst. 2008, A64, 112–122. 
 
Crystal structure determination of p16037_a. 
Crystal Data for C24H25F3O3 (M =418.44 g/mol): monoclinic, space group P21 
(no. 4), a = 5.4627(5) Å, b = 25.165(2) Å, c = 7.6160(8) Å, β = 91.544(5)°, V = 
1046.60(17) Å3, Z = 2, T = 100.0 K, µ(CuKα) = 0.875 mm-1, Dcalc = 1.328 g/cm3, 48849 
reflections measured (7.024° ≤ 2Θ ≤ 145.006°), 4128 unique (Rint = 0.0406, Rsigma = 
0.0169) which were used in all calculations. The final R1 was 0.0348 (I > 2σ(I)) and wR2 
was 0.0979 (all data). 
 
Table 5.6 Crystal Data and Structure Refinement for P16037_a.  
Identification code  p16037_a  
Empirical formula  C24H25F3O3  
Formula weight  418.44  
Temperature/K  100.0  
Crystal system  monoclinic  
Space group  P21  
a/Å  5.4627(5)  
b/Å  25.165(2)  
	 406 
c/Å  7.6160(8)  
α/°  90  
β/°  91.544(5)  
γ/°  90  
Volume/Å3  1046.60(17)  
Z  2  
ρcalcg/cm3  1.328  
µ/mm-1  0.875  
F(000)  440.0  
Crystal size/mm3 0.22 × 0.21 × 0.2 
Radiation  CuKα (λ = 1.54178)  
2Θ range for data collection/°  7.024 to 145.006  
Index ranges  -6 ≤ h ≤ 6, -31 ≤ k ≤ 31, -9 ≤ l ≤ 9  
Reflections collected  48849  
Independent reflections  4128 [Rint = 0.0406, Rsigma = 0.0169]  
Data/restraints/parameters  4128/1/273  
Goodness-of-fit on F2  1.196  
Final R indexes [I>=2σ (I)]  R1 = 0.0348, wR2 = 0.0979  
Final R indexes [all data]  R1 = 0.0349, wR2 = 0.0980  
Largest diff. peak/hole / e Å-3  0.20/-0.30  
Flack parameter 0.079(19) 
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Table 5.7. Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for P16037_a. U(eq) is defined as one third of  the trace of the 
orthogonalized U
ij
 tensor. 
________________________________________________________________________ 
                                 x                            y                         z                       U(eq) 
________________________________________________________________________ 
F001 2859(4) 6964.8(8) 10045(3) 36.1(4) 
F002 5516(4) 7449.0(7) 8783(3) 33.5(4) 
F003 6712(4) 6812.3(7) 10474(2) 34.3(4) 
O004 2064(4) 3449.3(7) 9960(3) 21.3(4) 
O005 8097(3) 5065.6(7) 3903(2) 19.0(4) 
O006 8303(4) 2550.6(8) 4540(3) 29.4(5) 
C007 5013(5) 6951.5(11) 9243(4) 24.3(6) 
C008 647(5) 4260(1) 8485(3) 17.5(5) 
C009 1088(5) 4793.9(11) 8164(3) 18.2(5) 
C00A 5490(5) 3830.9(11) 5364(3) 17.1(5) 
C00B 5862(5) 4365.5(10) 5061(3) 17.1(5) 
C00C 3172(5) 5048.3(10) 8866(3) 17.4(5) 
C00D 4364(4) 4222.8(11) 10276(3) 17.7(5) 
C00E 6825(5) 2870.5(11) 5095(3) 21.3(6) 
C00F 4788(5) 4750.2(11) 9940(3) 18.7(5) 
C00G 7457(5) 6564(1) 6786(4) 21.0(5) 
C00H 4971(5) 6582.5(10) 7674(3) 19.6(5) 
C00I 7146(5) 3450.8(10) 4764(3) 16.4(5) 
C00J 10162(5) 5260.6(11) 2966(4) 21.0(5) 
C00K 9602(4) 4158.9(11) 3561(3) 17.1(5) 
C00L 2290(5) 3971.4(10) 9547(3) 17.2(5) 
C00M 7911(5) 4533.9(11) 4155(3) 15.1(5) 
C00N 4179(5) 6046.5(11) 8193(4) 20.5(5) 
C00O 9791(5) 6206.4(11) 4196(4) 24.4(6) 
C00P 3676(5) 5595.4(11) 8508(3) 19.5(5) 
C00Q 9807(6) 5845.2(11) 2575(4) 24.2(6) 
C00R 9189(5) 3624.6(10) 3865(3) 18.4(5) 
C00S 4684(6) 2690.0(11) 6141(4) 26.6(6) 
C00T -80(5) 3174.4(11) 9336(4) 24.8(6) 
C00U 7357(5) 6223.6(11) 5122(4) 21.5(5) 
________________________________________________________________________
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Table 5.8. Anisotropic Displacement Parameters (Å
2 
x 10
3
) for P16037_a. The 
anisotropic displacement factor exponent takes the form:  -2π
2
[ h
2
 a*
2
U
11
 + ...  + 2 h k a* 
b* U
12
 ] 
________________________________________________________________________ 
    U11 U22  U33 U23 U13 U12 
________________________________________________________________________ 
F001 36.1(10) 34.6(10) 38.1(10) -12.2(8) 8.9(8) 4.8(8) 
F002 43.1(11) 17.2(8) 39.6(10) -5.1(7) -6.6(8) -0.9(7) 
F003 44.0(11) 33.5(9) 24.8(8) -7.8(7) -11.0(8) 8.5(8) 
O004 21.8(10) 19.0(9) 22.9(9) 0.5(7) -3.2(7) -1.6(7) 
O005 18.4(9) 20.3(9) 18.4(8) -0.8(7) 4.5(7) 0.4(7) 
O006 27.5(11) 22.2(10) 38.5(12) -3.6(9) 0.5(9) 5.1(8) 
C007 26.9(15) 23.0(14) 22.8(13) -4.1(11) -2.3(11) 3.4(11) 
C008 16.4(12) 23.2(13) 12.8(11) -2.3(9) -1.2(9) -0.7(10) 
C009 17.2(13) 22.7(13) 14.5(11) -1.2(10) -0.6(9) 1.7(10) 
C00A 13.4(12) 25.1(13) 12.6(11) -2.1(9) -1.5(9) 0.4(10) 
C00B 14.2(12) 24.1(13) 12.9(11) -2.9(9) -0.4(9) 3.5(9) 
C00C 16.9(12) 21.4(13) 14.1(11) -2.2(9) 3.9(9) -0.1(9) 
C00D 12.9(11) 24.8(13) 15.1(11) -1.9(10) -1.5(9) 2.8(10) 
C00E 22.6(14) 22.3(13) 18.6(13) -2.9(10) -6.7(10) 1.4(11) 
C00F 12.4(12) 25.2(13) 18.5(12) -4.1(10) 0.0(9) -0.2(10) 
C00G 22.9(13) 17.2(12) 22.9(13) -0.8(10) -1.8(10) -2.6(10) 
C00H 21.9(13) 17.7(12) 19.1(12) -1.1(10) -2.3(10) 0.1(10) 
C00I 14.6(12) 21.8(13) 12.4(11) -2.4(9) -4.5(9) 1.7(9) 
C00J 18.8(13) 26.3(14) 18.2(12) -0.1(10) 5.1(10) -1.7(10) 
C00K 11.5(11) 25.8(13) 14.0(11) -1.9(10) 0.8(9) 2.7(10) 
C00L 16.9(12) 18.0(12) 16.7(12) -2.1(9) 1.3(10) 0.6(9) 
C00M 13.3(11) 22.0(12) 9.9(10) -2.5(9) -1.8(8) 1.5(9) 
C00N 19.9(13) 21.2(13) 20.3(12) -2.2(10) 0.6(10) -0.1(10) 
C00O 25.5(15) 22.8(13) 25.2(14) -1.0(11) 3.8(11) -5.7(11) 
C00P 17.3(12) 25.5(15) 16.0(12) -2.8(10) 1.8(9) 1(1) 
C00Q 29.1(15) 25.5(13) 18.2(13) 2.6(10) 4.3(11) -2.2(11) 
C00R 15.7(12) 24.8(14) 14.5(11) -3.9(10) -2.7(9) 6.1(10) 
C00S 28.8(15) 21.7(13) 29.4(15) 1.4(11) 0.2(12) -2.7(11) 
C00T 23.3(15) 22.0(14) 28.9(14) -1.0(11) -2.3(11) -5.0(11) 
C00U 23.2(14) 20.0(12) 21.5(13) -0.9(10) 0.9(10) -2.3(10) 
________________________________________________________________________
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Table 5.9. Bond Lengths for P16037_a. 
_____________________________________________________ 
Atom Atom Length/Å 
_____________________________________________________ 
F001 C007 1.341(3) 
F002 C007 1.331(3) 
F003 C007 1.348(3) 
O004 C00L 1.357(3) 
O004 C00T 1.430(3) 
O005 C00J 1.438(3) 
O005 C00M 1.356(3) 
O006 C00E 1.224(4) 
C007 C00H 1.513(3) 
C008 C009 1.388(4) 
C008 C00L 1.396(4) 
C009 C00C 1.400(4) 
C00A C00B 1.381(4) 
C00A C00I 1.402(4) 
C00B C00M 1.397(4) 
C00C C00F 1.404(4) 
C00C C00P 1.432(4) 
C00D C00F 1.372(4) 
C00D C00L 1.400(4) 
C00E C00I 1.493(4) 
C00E C00S 1.503(4) 
C00G C00H 1.534(4) 
C00G C00U 1.529(4) 
C00H C00N 1.474(4) 
C00I C00R 1.396(4) 
C00J C00Q 1.512(4) 
C00K C00M 1.404(3) 
C00K C00R 1.384(4) 
C00N C00P 1.194(4) 
C00O C00Q 1.533(4) 
C00O C00U 1.523(4) 
_____________________________________________________ 
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Table 5.10. Bond Angles for P16037_a. 
_____________________________________________________ 
Atom Atom Atom Angle/˚ 
_____________________________________________________ 
C00L O004 C00T 118.0(2) 
C00M O005 C00J 118.03(19) 
F001 C007 F003 106.6(2) 
F001 C007 C00H 112.4(2) 
F002 C007 F001 106.7(2) 
F002 C007 F003 106.5(2) 
F002 C007 C00H 111.6(2) 
F003 C007 C00H 112.7(2) 
C009 C008 C00L 119.6(2) 
C008 C009 C00C 121.2(2) 
C00B C00A C00I 120.7(2) 
C00A C00B C00M 120.1(2) 
C009 C00C C00F 118.1(2) 
C009 C00C C00P 121.7(2) 
C00F C00C C00P 120.3(2) 
C00F C00D C00L 120.1(2) 
O006 C00E C00I 120.3(3) 
O006 C00E C00S 121.0(3) 
C00I C00E C00S 118.8(2) 
C00D C00F C00C 121.2(2) 
C00U C00G C00H 111.7(2) 
C007 C00H C00G 111.9(2) 
C00N C00H C007 110.4(2) 
C00N C00H C00G 111.1(2) 
C00A C00I C00E 122.2(2) 
C00R C00I C00A 118.6(2) 
C00R C00I C00E 119.2(2) 
O005 C00J C00Q 109.4(2) 
C00R C00K C00M 119.2(2) 
O004 C00L C008 125.2(2) 
O004 C00L C00D 115.0(2) 
C008 C00L C00D 119.7(2) 
O005 C00M C00B 115.7(2) 
O005 C00M C00K 124.4(2) 
C00B C00M C00K 119.9(2) 
C00P C00N C00H 174.3(3) 
C00U C00O C00Q 114.4(2) 
C00N C00P C00C 177.6(3) 
C00J C00Q C00O 114.9(2) 
C00K C00R C00I 121.5(2) 
C00O C00U C00G 112.8(2) 
_____________________________________________________ 
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Table 5.11. Torsion Angles for P16037_a. 
______________________________________________________________  
  A    B    C    D Angle/˚ 
______________________________________________________________ 
F001 C007 C00H C00G -179.1(2) 
F001 C007 C00H C00N -54.8(3) 
F002 C007 C00H C00G 61.2(3) 
F002 C007 C00H C00N -174.6(2) 
F003 C007 C00H C00G -58.6(3) 
F003 C007 C00H C00N 65.6(3) 
O005 C00J C00Q C00O 65.2(3) 
O006 C00E C00I C00A 179.5(2) 
O006 C00E C00I C00R -2.0(4) 
C008 C009 C00C C00F -1.3(4) 
C008 C009 C00C C00P 178.4(2) 
C009 C008 C00L O004 179.9(2) 
C009 C008 C00L C00D -0.1(4) 
C009 C00C C00F C00D 0.9(4) 
C00A C00B C00M O005 179.1(2) 
C00A C00B C00M C00K -0.4(4) 
C00A C00I C00R C00K 0.1(3) 
C00B C00A C00I C00E 178.9(2) 
C00B C00A C00I C00R 0.4(3) 
C00E C00I C00R C00K -178.4(2) 
C00F C00D C00L O004 179.7(2) 
C00F C00D C00L C008 -0.4(4) 
C00H C00G C00U C00O 179.0(2) 
C00I C00A C00B C00M -0.2(4) 
C00J O005 C00M C00B -179.5(2) 
C00J O005 C00M C00K 0.0(3) 
C00L C008 C009 C00C 0.9(4) 
C00L C00D C00F C00C -0.1(4) 
C00M O005 C00J C00Q 170.9(2) 
C00M C00K C00R C00I -0.8(4) 
C00P C00C C00F C00D -178.8(2) 
C00Q C00O C00U C00G 176.9(2) 
C00R C00K C00M O005 -178.6(2) 
C00R C00K C00M C00B 0.9(3) 
C00S C00E C00I C00A -1.4(4) 
C00S C00E C00I C00R 177.1(2) 
C00T O004 C00L C008 -3.2(4) 
C00T O004 C00L C00D 176.8(2) 
C00U C00G C00H C007 -175.7(2) 
C00U C00G C00H C00N 60.4(3) 
C00U C00O C00Q C00J -81.0(3) 
______________________________________________________________ 
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Table 5.12. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement 
Parameters (Å2×103) for P16037_a. 
________________________________________________________________________ 
Atom             x             y           z      U(eq) 
________________________________________________________________________  
H008 -764 4092 7984 21 
H009 -46 4990 7453 22 
H00A 4095 3719 5985 20 
H00B 4722 4619 5470 21 
H00D 5481 4028 11005 21 
H00F 6202 4917 10443 22 
H00C 7961 6930 6481 25 
H00E 8703 6417 7620 25 
H00H 3738 6723 6798 24 
H00G 10319 5061 1854 25 
H00I 11682 5208 3682 25 
H00K 11013 4271 2959 21 
H00J 11076 6083 5043 29 
H00L 10222 6572 3834 29 
H00M 8237 5891 1913 29 
H00N 11134 5964 1806 29 
H00R 10322 3370 3451 22 
H00O 4803 2306 6348 40 
H00P 3157 2769 5487 40 
H00Q 4694 2877 7270 40 
H00S -155 3183 8049 37 
H00T -1539 3347 9794 37 
H00U -15 2805 9737 37 
H00V 6876 5857 5435 26 
H00W 6084 6367 4303 26 
________________________________________________________________________  
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5.6.5 1H NMR Spectra of Selected Compounds 
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